Photo of Prof Gregory Lip

Prof Gregory Lip MD FRCP (London Edinburgh Glasgow) DFM FACC FESC FEHRA

Price-Evans Chair of Cardiovascular Medicine, University of Liverpool, United Kingdom; Distinguished Professor, Aalborg University, Denmark Institute of Ageing and Chronic Disease

Publications

2019

2018 ESC/ESH Guidelines for the management of arterial (Journal article)

Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Nadcisni, E. T. (2019). 2018 ESC/ESH Guidelines for the management of arterial. KARDIOLOGIA POLSKA, 77(2), 71-159. doi:10.5603/KP.2019.0018

DOI: 10.5603/KP.2019.0018

2018 ESC/ESH Guidelines for the management of arterial hypertension (vol 39, pg 3021, 2018) (Journal article)

Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Grp, E. S. C. S. D. (2019). 2018 ESC/ESH Guidelines for the management of arterial hypertension (vol 39, pg 3021, 2018). EUROPEAN HEART JOURNAL, 40(5), 475. doi:10.1093/eurheartj/ehy686

DOI: 10.1093/eurheartj/ehy686

2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) (vol 27, pg 314, 2018) (Journal article)

Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormai, I. (2019). 2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) (vol 27, pg 314, 2018). BLOOD PRESSURE, 28(1), 74. doi:10.1080/08037051.2018.1557365

DOI: 10.1080/08037051.2018.1557365

ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study (Journal article)

Pastori, D., Farcomeni, A., Pignatelli, P., Violi, F., & Lip, G. Y. H. (2019). ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study. AMERICAN JOURNAL OF MEDICINE, 132(7), 856-861. doi:10.1016/j.amjmed.2019.01.003

DOI: 10.1016/j.amjmed.2019.01.003

Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities. (Journal article)

Chao, T. -F., Lip, G. Y. H., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2019). Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.. European heart journal, 40(19), 1504-1514. doi:10.1093/eurheartj/ehy837

DOI: 10.1093/eurheartj/ehy837

Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study (Journal article)

Park, J., Choi, E. -K., Han, K. -D., Choi, Y. -J., Lee, S. -R., Cha, M. -J., . . . Lip, G. Y. H. (2019). Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study. AMERICAN JOURNAL OF CARDIOLOGY, 123(12), 1921-1926. doi:10.1016/j.amjcard.2019.03.024

DOI: 10.1016/j.amjcard.2019.03.024

Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey. (Journal article)

Lane, D. A., Dagres, N., Dan, G. -A., García Seara, J., Iliodromitis, K., Lenarczyk, R., . . . Potpara, T. S. (2019). Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 21(7), 1116-1125. doi:10.1093/europace/euz033

DOI: 10.1093/europace/euz033

Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation? (Journal article)

Khan, A. A., Boriani, G., & Lip, G. Y. H. (2019). Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?. Clinical research in cardiology : official journal of the German Cardiac Society. doi:10.1007/s00392-019-01545-4

DOI: 10.1007/s00392-019-01545-4

Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry. (Journal article)

Gao, Y., Chang, S., Du, X., Dong, J., Xu, X., Zhou, Y., . . . Ma, C. (2019). Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry.. American journal of cardiovascular drugs : drugs, devices, and other interventions. doi:10.1007/s40256-019-00350-8

DOI: 10.1007/s40256-019-00350-8

Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. (Journal article)

Boriani, G., Proietti, M., Laroche, C., Fauchier, L., Marin, F., Nabauer, M., . . . EORP-AF Long-Term General Registry Investigators. (2019). Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 21(7), 1013-1022. doi:10.1093/europace/euz032

DOI: 10.1093/europace/euz032

Association between epicardial adipose tissue and embolic stroke after catheter ablation of atrial fibrillation. (Journal article)

Ahn, J., Shin, S. Y., Shim, J., Kim, Y. -H., Han, S. -J., Choi, E. -K., . . . Lim, H. E. (2019). Association between epicardial adipose tissue and embolic stroke after catheter ablation of atrial fibrillation.. Journal of cardiovascular electrophysiology. doi:10.1111/jce.14154

DOI: 10.1111/jce.14154

Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial (Journal article)

Lee, T. C., Qian, M., Mu, L., Di Tullio, M. R., Graham, S., Mann, D. L., . . . Investigators, W. A. R. C. E. F. (2019). Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial. ESC HEART FAILURE, 6(2), 297-307. doi:10.1002/ehf2.12407

DOI: 10.1002/ehf2.12407

Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial (Journal article)

Kerneis, M., Yee, M. K., Mehran, R., Nafee, T., Bode, C., Halperin, J. L., . . . Gibson, C. M. (2019). Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 12(2). doi:10.1161/CIRCINTERVENTIONS.118.007124

DOI: 10.1161/CIRCINTERVENTIONS.118.007124

Atrial Fibrillation and Cognitive Function JACC Review Topic of the Week (Journal article)

Diener, H. -C., Hart, R. G., Koudstaal, P. J., Lane, D. A., & Lip, G. Y. H. (2019). Atrial Fibrillation and Cognitive Function JACC Review Topic of the Week. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(5), 612-619. doi:10.1016/j.jacc.2018.10.077

DOI: 10.1016/j.jacc.2018.10.077

Atrial Fibrillation and End-Stage COPD A Close Association Revisited (Journal article)

Shin, S. Y., Manuel, A. R. G., & Lip, G. Y. H. (2019). Atrial Fibrillation and End-Stage COPD A Close Association Revisited. CHEST, 155(5), 888-889. doi:10.1016/j.chest.2019.01.027

DOI: 10.1016/j.chest.2019.01.027

Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes (Journal article)

Miyazawa, K., Pastori, D., Li, Y. -G., Szekely, O., Shahid, F., Boriani, G., & Lip, G. Y. H. (2019). Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes. CLINICAL RESEARCH IN CARDIOLOGY, 108(9), 1034-1041. doi:10.1007/s00392-019-01432-y

DOI: 10.1007/s00392-019-01432-y

Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices. (Journal article)

Pastori, D., Miyazawa, K., Li, Y., Székely, O., Shahid, F., Farcomeni, A., & Lip, G. Y. H. (2019). Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices.. Clinical research in cardiology : official journal of the German Cardiac Society. doi:10.1007/s00392-019-01493-z

DOI: 10.1007/s00392-019-01493-z

Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: The West Birmingham Atrial Fibrillation Project (Journal article)

Li, Y. -G., Miyazawa, K., Pastori, D., Szekely, O., Shahid, F., & Lip, G. Y. H. (2019). Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: The West Birmingham Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 292, 126-130. doi:10.1016/j.ijcard.2019.04.055

DOI: 10.1016/j.ijcard.2019.04.055

Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study (Journal article)

Lim, Y. -M., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2019). Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study. MAYO CLINIC PROCEEDINGS, 94(2), 225-235. doi:10.1016/j.mayocp.2018.10.019

DOI: 10.1016/j.mayocp.2018.10.019

C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study. (Journal article)

Li, Y. -G., Bisson, A., Bodin, A., Herbert, J., Grammatico-Guillon, L., Joung, B., . . . Fauchier, L. (2019). C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study.. Journal of the American Heart Association, 8(13), e012546. doi:10.1161/jaha.119.012546

DOI: 10.1161/jaha.119.012546

COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS (Conference Paper)

Lip, G. Y. H., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Deitelzweig, S. (2019). COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 320). doi:10.1016/S0735-1097(19)30928-3

DOI: 10.1016/S0735-1097(19)30928-3

Cancer and atrial fibrillation. Author's reply (Journal article)

Malavasi, V. L., Marietta, M., Lip, G. Y. H., & Boriani, G. (2019). Cancer and atrial fibrillation. Author's reply. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 62, E24-E25. doi:10.1016/j.ejim.2019.01.002

DOI: 10.1016/j.ejim.2019.01.002

CaseReport: Aldosterone-secreting adrenal carcinoma complicating longstanding hypertension. (Journal article)

Shantsila, A., Lip, G. Y. H., & Beevers, D. G. (2019). CaseReport: Aldosterone-secreting adrenal carcinoma complicating longstanding hypertension.. Journal of human hypertension. doi:10.1038/s41371-019-0209-8

DOI: 10.1038/s41371-019-0209-8

Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies (Journal article)

Wilson, D., Ambler, G., Lee, K. -J., Lim, J. -S., Shiozawa, M., Koga, M., . . . Net, M. I. C. (2019). Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies. LANCET NEUROLOGY, 18(7), 653-665. doi:10.1016/S1474-4422(19)30197-8

DOI: 10.1016/S1474-4422(19)30197-8

Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association (Journal article)

Temporelli, P. L., Tilz, R. R., Arbelo, E., Dagres, N., Laroche, C., Crijns, H. J., . . . Tavazzi, L. (2019). Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association. EUROPEAN JOURNAL OF HEART FAILURE, 21(5), 690-+. doi:10.1002/ejhf.1458

DOI: 10.1002/ejhf.1458

Clinical factors and imaging leading to risk of incident atrial fibrillation. (Journal article)

Shantsila, A., Oxborough, D., Fairbairn, T. A., & Lip, G. Y. H. (2019). Clinical factors and imaging leading to risk of incident atrial fibrillation.. European Heart Journal Cardiovascular Imaging, 20(9), 988-989. doi:10.1093/ehjci/jez199

DOI: 10.1093/ehjci/jez199

Community screening for atrial fibrillation in the era of smart devices (Journal article)

Shin, S. Y., & Lip, G. Y. H. (2019). Community screening for atrial fibrillation in the era of smart devices. INTERNATIONAL JOURNAL OF CARDIOLOGY, 280, 95-96. doi:10.1016/j.ijcard.2019.01.001

DOI: 10.1016/j.ijcard.2019.01.001

Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation (Journal article)

Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2019). Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-43224-4

DOI: 10.1038/s41598-019-43224-4

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients (Journal article)

Deitelzweig, S., Keshishian, A., Li, X., Kang, A., Dhamane, A. D., Luo, X., . . . Lip, G. Y. H. (2019). Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 67(8), 1662-1671. doi:10.1111/jgs.15956

DOI: 10.1111/jgs.15956

Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding (Journal article)

Koziel, M., Ding, W. Y., Kalarus, Z., & Lip, G. Y. H. (2019). Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding. EXPERT REVIEW OF HEMATOLOGY. doi:10.1080/17474086.2019.1647779

DOI: 10.1080/17474086.2019.1647779

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry (Journal article)

Liang, H. -F., Du, X., Zhou, Y. -C., Yang, X. -Y., Xia, S. -J., Dong, J. -Z., . . . Ma, C. -S. (2019). Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry. MEDICAL SCIENCE MONITOR, 25, 4691-4698. doi:10.12659/MSM.917131

DOI: 10.12659/MSM.917131

Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme (Journal article)

Proietti, M., Farcomeni, A., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Week, B. H. R. (2019). Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 26(9), 964-972. doi:10.1177/2047487319839184

DOI: 10.1177/2047487319839184

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial. (Journal article)

Oldgren, J., Steg, P. G., Hohnloser, S. H., Lip, G. Y. H., Kimura, T., Nordaby, M., . . . Cannon, C. P. (2019). Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.. European heart journal, 40(19), 1553-1562. doi:10.1093/eurheartj/ehz059

DOI: 10.1093/eurheartj/ehz059

Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation. (Journal article)

Chua, W., Purmah, Y., Cardoso, V. R., Gkoutos, G. V., Tull, S. P., Neculau, G., . . . Fabritz, L. (2019). Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation.. European heart journal, 40(16), 1268-1276. doi:10.1093/eurheartj/ehy815

DOI: 10.1093/eurheartj/ehy815

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease (Journal article)

Lee, S. -R., Lee, H. -J., Choi, E. -K., Han, K. -D., Jung, J. -H., Cha, M. -J., . . . Lip, G. Y. H. (2019). Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(25), 3295-3308. doi:10.1016/j.jacc.2019.04.052

DOI: 10.1016/j.jacc.2019.04.052

Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight (Journal article)

Lee, S. -R., Choi, E. -K., Park, C. S., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2019). Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(8), 919-931. doi:10.1016/j.jacc.2018.11.051

DOI: 10.1016/j.jacc.2018.11.051

EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS (Conference Paper)

Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Lip, G. Y. H. (2019). EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 435). doi:10.1016/S0735-1097(19)31043-5

DOI: 10.1016/S0735-1097(19)31043-5

EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS COMPARED TO WARFARIN AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS (Conference Paper)

Lip, G. Y. H., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Deitelzweig, S. (2019). EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS COMPARED TO WARFARIN AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 432). doi:10.1016/S0735-1097(19)31040-X

DOI: 10.1016/S0735-1097(19)31040-X

EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS (Conference Paper)

Deitelzweig, S., Keshishian, A., Kang, A., Dhamane, A., Luo, X., Li, X., . . . Lip, G. Y. H. (2019). EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 434). doi:10.1016/S0735-1097(19)31042-3

DOI: 10.1016/S0735-1097(19)31042-3

EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. (Journal article)

Goette, A., Auricchio, A., Boriani, G., Braunschweig, F., Terradellas, J. B., Burri, H., . . . ESC Scientific Document Group. (2019). EHRA White Paper: knowledge gaps in arrhythmia management-status 2019.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 21(7), 993-994. doi:10.1093/europace/euz055

DOI: 10.1093/europace/euz055

ESC/ESH 2018 Guide on the diagnosis and treatment of arterial hypertension (Journal article)

Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2019). ESC/ESH 2018 Guide on the diagnosis and treatment of arterial hypertension. REVISTA ESPANOLA DE CARDIOLOGIA, 72(2). doi:10.1016/j.recesp.2018.12.005

DOI: 10.1016/j.recesp.2018.12.005

Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population (Journal article)

Kim, T. -H., Yang, P. -S., Yu, H. T., Jang, E., Shin, H., Kim, H. Y., . . . Lip, G. Y. H. (2019). Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population. EUROPEAN HEART JOURNAL, 40(10), 809-819. doi:10.1093/eurheartj/ehy877

DOI: 10.1093/eurheartj/ehy877

Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation (Journal article)

Lee, S. -R., Choi, E. -K., Kwon, S., Han, K. -D., Jung, J. -H., Cha, M. -J., . . . Lip, G. Y. H. (2019). Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation. STROKE, 50(8), 2245-2249. doi:10.1161/STROKEAHA.119.025536

DOI: 10.1161/STROKEAHA.119.025536

Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation (Journal article)

Chan, Y. -H., Lee, H. -F., See, L. -C., Tu, H. -T., Chao, T. -F., Yeh, Y. -H., . . . Lip, G. Y. H. (2019). Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation. CHEST, 156(3), 529-543. doi:10.1016/j.chest.2019.04.108

DOI: 10.1016/j.chest.2019.04.108

Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis (Journal article)

Petryszyn, P., Niewinski, P., Staniak, A., Piotrowski, P., Well, A., Well, M., . . . Ponikowski, P. (2019). Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis. PLOS ONE, 14(3). doi:10.1371/journal.pone.0213198

DOI: 10.1371/journal.pone.0213198

Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism (Journal article)

Zeng, J., Zhang, X., Lip, G. Y. H., Shu, X., Thabane, L., Tian, J., & Li, G. (2019). Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 25. doi:10.1177/1076029619853629

DOI: 10.1177/1076029619853629

Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals. (Journal article)

Lowres, N., Olivier, J., Chao, T. -F., Chen, S. -A., Chen, Y., Diederichsen, A., . . . Freedman, B. (2019). Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals.. PLoS medicine, 16(9), e1002903. doi:10.1371/journal.pmed.1002903

DOI: 10.1371/journal.pmed.1002903

Etiological Research Using Observational Data, and Net Clinical Benefit. Simplicity and Practicality Matter (Journal article)

Nielsen, P. B., Buchan, I., & Lip, G. Y. H. (2019). Etiological Research Using Observational Data, and Net Clinical Benefit. Simplicity and Practicality Matter. AMERICAN JOURNAL OF MEDICINE, 132(6), 671-672. doi:10.1016/j.amjmed.2019.01.038

DOI: 10.1016/j.amjmed.2019.01.038

Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation (Journal article)

Szekely, O., Borgi, M., & Lip, G. Y. H. (2019). Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation. EXPERT OPINION ON EMERGING DRUGS, 24(1), 55-61. doi:10.1080/14728214.2019.1591368

DOI: 10.1080/14728214.2019.1591368

Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study (Journal article)

Jung, H., Yang, P. -S., Sung, J. -H., Jang, E., Yu, H. T., Kim, T. -H., . . . Joung, B. (2019). Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study. THROMBOSIS AND HAEMOSTASIS, 119(2), 285-293. doi:10.1055/s-0038-1676818

DOI: 10.1055/s-0038-1676818

Impaired Cerebrovascular Reactivity in Patients With Atrial Fibrillation (Journal article)

Junejo, R. T., Braz, I. D., Lucas, S. J. E., van Lieshout, J. J., Lip, G. Y. H., & Fisher, J. P. (2019). Impaired Cerebrovascular Reactivity in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(10), 1230-1232. doi:10.1016/j.jacc.2019.01.009

DOI: 10.1016/j.jacc.2019.01.009

Importance of Risk Reassessment in Patients With Atrial Fibrillation in Guidelines: Assessing Risk as a Dynamic Process (Journal article)

Chang, T. -Y., Lip, G. Y. H., Chen, S. -A., & Chao, T. -F. (2019). Importance of Risk Reassessment in Patients With Atrial Fibrillation in Guidelines: Assessing Risk as a Dynamic Process. CANADIAN JOURNAL OF CARDIOLOGY, 35(5), 611-618. doi:10.1016/j.cjca.2019.01.018

DOI: 10.1016/j.cjca.2019.01.018

Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study. (Journal article)

Yoon, M., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2019). Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study.. Thrombosis and haemostasis. doi:10.1055/s-0039-1693516

DOI: 10.1055/s-0039-1693516

Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA(2)DS(2)-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially 'Low-Risk' Patients (Journal article)

Chao, T. -F., Liao, J. -N., Tuan, T. -C., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2019). Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA(2)DS(2)-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially 'Low-Risk' Patients. THROMBOSIS AND HAEMOSTASIS, 119(7), 1162-1170. doi:10.1055/s-0039-1683933

DOI: 10.1055/s-0039-1683933

Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial" (Journal article)

Guo, Y., Lip, G. Y. H., & Potpara, T. (2019). Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial". CIRCULATION, 139(24), E1037-E1038. doi:10.1161/CIRCULATIONAHA.118.038961

DOI: 10.1161/CIRCULATIONAHA.118.038961

Long-Term Impact of Newly Diagnosed Atrial Fibrillation During Critical Care A South Korean Nationwide Cohort Study (Journal article)

Kim, K., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -N., Uhm, J. -S., . . . Joung, B. (2019). Long-Term Impact of Newly Diagnosed Atrial Fibrillation During Critical Care A South Korean Nationwide Cohort Study. CHEST, 156(3), 518-528. doi:10.1016/j.chest.2019.04.011

DOI: 10.1016/j.chest.2019.04.011

Long-Term Persistence with Newly-Initiated Warfarin or Non-VKA Oral Anticoagulant (NOAC) in Patients with Non-Valvular Atrial Fibrillation: Insights from the Prospective China-AF Registry (Journal article)

Liu, C., Du, X., Jiang, C., He, L., Chang, S. -S., Guo, X. -Y., . . . Ma, C. -S. (2019). Long-Term Persistence with Newly-Initiated Warfarin or Non-VKA Oral Anticoagulant (NOAC) in Patients with Non-Valvular Atrial Fibrillation: Insights from the Prospective China-AF Registry. MEDICAL SCIENCE MONITOR, 25, 2649-2657. doi:10.12659/MSM.915875

DOI: 10.12659/MSM.915875

Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation (Journal article)

Cheng, W. -H., Chao, T. -F., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2019). Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation. STROKE, 50(9), 2574-2577. doi:10.1161/STROKEAHA.119.025623

DOI: 10.1161/STROKEAHA.119.025623

Malignant hypertension: not quite an obsolete diagnosis yet (Journal article)

Shantsila, A., & Lip, G. Y. H. (2019). Malignant hypertension: not quite an obsolete diagnosis yet. JOURNAL OF HYPERTENSION, 37(2), 282-283. doi:10.1097/HJH.0000000000001974

DOI: 10.1097/HJH.0000000000001974

Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS). (Journal article)

Arnar, D. O., Mairesse, G. H., Boriani, G., Calkins, H., Chin, A., Coats, A., . . . EHRA Scientific Documents Committee. (2019). Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS).. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. doi:10.1093/europace/euz046

DOI: 10.1093/europace/euz046

Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation. (Journal article)

Lee, S. -R., Rhee, T. -M., Kang, D. -Y., Choi, E. -K., Oh, S., & Lip, G. Y. H. (2019). Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation.. The American journal of cardiology, 124(6), 879-885. doi:10.1016/j.amjcard.2019.05.072

DOI: 10.1016/j.amjcard.2019.05.072

Microparticles and cardiovascular diseases (Journal article)

Voukalis, C., Shantsila, E., & Lip, G. Y. H. (2019). Microparticles and cardiovascular diseases. ANNALS OF MEDICINE. doi:10.1080/07853890.2019.1609076

DOI: 10.1080/07853890.2019.1609076

Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial (Journal article)

Guo, Y., Lane, D. A., Wang, L., Chen, Y., Lip, G. Y. H., Wang, L., . . . investigators, M. -A. I. I. T. (2019). Mobile Health (mHealth) technology for improved screening, patient involvement and optimising integrated care in atrial fibrillation: The mAFA (mAF-App) II randomised trial. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 73(7). doi:10.1111/ijcp.13352

DOI: 10.1111/ijcp.13352

Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices: The HUAWEI Heart study. (Journal article)

Guo, Y., Wang, H., Zhang, H., Liu, T., Liang, Z., Xia, Y., . . . MAFA II investigators. (2019). Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices: The HUAWEI Heart study.. Journal of the American College of Cardiology. doi:10.1016/j.jacc.2019.08.019

DOI: 10.1016/j.jacc.2019.08.019

Mon2 predicts poor outcome in ST-elevation myocardial infarction (Journal article)

Shantsila, E., Ghattas, A., Griffiths, H. R., & Lip, G. Y. H. (2019). Mon2 predicts poor outcome in ST-elevation myocardial infarction. JOURNAL OF INTERNAL MEDICINE, 285(3), 301-316. doi:10.1111/joim.12847

DOI: 10.1111/joim.12847

Neurovascular coupling and cerebral autoregulation in atrial fibrillation (Journal article)

Junejo, R. T., Braz, I. D., Lucas, S. J. E., van Lieshout, J. J., Phillips, A. A., Lip, G. Y. H., & Fisher, J. P. (2019). Neurovascular coupling and cerebral autoregulation in atrial fibrillation. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. doi:10.1177/0271678X19870770

DOI: 10.1177/0271678X19870770

Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage (Journal article)

Nielsen, P. B., Skjoth, F., Sogaard, M., Kjaeldgaard, J. N., Lip, G. Y. H., & Larsen, T. B. (2019). Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage. STROKE, 50(4), 939-946. doi:10.1161/STROKEAHA.118.023797

DOI: 10.1161/STROKEAHA.118.023797

Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function (Journal article)

Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Cha, M. -J., Oh, S., & Lip, G. Y. H. (2019). Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function. STROKE, 50(6), 1480-1489. doi:10.1161/STROKEAHA.118.024264

DOI: 10.1161/STROKEAHA.118.024264

Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF? (Journal article)

Khan, A. A., & Lip, G. Y. H. (2019). Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?. European heart journal. doi:10.1093/eurheartj/ehz005

DOI: 10.1093/eurheartj/ehz005

Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function. (Journal article)

Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2019). Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function.. Stroke, 50(5), 1140-1148. doi:10.1161/strokeaha.118.024210

DOI: 10.1161/strokeaha.118.024210

Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study. (Journal article)

Bonde, A. N., Blanche, P., Staerk, L., Gerds, T. A., Gundlund, A., Gislason, G., . . . Olesen, J. B. (2019). Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study.. European Heart Journal. doi:10.1093/eurheartj/ehz155

DOI: 10.1093/eurheartj/ehz155

Physician Estimation of Thrombotic and Bleeding Risks in Atrial Fibrillation: Let's Talk About Sex (Journal article)

Ding, W. Y., Gupta, D., & Lip, G. Y. H. (2019). Physician Estimation of Thrombotic and Bleeding Risks in Atrial Fibrillation: Let's Talk About Sex. CANADIAN JOURNAL OF CARDIOLOGY, 35(2), 145-146. doi:10.1016/j.cjca.2018.12.011

DOI: 10.1016/j.cjca.2018.12.011

Predicting stroke in patients without atrial fibrillation (Journal article)

Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Madsen, M., Jensen, S. E., . . . Maeng, M. (2019). Predicting stroke in patients without atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 49(6). doi:10.1111/eci.13103

DOI: 10.1111/eci.13103

Prothrombin Complex Concentrate or Coagulation Factor Xa (Recombinant), Inactivated-zhzo Response (Journal article)

Lip, G. Y. H., Ruff, C. T., Moores, L., & Panel, . C. H. E. S. T. G. E. (2019). Prothrombin Complex Concentrate or Coagulation Factor Xa (Recombinant), Inactivated-zhzo Response. CHEST, 155(6), 1309. doi:10.1016/j.chest.2019.03.001

DOI: 10.1016/j.chest.2019.03.001

Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction (Journal article)

Shah, N., Qian, M., Di Tullio, M. R., Graham, S., Mann, D. L., Sacco, R. L., . . . Investigators, W. A. R. C. E. F. (2019). Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 49(6). doi:10.1111/eci.13092

DOI: 10.1111/eci.13092

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review (Journal article)

Deitelzweig, S., & Lip, G. Y. H. (2019). Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 19(3), 243-244. doi:10.1080/14737167.2019.1592834

DOI: 10.1080/14737167.2019.1592834

Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation (Journal article)

Chao, T. -F., Chiang, C. -E., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2019). Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation. ANNALS OF INTERNAL MEDICINE, 170(9), 663-+. doi:10.7326/M18-1177

DOI: 10.7326/M18-1177

Recommendations on stroke prevention for patients having a CHA(2)DS(2)-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines (Journal article)

Chao, T. -F., Chen, S. -A., & Lip, G. Y. H. (2019). Recommendations on stroke prevention for patients having a CHA(2)DS(2)-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines. TRENDS IN CARDIOVASCULAR MEDICINE, 29(7), 427-428. doi:10.1016/j.tcm.2019.02.008

DOI: 10.1016/j.tcm.2019.02.008

Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial (Journal article)

Lip, G. Y. H., Mauri, L., Montalescot, G., Ozkor, M., Vardas, P., Steg, P. G., . . . Cannon, C. P. (2019). Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial. AMERICAN HEART JOURNAL, 212, 13-22. doi:10.1016/j.ahj.2019.02.006

DOI: 10.1016/j.ahj.2019.02.006

Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry (Journal article)

Deng, H., Shantsila, A., Xue, Y., Bai, Y., Guo, P., Potpara, T. S., . . . Lip, G. Y. H. (2019). Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry. ARCHIVES OF CARDIOVASCULAR DISEASES, 112(6-7), 420-429. doi:10.1016/j.acvd.2019.02.006

DOI: 10.1016/j.acvd.2019.02.006

Response by Chao et al to Letter Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study" (Journal article)

Chao, T. -F., Lip, G. Y. H., & Chen, S. -A. (2019). Response by Chao et al to Letter Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study". CIRCULATION, 139(1), 146-147. doi:10.1161/CIRCULATIONAHA.118.037670

DOI: 10.1161/CIRCULATIONAHA.118.037670

Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort. (Journal article)

Kim, D., Yang, P. -S., Yu, H. T., Kim, T. -H., Jang, E., Sung, J. -H., . . . Joung, B. (2019). Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort.. European Heart Journal, 40(28), 2313-2323. doi:10.1093/eurheartj/ehz386

DOI: 10.1093/eurheartj/ehz386

Safety of direct oral anticoagulants in real-world clinical practice: translating the trials to everyday clinical management (Journal article)

Fawzy, A. M., Yang, W. -Y., & Lip, G. Y. H. (2019). Safety of direct oral anticoagulants in real-world clinical practice: translating the trials to everyday clinical management. EXPERT OPINION ON DRUG SAFETY, 18(3), 187-209. doi:10.1080/14740338.2019.1578344

DOI: 10.1080/14740338.2019.1578344

Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis (Journal article)

Limeres, J., Lip, G. Y. H., Garcia del Blanco, B., Ferreira-Gonzalez, I., Mutuberria, M., Alfonso, F., . . . Sambola, A. (2019). Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis. THROMBOSIS RESEARCH, 177, 180-186. doi:10.1016/j.thromres.2019.02.021

DOI: 10.1016/j.thromres.2019.02.021

Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry (Journal article)

Deng, H., Shantsila, A., Guo, P., Potpara, T. S., Zhan, X., Fang, X., . . . Lip, G. Y. H. (2019). Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry. ARCHIVES OF CARDIOVASCULAR DISEASES, 112(3), 171-179. doi:10.1016/j.acvd.2018.10.006

DOI: 10.1016/j.acvd.2018.10.006

Short-Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity? (Journal article)

Ding, W. Y., Khan, A. A., Gupta, D., & Lip, G. Y. H. (2019). Short-Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 8(3). doi:10.1161/JAHA.119.011953

DOI: 10.1161/JAHA.119.011953

Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation Is Body Weight an Important Consideration? (Journal article)

Lip, G. Y. H., Khan, A. A., & Olshansky, B. (2019). Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation Is Body Weight an Important Consideration?. CIRCULATION, 139(20), 2301-2303. doi:10.1161/CIRCULATIONAHA.119.040021

DOI: 10.1161/CIRCULATIONAHA.119.040021

Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines (Journal article)

Proietti, M., Lane, D. A., Boriani, G., & Lip, G. Y. H. (2019). Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines. CANADIAN JOURNAL OF CARDIOLOGY, 35(5), 619-633. doi:10.1016/j.cjca.2019.02.009

DOI: 10.1016/j.cjca.2019.02.009

Tackling anti-coagulation under-prescription in the elderly (Journal article)

Fawzy, A. M., Chao, T. -F., & Lip, G. Y. H. (2019). Tackling anti-coagulation under-prescription in the elderly. AGING-US, 11(4), 1070-1072. doi:10.18632/aging.101809

DOI: 10.18632/aging.101809

Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study (Journal article)

Park, J., Choi, E. -K., Han, K. -D., Choi, Y. -J., Lee, E., Choe, W., . . . Lip, G. Y. H. (2019). Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study. PLOS ONE, 14(1). doi:10.1371/journal.pone.0209593

DOI: 10.1371/journal.pone.0209593

The CHA(2)DS(2)-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history (Retraction of Vol 36, Pg 2880, 2015) (Journal article)

Lip, G. Y. H. (2019). The CHA(2)DS(2)-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history (Retraction of Vol 36, Pg 2880, 2015). EUROPEAN HEART JOURNAL, 40(7). Retrieved from http://gateway.webofknowledge.com/

The Liverpool Centre for Cardiovascular Science: The Centre was established to advance cardiovascular and stroke research and innovation locally, nationally and internationally (Journal article)

Lip, G. Y. H., & Lane, D. A. (2019). The Liverpool Centre for Cardiovascular Science: The Centre was established to advance cardiovascular and stroke research and innovation locally, nationally and internationally. EUROPEAN HEART JOURNAL, 40(12), 957-958. doi:10.1093/eurheartj/ehz107

DOI: 10.1093/eurheartj/ehz107

The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations (Journal article)

De Caterina, R., Ageno, W., Agnelli, G., Chan, N. C., Diener, H. -C., Hylek, E., . . . Weitz, J. I. (2019). The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations. THROMBOSIS AND HAEMOSTASIS, 119(1), 14-38. doi:10.1055/s-0038-1675816

DOI: 10.1055/s-0038-1675816

The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal. (Journal article)

Esteve-Pastor, M. A., Roldán, V., Rivera-Caravaca, J. M., Ramírez-Macías, I., Lip, G. Y. H., & Marín, F. (2019). The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal.. Thrombosis and haemostasis. doi:10.1055/s-0039-1696955

DOI: 10.1055/s-0039-1696955

The Use of Rivaroxaban in Patients With Atrial Fibrillation Receiving Hemodialysis-Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report Response (Journal article)

Lip, G. Y. H., Ruff, C. T., Moores, L., & Panel, . C. H. E. S. T. G. E. (2019). The Use of Rivaroxaban in Patients With Atrial Fibrillation Receiving Hemodialysis-Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report Response. CHEST, 155(6), 1307. doi:10.1016/j.chest.2019.02.329

DOI: 10.1016/j.chest.2019.02.329

Thrombosis and Haemostasis 2018 Editor's Choice Papers (Journal article)

Weber, C., & Lip, G. Y. H. (2019). Thrombosis and Haemostasis 2018 Editor's Choice Papers. THROMBOSIS AND HAEMOSTASIS, 119(1), 183-186. doi:10.1055/s-0038-1676653

DOI: 10.1055/s-0038-1676653

Thrombosis and Haemostasis Wishes You a Happy New Year Ahead! (Journal article)

Lip, G. Y. H., & Weber, C. (2019). Thrombosis and Haemostasis Wishes You a Happy New Year Ahead!. THROMBOSIS AND HAEMOSTASIS, 119(1), 1-2. doi:10.1055/s-0038-1676651

DOI: 10.1055/s-0038-1676651

Triple or dual antithrombotic therapy post-percutaneous coronary intervention: Which one is better? (Journal article)

Ding, W. Y., Potpara, T. S., Stables, R. H., & Lip, G. Y. H. (2019). Triple or dual antithrombotic therapy post-percutaneous coronary intervention: Which one is better?. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. doi:10.1111/jce.14130

DOI: 10.1111/jce.14130

USING THE CHA2DS2-VASC SCORE TO PREDICT ISCHEMIC STROKE IN PATIENTS WITH INTRACEREBRAL HEMORRHAGE: A NATIONWIDE COHORT STUDY (Conference Paper)

Nielsen, P. B., Overvad, T. F., Skjoth, F., Andersen, S. D., Sogaard, M., Larsen, T. B., & Lip, G. Y. H. (2019). USING THE CHA2DS2-VASC SCORE TO PREDICT ISCHEMIC STROKE IN PATIENTS WITH INTRACEREBRAL HEMORRHAGE: A NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 503). doi:10.1016/S0735-1097(19)31111-8

DOI: 10.1016/S0735-1097(19)31111-8

Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response (Journal article)

Mahmood, M., & Lip, G. Y. H. (2019). Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response. REVISTA ESPANOLA DE CARDIOLOGIA, 72(1), 97-98. doi:10.1016/j.recesp.2018.07.023

DOI: 10.1016/j.recesp.2018.07.023

Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation. (Journal article)

Malavasi, V. L., Proietti, M., Spagni, S., Valenti, A. C., Battista, A., Pettorelli, D., . . . Boriani, G. (2019). Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation.. The American journal of cardiology. doi:10.1016/j.amjcard.2019.08.008

DOI: 10.1016/j.amjcard.2019.08.008

Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke: Balancing Simplicity and Practicality (Journal article)

Koziel, M., Potpara, T. S., & Lip, G. Y. H. (2019). Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke: Balancing Simplicity and Practicality. STROKE, 50(8), 1956-1957. doi:10.1161/STROKEAHA.119.026185

DOI: 10.1161/STROKEAHA.119.026185

VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER CIRRHOSIS: FINDINGS FROM THE RIETE REGISTRY (Conference Paper)

Bikdeli, B., Jimenez, D., Garcia-Tsao, G., Barba, R., Font, C., Diaz-Pedroche, M. D. C., . . . Monreal, M. (2019). VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER CIRRHOSIS: FINDINGS FROM THE RIETE REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 2043). doi:10.1016/S0735-1097(19)32649-X

DOI: 10.1016/S0735-1097(19)32649-X

Venous thromboembolism prophylaxis strategies for patients undergoing elective total knee replacement. (Journal article)

Kozieł, M., & Lip, G. Y. H. (2019). Venous thromboembolism prophylaxis strategies for patients undergoing elective total knee replacement.. The Lancet. Haematology. doi:10.1016/s2352-3026(19)30164-4

DOI: 10.1016/s2352-3026(19)30164-4

Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials. (Journal article)

Fogacci, S., Fogacci, F., Banach, M., Michos, E. D., Hernandez, A. V., Lip, G. Y. H., . . . Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. (2019). Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials.. Clinical nutrition (Edinburgh, Scotland). doi:10.1016/j.clnu.2019.08.015

DOI: 10.1016/j.clnu.2019.08.015

WORLDWIDE ORAL ANTICOAGULANT PRESCRIPTION PREVALENCE AND TRENDS IN PATIENTS WITH ATRIAL FIBRILLATION FROM A MULTI-NATIONAL COHORT: INSIGHTS FROM THE INTERNATIONAL COLLABORATIVE PARTNERSHIP FOR THE STUDY OF ATRIAL FIBRILLATION (INTERAF) COLLABORATIVE (Conference Paper)

Hsu, J. C., Akao, M., Avezum Junior, A., Bloomfield, G., Kohsaka, S., Lane, D., . . . Maddox, T. (2019). WORLDWIDE ORAL ANTICOAGULANT PRESCRIPTION PREVALENCE AND TRENDS IN PATIENTS WITH ATRIAL FIBRILLATION FROM A MULTI-NATIONAL COHORT: INSIGHTS FROM THE INTERNATIONAL COLLABORATIVE PARTNERSHIP FOR THE STUDY OF ATRIAL FIBRILLATION (INTERAF) COLLABORATIVE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 376). doi:10.1016/S0735-1097(19)30984-2

DOI: 10.1016/S0735-1097(19)30984-2

beta-Blocker Use in Pregnancy and the Risk for Congenital Malformations (Journal article)

Shantsila, A., Beevers, D. G., & Lip, G. Y. H. (2019). beta-Blocker Use in Pregnancy and the Risk for Congenital Malformations. ANNALS OF INTERNAL MEDICINE, 170(12), 909. doi:10.7326/L19-0156

DOI: 10.7326/L19-0156

2018

10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population (Journal article)

Kim, D., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2018). 10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population. AMERICAN HEART JOURNAL, 202, 20-26. doi:10.1016/j.ahj.2018.04.017

DOI: 10.1016/j.ahj.2018.04.017

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) (Journal article)

Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., . . . Cardiology, E. S. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). EUROPEAN HEART JOURNAL, 39(2), 119-177. doi:10.1093/eurheartj/ehx393

DOI: 10.1093/eurheartj/ehx393

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS (Journal article)

Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., . . . Surg, E. A. C. -T. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. EUROPEAN HEART JOURNAL, 39(3), 213-+. doi:10.1093/eurheartj/ehx419

DOI: 10.1093/eurheartj/ehx419

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS) (Journal article)

Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., . . . Aboyans, V. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 53(1), 34-78. doi:10.1093/ejcts/ezx334

DOI: 10.1093/ejcts/ezx334

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. (Journal article)

Calkins, H., Hindricks, G., Cappato, R., Kim, Y. -H., Saad, E. B., Aguinaga, L., . . . Document Reviewers:. (2018). 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 20(1), e1-e160. doi:10.1093/europace/eux274

DOI: 10.1093/europace/eux274

2018 ESC/ESH Guidelines for the management of arterial hypertension (Journal article)

Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . ESH, E. S. H. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. EUROPEAN HEART JOURNAL, 39(33), 3021-+. doi:10.1093/eurheartj/ehy339

DOI: 10.1093/eurheartj/ehy339

2018 ESC/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension (Journal article)

Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Hypertension, E. S. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. JOURNAL OF HYPERTENSION, 36(10), 1953-2041. doi:10.1097/HJH.0000000000001940

DOI: 10.1097/HJH.0000000000001940

2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) (Journal article)

Lip, G. Y. H., Collet, J. -P., Haude, M., Byrne, R., Chung, E. H., Fauchier, L., . . . Grp, E. S. C. S. D. (2019). 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). EUROPACE, 21(2), 192-+. doi:10.1093/europace/euy174

DOI: 10.1093/europace/euy174

2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology andthe European Society of Hypertension ESC/ESH Task Force for the Management of Arterial Hypertension (Journal article)

Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Art, E. S. C. E. S. H. T. F. M. (2018). 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology andthe European Society of Hypertension ESC/ESH Task Force for the Management of Arterial Hypertension. JOURNAL OF HYPERTENSION, 36(12), 2284-2309. doi:10.1097/HJH.0000000000001961

DOI: 10.1097/HJH.0000000000001961

A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials (Journal article)

Miguel Rivera-Caravaca, J., Asuncion Esteve-Pastor, M., Marin, F., Valdes, M., Vicente, V., Roldan, V., & Lip, G. Y. H. (2018). A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials. MAYO CLINIC PROCEEDINGS, 93(8), 1065-1073. doi:10.1016/j.mayocp.2018.01.028

DOI: 10.1016/j.mayocp.2018.01.028

A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects (Journal article)

Li, Y. -G., Pastori, D., Farcomeni, A., Yang, P. -S., Jang, E., Joung, B., . . . Lip, G. Y. H. (2019). A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects. CHEST, 155(3), 510-518. doi:10.1016/j.chest.2018.09.011

DOI: 10.1016/j.chest.2018.09.011

A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry (Journal article)

Deng, H., Shantsila, A., Guo, P., Potpara, T. S., Zhan, X., Fang, X., . . . Lip, G. Y. H. (2018). A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry. EBIOMEDICINE, 35, 40-45. doi:10.1016/j.ebiom.2018.08.034

DOI: 10.1016/j.ebiom.2018.08.034

A novel model for prediction of ischemic stroke in patients without atrial fibrillation (Conference Paper)

Steensig, K., Olesen, K. K. W., Madsen, M., Thim, T., Jensen, L. O., Raungaard, B., . . . Maeng, M. (2018). A novel model for prediction of ischemic stroke in patients without atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1273). Retrieved from http://gateway.webofknowledge.com/

A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics (Conference Paper)

Huisman, M. V., Diener, H. -C., Dubner, S. J., Halperin, J. L., Rothman, K. J., Ma, C. -S., . . . Investigators, G. L. O. R. I. A. -A. F. (2018). A prospective global registry on oral antithrombotic treatment in patients with atrial fibrillation: GLORIA-AF Phase III baseline characteristics. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 825). Retrieved from http://gateway.webofknowledge.com/

A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program-AIM-HY INFORM trial (Journal article)

Mukhtar, O., Cheriyan, J., Cockcroft, J. R., Collier, D., Coulson, J. M., Dasgupta, I., . . . Wilkinson, I. B. (2018). A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program-AIM-HY INFORM trial. AMERICAN HEART JOURNAL, 204, 102-108. doi:10.1016/j.ahj.2018.05.006

DOI: 10.1016/j.ahj.2018.05.006

Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS (Journal article)

Valgimigli, A. D. G. D. T. M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., . . . Aboyans, V. (2018). Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS. Revista Española de Cardiología, 71(1), 42.e1-42.e58. doi:10.1016/j.recesp.2017.11.014

DOI: 10.1016/j.recesp.2017.11.014

Acute hydrocortisone administration reduces cardiovagal baroreflex sensitivity and heart rate variability in young men (Journal article)

Adlan, A. M., van Zanten, J. J. C. S. V., Lip, G. Y. H., Paton, J. F. R., Kitas, G. D., & Fisher, J. P. (2018). Acute hydrocortisone administration reduces cardiovagal baroreflex sensitivity and heart rate variability in young men. JOURNAL OF PHYSIOLOGY-LONDON, 596(20), 4847-4861. doi:10.1113/JP276644

DOI: 10.1113/JP276644

Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation: Cohort Data Covering the Entire Korean Population (Journal article)

Kim, T. -H., Yang, P. -S., Yu, H. T., Jang, E., Uhm, J. -S., Kim, J. -Y., . . . Lip, G. Y. H. (2018). Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation: Cohort Data Covering the Entire Korean Population. STROKE, 49(8), 1872-1879. doi:10.1161/STROKEAHA.118.021047

DOI: 10.1161/STROKEAHA.118.021047

Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population (Conference Paper)

Kim, T. -H., Yang, P. -S., Yu, H. -T., Jang, E. S., Uhm, J. -S., Kim, J. -Y., . . . Lip, G. Y. H. (2018). Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 613). Retrieved from http://gateway.webofknowledge.com/

Age-dependency in the implementation of guideline-recommended therapy for stroke prevention in patients with non-valvular atrial fibrillation: insights from the BALKAN-AF Survey (Conference Paper)

Potpara, S., Dan, G. A., Kusljugic, Z., Paparisto, V., Goda, A., Trendafilova, E., . . . Investigators, B. A. L. K. A. N. -A. F. (2018). Age-dependency in the implementation of guideline-recommended therapy for stroke prevention in patients with non-valvular atrial fibrillation: insights from the BALKAN-AF Survey. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 615-616). Retrieved from http://gateway.webofknowledge.com/

Ambulatory blood pressure and long-term risk for atrial fibrillation (Journal article)

Tihonoff, V., Kuznetsova, T., Thijs, L., Cauwenberghs, N., Stolarz-Skrzypek, K., Seidlerova, J., . . . Genes, E. P. (2018). Ambulatory blood pressure and long-term risk for atrial fibrillation. HEART, 104(15), 1263-+. doi:10.1136/heartjnl-2017-312488

DOI: 10.1136/heartjnl-2017-312488

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) (Journal article)

Dan, G. -A., Martinez-Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaita, F., . . . Grp, E. S. C. S. D. (2018). Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). EUROPACE, 20(5), 731-+. doi:10.1093/europace/eux373

DOI: 10.1093/europace/eux373

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) (vol 20, pg 731, 2018) (Journal article)

Dan, G. -A., Martinez-Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaita, F., . . . Grp, E. S. C. S. D. (2018). Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) (vol 20, pg 731, 2018). EUROPACE, 20(5), 738. doi:10.1093/europace/euy119

DOI: 10.1093/europace/euy119

Anticoagulation Resumption After Intracerebral Hemorrhage (Journal article)

Li, Y. -G., & Lip, G. Y. H. (2018). Anticoagulation Resumption After Intracerebral Hemorrhage. CURRENT ATHEROSCLEROSIS REPORTS, 20(7). doi:10.1007/s11883-018-0733-y

DOI: 10.1007/s11883-018-0733-y

Anticoagulation control in octogenarian patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west birmingham AF project (Conference Paper)

Zulkifly, H., Cheli, P., Lutchman, I., Bai, Y., Lip, G. Y. H., & Lane, D. (2018). Anticoagulation control in octogenarian patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west birmingham AF project. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1005). Retrieved from http://gateway.webofknowledge.com/

Anticoagulation in elderly patients with nonvalvular atrial fibrillation: A balancing act (Journal article)

Fawzy, A. M., & Lip, G. Y. H. (2019). Anticoagulation in elderly patients with nonvalvular atrial fibrillation: A balancing act. HEART RHYTHM, 16(1), 38-40. doi:10.1016/j.hrthm.2018.09.011

DOI: 10.1016/j.hrthm.2018.09.011

Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality (Journal article)

Miguel Rivera-Caravaca, J., Marin, F., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Roldan, V., & Lip, G. Y. H. (2018). Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(3). doi:10.1111/ijcp.13069

DOI: 10.1111/ijcp.13069

Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry (Conference Paper)

Esteve Pastor, M. A., Roldan-Rabadan, I., Rivera-Caravaca, J. M., Roldan, V., Muniz, J., Cequier, A., . . . FANTASIIA. (2018). Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 613). Retrieved from http://gateway.webofknowledge.com/

Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report (Journal article)

Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., . . . Moores, L. (2018). Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report. CHEST, 154(5), 1121-1201. doi:10.1016/j.chest.2018.07.040

DOI: 10.1016/j.chest.2018.07.040

Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of CardiologyWorking Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (vol 19, pg 1757, 2017) (Journal article)

Lip, G. Y. H. (2018). Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of CardiologyWorking Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (vol 19, pg 1757, 2017). EUROPACE, 20(4), 658. Retrieved from http://gateway.webofknowledge.com/

Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach (Journal article)

Li, X., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., Luo, X., . . . Deitelzweig, S. (2018). Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach. PLOS ONE, 13(1). doi:10.1371/journal.pone.0191722

DOI: 10.1371/journal.pone.0191722

Are Alpha-Adrenergic Receptor Antagonists Beneficial to Prevent Heart Failure? Alpha-Adrenergic Receptor Antagonists Revisited (Journal article)

Shin, S. Y., & Lip, G. Y. H. (2018). Are Alpha-Adrenergic Receptor Antagonists Beneficial to Prevent Heart Failure? Alpha-Adrenergic Receptor Antagonists Revisited. JACC-HEART FAILURE, 6(11), 926-927. doi:10.1016/j.jchf.2018.07.013

DOI: 10.1016/j.jchf.2018.07.013

Arrhythmias and cognitive function (Journal article)

Dagres, N., Chao, T. -F., Fenelon, G., Lip, G. Y. H., & Chung, M. (2018). Arrhythmias and cognitive function. EUROPEAN HEART JOURNAL, 39(26), 2446-2447. doi:10.1093/eurheartj/ehy317

DOI: 10.1093/eurheartj/ehy317

Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation (Journal article)

Dan, G. A., Badila, E., Weiss, E., Laroche, C., Boriani, G., Dan, A., . . . Inve, E. O. R. P. -A. F. G. P. R. (2018). Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 254, 136-141. doi:10.1016/j.ijcard.2017.10.092

DOI: 10.1016/j.ijcard.2017.10.092

Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients. (Journal article)

Proietti, M., Farcomeni, A., Romiti, G. F., Di Rocco, A., Placentino, F., Diemberger, I., . . . Boriani, G. (2018). Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients.. European journal of preventive cardiology, 2047487318817662. doi:10.1177/2047487318817662

DOI: 10.1177/2047487318817662

Association of circulating apoptotic (annexin V plus ) microparticles with ventricular fibrosis and diastolic dysfunction in atrial fibrillation patients with heart failure with preserved ejection fraction (Conference Paper)

Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Association of circulating apoptotic (annexin V plus ) microparticles with ventricular fibrosis and diastolic dysfunction in atrial fibrillation patients with heart failure with preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 612). Retrieved from http://gateway.webofknowledge.com/

Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review. (Journal article)

Lunde, E. D., Nielsen, P. B., Riahi, S., Larsen, T. B., Lip, G. Y. H., Fonager, K., . . . Joensen, A. M. (2018). Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review.. Expert review of cardiovascular therapy, 16(11), 857-873. doi:10.1080/14779072.2018.1533118

DOI: 10.1080/14779072.2018.1533118

Atrial Tachyarrhythmia Prevalence in Patients with Implantable Cardiac Resynchronization Defibrillators (Conference Paper)

Gillett, S., Reyes, C., Martin, D., & Lip, G. (2018). Atrial Tachyarrhythmia Prevalence in Patients with Implantable Cardiac Resynchronization Defibrillators. In JOURNAL OF CARDIAC FAILURE Vol. 24 (pp. S57). doi:10.1016/j.cardfail.2018.07.257

DOI: 10.1016/j.cardfail.2018.07.257

Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy (Journal article)

Pastori, D., Mezzaroma, I., Pignatelli, P., Violi, F., & Lip, G. Y. H. (2019). Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 85(3), 508-515. doi:10.1111/bcp.13837

DOI: 10.1111/bcp.13837

Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care (Journal article)

Diemberger, I., Fantecchi, E., Reggiani, M. L. B., Martignani, C., Angeletti, A., Massaro, G., . . . Boriani, G. (2018). Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care. INTERNATIONAL JOURNAL OF CARDIOLOGY, 261, 73-77. doi:10.1016/j.ijcard.2018.03.058

DOI: 10.1016/j.ijcard.2018.03.058

Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality (Journal article)

Malavasi, V. L., Fantecchi, E., Gianolio, L., Pesce, F., Longo, G., Marietta, M., . . . Boriani, G. (2019). Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 59, 27-33. doi:10.1016/j.ejim.2018.10.012

DOI: 10.1016/j.ejim.2018.10.012

Atrial fibrillation in the Middle East: unmapped, underdiagnosed, undertreated. (Journal article)

Al-Shamkhani, W., Ayetey, H., & Lip, G. Y. H. (2018). Atrial fibrillation in the Middle East: unmapped, underdiagnosed, undertreated.. Expert review of cardiovascular therapy, 16(5), 341-348. doi:10.1080/14779072.2018.1457953

DOI: 10.1080/14779072.2018.1457953

Atrial fibrillation occurring initially during acute medical illness: the heterogeneous nature of disease, outcomes and management strategies. (Journal article)

Li, Y. -G., Borgi, M., & Lip, G. Y. (2018). Atrial fibrillation occurring initially during acute medical illness: the heterogeneous nature of disease, outcomes and management strategies.. European heart journal. Acute cardiovascular care, 2048872618801763. doi:10.1177/2048872618801763

DOI: 10.1177/2048872618801763

Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis (Journal article)

Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2018). Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis. CLINICAL CARDIOLOGY, 41(6), 855-861. doi:10.1002/clc.22971

DOI: 10.1002/clc.22971

Atrial high rate episodes burden improves stroke risk stratification using the CHA2DS2-VASc score: implications for anticoagulating device patients with high atrial arrhythmia burden (Conference Paper)

Miyazawa, K., Kondo, Y., Nakano, M., Senoo, K., Kobayashi, Y., & Lip, G. Y. H. (2018). Atrial high rate episodes burden improves stroke risk stratification using the CHA2DS2-VASc score: implications for anticoagulating device patients with high atrial arrhythmia burden. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 825). Retrieved from http://gateway.webofknowledge.com/

BLEEDING EVENTS AND THEIR CONSEQUENCES ON CARDIOVASCULAR EVENTS, READMISSION AND NET CLINICAL BENEFIT (Conference Paper)

Steg, P., Bhatt, D., Ellis, S., Hohnloser, S., Kleine, E., Nordaby, M., . . . Cannon, C. (2018). BLEEDING EVENTS AND THEIR CONSEQUENCES ON CARDIOVASCULAR EVENTS, READMISSION AND NET CLINICAL BENEFIT. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 1154). doi:10.1016/S0735-1097(18)31695-4

DOI: 10.1016/S0735-1097(18)31695-4

Blood glucose reduction by diabetic drugs with minimal hypoglycaemia risk for cardiovascular outcomes: Evidence from meta-regression analysis of randomized controlled trials (Journal article)

Huang, C. -J., Wang, W. -T., Sung, S. -H., Chen, C. -H., Lip, G. Y. H., Cheng, H. -M., & Chiang, C. -E. (2018). Blood glucose reduction by diabetic drugs with minimal hypoglycaemia risk for cardiovascular outcomes: Evidence from meta-regression analysis of randomized controlled trials. DIABETES OBESITY & METABOLISM, 20(9), 2131-2139. doi:10.1111/dom.13342

DOI: 10.1111/dom.13342

Burden of comorbidities, quality of anticoagulation control and outcomes: an analysis from the AFFIRM study (Conference Paper)

Proietti, M., Romiti, G. F., Olshansky, B., & Lip, G. Y. H. (2018). Burden of comorbidities, quality of anticoagulation control and outcomes: an analysis from the AFFIRM study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 193). Retrieved from http://gateway.webofknowledge.com/

CAD Is an Independent Risk Factor for Stroke Among Patients With Atrial Fibrillation (Journal article)

Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Jensen, S. E., Jensen, L. O., . . . Maeng, M. (2018). CAD Is an Independent Risk Factor for Stroke Among Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(20), 2540-2542. doi:10.1016/j.jacc.2018.08.1046

DOI: 10.1016/j.jacc.2018.08.1046

CHA(2)DS(2)-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation? (Journal article)

Mazurek, M., & Lip, G. Y. H. (2018). CHA(2)DS(2)-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation?. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 7(3), 275-277. doi:10.1177/2048872616688455

DOI: 10.1177/2048872616688455

CHA2DS2VASc score predicts exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function (Conference Paper)

Khan, A., Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). CHA2DS2VASc score predicts exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 402). Retrieved from http://gateway.webofknowledge.com/

COMPARATIVE EFFECTIVENESS AND SAFETY OF NOACS VERSUS WARFARIN FOR SECONDARY STROKE PREVENTION IN ATRIAL FIBRILLATION: A NATIONWIDE DANISH COHORT STUDY (Conference Paper)

Nielsen, P. B., Togersen, F. A., Skjoth, F., Sogaard, M., Larsen, T. B., & Lip, G. (2018). COMPARATIVE EFFECTIVENESS AND SAFETY OF NOACS VERSUS WARFARIN FOR SECONDARY STROKE PREVENTION IN ATRIAL FIBRILLATION: A NATIONWIDE DANISH COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 501). doi:10.1016/S0735-1097(18)31042-8

DOI: 10.1016/S0735-1097(18)31042-8

COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE (Conference Paper)

Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Lip, G. Y. H. (2018). COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 275). doi:10.1016/S0735-1097(18)30816-7

DOI: 10.1016/S0735-1097(18)30816-7

Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis. (Journal article)

Cheung, A., Gong, M., Bellanti, R., Ali-Hasan-Al-Saegh, S., Li, G., Roig, E., . . . Tse, G. (2018). Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis.. Heart Asia, 10(1), e010970. doi:10.1136/heartasia-2017-010970

DOI: 10.1136/heartasia-2017-010970

Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor (Journal article)

Wang, Z., Stuckey, D. J., Murdoch, C. E., Camelliti, P., Lip, G. Y. H., & Griffin, M. (2018). Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. CELL DEATH & DISEASE, 9. doi:10.1038/s41419-018-0573-2

DOI: 10.1038/s41419-018-0573-2

Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry. (Journal article)

An, Y., Ogawa, H., Yamashita, Y., Ishii, M., Iguchi, M., Masunaga, N., . . . Akao, M. (2019). Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry.. European heart journal. Quality of care & clinical outcomes, 5(1), 35-42. doi:10.1093/ehjqcco/qcy033

DOI: 10.1093/ehjqcco/qcy033

Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study (Journal article)

Wilson, D., Ambler, G., Shakeshaft, C., Brown, M. M., Charidimou, A., Salman, R. A. -S., . . . Collaborators, C. (2018). Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. LANCET NEUROLOGY, 17(6), 539-547. doi:10.1016/S1474-4422(18)30145-5

DOI: 10.1016/S1474-4422(18)30145-5

Change in CHA2DS2-VASc score (delta CHA2DS2-VASc score) and the risk of thromboembolism over 12-years follow-up in initially low-risk patients with first-diagnosed atrial fibrillation (Conference Paper)

Potpara, T. S., Mujovic, N., Marinkovic, J., & Lip, G. Y. H. (2018). Change in CHA2DS2-VASc score (delta CHA2DS2-VASc score) and the risk of thromboembolism over 12-years follow-up in initially low-risk patients with first-diagnosed atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 616). Retrieved from http://gateway.webofknowledge.com/

Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation (Journal article)

Fauchier, L., Bisson, A., Clementy, N., Vourc'h, P., Angoulvant, D., Babuty, D., . . . Lip, G. Y. H. (2018). Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation. AMERICAN HEART JOURNAL, 198, 39-45. doi:10.1016/j.ahj.2017.12.017

DOI: 10.1016/j.ahj.2017.12.017

Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants (Journal article)

Miyazawa, K., Pastori, D., & Lip, G. Y. H. (2018). Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants. AMERICAN HEART JOURNAL, 198, 166-168. doi:10.1016/j.ahj.2017.11.015

DOI: 10.1016/j.ahj.2017.11.015

Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry (Journal article)

Boriani, G., Proietti, M., Laroche, C., Diemberger, I., Popescu, M. I., Riahi, S., . . . Invest, E. O. R. P. -A. F. P. G. R. (2018). Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 271, 68-74. doi:10.1016/j.ijcard.2018.05.034

DOI: 10.1016/j.ijcard.2018.05.034

Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study (Journal article)

Paciullo, F., Proietti, M., Bianconi, V., Nobili, A., Pirro, M., Mannucci, P. M., . . . Investigators, R. E. P. O. S. I. (2018). Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study. DRUGS & AGING, 35(4), 365-373. doi:10.1007/s40266-018-0532-8

DOI: 10.1007/s40266-018-0532-8

Circulating monocyte-derived (CD14+) and apoptotic (annexin V-binding) microparticles correlate with recurrent atrial fibrillation (Conference Paper)

Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Circulating monocyte-derived (CD14+) and apoptotic (annexin V-binding) microparticles correlate with recurrent atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 412-413). Retrieved from http://gateway.webofknowledge.com/

Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis (Journal article)

Garcia Garre, E., Luengo Gil, G., Montoro Garcia, S., Gonzalez Billalabeitia, E., Zafra Poves, M., Garcia Martinez, E., . . . Ayala de la Pena, F. (2018). Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis. BREAST CANCER RESEARCH AND TREATMENT, 169(1), 83-92. doi:10.1007/s10549-017-4656-z

DOI: 10.1007/s10549-017-4656-z

Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry (Journal article)

An, Y., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., Tsuji, H., . . . Akao, M. (2018). Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry. HEART AND VESSELS, 33(12), 1534-1546. doi:10.1007/s00380-018-1194-5

DOI: 10.1007/s00380-018-1194-5

Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry (vol 33, pg 1534, 2018) (Journal article)

An, Y., Esato, M., Ishii, M., Iguchi, M., Masunaga, N., Tsuji, H., . . . Akao, M. (2018). Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry (vol 33, pg 1534, 2018). HEART AND VESSELS, 33(12), 1547-1548. doi:10.1007/s00380-018-1212-7

DOI: 10.1007/s00380-018-1212-7

Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation (Journal article)

Kosich, F., Schumacher, K., Potpara, T., Lip, G. Y., Hindricks, G., & Kornej, J. (2019). Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation. CLINICAL CARDIOLOGY, 42(2), 320-329. doi:10.1002/clc.23139

DOI: 10.1002/clc.23139

Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy (Journal article)

Banerjee, G., Wilson, D., Ambler, G., Appiah, K. O. -B., Shakeshaft, C., Lunawat, S., . . . Collaborators, C. (2018). Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy. STROKE, 49(1), 40-+. doi:10.1161/STROKEAHA.117.019409

DOI: 10.1161/STROKEAHA.117.019409

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study (Conference Paper)

Lip, G. Y. H., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Deitelzweig, S. (2018). Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 612-613). Retrieved from http://gateway.webofknowledge.com/

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study (Conference Paper)

Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Lip, G. Y. H. (2018). Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 610-611). Retrieved from http://gateway.webofknowledge.com/

Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients (Journal article)

Pastori, D., Miguel Rivera-Caravaca, J., Asuncion Esteve-Pastor, M., Roldan, V., Marin, F., Pignatelli, P., . . . Lip, G. Y. H. (2018). Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients. CIRCULATION JOURNAL, 82(5), 1286-+. doi:10.1253/circj.CJ-17-1318

DOI: 10.1253/circj.CJ-17-1318

Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants among non-valvular atrial fibrillation patients: the ARISTOPHANES study (Conference Paper)

Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Lip, G. Y. H. (2018). Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants among non-valvular atrial fibrillation patients: the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 505). Retrieved from http://gateway.webofknowledge.com/

Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants and warfarin among non-valvular atrial fibrillation patients: the ARISTOPHANES study (Conference Paper)

Lip, G. Y. H., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Dhamane, A., . . . Deitelzweig, S. (2018). Comparisons of clinical and economic outcomes between non-VKA oral anticoagulants and warfarin among non-valvular atrial fibrillation patients: the ARISTOPHANES study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 506). Retrieved from http://gateway.webofknowledge.com/

Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry (Journal article)

Boriani, G., Proietti, M., Laroche, C., Fauchier, L., Marin, F., Nabauer, M., . . . Inv, E. O. R. P. -A. F. L. -T. G. R. (2018). Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry. EUROPACE, 20(5), 747-757. doi:10.1093/europace/eux301

DOI: 10.1093/europace/eux301

Coronary artery disease is an independent risk factor for ischemic stroke among patients with atrial fibrillation (Conference Paper)

Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Madsen, M., Jensen, S. E., . . . Maeng, M. (2018). Coronary artery disease is an independent risk factor for ischemic stroke among patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 432). Retrieved from http://gateway.webofknowledge.com/

Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis) (Journal article)

Korjian, S., Daaboul, Y., Laliberte, F., Zhao, Q., Mehran, R., Bode, C., . . . Investigators, P. I. O. N. E. E. R. A. F. -P. C. I. (2019). Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis). AMERICAN JOURNAL OF CARDIOLOGY, 123(3), 355-360. doi:10.1016/j.amjcard.2018.10.033

DOI: 10.1016/j.amjcard.2018.10.033

Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation - The Fushimi AF Registry - (Journal article)

Masunaga, N., Abe, M., Ogawa, H., Aono, Y., Ikeda, S., Doi, K., . . . Investigators, F. A. F. R. (2018). Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation - The Fushimi AF Registry -. CIRCULATION JOURNAL, 82(12), 2983-+. doi:10.1253/circj.CJ-18-0872

DOI: 10.1253/circj.CJ-18-0872

Current and emerging pharmacotherapy for ischemic stroke prevention in patients with atrial fibrillation (Journal article)

Szekely, O., Miyazawa, K., & Lip, G. Y. H. (2018). Current and emerging pharmacotherapy for ischemic stroke prevention in patients with atrial fibrillation. EXPERT OPINION ON PHARMACOTHERAPY, 19(18), 1999-2009. doi:10.1080/14656566.2018.1537368

DOI: 10.1080/14656566.2018.1537368

DOES RENAL FUNCTION INFLUENCE THE BENEFIT OF DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM RE-DUAL PCI (Conference Paper)

Hohnloser, S., Steg, P., Oldgren, J., Nickenig, G., Kiss, R. G., Ongen, Z., . . . Cannon, C. (2018). DOES RENAL FUNCTION INFLUENCE THE BENEFIT OF DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM RE-DUAL PCI. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 314). doi:10.1016/S0735-1097(18)30855-6

DOI: 10.1016/S0735-1097(18)30855-6

Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study (Journal article)

Verdecchia, P., Reboldi, G., Angeli, F., Mazzotta, G., Lip, G. Y. H., Brueckmann, M., . . . Di Pasquale, G. (2018). Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study. EUROPACE, 20(2), 253-262. doi:10.1093/europace/eux022

DOI: 10.1093/europace/eux022

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants. (Journal article)

Pastori, D., Lip, G. Y. H., Farcomeni, A., Del Sole, F., Sciacqua, A., Perticone, F., . . . ATHERO-AF study group. (2018). Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.. Data in brief, 17, 830-836. doi:10.1016/j.dib.2018.01.109

DOI: 10.1016/j.dib.2018.01.109

Dementia and Atrial Fibrillation: A Dangerous Combination for Ischemic Stroke and Mortality (Journal article)

Pastori, D., Miyazawa, K., & Lip, G. Y. H. (2018). Dementia and Atrial Fibrillation: A Dangerous Combination for Ischemic Stroke and Mortality. JOURNAL OF ALZHEIMERS DISEASE, 61(3), 1129-1132. doi:10.3233/JAD-170955

DOI: 10.3233/JAD-170955

Development of a risk score for incident atrial fibrillation on 471,446 chinese subjects. The C2HEST score (Conference Paper)

Li, Y. G., Pastori, D., Farcomeni, A., Wang, Y. T., Guo, Y. T., & Lip, G. Y. H. (2018). Development of a risk score for incident atrial fibrillation on 471,446 chinese subjects. The C2HEST score. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 407). Retrieved from http://gateway.webofknowledge.com/

Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry (Conference Paper)

Proietti, M., Laroche, C., Fantecchi, E., Zdravkovic, M., Lenarczyk, R., Piot, O., . . . Registry, E. O. R. P. -A. F. G. L. -T. (2018). Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1265). Retrieved from http://gateway.webofknowledge.com/

Differences in Heart Rate Response and Recovery After 6-Minute Walk Test Between Patients With Atrial Fibrillation and in Sinus Rhythm (Journal article)

Luo, X., Xiong, Q., Xu, J., Hong, K., Peng, Q., Li, J., . . . Hai, S. (2018). Differences in Heart Rate Response and Recovery After 6-Minute Walk Test Between Patients With Atrial Fibrillation and in Sinus Rhythm. AMERICAN JOURNAL OF CARDIOLOGY, 122(4), 592-596. doi:10.1016/j.amjcard.2018.04.048

DOI: 10.1016/j.amjcard.2018.04.048

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies (Journal article)

Li, G., Lip, G. Y. H., Holbrook, A., Chang, Y., Larsen, T. B., Sun, X., . . . Levine, M. A. H. (2019). Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 34(2), 173-190. doi:10.1007/s10654-018-0415-7

DOI: 10.1007/s10654-018-0415-7

Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban (Journal article)

Lip, G. Y. H., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., & Phatak, H. (2018). Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban. PLOS ONE, 13(4). doi:10.1371/journal.pone.0195950

DOI: 10.1371/journal.pone.0195950

Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study (Journal article)

Skjoth, F., Vadmann, H., Hjortshoj, S. P., Riahi, S., Lip, G. Y. H., & Larsen, T. B. (2018). Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(11). doi:10.1111/ijcp.13258

DOI: 10.1111/ijcp.13258

Does ECG have additive benefit for predicting atrial fibrillation in patients with or without hypertension? (Journal article)

Shin, S. Y., Shantsilla, A., & Lip, G. Y. H. (2018). Does ECG have additive benefit for predicting atrial fibrillation in patients with or without hypertension?. JOURNAL OF HYPERTENSION, 36(9), 1793-1794. doi:10.1097/HJH.0000000000001788

DOI: 10.1097/HJH.0000000000001788

Does Renal Function Predict Short- and Medium-Term Mortality and Hospital Readmissions in Poststroke Patients? (Journal article)

Ding, W. Y., & Lip, G. Y. H. (2018). Does Renal Function Predict Short- and Medium-Term Mortality and Hospital Readmissions in Poststroke Patients?. STROKE, 49(12), 2812-2813. doi:10.1161/STROKEAHA.118.023723

DOI: 10.1161/STROKEAHA.118.023723

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation REPLY (Journal article)

Cannon, C. P., Lip, G. Y. H., & Oldgren, J. (2018). Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 378(5), 485-486. Retrieved from http://gateway.webofknowledge.com/

Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis) (Conference Paper)

Maeng, M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., . . . Inves, R. E. -D. U. A. L. P. C. I. S. C. (2018). Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis). In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1090-1091). Retrieved from http://gateway.webofknowledge.com/

Dynamic Changes of CHA(2)DS(2)-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study (Journal article)

Yoon, M., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Joung, B. (2018). Dynamic Changes of CHA(2)DS(2)-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study. THROMBOSIS AND HAEMOSTASIS, 118(7), 1296-1304. doi:10.1055/s-0038-1651482

DOI: 10.1055/s-0038-1651482

EFFECTIVENESS AND SAFETY OF NOAC VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH HEMORRHAGIC STROKE (Conference Paper)

Nielsen, P. B., Skjoth, F., Sogaard, M., Larsen, T. B., & Lip, G. (2018). EFFECTIVENESS AND SAFETY OF NOAC VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH HEMORRHAGIC STROKE. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 502). doi:10.1016/S0735-1097(18)31043-X

DOI: 10.1016/S0735-1097(18)31043-X

ESC Council on hypertension position document on themanagement of hypertensive emergencies (Journal article)

van den Born, B. -J. H., Lip, G. Y. H., Brguljan-Hitij, J., Cremer, A., Segura, J., Morales, E., . . . Williams, B. (2019). ESC Council on hypertension position document on themanagement of hypertensive emergencies. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 5(1), 37-46. doi:10.1093/ehjcvp/pvy032

DOI: 10.1093/ehjcvp/pvy032

Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study (Journal article)

Wilson, D., Ambler, G., Banerjee, G., Shakeshaft, C., Cohen, H., Yousry, T. A., . . . Str, C. R. M. (2019). Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90(3), 320-325. doi:10.1136/jnnp-2018-318890

DOI: 10.1136/jnnp-2018-318890

Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands. (Journal article)

Bennaghmouch, N., de Veer, A. J. W. M., Mahmoodi, B. K., Jofre-Bonet, M., Lip, G. Y. H., Bode, K., & Ten Berg, J. M. (2019). Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands.. European heart journal. Quality of care & clinical outcomes, 5(2), 127-135. doi:10.1093/ehjqcco/qcy030

DOI: 10.1093/ehjqcco/qcy030

Editor's Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association. (Journal article)

Walker, D. M., Gale, C. P., Lip, G., Martin-Sanchez, F. J., McIntyre, H. F., Mueller, C., . . . Bueno, H. (2018). Editor's Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association.. European heart journal. Acute cardiovascular care, 7(2), 176-193. doi:10.1177/2048872618758931

DOI: 10.1177/2048872618758931

Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future (Journal article)

Weber, C., & Lip, G. Y. H. (2018). Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future. THROMBOSIS AND HAEMOSTASIS, 118(1), 225-227. doi:10.1160/TH17-11-0844

DOI: 10.1160/TH17-11-0844

Edoxaban in Asian Patients With Atrial Fibrillation Effectiveness and Safety (Journal article)

Lee, S. -R., Choi, E. -K., Han, K. -D., Jung, J. -H., Oh, S., & Lip, G. Y. H. (2018). Edoxaban in Asian Patients With Atrial Fibrillation Effectiveness and Safety. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(8), 838-853. doi:10.1016/j.jacc.2018.05.066

DOI: 10.1016/j.jacc.2018.05.066

Edoxaban vs warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial (Conference Paper)

Lip, G. Y. H., Al-Saady, N., Hjortshoj, S. P., Goudev, A., Huber, K., Cohen, A. -A., . . . Goette, A. (2018). Edoxaban vs warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 414). Retrieved from http://gateway.webofknowledge.com/

Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial (Conference Paper)

Lee, T. C., Qian, M., Mu, L., Di Tullio, M. R., Graham, S., Mann, D. L., . . . Ye, S. (2018). Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial. In JOURNAL OF CARDIAC FAILURE Vol. 24 (pp. S75). doi:10.1016/j.cardfail.2018.07.311

DOI: 10.1016/j.cardfail.2018.07.311

Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial (Journal article)

Kerneis, M., Gibson, C. M., Chi, G., Mehran, R., AlKhalfan, F., Talib, U., . . . Cohen, M. (2018). Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Insights From the PIONEER AF-PCI Trial. JACC-CARDIOVASCULAR INTERVENTIONS, 11(7), 626-634. doi:10.1016/j.jcin.2017.11.009

DOI: 10.1016/j.jcin.2017.11.009

Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey) (Journal article)

Erkuner, O., Dudink, E. A. M. P., Nieuwlaat, R., Rienstra, M., Van Gelder, I. C., Camm, A. J., . . . Luermans, J. G. L. M. (2018). Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey). AMERICAN JOURNAL OF CARDIOLOGY, 122(4), 578-583. doi:10.1016/j.amjcard.2018.04.053

DOI: 10.1016/j.amjcard.2018.04.053

Effect of concomitant antiplatelet agents on clinical outcomes in the Edoxaban versus Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial (Conference Paper)

Goette, A., Merino, J., De Caterina, R., Huber, K., Heidbuchel, H., Jin, J., . . . Lip, G. Y. H. (2018). Effect of concomitant antiplatelet agents on clinical outcomes in the Edoxaban versus Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 205-206). Retrieved from http://gateway.webofknowledge.com/

Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA (Conference Paper)

Banerjee, G., Chan, E., Ambler, G., Wilson, D., Cipolotti, L., Shakeshaft, C., . . . Collaborators, C. (2019). Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA. In JOURNAL OF NEUROLOGY Vol. 266 (pp. 1250-1259). doi:10.1007/s00415-019-09256-6

DOI: 10.1007/s00415-019-09256-6

Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial (Conference Paper)

Yee, M. K., Kerneis, M., Nafee, T., Travis, R., Chi, G., Mehran, R., . . . Gibson, C. M. (2018). Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 271-272). Retrieved from http://gateway.webofknowledge.com/

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy A Nationwide Cohort Study (Journal article)

Jung, H., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2019). Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy A Nationwide Cohort Study. CHEST, 155(2), 354-363. doi:10.1016/j.chest.2018.11.009

DOI: 10.1016/j.chest.2018.11.009

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study (Journal article)

Lip, G. Y. H., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Deitelzweig, S. (2018). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study. STROKE, 49(12), 2933-2944. doi:10.1161/STROKEAHA.118.020232

DOI: 10.1161/STROKEAHA.118.020232

Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis (Journal article)

Bai, Y., Guo, S. -D., Deng, H., Shantsila, A., Fauchier, L., Ma, C. -S., & Lip, G. Y. H. (2018). Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis. AGE AND AGEING, 47(1), 9-17. doi:10.1093/ageing/afx103

DOI: 10.1093/ageing/afx103

Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy A Meta-Analysis of Randomized Trials (Journal article)

Bennaghmouch, N., de Veer, A. J. W. M., Bode, K., Mahmoodi, B. K., Dewilde, W. J. M., Lip, G. Y. H., . . . ten Berg, J. M. (2018). Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy A Meta-Analysis of Randomized Trials. CIRCULATION, 137(11), 1117-1129. doi:10.1161/CIRCULATIONAHA.117.028513

DOI: 10.1161/CIRCULATIONAHA.117.028513

Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials (Journal article)

Fu, L., Zhu, W., Huang, L., Hu, J., Ma, J., Lip, G. Y. H., & Hong, K. (2019). Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 19(1), 37-47. doi:10.1007/s40256-018-0299-7

DOI: 10.1007/s40256-018-0299-7

Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study (Conference Paper)

Jung, H., Yang, P. S., Jang, E., Yu, H. T., Kim, T. H., Uhm, J. S., . . . Lip, G. Y. H. (2018). Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 274-275). Retrieved from http://gateway.webofknowledge.com/

Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation (Journal article)

Mork, M., Andreasen, J. J., Rasmussen, L. H., Lip, G. Y. H., Pedersen, S., Baek, R., . . . Kristensen, S. R. (2019). Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation. THROMBOSIS RESEARCH, 173, 141-150. doi:10.1016/j.thromres.2018.11.026

DOI: 10.1016/j.thromres.2018.11.026

Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA(2)DS(2)-VASc and HAS-BLED scores using multiple biomarkers (Journal article)

Roldan, V., Miguel Rivera-Caravaca, J., Shantsila, A., Garcia-Fernandez, A., Asuncion Esteve-Pastor, M., Antonio Vilchez, J., . . . Lip, G. Y. H. (2018). Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA(2)DS(2)-VASc and HAS-BLED scores using multiple biomarkers. ANNALS OF MEDICINE, 50(1), 26-34. doi:10.1080/07853890.2017.1378429

DOI: 10.1080/07853890.2017.1378429

Epidemiology of atrial fibrillation (Journal article)

Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2018). Epidemiology of atrial fibrillation. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(3). doi:10.1111/ijcp.13070

DOI: 10.1111/ijcp.13070

Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation (Journal article)

Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan, V., Orenes-Pinero, E., Romiti, G. F., Romanazzi, I., . . . Lip, G. Y. H. (2018). Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 122(5), 785-792. doi:10.1016/j.amjcard.2018.05.012

DOI: 10.1016/j.amjcard.2018.05.012

Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients (Journal article)

Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan, V., Vicente, V., Romiti, G. F., Romanazzi, I., . . . Lip, G. Y. H. (2018). Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients. INTERNATIONAL JOURNAL OF CARDIOLOGY, 254, 125-131. doi:10.1016/j.ijcard.2017.11.087

DOI: 10.1016/j.ijcard.2017.11.087

Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol (Conference Paper)

Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Orenes-Pinero, E., Romiti, G. F., Romanazzi, I., . . . Lip, G. Y. H. (2018). Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 873). Retrieved from http://gateway.webofknowledge.com/

European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS) (Journal article)

Boriani, G., Fauchier, L., Aguinaga, L., Beattie, J. M., Lundqvist, C. B., Cohen, A., . . . Grp, E. S. C. S. D. (2019). European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). EUROPACE, 21(1), 7-+. doi:10.1093/europace/euy110

DOI: 10.1093/europace/euy110

European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (Journal article)

Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jais, P., Josephson, M. E., . . . Blomstrom-Lundqvist, C. (2018). European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). EUROPEAN HEART JOURNAL, 39(16), 1442-1445. doi:10.1093/eurheartj/ehw455

DOI: 10.1093/eurheartj/ehw455

European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS) (Journal article)

Gorenek, B., Boriani, G., Dan, G. -A., Fauchier, L., Fenelon, G., Huang, H., . . . Grp, E. S. C. S. D. (2018). European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). EUROPACE, 20(6), 895-+. doi:10.1093/europace/euy051

DOI: 10.1093/europace/euy051

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? (Journal article)

Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Shantsila, A. (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?. Journal of arrhythmia, 34(2), 99-123. doi:10.1002/joa3.12050

DOI: 10.1002/joa3.12050

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? (Journal article)

Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Chung, M. K. (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?. HEART RHYTHM, 15(6), E37-E60. doi:10.1016/j.hrthm.2018.03.005

DOI: 10.1016/j.hrthm.2018.03.005

European Heart RhythmAssociation (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? (Journal article)

Dagres, N., Chao, T. -F., Fenelon, G., Aguinaga, L., Benhayon, D., Benjamin, E. J., . . . Grp, E. S. C. S. D. (2018). European Heart RhythmAssociation (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?. EUROPACE, 20(9), 1399-+. doi:10.1093/europace/euy046

DOI: 10.1093/europace/euy046

Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan (Journal article)

Chao, T. -F., Chiang, C. -E., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan. CIRCULATION, 138(14), 1485-1487. doi:10.1161/CIRCULATIONAHA.118.036046

DOI: 10.1161/CIRCULATIONAHA.118.036046

Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation Should We Use a CHA(2)DS(2)-VA Score Rather Than CHA(2)DS(2)-VASc? (Journal article)

Nielsen, P. B., Skjoth, F., Overvad, T. F., Larsen, T. B., & Lip, G. Y. H. (2018). Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation Should We Use a CHA(2)DS(2)-VA Score Rather Than CHA(2)DS(2)-VASc?. CIRCULATION, 137(8), 832-840. doi:10.1161/CIRCULATIONAHA.117.029081

DOI: 10.1161/CIRCULATIONAHA.117.029081

Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China-AF Study (Journal article)

Lan, D. -H., Jiang, C., Du, X., He, L., Guo, X. -Y., Zuo, S., . . . Ma, C. -S. (2018). Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China-AF Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(19). doi:10.1161/JAHA.118.009391

DOI: 10.1161/JAHA.118.009391

Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice (Journal article)

Li, Y. -G., Pastori, D., & Lip, G. Y. H. (2018). Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice. ANNALS OF MEDICINE, 50(4), 288-302. doi:10.1080/07853890.2018.1460489

DOI: 10.1080/07853890.2018.1460489

Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice (vol 50, pg 288, 2018) (Journal article)

Li, Y. -G., Pastori, D., & Lip, G. Y. H. (2018). Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice (vol 50, pg 288, 2018). ANNALS OF MEDICINE, 50(4), 361. doi:10.1080/07853890.2018.1468134

DOI: 10.1080/07853890.2018.1468134

Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation (Journal article)

Fawzy, A. M., Olshansky, B., & Lip, G. Y. H. (2019). Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation. AMERICAN HEART JOURNAL, 208, 120-122. doi:10.1016/j.ahj.2018.10.003

DOI: 10.1016/j.ahj.2018.10.003

Galectin 3 as a marker of diastolic dysfunction in patients with atrial fibrillation and heart failure with preserved ejection fraction (Conference Paper)

Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Galectin 3 as a marker of diastolic dysfunction in patients with atrial fibrillation and heart failure with preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1387). Retrieved from http://gateway.webofknowledge.com/

Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program (Journal article)

Mazurek, M., Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., . . . Investigators, G. L. O. R. I. A. -A. F. (2018). Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program. AMERICAN JOURNAL OF MEDICINE, 131(8), 945-+. doi:10.1016/j.amjmed.2018.03.024

DOI: 10.1016/j.amjmed.2018.03.024

Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials (Journal article)

Tse, G., Gong, M., Li, G., Wong, S. H., Wu, W. K. K., Wong, W. T., . . . Network, I. H. I. S. (2018). Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 84(9), 1868-1882. doi:10.1111/bcp.13621

DOI: 10.1111/bcp.13621

Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program (Conference Paper)

Beier, L., Franca, L. R., Lip, G. Y. H., Huisman, M. V., Zint, K., Halperin, J. L., . . . Investigators, G. L. O. R. I. A. A. F. (2018). Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1074). Retrieved from http://gateway.webofknowledge.com/

Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence (Journal article)

Szekely, O., Lane, D. A., & Lip, G. Y. H. (2018). Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence. EUROPEAN HEART JOURNAL, 39(25), 2365-2367. doi:10.1093/eurheartj/ehy308

DOI: 10.1093/eurheartj/ehy308

HIGH HEART RATE PREDICTS CARDIAC FIBROSIS IN PATIENTS WITH ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION (Conference Paper)

Shahid, F., Lip, G., & Shantsila, E. (2018). HIGH HEART RATE PREDICTS CARDIAC FIBROSIS IN PATIENTS WITH ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION. In HEART Vol. 104 (pp. A76-A77). doi:10.1136/heartjnl-2018-BCS.91

DOI: 10.1136/heartjnl-2018-BCS.91

Health care facility type-related challenges in the management of stroke risk in patients with atrial fibrillation: practical implications (Journal article)

Potpara, T. S., Andrei-Dan, G., & Lip, G. Y. H. (2018). Health care facility type-related challenges in the management of stroke risk in patients with atrial fibrillation: practical implications. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 128(5), 271-273. Retrieved from http://gateway.webofknowledge.com/

Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial) (Journal article)

Lee, T. C., Qian, M., Lip, G. Y. H., Di Tullio, M. R., Graham, S., Mann, D. L., . . . Investigators, W. A. R. C. E. F. (2018). Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial). AMERICAN JOURNAL OF CARDIOLOGY, 122(5), 821-827. doi:10.1016/j.amjcard.2018.05.024

DOI: 10.1016/j.amjcard.2018.05.024

Heart Failure and Stroke. (Journal article)

Schumacher, K., Kornej, J., Shantsila, E., & Lip, G. Y. H. (2018). Heart Failure and Stroke.. Current heart failure reports, 15(5), 287-296. doi:10.1007/s11897-018-0405-9

DOI: 10.1007/s11897-018-0405-9

High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI (Conference Paper)

De Caterina, R., Lopez Sendon, J. L., Mehta, S., Opolski, G., Oldgren, J., Steg, P. G., . . . Comm, R. E. -D. U. A. L. P. C. I. S. (2018). High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 458). Retrieved from http://gateway.webofknowledge.com/

How could non-vitamin K antagonist oral anticoagulants change clinical practice for stroke prevention and improve outcomes in patients with newly-diagnosed atrial fibrillation? (Conference Paper)

Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2018). How could non-vitamin K antagonist oral anticoagulants change clinical practice for stroke prevention and improve outcomes in patients with newly-diagnosed atrial fibrillation?. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 457-458). Retrieved from http://gateway.webofknowledge.com/

IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL (Conference Paper)

Lip, G., Merino, J. L., Banach, M., de Groot, J., Maier, L., Themistoclakis, S., . . . Goette, A. (2018). IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 518). doi:10.1016/S0735-1097(18)31059-3

DOI: 10.1016/S0735-1097(18)31059-3

IS IT SAFE TO SWITCH OAC IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM A RE-DUAL PCI SUBANALYSIS (Conference Paper)

Ten Berg, J., de Veer, A., Oldgren, J., Steg, P., Zateyshchikov, D. A., Jansky, P., . . . Cannon, C. (2018). IS IT SAFE TO SWITCH OAC IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM A RE-DUAL PCI SUBANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 1206). doi:10.1016/S0735-1097(18)31747-9

DOI: 10.1016/S0735-1097(18)31747-9

Ideal Blood Pressure in Patients With Atrial Fibrillation (Journal article)

Kim, D., Yang, P. -S., Kim, T. -H., Jang, E., Shin, H., Kim, H. Y., . . . Lip, G. Y. H. (2018). Ideal Blood Pressure in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(11), 1233-1245. doi:10.1016/j.jacc.2018.05.076

DOI: 10.1016/j.jacc.2018.05.076

Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial (Conference Paper)

Nafee, T., Yee, M. K., Kerneis, M., Travis, R., Alkhalfan, F., Mehran, R., . . . Gibson, C. M. (2018). Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1073-1074). Retrieved from http://gateway.webofknowledge.com/

Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF) (Journal article)

Lip, G. Y. H., Merino, J. L., Banach, M., de Groot, J. R., Maier, L. S., Themistoclakis, S., . . . Goette, A. (2019). Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF). AMERICAN JOURNAL OF CARDIOLOGY, 123(4), 592-597. doi:10.1016/j.amjcard.2018.11.019

DOI: 10.1016/j.amjcard.2018.11.019

Impact of Mon2 monocyte-platelet aggregates on human coronary artery disease (Journal article)

Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2018). Impact of Mon2 monocyte-platelet aggregates on human coronary artery disease. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 48(5). doi:10.1111/eci.12911

DOI: 10.1111/eci.12911

Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation A Nationwide Cohort Study (Journal article)

Yu, H. T., Yang, P. -S., Kim, T. -H., Jang, E., Kim, D., Uhm, J. -S., . . . Joung, B. (2018). Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation A Nationwide Cohort Study. STROKE, 49(10), 2421-2429. doi:10.1161/STROKEAHA.118.021387

DOI: 10.1161/STROKEAHA.118.021387

Impact of comorbidities on major adverse events in atrial fibrillation: 3 years follow-up of the EORP-AF general pilot registry (Conference Paper)

Proietti, M., Laroche, C., Maggioni, A. P., Boriani, G., Lip, G. Y. H., & Registry, E. O. R. P. -A. F. G. P. (2018). Impact of comorbidities on major adverse events in atrial fibrillation: 3 years follow-up of the EORP-AF general pilot registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1292). Retrieved from http://gateway.webofknowledge.com/

Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials (Journal article)

Proietti, M., & Lip, G. Y. H. (2018). Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 252, 96-100. doi:10.1016/j.ijcard.2017.10.091

DOI: 10.1016/j.ijcard.2017.10.091

Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway (Journal article)

Proietti, M., Romiti, G. F., Olshansky, B., Lane, D. A., & Lip, G. Y. H. (2018). Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway. AMERICAN JOURNAL OF MEDICINE, 131(11), 1359-+. doi:10.1016/j.amjmed.2018.06.012

DOI: 10.1016/j.amjmed.2018.06.012

In-hospital direct costs for thromboembolism and bleeding in Chinese patients with atrial fibrillation. (Journal article)

Chang, S. -S., Wu, J. -H., Liu, Y., Zhang, T., Du, X., Dong, J. -Z., . . . Ma, C. -S. (2018). In-hospital direct costs for thromboembolism and bleeding in Chinese patients with atrial fibrillation.. Chronic diseases and translational medicine, 4(2), 127-134. doi:10.1016/j.cdtm.2018.01.001

DOI: 10.1016/j.cdtm.2018.01.001

Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure - The Fushimi AF Registry (Journal article)

Iguchi, M., Tezuka, Y., Ogawa, H., Hamatani, Y., Takagi, D., An, Y., . . . Akao, M. (2018). Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure - The Fushimi AF Registry. CIRCULATION JOURNAL, 82(5), 1327-+. doi:10.1253/circj.CJ-17-1155

DOI: 10.1253/circj.CJ-17-1155

Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants (Journal article)

Pastori, D., Lip, G. Y. H., Farcomeni, A., Del Sole, F., Sciacqua, A., Perticone, F., . . . Grp, A. T. H. E. R. O. -A. F. S. (2018). Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants. INTERNATIONAL JOURNAL OF CARDIOLOGY, 264, 58-63. doi:10.1016/j.ijcard.2018.01.097

DOI: 10.1016/j.ijcard.2018.01.097

Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors (Journal article)

Chao, T. -F., Lip, G. Y. H., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors. THROMBOSIS AND HAEMOSTASIS, 118(4), 768-777. doi:10.1055/s-0038-1636534

DOI: 10.1055/s-0038-1636534

Incident comorbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): how frequent should we reassess stroke risk in these patients? (Conference Paper)

Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2018). Incident comorbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): how frequent should we reassess stroke risk in these patients?. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 264-265). Retrieved from http://gateway.webofknowledge.com/

Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries (Journal article)

Proietti, M., Laroche, C., Nieuwlaat, R., Crijns, H. J. G. M., Maggioni, A. P., Lane, D. A., . . . Investigators, E. H. S. A. F. (2018). Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 55, 28-34. doi:10.1016/j.ejim.2018.05.016

DOI: 10.1016/j.ejim.2018.05.016

Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015 (Journal article)

Kim, D., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. H. (2018). Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015. HEART, 104(24), 2010-2017. doi:10.1136/heartjnl-2017-312930

DOI: 10.1136/heartjnl-2017-312930

Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices (Journal article)

Pastori, D., Miyazawa, K., Li, Y., Shahid, F., Hado, H., & Lip, G. Y. H. (2018). Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices. CLINICAL RESEARCH IN CARDIOLOGY, 107(9), 772-777. doi:10.1007/s00392-018-1244-0

DOI: 10.1007/s00392-018-1244-0

Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation (Journal article)

Lip, G. Y. H., Lane, D. A., & Potpara, T. S. (2018). Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation. EUROPEAN HEART JOURNAL, 39(16), 1404-1406. doi:10.1093/eurheartj/ehx807

DOI: 10.1093/eurheartj/ehx807

Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort (Journal article)

Pastori, D., Pignatelli, P., Menichelli, D., Violi, F., & Lip, G. Y. H. (2019). Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort. MAYO CLINIC PROCEEDINGS, 94(7), 1261-1267. doi:10.1016/j.mayocp.2018.10.022

DOI: 10.1016/j.mayocp.2018.10.022

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference (Journal article)

Kotecha, D., Breithardt, G., Camm, A. J., Lip, G. Y. H., Schotten, U., Ahlsson, A., . . . Kirchhof, P. (2018). Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. EUROPACE, 20(3), 395-407. doi:10.1093/europace/eux318

DOI: 10.1093/europace/eux318

Is there an obesity paradox for adverse outcomes in patients with atrial fibrillation? insights from the FANTASIIA registry (Conference Paper)

Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., Cequier, A., . . . FANTASIIA. (2018). Is there an obesity paradox for adverse outcomes in patients with atrial fibrillation? insights from the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 198-199). Retrieved from http://gateway.webofknowledge.com/

Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA) (Journal article)

Miyazawa, K., Pastori, D., Hammerstingl, C., Cappato, R., Meng, I. L., Kramer, F., . . . Investigators, X. -T. R. A. S. (2018). Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA). ANNALS OF MEDICINE, 50(6), 511-518. doi:10.1080/07853890.2018.1495337

DOI: 10.1080/07853890.2018.1495337

Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study (Journal article)

Begg, G. A., Karim, R., Oesterlein, T., Graham, L. N., Hogarth, A. J., Page, S. P., . . . Tayebjeel, M. H. (2018). Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study. PLOS ONE, 13(1). doi:10.1371/journal.pone.0189936

DOI: 10.1371/journal.pone.0189936

Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment (Journal article)

Di Tullio, M. R., Qian, M., Thompson, J. L. P., Labovitz, A. J., Mann, D. L., Sacco, R. L., . . . Investigators, W. A. R. C. E. F. (2018). Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment. ESC HEART FAILURE, 5(5), 800-808. doi:10.1002/ehf2.12331

DOI: 10.1002/ehf2.12331

Letter by Shahid and Lip Regarding Article, "Stroke Risk Factors Unique to Women" (Journal article)

Shahid, F., & Lip, G. Y. H. (2018). Letter by Shahid and Lip Regarding Article, "Stroke Risk Factors Unique to Women". STROKE, 49(9), E290. doi:10.1161/STROKEAHA.118.021933

DOI: 10.1161/STROKEAHA.118.021933

Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation A Report From the Taiwan Nationwide AF Cohort Study (Journal article)

Chao, T. -F., Liu, C. -J., Tuan, T. -C., Chen, T. -J., Hsieh, M. -H., Lip, G. Y. H., & Chen, S. -A. (2018). Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation A Report From the Taiwan Nationwide AF Cohort Study. CHEST, 153(2), 453-466. doi:10.1016/j.chest.2017.10.001

DOI: 10.1016/j.chest.2017.10.001

Long term cardiovascular risk prediction in Real- World atrial fibrillation patients: Validation of the 2MACE score in the FANTASIIA registry (Conference Paper)

Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan-Rabadan, I., Muniz, J., Cequier, A., . . . Fantasiia. (2018). Long term cardiovascular risk prediction in Real- World atrial fibrillation patients: Validation of the 2MACE score in the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1295). Retrieved from http://gateway.webofknowledge.com/

Long-term relationship between atrial fibrillation and charlson comorbidity index in a population-based cohort study (Conference Paper)

Proietti, M., Marzona, I., Vannini, T., Basili, S., Mannucci, P. M., Boriani, G., . . . Nobili, A. (2018). Long-term relationship between atrial fibrillation and charlson comorbidity index in a population-based cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1410-1411). Retrieved from http://gateway.webofknowledge.com/

MONOCYTE SUBPOPULATIONS IN PATIENTS FOLLOWING ST-ELEVATION MYOCARDIAL INFARCTION: IMPLICATIONS FOR POST-INFARCTION LEFT VENTRICULAR REMODELLING AND CLINICAL OUTCOMES (Conference Paper)

Ghattas, A., Shantsila, E., Griffiths, H., & Lip, G. (2018). MONOCYTE SUBPOPULATIONS IN PATIENTS FOLLOWING ST-ELEVATION MYOCARDIAL INFARCTION: IMPLICATIONS FOR POST-INFARCTION LEFT VENTRICULAR REMODELLING AND CLINICAL OUTCOMES. In HEART Vol. 104 (pp. A4). doi:10.1136/heartjnl-2018-BCIS.7

DOI: 10.1136/heartjnl-2018-BCIS.7

Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Journal article)

Raparelli, V., Pastori, D., Pignataro, S. F., Vestri, A. R., Pignatelli, P., Cangemi, R., . . . Collaborators, A. R. A. P. A. C. I. S. S. (2018). Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study. INTERNAL AND EMERGENCY MEDICINE, 13(5), 651-660. doi:10.1007/s11739-018-1835-9

DOI: 10.1007/s11739-018-1835-9

Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (vol 13, pg 651, 2018) (Journal article)

Raparelli, V., Pastori, D., Pignataro, S. F., Vestri, A. R., Pignatelli, P., Cangemi, R., . . . Collaborators, A. R. A. P. A. C. I. S. S. (2018). Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (vol 13, pg 651, 2018). INTERNAL AND EMERGENCY MEDICINE, 13(8), 1349. doi:10.1007/s11739-018-1922-y

DOI: 10.1007/s11739-018-1922-y

Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study (Journal article)

Chao, T. -F., Lip, G. Y. H., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 254, 157-161. doi:10.1016/j.ijcard.2017.11.025

DOI: 10.1016/j.ijcard.2017.11.025

Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report (Journal article)

Fumagalli, S., Said, S. A., Laroche, C., Gabbai, D., Boni, S., Marchionni, N., . . . Investi, E. O. R. P. -A. F. G. P. R. (2018). Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 4(3), 172-179. doi:10.1093/ehjcvp/pvx037

DOI: 10.1093/ehjcvp/pvx037

Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI (Journal article)

Lip, G. Y. H., Collet, J. -P., Haude, M., & Huber, K. (2018). Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI. EUROPEAN HEART JOURNAL, 39(31), 2847-2850. doi:10.1093/eurheartj/ehy396

DOI: 10.1093/eurheartj/ehy396

Management of atrial fibrillation: easy as ABC (Journal article)

Mahmood, M., & Lip, G. Y. (2019). Management of atrial fibrillation: easy as ABC. MINERVA MEDICA, 110(1), 27-34. doi:10.23736/S0026-4806.18.05824-X

DOI: 10.23736/S0026-4806.18.05824-X

Mechanisms and prognostic significance of pre-existing cognitive impairment in patients with atrial fibrillation related ischaemic stroke or TIA: the CROMIS-2 study (Conference Paper)

Banerjee, G., Wilson, D., Ambler, G., Shakeshaft, C., Chan, E., Cohen, H., . . . Collaborators, C. (2018). Mechanisms and prognostic significance of pre-existing cognitive impairment in patients with atrial fibrillation related ischaemic stroke or TIA: the CROMIS-2 study. In INTERNATIONAL JOURNAL OF STROKE Vol. 13 (pp. 51). Retrieved from http://gateway.webofknowledge.com/

Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project. (Journal article)

Deng, H., Shantsila, A., Guo, P., Zhan, X., Fang, X., Liao, H., . . . Lip, G. Y. H. (2018). Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project.. Journal of Arrhythmia, 34(6), 617-625. doi:10.1002/joa3.12111

DOI: 10.1002/joa3.12111

NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study (Conference Paper)

Soegaard, M., Skjoth, F., Jensen, M., Kjaeldgaard, J. N., Lip, G. Y. H., Larsen, T. B., & Nielsen, P. B. (2018). NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1073). Retrieved from http://gateway.webofknowledge.com/

NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study (Journal article)

Kalarus, Z., Balsam, P., Bandosz, P., Grodzicki, T., Kazmierczak, J., Kiedrowicz, R., . . . Lip, G. Y. H. (2018). NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study. KARDIOLOGIA POLSKA, 76(10), 1482-1485. doi:10.5603/KP.a2018.0193

DOI: 10.5603/KP.a2018.0193

New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds (Journal article)

Dimitropoulos, G., Rahim, S. M. Z., Moss, A. S., & Lip, G. Y. H. (2018). New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 27(1), 71-86. doi:10.1080/13543784.2018.1416090

DOI: 10.1080/13543784.2018.1416090

Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation (Journal article)

Borgognone, A., Shantsila, E., Worrall, S. M., Prompunt, E., Loka, T., Loudon, B. L., . . . Madhani, M. (2018). Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation. CARDIOVASCULAR RESEARCH, 114(10), 1313-1323. doi:10.1093/cvr/cvy087

DOI: 10.1093/cvr/cvy087

Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis (Journal article)

Telles-Garcia, N., Dahal, K., Kocherla, C., Lip, G. Y. H., Reddy, P., & Dominic, P. (2018). Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 268, 143-148. doi:10.1016/j.ijcard.2018.04.034

DOI: 10.1016/j.ijcard.2018.04.034

Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction (Journal article)

Mahmood, M., & Lip, G. Y. H. (2018). Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction. REVISTA ESPANOLA DE CARDIOLOGIA, 71(10), 847-855. doi:10.1016/j.recesp.2018.03.023

DOI: 10.1016/j.recesp.2018.03.023

Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction. (Journal article)

Mahmood, M., & Lip, G. Y. H. (2018). Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction.. Revista espanola de cardiologia (English ed.), 71(10), 847-855. doi:10.1016/j.rec.2018.05.015

DOI: 10.1016/j.rec.2018.05.015

Novel biomarker-based risk prediction for new onset atrial fibrillation in patients with ST elevation myocardial infarction: Balancing simplicity and practicality (Journal article)

Shin, S. Y., & Lip, G. Y. H. (2018). Novel biomarker-based risk prediction for new onset atrial fibrillation in patients with ST elevation myocardial infarction: Balancing simplicity and practicality. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(4). doi:10.1111/ijcp.13090

DOI: 10.1111/ijcp.13090

ORAL ANTICOAGULATION IN ATRIAL FIBRILLATION AND ANEMIA: A REPORT FROM DANISH NATIONWIDE REGISTRIES (Conference Paper)

Bonde, A. N., Lip, G., Staerk, L., Gundlund, A., Torp-Pedersen, C., Gislason, G., & Olesen, J. (2018). ORAL ANTICOAGULATION IN ATRIAL FIBRILLATION AND ANEMIA: A REPORT FROM DANISH NATIONWIDE REGISTRIES. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 508). doi:10.1016/S0735-1097(18)31049-0

DOI: 10.1016/S0735-1097(18)31049-0

One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry (Journal article)

Li, Y. -G., Miyazawa, K., Wolff, A., Zubaid, M., Alsheikh-Ali, A. A., Sulaiman, K., & Lip, G. Y. H. (2019). One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 274, 158-162. doi:10.1016/j.ijcard.2018.08.091

DOI: 10.1016/j.ijcard.2018.08.091

Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study (Journal article)

Guo, Y., Wang, Y., Li, X., Shan, Z., Shi, X., Xi, G., . . . Investigators, C. R. (2018). Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study. BMJ OPEN, 8(5). doi:10.1136/bmjopen-2017-020191

DOI: 10.1136/bmjopen-2017-020191

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study (Journal article)

Chao, T. -F., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., Hu, Y. -F., . . . Chen, S. -A. (2018). Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study. CIRCULATION, 138(1), 37-47. doi:10.1161/CIRCULATIONAHA.117.031658

DOI: 10.1161/CIRCULATIONAHA.117.031658

Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control (Journal article)

Bonde, A. N., Staerk, L., Lee, C. J. -Y., Vinding, N. E., Bang, C. N., Torp-Pedersen, C., . . . Olesen, J. B. (2018). Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(12), 1357-1365. doi:10.1016/j.jacc.2018.06.065

DOI: 10.1016/j.jacc.2018.06.065

Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry (Journal article)

Boriani, G., Laroche, C., Diemberger, I., Fantecchi, E., Meeder, J., Kurpesa, M., . . . Investi, E. O. R. P. -A. F. G. P. R. (2018). Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 29(4), 566-572. doi:10.1111/jce.13428

DOI: 10.1111/jce.13428

Performance of the Cockcroft-Gault, MDRD and CKD-EPI Formulae in Atrial Fibrillation patients. The FANTASIIA Registry (Conference Paper)

Pastor, M. A. E., Rivera-Caravaca, J. M., Roldan, V., Roldan-Rabadan, I., Muniz, J., Cequier, A., . . . FANTASIIA. (2018). Performance of the Cockcroft-Gault, MDRD and CKD-EPI Formulae in Atrial Fibrillation patients. The FANTASIIA Registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 714). Retrieved from http://gateway.webofknowledge.com/

Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation (Journal article)

Jose Serna, M., Miguel Rivera-Caravaca, J., Gonzalez-Conejero, R., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., . . . Marin, F. (2018). Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 48(6). doi:10.1111/eci.12929

DOI: 10.1111/eci.12929

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores (Journal article)

Proietti, M., Miguel Rivera-Caravaca, J., Asuncion Esteve-Pastor, M., Romiti, G. F., Marin, F., & Lip, G. Y. H. (2018). Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(18). doi:10.1161/JAHA.118.009766

DOI: 10.1161/JAHA.118.009766

Predicting bleeding events in anticoagulated patients with atrial fibrillation: a comparison between HAS-BLED and GARFIELD-AF bleeding score (Conference Paper)

Proietti, M., Rivera-Caravaca, J. M., Esteve-Pastor, M. A., Romiti, G. F., Marin, F., & Lip, G. Y. H. (2018). Predicting bleeding events in anticoagulated patients with atrial fibrillation: a comparison between HAS-BLED and GARFIELD-AF bleeding score. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 20). Retrieved from http://gateway.webofknowledge.com/

Predicting recurrent atrial fibrillation after catheter ablation (Journal article)

Mujovic, N., Marinkovic, M., Lip, G. Y. H., & Potpara, T. S. (2018). Predicting recurrent atrial fibrillation after catheter ablation. EUROPACE, 20, F460. doi:10.1093/europace/euy022

DOI: 10.1093/europace/euy022

Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort (Journal article)

Bisson, A., Bodin, A., Clementy, N., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2018). Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort. AMERICAN JOURNAL OF CARDIOLOGY, 121(4), 437-444. doi:10.1016/j.amjcard.2017.11.016

DOI: 10.1016/j.amjcard.2017.11.016

Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation (Journal article)

Kornej, J., Schumacher, K., Dinov, B., Kosich, F., Sommer, P., Arya, A., . . . Hindricks, G. (2018). Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation. SCIENTIFIC REPORTS, 8. doi:10.1038/s41598-018-31133-x

DOI: 10.1038/s41598-018-31133-x

Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA(2)DS(2)-VASc and HAS-BLED (Journal article)

Miguel Rivera-Caravaca, J., Roldan, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Marin, F., & Lip, G. Y. H. (2018). Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA(2)DS(2)-VASc and HAS-BLED. AMERICAN HEART JOURNAL, 197, 27-34. doi:10.1016/j.ahj.2017.11.004

DOI: 10.1016/j.ahj.2017.11.004

Predictors of diastolic dysfunction in ethnic groups: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) (Journal article)

Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2018). Predictors of diastolic dysfunction in ethnic groups: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). JOURNAL OF HUMAN HYPERTENSION, 32(7), 477-486. doi:10.1038/s41371-018-0064-z

DOI: 10.1038/s41371-018-0064-z

Predictors of exercise capacity in the elderly population with permanent atrial fibrillation and preserved left ventricular function (Conference Paper)

Khan, A. A., Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). Predictors of exercise capacity in the elderly population with permanent atrial fibrillation and preserved left ventricular function. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 95). Retrieved from http://gateway.webofknowledge.com/

Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation (Journal article)

Shahid, F., Pastori, D., Violi, F., & Lip, G. Y. H. (2018). Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation. PHARMACOLOGICAL RESEARCH, 132, 149-159. doi:10.1016/j.phrs.2018.04.019

DOI: 10.1016/j.phrs.2018.04.019

Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project (Journal article)

Shahid, F., Rahmat, N. A., Lip, G. Y. H., & Shantsila, E. (2018). Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project. PLOS ONE, 13(7). doi:10.1371/journal.pone.0200373

DOI: 10.1371/journal.pone.0200373

Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events (Journal article)

Ogawa, H., An, Y., Ikeda, S., Aono, Y., Doi, K., Ishii, M., . . . Investigators, F. A. F. R. (2018). Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events. STROKE, 49(10), 2301-2308. doi:10.1161/STROKEAHA.118.021396

DOI: 10.1161/STROKEAHA.118.021396

Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry (Journal article)

Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan-Rabadan, I., Roldan, V., Muniz, J., Rana-Miguez, P., . . . Investigators, F. A. N. T. A. S. H. A. (2018). Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry. EUROPACE, 20(9), 1435-1441. doi:10.1093/europace/eux314

DOI: 10.1093/europace/eux314

Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation (Journal article)

Miyazawa, K., Pastori, D., & Lip, G. Y. H. (2018). Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation. PROGRESS IN CARDIOVASCULAR DISEASES, 60(4-5), 537-541. doi:10.1016/j.pcad.2017.12.002

DOI: 10.1016/j.pcad.2017.12.002

RELATION OF STROKE AND BLEEDING RISK PROFILES TO EFFICACY AND SAFETY OF DABIGATRAN IN ATRIAL FIBRILLATION AFTER PCI: AN ANCILLARY ANALYSIS FROM THE RE-DUAL PCI TRIAL (Conference Paper)

Lip, G., Mauri, L., Montalescot, G., Ozkor, M., Vardas, P., Steg, P. G., . . . Cannon, C. (2018). RELATION OF STROKE AND BLEEDING RISK PROFILES TO EFFICACY AND SAFETY OF DABIGATRAN IN ATRIAL FIBRILLATION AFTER PCI: AN ANCILLARY ANALYSIS FROM THE RE-DUAL PCI TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 71 (pp. 289). Retrieved from http://gateway.webofknowledge.com/

REPLY: The Case of Dynamic CHA(2)DS(2)-VASc Score Beyond Risk Prediction (Journal article)

Chao, T. -F., Lip, G. Y. H., & Chen, S. -A. (2018). REPLY: The Case of Dynamic CHA(2)DS(2)-VASc Score Beyond Risk Prediction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 71(17), 1942-1943. doi:10.1016/j.jacc.2018.03.012

DOI: 10.1016/j.jacc.2018.03.012

Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation (Journal article)

Purmah, Y., Proietti, M., Laroche, C., Mazurek, M., Tahmatzidis, D., Boriani, G., . . . Registry, E. O. R. P. -A. F. G. P. (2018). Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation. EUROPACE, 20(2), 243-252. doi:10.1093/europace/euw421

DOI: 10.1093/europace/euw421

Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis (Journal article)

Proietti, M., Romanazzi, I., Romiti, G. F., Farcomeni, A., & Lip, G. Y. H. (2018). Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis. STROKE, 49(1), 98-+. doi:10.1161/STROKEAHA.117.018395

DOI: 10.1161/STROKEAHA.117.018395

Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban (Journal article)

Tepper, P. G., Mardekian, J., Masseria, C., Phatak, H., Kamble, S., Abdulsattar, Y., . . . Lip, G. Y. H. (2018). Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban. PLOS ONE, 13(11). doi:10.1371/journal.pone.0205989

DOI: 10.1371/journal.pone.0205989

Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol (Journal article)

Miguel Rivera-Caravaca, J., Roldar, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Marin, F., & Lip, G. Y. H. (2018). Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol. CLINICAL THERAPEUTICS, 40(1), 114-122. doi:10.1016/j.clinthera.2017.11.014

DOI: 10.1016/j.clinthera.2017.11.014

Refining stroke and bleeding risk prediction by adding consecutive biomarkers to CHA2DS2-VASc and HAS-BLED scores (Conference Paper)

Rivera Caravaca, J. M., Esteve-Pastor, M. A., Vilchez, J. A., Galvez, J., Vicente, V., Marin, F., . . . Lip, G. Y. H. (2018). Refining stroke and bleeding risk prediction by adding consecutive biomarkers to CHA2DS2-VASc and HAS-BLED scores. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 821-822). Retrieved from http://gateway.webofknowledge.com/

Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry (Conference Paper)

Proietti, M., Laroche, C., Popescu, M. I., Tello-Montoliu, A., Garcia-Bolao, I., Lane, D. A., . . . Registry, E. O. R. P. -A. F. G. L. T. (2018). Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 694-695). Retrieved from http://gateway.webofknowledge.com/

Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry (Journal article)

Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldan-Rabadan, I., Roldan, V., Muniz, J., Rana-Miguez, P., . . . Investigators, F. A. N. T. A. S. I. I. A. S. (2018). Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry. THROMBOSIS AND HAEMOSTASIS, 118(2), 279-287. doi:10.1160/TH17-06-0416

DOI: 10.1160/TH17-06-0416

Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study) (Journal article)

Lip, G. Y. H., Merino, J. L., Dan, G. A., Themistoclakis, S., Ellenbogen, K. A., De Caterina, R., . . . Goette, A. (2018). Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study). AMERICAN JOURNAL OF CARDIOLOGY, 121(2), 193-198. doi:10.1016/j.amjcard.2017.10.008

DOI: 10.1016/j.amjcard.2017.10.008

Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry (Journal article)

Roldan Rabadan, I., Asuncion Esteve-Pastor, M., Anguita-Sanchez, M., Muniz, J., Camacho Siles, J., Angustias Quesada, M., . . . Investigators, F. A. N. T. A. S. I. I. A. S. (2018). Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 48(5). doi:10.1111/eci.12910

DOI: 10.1111/eci.12910

Relation of the CHA(2)DS(2)-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study) (Journal article)

Koene, R. J., Alraies, M. C., Norby, F. L., Soliman, E. Z., Maheshwari, A., Lip, G. Y. H., . . . Chen, L. Y. (2019). Relation of the CHA(2)DS(2)-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study). AMERICAN JOURNAL OF CARDIOLOGY, 123(3), 402-408. doi:10.1016/j.amjcard.2018.10.037

DOI: 10.1016/j.amjcard.2018.10.037

Relationship between age and use of oral anticoagulant drugs in european atrial fibrillation patients: the EORP-AF general long-term registry (Conference Paper)

Boriani, G., Proietti, M., Laroche, C., Diemberger, I., Rheinert, C., Serdechnaya, E. V., . . . Registry, E. O. R. P. -A. F. G. L. -T. (2018). Relationship between age and use of oral anticoagulant drugs in european atrial fibrillation patients: the EORP-AF general long-term registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 703-704). Retrieved from http://gateway.webofknowledge.com/

Relationship between charlson comorbidity index and risk of adverse outcomes in patients with atrial fibrillation: an analysis from the FANTASIIA registry (Conference Paper)

Proietti, M., Esteve-Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., . . . Marin, P. (2018). Relationship between charlson comorbidity index and risk of adverse outcomes in patients with atrial fibrillation: an analysis from the FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1420-1421). Retrieved from http://gateway.webofknowledge.com/

Relationship between inflammation and atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices (Conference Paper)

Pastori, D., Miyazawa, K., Li, Y., Shahid, F., Hado, H., & Lip, G. Y. H. (2018). Relationship between inflammation and atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 401). Retrieved from http://gateway.webofknowledge.com/

Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation (Journal article)

Chao, T. -F., Lip, G. Y. H., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2018). Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 71(2), 122-132. doi:10.1016/j.jacc.2017.10.085

DOI: 10.1016/j.jacc.2017.10.085

Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation (Journal article)

Pastori, D., Pignatelli, P., Sciacqua, A., Perticone, M., Violi, F., & Lip, G. Y. H. (2018). Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 255, 69-73. doi:10.1016/j.ijcard.2017.12.076

DOI: 10.1016/j.ijcard.2017.12.076

Relationship of troponin to incident atrial fibrillation occurrence, recurrence after radiofrequency ablation and prognosis: a systematic review, meta-analysis and meta-regression (Journal article)

Bai, Y., Guo, S. -D., Liu, Y., Ma, C. -S., & Lip, G. Y. H. (2018). Relationship of troponin to incident atrial fibrillation occurrence, recurrence after radiofrequency ablation and prognosis: a systematic review, meta-analysis and meta-regression. BIOMARKERS, 23(6), 512-517. doi:10.1080/1354750X.2018.1463562

DOI: 10.1080/1354750X.2018.1463562

Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source (Journal article)

Ntaios, G., Lip, G. Y. H., Lambrou, D., Michel, P., Perlepe, K., Eskandari, A., . . . Papavasileiou, V. (2018). Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source. STROKE, 49(12), 2904-2909. doi:10.1161/STROKEAHA.118.023281

DOI: 10.1161/STROKEAHA.118.023281

Renal function stratification and outcomes following catheter ablation of patients with atrial fibrillation (Conference Paper)

Deng, H., Shantsila, A., Xue, Y. M., Potpapa, T. S., Zhan, X. Z., Liao, H. T., . . . Abla, G. A. F. (2018). Renal function stratification and outcomes following catheter ablation of patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1221). Retrieved from http://gateway.webofknowledge.com/

Reply to 'Comment on 'Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and metaanalysis of randomized clinical trials' by Tse et al.' (Journal article)

Tse, G., Roever, L., Wong, M. C. S., Lip, G. Y. H., Liu, T., & Network, I. H. I. S. (2018). Reply to 'Comment on 'Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and metaanalysis of randomized clinical trials' by Tse et al.'. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 84(9), 2165-2166. doi:10.1111/bcp.13658

DOI: 10.1111/bcp.13658

Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis (Journal article)

Proietti, M., Romiti, G. F., Romanazzi, I., Farcomeni, A., Staerk, L., Nielsen, P. B., & Lip, G. Y. H. (2018). Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 261, 84-91. doi:10.1016/j.ijcard.2018.03.053

DOI: 10.1016/j.ijcard.2018.03.053

Resumption of antiplatelet therapy in patients with primary intracranial haemorrhage: Balancing benefits and risks (Journal article)

Khan, A. A., & Lip, G. Y. H. (2018). Resumption of antiplatelet therapy in patients with primary intracranial haemorrhage: Balancing benefits and risks. JOURNAL OF THE NEUROLOGICAL SCIENCES, 384, 139-140. doi:10.1016/j.jns.2017.11.038

DOI: 10.1016/j.jns.2017.11.038

Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study (Journal article)

Staerk, L., Fosbol, E. L., Lamberts, M., Bonde, A. N., Gadsboll, K., Sindet-Pedersen, C., . . . Olesen, J. B. (2018). Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study. EUROPEAN HEART JOURNAL, 39(19), 1698-+. doi:10.1093/eurheartj/ehx598

DOI: 10.1093/eurheartj/ehx598

Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment (Journal article)

Brown, J. D., Goodin, A. J., Lip, G. Y. H., & Adams, V. R. (2018). Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(6). doi:10.1161/JAHA.117.007901

DOI: 10.1161/JAHA.117.007901

Risk assessment and management of atrial fibrillation patients with left atrial thrombus (Journal article)

Miyazawa, K., & Lip, G. Y. H. (2019). Risk assessment and management of atrial fibrillation patients with left atrial thrombus. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 42(1), 1-3. doi:10.1111/pace.13556

DOI: 10.1111/pace.13556

Risk factors for new-onset atrial fibrillation: A focus on Asian populations (Journal article)

Li, Y., Pastori, D., Guo, Y., Wang, Y., & Lip, G. Y. H. (2018). Risk factors for new-onset atrial fibrillation: A focus on Asian populations. INTERNATIONAL JOURNAL OF CARDIOLOGY, 261, 92-98. doi:10.1016/j.ijcard.2018.02.051

DOI: 10.1016/j.ijcard.2018.02.051

Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices (Journal article)

Miyazawa, K., Kondo, Y., Nakano, M., Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Senoo, K., . . . Lip, G. Y. H. (2018). Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 52, 54-59. doi:10.1016/j.ejim.2018.02.019

DOI: 10.1016/j.ejim.2018.02.019

Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study (Journal article)

Christiansen, C. B., Torp-Pedersen, C., Olesen, J. B., Gislason, G., Lamberts, M., Carlson, N., . . . Lip, G. Y. H. (2018). Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study. BMC CARDIOVASCULAR DISORDERS, 18. doi:10.1186/s12872-018-0825-1

DOI: 10.1186/s12872-018-0825-1

Risk of recurrent intracerebral haemorrhage and ischaemic stroke after intracerebral haemorrhage: a multicentre prospective cohort study (Conference Paper)

Wilson, D., Ambler, G., Hostettler, I. C., Banerjee, G., Shakeshaft, C., Cohen, H., . . . Werring, D. J. (2018). Risk of recurrent intracerebral haemorrhage and ischaemic stroke after intracerebral haemorrhage: a multicentre prospective cohort study. In INTERNATIONAL JOURNAL OF STROKE Vol. 13 (pp. 11). Retrieved from http://gateway.webofknowledge.com/

Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study (Journal article)

Melgaard, L., Overvad, T. F., Skjoth, F., Christensen, J. H., Larsen, T. B., & Lip, G. Y. H. (2018). Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study. ESC HEART FAILURE, 5(2), 319-326. doi:10.1002/ehf2.12256

DOI: 10.1002/ehf2.12256

Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus (Journal article)

Li, Y. -G., Pastori, D., & Lip, G. Y. H. (2018). Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus. DIABETIC MEDICINE, 35(8), 1134-1135. doi:10.1111/dme.13685

DOI: 10.1111/dme.13685

Role of Monocytes in Heart Failure and Atrial Fibrillation (Journal article)

Shahid, F., Lip, G. Y. H., & Shantsila, E. (2018). Role of Monocytes in Heart Failure and Atrial Fibrillation. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(3). doi:10.1161/JAHA.117.007849

DOI: 10.1161/JAHA.117.007849

Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic stroke (Journal article)

Khan, A. A., & Lip, G. Y. H. (2018). Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic stroke. EUROPEAN JOURNAL OF NEUROLOGY, 25(8), 1009-1010. doi:10.1111/ene.13664

DOI: 10.1111/ene.13664

SAFETY AND EFFECTIVENESS OF DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION WITH AND WITHOUT PRIOR STROKE: DATA FROM THE GLORIA-AF REGISTRY PROGRAM (Conference Paper)

Diener, H. C., Teutsch, C., Huisman, M. V., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Lip, G. Y. H. (2018). SAFETY AND EFFECTIVENESS OF DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION WITH AND WITHOUT PRIOR STROKE: DATA FROM THE GLORIA-AF REGISTRY PROGRAM. In INTERNATIONAL JOURNAL OF STROKE Vol. 13 (pp. 99). Retrieved from http://gateway.webofknowledge.com/

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review andmeta-analysis of randomized clinical trials (Journal article)

Golwala, H. B., Cannon, C. P., Steg, P. G., Doros, G., Qamar, A., Ellis, S. G., . . . Bhatt, D. L. (2018). Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review andmeta-analysis of randomized clinical trials. EUROPEAN HEART JOURNAL, 39(19), 1726-+. doi:10.1093/eurheartj/ehy162

DOI: 10.1093/eurheartj/ehy162

Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial (Journal article)

Chi, G., Kerneis, M., Kalayci, A., Liu, Y., Mehran, R., Bode, C., . . . Gibson, C. M. (2018). Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial. AMERICAN HEART JOURNAL, 203, 17-24. doi:10.1016/j.ahj.2018.06.003

DOI: 10.1016/j.ahj.2018.06.003

Screening for atrial fibrillation: look harder, look longer, and improve stroke outcomes with oral anticoagulation (Journal article)

Miyazawa, K., Mairesse, G. H., & Lip, G. Y. H. (2018). Screening for atrial fibrillation: look harder, look longer, and improve stroke outcomes with oral anticoagulation. EUROPACE, 20, F278-F279. doi:10.1093/europace/euy088

DOI: 10.1093/europace/euy088

Seasonal variation in the risk of ischemic stroke in patients with atrial fibrillation: A nationwide cohort study (Journal article)

Liao, J. -N., Chao, T. -F., Liu, C. -J., Chen, S. -J., Hung, C. -L., Lin, Y. -J., . . . Chen, S. -A. (2018). Seasonal variation in the risk of ischemic stroke in patients with atrial fibrillation: A nationwide cohort study. HEART RHYTHM, 15(11), 1611-1616. doi:10.1016/j.hrthm.2018.06.043

DOI: 10.1016/j.hrthm.2018.06.043

Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE) (Journal article)

Miyazawa, K., Li, Y. -G., Rashed, W. A., Al Mahmeed, W., Shehab, A., Zubaid, M., & Lip, G. Y. H. (2019). Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE). INTERNATIONAL JOURNAL OF CARDIOLOGY, 274, 126-131. doi:10.1016/j.ijcard.2018.07.120

DOI: 10.1016/j.ijcard.2018.07.120

Self-reported physical activity is associated with biomarkers of cardiac fibrosis and cell apoptosis in patients with atrial fibrillation (Conference Paper)

Dzeshka, M. S., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2018). Self-reported physical activity is associated with biomarkers of cardiac fibrosis and cell apoptosis in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 611). Retrieved from http://gateway.webofknowledge.com/

Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society (Journal article)

Linde, C., Bongiorni, M. G., Birgersdotter-Green, T., Curtis, A. B., Deisenhofer, I., Furokawa, T., . . . Grp, E. S. C. S. D. (2018). Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. EUROPACE, 20(10), 1565-+. doi:10.1093/europace/euy067

DOI: 10.1093/europace/euy067

Sex differences in risk of incident venous thromboembolism in heart failure patients (Journal article)

Melgaard, L., Nielsen, P. B., Overvad, T. F., Skjoth, F., Lip, G. Y. H., & Larsen, T. B. (2019). Sex differences in risk of incident venous thromboembolism in heart failure patients. CLINICAL RESEARCH IN CARDIOLOGY, 108(1), 101-109. doi:10.1007/s00392-018-1329-9

DOI: 10.1007/s00392-018-1329-9

Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients (Journal article)

Marzona, I., Proietti, M., Farcomeni, A., Romiti, G. F., Romanazzi, I., Raparelli, V., . . . Roncaglioni, M. C. (2018). Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients. INTERNATIONAL JOURNAL OF CARDIOLOGY, 269, 182-191. doi:10.1016/j.ijcard.2018.07.044

DOI: 10.1016/j.ijcard.2018.07.044

Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients (Conference Paper)

Marzona, I., Proietti, M., Farcomeni, A., Romiti, G. F., Romanazzi, I., Raparelli, V., . . . Roncaglioni, M. C. (2018). Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 235). Retrieved from http://gateway.webofknowledge.com/

Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation (Journal article)

Law, S. W. Y., Lau, W. C. Y., Wong, I. C. K., Lip, G. Y. H., Mok, M. T., Siu, C. -W., & Chan, E. W. (2018). Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(3), 271-282. doi:10.1016/j.jacc.2018.04.066

DOI: 10.1016/j.jacc.2018.04.066

Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA(2)DS(2)-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry (Journal article)

Steensig, K., Olesen, K. K. W., Thim, T., Nielsen, J. C., Jensen, S. E., Jensen, L. O., . . . Maeng, M. (2018). Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA(2)DS(2)-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry. THROMBOSIS AND HAEMOSTASIS, 118(12), 2162-2170. doi:10.1055/s-0038-1675401

DOI: 10.1055/s-0038-1675401

Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients - Meta - Analysis (Journal article)

Senoo, K., Kondo, Y., Kobayashi, Y., & Lip, G. Y. H. (2018). Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients - Meta - Analysis. CIRCULATION JOURNAL, 82(3), 672-676. doi:10.1253/circj.CJ-17-1164

DOI: 10.1253/circj.CJ-17-1164

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia (Journal article)

Dias, I. H. K., Milic, I., Lip, G. Y. H., Devitt, A., Polidori, M. C., & Griffiths, H. R. (2018). Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia. REDOX BIOLOGY, 16, 139-145. doi:10.1016/j.redox.2018.02.014

DOI: 10.1016/j.redox.2018.02.014

Single right coronary artery with congenital absence of left coronary system. (Journal article)

Upadhyaya, S. G. N., Mughal, L. H., Connolly, D., & Lip, G. (2018). Single right coronary artery with congenital absence of left coronary system.. BMJ case reports, 11(1). doi:10.1136/bcr-2018-228296

DOI: 10.1136/bcr-2018-228296

Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project (Journal article)

Miguel Rivera-Caravaca, J., Roldan, V., Romera, M., Asuncion Esteve-Pastor, M., Valdes, M., Lip, G. Y. H., . . . Marin, F. (2018). Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project. JOURNAL OF GENERAL INTERNAL MEDICINE, 33(6), 847-854. doi:10.1007/s11606-017-4279-4

DOI: 10.1007/s11606-017-4279-4

Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial (Journal article)

Cohen, A. A., Heidbuchel, H., Le Heuzey, J. -Y., De Caterina, R., Merino, J. L., Jin, J., . . . Lip, G. Y. H. (2019). Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial. ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 38(2), 131-135. doi:10.1016/j.ahj.2018.10.008

DOI: 10.1016/j.ahj.2018.10.008

Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study (Journal article)

Staerk, L., Gerds, T. A., Lip, G. Y. H., Ozenne, B., Bonde, A. N., Lamberts, M., . . . Olesen, J. B. (2018). Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study. JOURNAL OF INTERNAL MEDICINE, 283(1), 45-55. doi:10.1111/joim.12683

DOI: 10.1111/joim.12683

State of play and future direction with NOACs: An expert consensus (Journal article)

Cohen, A. T., Lip, G. Y., De Caterina, R., Heidbuchel, H., Zamorano, J. L., Agnelli, G., . . . Camm, A. J. (2018). State of play and future direction with NOACs: An expert consensus. VASCULAR PHARMACOLOGY, 106, 9-21. doi:10.1016/j.vph.2018.04.001

DOI: 10.1016/j.vph.2018.04.001

Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients (Journal article)

Li, Y. -G., Lee, S. -R., Choi, E. -K., & Lip, G. Y. H. (2018). Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients. KOREAN CIRCULATION JOURNAL, 48(8), 665-684. doi:10.4070/kcj.2018.0190

DOI: 10.4070/kcj.2018.0190

Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation (Journal article)

Kea, B., Lin, A. L., Olshansky, B., Malveau, S., Fu, R., Raitt, M., . . . Sun, B. C. (2018). Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(4), 471-472. doi:10.1016/j.jacc.2018.05.022

DOI: 10.1016/j.jacc.2018.05.022

Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy (Journal article)

Jung, H., Sung, J. -H., Yang, P. -S., Jang, E., Yu, H. T., Kim, T. -H., . . . Lip, G. Y. H. (2018). Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(19), 2409-2411. doi:10.1016/j.jacc.2018.07.098

DOI: 10.1016/j.jacc.2018.07.098

Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study (Journal article)

Lip, G. Y. H., Jensen, M., Melgaard, L., Skjoth, F., Nielsen, P. B., & Larsen, T. B. (2019). Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study. EUROPACE, 21(1), 33-40. doi:10.1093/europace/euy151

DOI: 10.1093/europace/euy151

Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: prospective validation of the EHRA classification in a nationwide cohort study (Conference Paper)

Jensen, M., Skjoeth, F., Nielsen, P. B., Larsen, T. B., Melgaard, L., & Lip, G. Y. H. (2018). Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: prospective validation of the EHRA classification in a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 25). Retrieved from http://gateway.webofknowledge.com/

Stroke prevention in atrial fibrillation: State of the art (Journal article)

Li, Y. -G., & Lip, G. Y. H. (2019). Stroke prevention in atrial fibrillation: State of the art. INTERNATIONAL JOURNAL OF CARDIOLOGY, 287, 201-209. doi:10.1016/j.ijcard.2018.09.057

DOI: 10.1016/j.ijcard.2018.09.057

Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe (Journal article)

Fanaroff, A. C., Steffel, J., Alexander, J. H., Lip, G. Y. H., Califf, R. M., & Lopes, R. D. (2018). Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe. EUROPEAN HEART JOURNAL, 39(32), 2932-+. doi:10.1093/eurheartj/ehy236

DOI: 10.1093/eurheartj/ehy236

Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations (Journal article)

Nielsen, P. B., Potpara, T. S., & Lip, G. Y. H. (2019). Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations. TRENDS IN CARDIOVASCULAR MEDICINE, 29(3), 150-152. doi:10.1016/j.tcm.2018.07.003

DOI: 10.1016/j.tcm.2018.07.003

Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification (Journal article)

Bisson, A., Bodin, A., Clementy, N., Bernard, A., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2018). Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification. INTERNATIONAL JOURNAL OF CARDIOLOGY, 260, 93-98. doi:10.1016/j.ijcard.2018.03.017

DOI: 10.1016/j.ijcard.2018.03.017

Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program (Journal article)

McIntyre, W. F., Conen, D., Olshansky, B., Halperin, J. L., Hayek, E., Huisman, M. V., . . . Healey, J. S. (2018). Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program. CLINICAL CARDIOLOGY, 41(6), 744-751. doi:10.1002/clc.22936

DOI: 10.1002/clc.22936

TOTAL MONOCYTE COUNT AS PREDICTOR OF EXERCISE CAPACITY IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION - THE WEST BIRMINGHAM AF PROJECT (Conference Paper)

Khan, A., Shahid, F., Lip, G., & Shantsila, E. (2018). TOTAL MONOCYTE COUNT AS PREDICTOR OF EXERCISE CAPACITY IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION AND PRESERVED LEFT VENTRICULAR FUNCTION - THE WEST BIRMINGHAM AF PROJECT. In HEART Vol. 104 (pp. A79). doi:10.1136/heartjnl-2018-BCS.96

DOI: 10.1136/heartjnl-2018-BCS.96

Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation (Journal article)

Pastori, D., Farcomeni, A., Saliola, M., Del Sole, F., Pignatelli, P., Violi, F., . . . Grp, A. T. H. E. R. O. -A. F. S. (2018). Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 54, 34-39. doi:10.1016/j.ejim.2018.04.007

DOI: 10.1016/j.ejim.2018.04.007

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: comment (Journal article)

Brown, J. D., Goodin, A., & Lip, G. Y. H. (2018). The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: comment. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 16(12), 2537-2539. doi:10.1111/jth.14301

DOI: 10.1111/jth.14301

The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants (Journal article)

Lip, G. Y. H., Skjoth, F., Nielsen, P. B., Kjaeldgaard, J. N., & Larsen, T. B. (2018). The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants. AMERICAN JOURNAL OF MEDICINE, 131(5). doi:10.1016/j.amjmed.2017.11.046

DOI: 10.1016/j.amjmed.2017.11.046

The Importance and Future of Population Screening for Atrial Fibrillation (Journal article)

Shin, S. Y., & Lip, G. Y. H. (2018). The Importance and Future of Population Screening for Atrial Fibrillation. CANADIAN JOURNAL OF CARDIOLOGY, 34(11), 1407-1411. doi:10.1016/j.cjca.2018.08.016

DOI: 10.1016/j.cjca.2018.08.016

The effect of PCI complexity on the efficacy and safety of dabigatran dual therapy vs warfarin triple therapy in atrial fibrillation: a subgroup analysis from the RE-DUAL PCI trial (Conference Paper)

Mauri, L., Steg, P. S., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., . . . Inv, R. E. -D. U. A. L. P. C. I. S. C. (2018). The effect of PCI complexity on the efficacy and safety of dabigatran dual therapy vs warfarin triple therapy in atrial fibrillation: a subgroup analysis from the RE-DUAL PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 653). Retrieved from http://gateway.webofknowledge.com/

The effect of age on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial (Conference Paper)

Ten Berg, J. M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., De Veer, A. N. N. E., Nordaby, M., . . . Investig, R. E. D. P. C. I. S. C. (2018). The effect of age on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 439-440). Retrieved from http://gateway.webofknowledge.com/

The impact of hypertension on stroke and mortality in patients with atrial fibrillation: the loire valley atrial fibrillation project (Conference Paper)

Shantsila, A., Fauchier, L., Bisson, A., Bodin, A., & Lip, G. Y. H. (2018). The impact of hypertension on stroke and mortality in patients with atrial fibrillation: the loire valley atrial fibrillation project. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1411). Retrieved from http://gateway.webofknowledge.com/

The increased risk of stroke, bleeding and mortality with new-onset atrial fibrillation in critically ill patients: a nationwide cohort study (Conference Paper)

Kim, K., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., . . . Lip, G. Y. H. (2018). The increased risk of stroke, bleeding and mortality with new-onset atrial fibrillation in critically ill patients: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1075). Retrieved from http://gateway.webofknowledge.com/

The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis (Conference Paper)

Penson, P. E., Awad, K., Lane, D., Banach, M., & Lip, G. Y. H. (2018). The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 817). Retrieved from http://gateway.webofknowledge.com/

The prothrombotic state in atrial fibrillation: pathophysiological and management implications (Journal article)

Khan, A. A., & Lip, G. Y. H. (2019). The prothrombotic state in atrial fibrillation: pathophysiological and management implications. CARDIOVASCULAR RESEARCH, 115(1), 31-45. doi:10.1093/cvr/cvy272

DOI: 10.1093/cvr/cvy272

The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set (Journal article)

Mujovic, N., Marinkovic, M., Markovic, N., Vucicevic, V., Lip, G. Y. H., Bunch, T. J., & Potpara, T. S. (2018). The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set. SCIENTIFIC REPORTS, 8. doi:10.1038/s41598-018-28072-y

DOI: 10.1038/s41598-018-28072-y

The relationship of systemic markers of haemostasis with retinal blood vessel responses in cardiovascular disease and/or diabetes (Journal article)

Heitmar, R., Nicholl, P., Lee, B., Lau, Y. C., & Lip, G. Y. H. (2018). The relationship of systemic markers of haemostasis with retinal blood vessel responses in cardiovascular disease and/or diabetes. BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 75(3), 116-121. doi:10.1080/09674845.2017.1420130

DOI: 10.1080/09674845.2017.1420130

The safety of NOACs in atrial fibrillation patient subgroups: A narrative review (Journal article)

Lip, G. Y. H. (2019). The safety of NOACs in atrial fibrillation patient subgroups: A narrative review. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 73(2). doi:10.1111/ijcp.13285

DOI: 10.1111/ijcp.13285

Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF) (Journal article)

Sobue, Y., Watanabe, E., Lip, G. Y. H., Koshikawa, M., Ichikawa, T., Kawai, M., . . . Ozaki, Y. (2018). Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF). HEART AND VESSELS, 33(4), 403-412. doi:10.1007/s00380-017-1073-5

DOI: 10.1007/s00380-017-1073-5

Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation (Journal article)

Pastori, D., Pignatelli, P., Cribari, F., Carnevale, R., Saliola, M., Violi, F., & Lip, G. Y. H. (2018). Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation. AMERICAN HEART JOURNAL, 200, 32-36. doi:10.1016/j.ahj.2018.03.004

DOI: 10.1016/j.ahj.2018.03.004

Time trends in use of the CHADS(2) and CHA(2)DS(2)VASc scores, and the geographical and specialty uptake of these scores from a popular online clinical decision tool and medical reference (Journal article)

Habboushe, J., Altman, C., & Lip, G. Y. H. (2019). Time trends in use of the CHADS(2) and CHA(2)DS(2)VASc scores, and the geographical and specialty uptake of these scores from a popular online clinical decision tool and medical reference. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 73(2). doi:10.1111/ijcp.13280

DOI: 10.1111/ijcp.13280

Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention (Journal article)

Chi, G., Yee, M. K., Kalayci, A., Kerneis, M., AlKhalfan, F., Mehran, R., . . . Gibson, C. M. (2018). Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 46(3), 346-350. doi:10.1007/s11239-018-1703-5

DOI: 10.1007/s11239-018-1703-5

Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey (Journal article)

Dan, G. -A., Iliodromitis, K., Scherr, D., Marin, F., Lenarczyk, R., Estner, H. L., . . . Lip, G. Y. H. (2018). Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey. EUROPACE, 20(8), 1382-1387. doi:10.1093/europace/euy094

DOI: 10.1093/europace/euy094

Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry (Journal article)

Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., Dubner, S. J., . . . Lip, G. Y. H. (2018). Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry. AMERICAN HEART JOURNAL, 198, 55-63. doi:10.1016/j.ahj.2017.08.018

DOI: 10.1016/j.ahj.2017.08.018

Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF (Conference Paper)

Halperin, J. L., Teutsch, C., Huisman, M. V., Diener, H. -C., Rothman, K. J., Ma, C. S., . . . Lip, G. Y. H. (2018). Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 610). Retrieved from http://gateway.webofknowledge.com/

Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry (Conference Paper)

Dubner, S. J., Huisman, M. V., Diener, H. C., Halperin, J. L., Rothman, K. J., Ma, C. S., . . . Investigators, G. L. O. R. I. A. -A. F. (2018). Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 606-607). Retrieved from http://gateway.webofknowledge.com/

Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry Program (Conference Paper)

Ma, C., Kim, Y. H., Higashino, Y., Shlyakhto, E. V., Dubner, S. J., Halperin, J. L., . . . Lip, G. Y. H. (2018). Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry Program. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 72 (pp. C175-C176). doi:10.1016/j.jacc.2018.08.783

DOI: 10.1016/j.jacc.2018.08.783

Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study (Journal article)

Fangel, M. V., Nielsen, P. B., Larsen, T. B., Christensen, B., Overvad, T. F., Lip, G. Y. H., . . . Jensen, M. B. (2018). Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 268, 137-142. doi:10.1016/j.ijcard.2018.05.037

DOI: 10.1016/j.ijcard.2018.05.037

Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: a nationwide cohort study (Conference Paper)

Fangel, M. V., Nielsen, P. B., Larsen, T. B., Christensen, B., Overvad, T. F., Lip, G. Y. H., . . . Jensen, M. B. (2018). Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 404). Retrieved from http://gateway.webofknowledge.com/

Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response. (Journal article)

Mahmood, M., & Lip, G. Y. H. (2019). Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response.. Revista espanola de cardiologia (English ed.), 72(1), 97-98. doi:10.1016/j.rec.2018.08.002

DOI: 10.1016/j.rec.2018.08.002

Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction (Journal article)

Potpara, T. S., Ferro, C. J., & Lip, G. Y. H. (2018). Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction. NATURE REVIEWS NEPHROLOGY, 14(5), 337-351. doi:10.1038/nrneph.2018.19

DOI: 10.1038/nrneph.2018.19

Use of oral anticoagulation and association to outcomes in atrial fibrillation patients who develop chronic kidney disease: a nationwide cohort study (Conference Paper)

Bonde, A. N., Lip, G. Y. H., Kamper, A. L., Gislason, G., Torp-Pedersen, C., Hlatky, M., & Olesen, J. B. (2018). Use of oral anticoagulation and association to outcomes in atrial fibrillation patients who develop chronic kidney disease: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 820). Retrieved from http://gateway.webofknowledge.com/

Use of the SAMe-TT2R2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review (Journal article)

Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2018). Use of the SAMe-TT2R2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review. HEART RHYTHM, 15(4), 615-623. doi:10.1016/j.hrthm.2017.11.026

DOI: 10.1016/j.hrthm.2017.11.026

Using the MB-LATER score for predicting arrhythmia outcome after catheter ablation for atrial fibrillation: The Guangzhou atrial fibrillation project (Journal article)

Deng, H., Shantsila, A., Xue, Y., Potpara, T. S., Bai, Y., Zhan, X., . . . Lip, G. Y. H. (2018). Using the MB-LATER score for predicting arrhythmia outcome after catheter ablation for atrial fibrillation: The Guangzhou atrial fibrillation project. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 72(11). doi:10.1111/ijcp.13247

DOI: 10.1111/ijcp.13247

Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation (Journal article)

Potpara, T. S., Mujovic, N., Sivasambu, B., Shantsila, A., Marinkovic, M., Calkins, H., . . . Lip, G. Y. H. (2019). Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 276, 130-135. doi:10.1016/j.ijcard.2018.08.018

DOI: 10.1016/j.ijcard.2018.08.018

Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry (Journal article)

Nammas, W., Kiviniemi, T., Schlitt, A., Rubboli, A., Valencia, J., Lip, G. Y. H., . . . Airaksinen, K. E. J. (2018). Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 253, 35-39. doi:10.1016/j.ijcard.2017.07.074

DOI: 10.1016/j.ijcard.2017.07.074

Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function: Post hoc analysis of a prospective cohort (Journal article)

Malavasi, V. L., Pettorelli, D., Fantecchi, E., Zoccali, C., Laronga, G., Trenti, T., . . . Boriani, G. (2018). Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function: Post hoc analysis of a prospective cohort. INTERNAL AND EMERGENCY MEDICINE, 13(7), 1059-1067. doi:10.1007/s11739-018-1857-3

DOI: 10.1007/s11739-018-1857-3

Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches (Journal article)

Yang, P. -S., Ryu, S., Kim, D., Jang, E., Yu, H. T., Kim, T. -H., . . . Lip, G. Y. H. (2018). Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches. SCIENTIFIC REPORTS, 8. doi:10.1038/s41598-018-25111-6

DOI: 10.1038/s41598-018-25111-6

When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry (Conference Paper)

Paquette, M., Huisman, M. V., Lip, G. Y. H., Diener, H. -C., Dubner, S. J., Halperin, J. L., . . . Nieuwlaat, R. (2018). When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 1007). Retrieved from http://gateway.webofknowledge.com/

[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. (Journal article)

Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., . . . Desormais, I. (2018). [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].. Giornale italiano di cardiologia (2006), 19(11), 3-73. doi:10.1714/3026.30245

DOI: 10.1714/3026.30245

2017

'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (Journal article)

Proietti, M., Laroche, C., Opolski, G., Maggioni, A. P., Boriani, G., Lip, G. Y. H., & Investigators, A. F. G. P. (2017). 'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase. EUROPACE, 19(5), 722-733. doi:10.1093/europace/euw112

DOI: 10.1093/europace/euw112

'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (vol 19, pg 722, 2017) (Journal article)

Proietti, M., Laroche, C., Opolski, G., Maggioni, A. P., Boriani, G., Lip, G. Y. H., & Investigators, A. F. G. P. (2017). 'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (vol 19, pg 722, 2017). EUROPACE, 19(4), 543. doi:10.1093/europace/euw443

DOI: 10.1093/europace/euw443

2016 ESC GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPEDIN COLLABORATION WITH EACTS (Journal article)

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . Vardas, P. (2017). 2016 ESC GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPEDIN COLLABORATION WITH EACTS. Russian Journal of Cardiology, (7), 7-86. doi:10.15829/1560-4071-2017-7-7-86

DOI: 10.15829/1560-4071-2017-7-7-86

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) (Journal article)

Luis Zamorano, J., Lancellotti, P., Rodriguez Munoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., . . . Ringwald, J. (2017). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). EUROPEAN JOURNAL OF HEART FAILURE, 19(1), 9-42. doi:10.1002/ejhf.654

DOI: 10.1002/ejhf.654

2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: The task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (ESC) (Journal article)

Zamorano, J. L., Lancellotti, P., Muñoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., . . . Suter, T. M. (2017). 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: The task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (ESC). Russian Journal of Cardiology, 143(3), 105-139. doi:10.15829/1560-4071-2017-3-105-139

DOI: 10.15829/1560-4071-2017-3-105-139

A happy and prosperous New Year 2017 with "Thrombosis and Haemostasis".... and our 60th Anniversary! (Journal article)

Lip, G. Y. H., & Weber, C. (2017). A happy and prosperous New Year 2017 with "Thrombosis and Haemostasis".... and our 60th Anniversary!. THROMBOSIS AND HAEMOSTASIS, 117(1), 1-2. doi:10.1160/TH16-12-0903

DOI: 10.1160/TH16-12-0903

A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial (Journal article)

Kotecha, D., Calvert, M., Deeks, J. J., Griffith, M., Kirchhof, P., Lip, G. Y. H., . . . Townend, J. N. (2017). A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial. BMJ OPEN, 7(7). doi:10.1136/bmjopen-2016-015099

DOI: 10.1136/bmjopen-2016-015099

Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation (Journal article)

Nielsen, P. B., & Lip, G. Y. H. (2017). Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation. CIRCULATION, 135(3), 220-223. doi:10.1161/CIRCULATIONAHA.116.025944

DOI: 10.1161/CIRCULATIONAHA.116.025944

Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants (Journal article)

Raparelli, V., Proietti, M., Cangemi, R., Lip, G. Y. H., Lane, D. A., & Basili, S. (2017). Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants. THROMBOSIS AND HAEMOSTASIS, 117(2), 209-218. doi:10.1160/TH16-10-0757

DOI: 10.1160/TH16-10-0757

Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report fromthe EURObservational research programme pilot survey on atrial fibrillation (Journal article)

Proietti, M., Raparelli, V., Laroche, C., Dan, G. -A., Janion, M., Popescu, R., . . . Investigators, E. O. R. P. -A. F. G. P. (2017). Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report fromthe EURObservational research programme pilot survey on atrial fibrillation. EUROPACE, 19(9), 1439-1448. doi:10.1093/europace/euw169

DOI: 10.1093/europace/euw169

Age- and sex-specific analysis of patients with embolic stroke of undetermined source (Journal article)

Ntaios, G., Lip, G. Y. H., Vemmos, K., Koroboki, E., Manios, E., Vemmou, A., . . . Papavasileiou, V. (2017). Age- and sex-specific analysis of patients with embolic stroke of undetermined source. NEUROLOGY, 89(6), 532-539. doi:10.1212/WNL.0000000000004199

DOI: 10.1212/WNL.0000000000004199

All Types of Hemorrhagic Stroke Are Not Created Equally Reply (Journal article)

Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2017). All Types of Hemorrhagic Stroke Are Not Created Equally Reply. JAMA INTERNAL MEDICINE, 177(9), 1399. doi:10.1001/jamainternmed.2017.3240

DOI: 10.1001/jamainternmed.2017.3240

Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial) (Journal article)

Lip, G. Y. H., Al-Saady, N., Jin, J., Sun, M., Melino, M., Winters, S. M., . . . Goette, A. (2017). Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial). AMERICAN JOURNAL OF CARDIOLOGY, 120(5), 792-796. doi:10.1016/j.amjcard.2017.06.005

DOI: 10.1016/j.amjcard.2017.06.005

Anticoagulation control in different ethnic-minority patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west Birmingham AF Project (Conference Paper)

Zulkifly, H., Cheli, P., Lutchman, I., Bai, Y., Lip, G. Y. H., & Lane, D. A. (2017). Anticoagulation control in different ethnic-minority patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west Birmingham AF Project. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 770-771). Retrieved from http://gateway.webofknowledge.com/

Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting. (Journal article)

Dzeshka, M. S., Brown, R. A., Capodanno, D., & Lip, G. Y. H. (2017). Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting.. Interventional cardiology clinics, 6(1), 91-117. doi:10.1016/j.iccl.2016.08.007

DOI: 10.1016/j.iccl.2016.08.007

Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)

Lip, G. Y. H., Collet, J. P., de Caterina, R., Fauchier, L., Lane, D. A., Larsen, T. B., . . . Rocca, B. (2017). Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). THROMBOSIS AND HAEMOSTASIS, 117(12), 2215-2236. doi:10.1160/TH-17-10-0709

DOI: 10.1160/TH-17-10-0709

Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)

Lip, G. Y. H., Collet, J. P., de Caterina, R., Fauchier, L., Lane, D. A., Larsen, T. B., . . . Grp, E. S. C. S. D. (2017). Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 19(11), 1757-+. doi:10.1093/europace/eux240

DOI: 10.1093/europace/eux240

Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation. (Journal article)

Rivera-Caravaca, J. M., & Lip, G. Y. H. (2017). Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation.. Evidence-based medicine, 22(4), 154-155. doi:10.1136/ebmed-2017-110764

DOI: 10.1136/ebmed-2017-110764

Applicability of the modified CHA(2)DS(2)-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients (Journal article)

Garcia-Fernandez, A., Roldan, V., Rivera-Caravaca, J. M., Lip, G. Y. H., & Marin, F. (2017). Applicability of the modified CHA(2)DS(2)-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 38, E21-E22. doi:10.1016/j.ejim.2016.11.006

DOI: 10.1016/j.ejim.2016.11.006

Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients From the WARCEF Trial (Journal article)

Teerlink, J. R., Qian, M., Bello, N. A., Freudenberger, R. S., Levin, B., Di Tullio, M. R., . . . Investigators, W. A. R. C. E. F. (2017). Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients From the WARCEF Trial. JACC-HEART FAILURE, 5(8), 603-610. doi:10.1016/j.jchf.2017.04.011

DOI: 10.1016/j.jchf.2017.04.011

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial (Journal article)

Asuncion Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Shantsila, A., Roldan, V., Lip, G. Y. H., & Marin, F. (2017). Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial. THROMBOSIS AND HAEMOSTASIS, 117(12), 2261-2266. doi:10.1160/TH17-10-0710

DOI: 10.1160/TH17-10-0710

Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation (Journal article)

Lau, W. C. Y., Chan, E. W., Cheung, C. -L., Sing, C. W., Man, K. K. C., Lip, G. Y. H., . . . Wong, I. C. K. (2017). Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 317(11), 1151-1158. doi:10.1001/jama.2017.1363

DOI: 10.1001/jama.2017.1363

Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study (Journal article)

Nayarese, E. P., Kolodziejczak, M., Winter, M. -P., Alimohammadi, A., Lang, I. M., Buffon, A., . . . Siller-Matula, J. M. (2017). Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 227, 644-649. doi:10.1016/j.ijcard.2016.10.084

DOI: 10.1016/j.ijcard.2016.10.084

Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke (Journal article)

Lip, G. Y. H., Hunter, T. D., Quiroz, M. E., Ziegler, P. D., & Turakhia, M. P. (2017). Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 10(1). doi:10.1161/CIRCOUTCOMES.116.002864

DOI: 10.1161/CIRCOUTCOMES.116.002864

Atrial Fibrillation and End Stage Renal Failure in Patients Receiving Dialysis: Balancing the Risks and Benefits of Stroke Prevention (Journal article)

Voukalis, C., & Lip, G. Y. H. (2017). Atrial Fibrillation and End Stage Renal Failure in Patients Receiving Dialysis: Balancing the Risks and Benefits of Stroke Prevention. CANADIAN JOURNAL OF CARDIOLOGY, 33(6), 705-707. doi:10.1016/j.cjca.2017.02.010

DOI: 10.1016/j.cjca.2017.02.010

Atrial Fibrillation and Hypertension (Journal article)

Dzeshka, M. S., Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2017). Atrial Fibrillation and Hypertension. HYPERTENSION, 70(5), 854-+. doi:10.1161/HYPERTENSIONAHA.117.08934

DOI: 10.1161/HYPERTENSIONAHA.117.08934

Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks (Journal article)

Miyazawa, K., & Lip, G. Y. H. (2017). Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks. HELLENIC JOURNAL OF CARDIOLOGY, 58(5), 340-341. doi:10.1016/j.hjc.2017.11.012

DOI: 10.1016/j.hjc.2017.11.012

Atrial high-rate episodes and stroke prevention (Journal article)

Camm, A. J., Simantirakis, E., Goette, A., Lip, G. Y. H., Vardas, P., Calvert, M., . . . Kirchhof, P. (2017). Atrial high-rate episodes and stroke prevention. EUROPACE, 19(2), 169-179. doi:10.1093/europace/euw279

DOI: 10.1093/europace/euw279

Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences (Journal article)

Proietti, M., Cheli, P., Basili, S., Mazureka, M., & Lip, G. Y. H. (2017). Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences. PHARMACOLOGICAL RESEARCH, 117, 274-282. doi:10.1016/j.phrs.2017.01.004

DOI: 10.1016/j.phrs.2017.01.004

Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity-Weighted Cohort Study (Journal article)

Sogaard, M., Skjoth, F., Kjaeldgaard, J. N., Lip, G. Y. H., & Larsen, T. B. (2017). Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity-Weighted Cohort Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 6(11). doi:10.1161/JAHA.117.007453

DOI: 10.1161/JAHA.117.007453

Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism (Journal article)

Zulkifly, H., Lip, G. Y. H., & Lane, D. A. (2017). Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism. AMERICAN JOURNAL OF CARDIOLOGY, 120(7), 1139-1145. doi:10.1016/j.amjcard.2017.06.058

DOI: 10.1016/j.amjcard.2017.06.058

Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin (Journal article)

Lau, W. C. Y., Li, X., Wong, I. C. K., Man, K. K. C., Lip, G. Y. H., Leung, W. K., . . . Chan, E. W. (2017). Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 15(10), 1923-1933. doi:10.1111/jth.13780

DOI: 10.1111/jth.13780

Brugada syndrome: A general cardiologist's perspective (Journal article)

Polovina, M. M., Vukicevic, M., Banko, B., Lip, G. Y. H., & Potpara, T. S. (2017). Brugada syndrome: A general cardiologist's perspective. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 44, 19-27. doi:10.1016/j.ejim.2017.06.019

DOI: 10.1016/j.ejim.2017.06.019

CHA(2)DS(2) - VASc Score (Congestive Heart Failure, Hypertension, Age >= 75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation A Korean Nationwide Sample Cohort Study (Journal article)

Kim, T. -H., Yang, P. -S., Uhm, J. -S., Kim, J. -Y., Pak, H. -N., Lee, M. -H., . . . Lip, G. Y. H. (2017). CHA(2)DS(2) - VASc Score (Congestive Heart Failure, Hypertension, Age >= 75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation A Korean Nationwide Sample Cohort Study. STROKE, 48(6), 1524-+. doi:10.1161/STROKEAHA.117.016926

DOI: 10.1161/STROKEAHA.117.016926

CHA(2)DS(2)-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke A Korean Nationwide Cohort Study (Journal article)

Kim, T. -H., Yang, P. -S., Kim, D., Yu, H. T., Uhm, J. -S., Kim, J. -Y., . . . Lip, G. Y. H. (2017). CHA(2)DS(2)-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke A Korean Nationwide Cohort Study. STROKE, 48(11), 2984-+. doi:10.1161/STROKEAHA.117.018551

DOI: 10.1161/STROKEAHA.117.018551

CLINICAL PORTRAIT OF THE ATRIAL FIBRILLATION PATIENT IN Russian FEDERATION. DATA FROM THE GLOBAL REGISTRY Gloria AF (Journal article)

Shlyakhto, E. V., Ezhov, А. V., Zenin , S. А., Koziolova, N. А., Korennova, О. Y., Novikova, Т. N., . . . Rothman, K. J. (2017). CLINICAL PORTRAIT OF THE ATRIAL FIBRILLATION PATIENT IN Russian FEDERATION. DATA FROM THE GLOBAL REGISTRY Gloria AF. Russian Journal of Cardiology, (9), 21-27. doi:10.15829/1560-4071-2017-9-21-27

DOI: 10.15829/1560-4071-2017-9-21-27

Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis (Journal article)

Adlan, A. M., van Zanten, J. J. C. S. V., Lip, G. Y. H., Paton, J. F. R., Kitas, G. D., & Fisher, J. P. (2017). Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 208, 137-145. doi:10.1016/j.autneu.2017.09.003

DOI: 10.1016/j.autneu.2017.09.003

Carotid plaque detection improves the predictive value of CHA(2)DS(2)-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study (Journal article)

Basili, S., Loffredo, L., Pastori, D., Proietti, M., Farcomeni, A., Vestri, A. R., . . . Investigators, A. R. A. P. A. C. I. S. S. (2017). Carotid plaque detection improves the predictive value of CHA(2)DS(2)-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 231, 143-149. doi:10.1016/j.ijcard.2017.01.001

DOI: 10.1016/j.ijcard.2017.01.001

Cerebrovascular Reactivity in Atrial Fibrillation (Conference Paper)

Fisher, J. P., Braz, I. D., Lucas, S. J. E., Edwards, L., Van Lieshout, J. J., & Lip, G. Y. H. (2017). Cerebrovascular Reactivity in Atrial Fibrillation. In FASEB JOURNAL Vol. 31. Retrieved from http://gateway.webofknowledge.com/

Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme (Journal article)

Proietti, M., Mairesse, G. H., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Investi, B. H. R. W. (2017). Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 24(3), 328-334. doi:10.1177/2047487316682349

DOI: 10.1177/2047487316682349

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients (Journal article)

Rivera-Caravaca, J. M., Roldan, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. THROMBOSIS AND HAEMOSTASIS, 117(7), 1448-1454. doi:10.1160/TH16-12-0961

DOI: 10.1160/TH16-12-0961

Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry (Conference Paper)

Proietti, M., Bouvet, P. E., Laroche, C., Nieuwlaat, R., Crijns, H. J. G. M., Maggioni, A. P., . . . Investigator, E. H. S. A. F. (2017). Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1220-1221). Retrieved from http://gateway.webofknowledge.com/

Characterization of Access vs. Non-Access Site Bleeding Following PCI in Patients With Atrial Fibrillation (Conference Paper)

Nafee, T., Chi, G., Yee, M. K., Arbetter, D., Pinto, D. S., Mehran, R., . . . Gibson, C. M. (2017). Characterization of Access vs. Non-Access Site Bleeding Following PCI in Patients With Atrial Fibrillation. In CIRCULATION Vol. 136. Retrieved from http://gateway.webofknowledge.com/

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1 (Journal article)

Diener, H. -C., Aisenberg, J., Ansell, J., Atar, D., Breithardt, G., Eikelboom, J., . . . Lip, G. Y. H. (2017). Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. EUROPEAN HEART JOURNAL, 38(12), 852-859B. doi:10.1093/eurheartj/ehv643

DOI: 10.1093/eurheartj/ehv643

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2 (Journal article)

Diener, H. -C., Aisenberg, J., Ansell, J., Atar, D., Breithardt, G., Eikelboom, J., . . . Lip, G. Y. H. (2017). Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. EUROPEAN HEART JOURNAL, 38(12), 860-868B. doi:10.1093/eurheartj/ehw069

DOI: 10.1093/eurheartj/ehw069

Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study (Journal article)

Begg, G. A., Lip, G. Y. H., Plein, S., & Tayebjee, M. H. (2017). Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study. CLINICAL BIOCHEMISTRY, 50(1-2), 11-15. doi:10.1016/j.clinbiochem.2016.09.008

DOI: 10.1016/j.clinbiochem.2016.09.008

Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries (Journal article)

Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2017). Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries. EBIOMEDICINE, 18, 199-203. doi:10.1016/j.ebiom.2017.03.022

DOI: 10.1016/j.ebiom.2017.03.022

Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation The Fushimi AF Registry (Journal article)

Esato, M., Chun, Y. -H., An, Y., Ogawa, H., Wada, H., Hasegawa, K., . . . Akao, M. (2017). Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation The Fushimi AF Registry. CHEST, 152(6), 1266-1275. doi:10.1016/j.chest.2017.08.004

DOI: 10.1016/j.chest.2017.08.004

Clinical Stroke prevention in atrial fibrillation. (Journal article)

Voukalis, C., Shantsila, E., & Lip, G. Y. (2017). Clinical Stroke prevention in atrial fibrillation.. The journal of the Royal College of Physicians of Edinburgh, 47(1), 13-23. doi:10.4997/jrcpe.2017.105

DOI: 10.4997/jrcpe.2017.105

Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants (Journal article)

Moss, A. S., Dimitropoulous, G., & Lip, G. Y. H. (2017). Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants. EXPERT REVIEW OF HEMATOLOGY, 10(9), 833-845. doi:10.1080/17474086.2017.1358085

DOI: 10.1080/17474086.2017.1358085

Clinical predictors of left atrium thrombi in patients scheduled for cardioversion of atrial fibrillation: a subanalysis from the ENSURE-AF study (Conference Paper)

Merino, J. L., Lip, G. Y. H., Heidbuchel, H., Cohen, A. -A., De Caterina, R., De Groot, J. R., . . . Goette, A. (2017). Clinical predictors of left atrium thrombi in patients scheduled for cardioversion of atrial fibrillation: a subanalysis from the ENSURE-AF study. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1367-1368). Retrieved from http://gateway.webofknowledge.com/

Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review (Journal article)

Deng, H., Bai, Y., Shantsila, A., Fauchier, L., Potpara, T. S., & Lip, G. Y. H. (2017). Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review. CLINICAL RESEARCH IN CARDIOLOGY, 106(10), 813-823. doi:10.1007/s00392-017-1123-0

DOI: 10.1007/s00392-017-1123-0

Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation (Journal article)

Guo, Y., Zhu, H., Chen, Y., & Lip, G. Y. H. (2018). Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 131(2), 185-192. doi:10.1016/j.amjmed.2017.09.009

DOI: 10.1016/j.amjmed.2017.09.009

Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis (Journal article)

Wang, C., Yu, Y., Zhu, W., Yu, J., Lip, G. Y. H., & Hong, K. (2017). Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis. ONCOTARGET, 8(65), 109703-109711. doi:10.18632/oncotarget.19858

DOI: 10.18632/oncotarget.19858

Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis (Journal article)

Tervonen, T., Ustyugova, A., Bhashyam, S. S., Lip, G. Y. H., Verdecchia, P., Kwan, R., . . . Marsh, K. (2017). Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis. VALUE IN HEALTH, 20(10), 1394-1402. doi:10.1016/j.jval.2017.06.006

DOI: 10.1016/j.jval.2017.06.006

Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus (Journal article)

Moss, A. S., Dimitropoulos, G., Connolly, D. L., & Lip, G. Y. H. (2017). Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus. EXPERT OPINION ON PHARMACOTHERAPY, 18(11), 1101-1114. doi:10.1080/14656566.2017.1350647

DOI: 10.1080/14656566.2017.1350647

Coronary artery disease and risk of adverse cardiac events and stroke (Journal article)

Olesen, K. K. W., Madsen, M., Lip, G. Y. H., Egholm, G., Thim, T., Jensen, L. O., . . . Maeng, M. (2017). Coronary artery disease and risk of adverse cardiac events and stroke. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 47(11), 819-828. doi:10.1111/eci.12804

DOI: 10.1111/eci.12804

Cost-effectiveness analysis of a handheld ECG machine used for a population-wide screening programme: the Belgian Heart Rhythm Week Screening programme (Conference Paper)

Proietti, M., Farcomeni, A., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Investigators, B. H. R. W. (2017). Cost-effectiveness analysis of a handheld ECG machine used for a population-wide screening programme: the Belgian Heart Rhythm Week Screening programme. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 973-974). Retrieved from http://gateway.webofknowledge.com/

Current Understanding of Atherogenesis (Journal article)

Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2017). Current Understanding of Atherogenesis. AMERICAN JOURNAL OF MEDICINE, 130(3), 268-282. doi:10.1016/j.amjmed.2016.10.022

DOI: 10.1016/j.amjmed.2016.10.022

Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study (Journal article)

Vadmann, H., Gorst-Rasmussen, A., Hjortshoj, S. P., Riahi, S., Lip, G. Y. H., & Larsen, T. B. (2017). Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study. EUROPACE, 19(5), 838-842. doi:10.1093/europace/euw107

DOI: 10.1093/europace/euw107

Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor (Journal article)

Potpara, T. S., Dagres, N., Mujovic, N., Vasic, D., Asanin, M., Nedeljkovic, M., . . . Lip, G. Y. H. (2017). Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor. ADVANCES IN THERAPY, 34(2), 357-377. doi:10.1007/s12325-016-0458-7

DOI: 10.1007/s12325-016-0458-7

Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami (Journal article)

Cerasuolo, J. O., Montero-Odasso, M., Ibanez, A., Doocy, S., Lip, G. Y. H., & Sposato, L. A. (2017). Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami. INTERNATIONAL JOURNAL OF STROKE, 12(3), 222-228. doi:10.1177/1747493016687579

DOI: 10.1177/1747493016687579

Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)

Gorenek, B., Bax, J., Boriani, G., Chen, S. -A., Dagres, N., Glotzer, T. V., . . . Savelieva, I. (2017). Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 19(9), 1556-1578. doi:10.1093/europace/eux163

DOI: 10.1093/europace/eux163

Direct oral anticoagulant reversal: how, when and issues faced (Journal article)

Dzeshka, M. S., Pastori, D., & Lip, G. Y. H. (2017). Direct oral anticoagulant reversal: how, when and issues faced. EXPERT REVIEW OF HEMATOLOGY, 10(11), 1005-1022. doi:10.1080/17474086.2017.1379896

DOI: 10.1080/17474086.2017.1379896

Does Reader Performance with Digital Breast Tomosynthesis Vary according to Experience with Two-dimensional Mammography? (Journal article)

Tucker, L., Gilbert, F. J., Astley, S. M., Dibden, A., Seth, A., Morel, J., . . . Stoner, K. (2017). Does Reader Performance with Digital Breast Tomosynthesis Vary according to Experience with Two-dimensional Mammography?. RADIOLOGY, 283(2), 371-380. doi:10.1148/radiol.2017151936

DOI: 10.1148/radiol.2017151936

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation? (Journal article)

Garcia-Fernandez, A., Roldan, V., Rivera-Caravaca, J. M., Hernandez-Romero, D., Valdes, M., Vicente, V., . . . Marin, F. (2017). Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?. SCIENTIFIC REPORTS, 7. doi:10.1038/srep41565

DOI: 10.1038/srep41565

Drug-induced liver injury with oral anticoagulants: a threat or not? (Journal article)

Potpara, T. S., & Lip, G. Y. H. (2017). Drug-induced liver injury with oral anticoagulants: a threat or not?. HEART, 103(11), 809-811. doi:10.1136/heartjnl-2016-310983

DOI: 10.1136/heartjnl-2016-310983

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (Journal article)

Cannon, C. P., Bhatt, D. L., Oldgren, J., Lip, G. Y. H., Ellis, S. G., Kimura, T., . . . Comm, R. E. -D. U. A. L. P. C. I. S. (2017). Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. NEW ENGLAND JOURNAL OF MEDICINE, 377(16), 1513-1524. doi:10.1056/NEJMoa1708454

DOI: 10.1056/NEJMoa1708454

Dynamic CHA2DS2-VASc score and risk of ischemic stroke in patients with atrial fibrillation (Conference Paper)

Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2017). Dynamic CHA2DS2-VASc score and risk of ischemic stroke in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 774). Retrieved from http://gateway.webofknowledge.com/

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication (Journal article)

Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Angel Cabrera, J., Chen, S. A., . . . Nattel, S. (2017). EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. HEART RHYTHM, 14(1), E3-E40. doi:10.1016/j.hrthm.2016.05.028

DOI: 10.1016/j.hrthm.2016.05.028

Editors' Choice 2016 papers in Thrombosis and Haemostasis (Journal article)

Weber, C., & Lip, G. Y. H. (2017). Editors' Choice 2016 papers in Thrombosis and Haemostasis. THROMBOSIS AND HAEMOSTASIS, 117(1), 204-206. doi:10.1160/TH16-11-0899

DOI: 10.1160/TH16-11-0899

Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study (Journal article)

Okumura, K., Lip, G. Y. H., Akao, M., Tanizawa, K., Fukuzawae, M., Abe, K., . . . Yamashita, T. (2017). Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study. AMERICAN HEART JOURNAL, 194, 99-106. doi:10.1016/j.ahj.2017.08.017

DOI: 10.1016/j.ahj.2017.08.017

Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study (Conference Paper)

Goette, A., Kwong, W. J., Ezekowitz, M. D., Banach, M., Hjortshoj, S. P., Zamoryakhin, D., & Lip, G. Y. H. (2018). Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study. In EUROPACE Vol. 20 (pp. 1936-1943). doi:10.1093/europace/euy141

DOI: 10.1093/europace/euy141

Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients (Journal article)

Bonde, A. N., Lip, G. Y. H., Kamper, A. -L., Staerk, L., Torp-Pedersen, C., Gislason, G. H., & Olesen, J. B. (2017). Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(6), 752-753. doi:10.1016/j.jacc.2016.11.031

DOI: 10.1016/j.jacc.2016.11.031

Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from the PIONEER AF-PCI trial (Conference Paper)

Chi, G., Korjian, S., Daaboul, Y., Nafee, T., Mehran, R., Bode, C., . . . Gibson, C. M. (2017). Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1290). Retrieved from http://gateway.webofknowledge.com/

Effectiveness and Safety of Apixaban Compared to Other Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients With Coronary Artery Disease or Peripheral Arterial Disease: A Propensity Score Matched Analysis of Four Large Databases (Conference Paper)

Lip, G. Y., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Deitelzweig, S. (2017). Effectiveness and Safety of Apixaban Compared to Other Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients With Coronary Artery Disease or Peripheral Arterial Disease: A Propensity Score Matched Analysis of Four Large Databases. In CIRCULATION Vol. 136. Retrieved from http://gateway.webofknowledge.com/

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Among Non-Valvular Atrial Fibrillation Patients: A Propensity Score Matched Analysis of Four Large Databases (Conference Paper)

Deitelzweig, S., Keshishian, A., Li, X., Hamilton, M., Masseria, C., Gupta, K., . . . Lip, G. Y. (2017). Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Among Non-Valvular Atrial Fibrillation Patients: A Propensity Score Matched Analysis of Four Large Databases. In CIRCULATION Vol. 136. Retrieved from http://gateway.webofknowledge.com/

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation (Journal article)

Cha, M. -J., Choi, E. -K., Han, K. -D., Lee, S. -R., Lim, W. -H., Oh, S., & Lip, G. Y. H. (2017). Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation. STROKE, 48(11), 3040-+. doi:10.1161/STROKEAHA.117.018773

DOI: 10.1161/STROKEAHA.117.018773

Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor A Nationwide Cohort Study (Journal article)

Lip, G. Y. H., Skjoth, F., Nielsen, P. B., Kjaeldgaard, J. N., & Larsen, T. B. (2017). Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor A Nationwide Cohort Study. JAMA CARDIOLOGY, 2(8), 872-881. doi:10.1001/jamacardio.2017.1883

DOI: 10.1001/jamacardio.2017.1883

Effectiveness and safety of apixaban versus warfarin among high-risk subgroups of non-valvular atrial fibrillation patients: a propensity score matched analysis (Conference Paper)

Li, X., Deitelzweig, S., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., . . . Lip, G. Y. H. (2017). Effectiveness and safety of apixaban versus warfarin among high-risk subgroups of non-valvular atrial fibrillation patients: a propensity score matched analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 767). Retrieved from http://gateway.webofknowledge.com/

Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice (Journal article)

Li, X., Deitelzweig, S., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., . . . Lip, G. Y. H. (2017). Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. THROMBOSIS AND HAEMOSTASIS, 117(6), 1072-1082. doi:10.1160/TH17-01-0068

DOI: 10.1160/TH17-01-0068

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study (Journal article)

Nielsen, P. B., Skjoth, F., Sogaard, M., Kjaeldgaard, J. N., Lip, G. Y. H., & Larsen, T. B. (2017). Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ-BRITISH MEDICAL JOURNAL, 356. doi:10.1136/bmj.j510

DOI: 10.1136/bmj.j510

Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study (Journal article)

Larsen, T. B., Skjoth, F., Kjaeldgaard, J. N., Lip, G. Y. H., Nielsen, P. B., & Sogaard, M. (2017). Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study. LANCET HAEMATOLOGY, 4(5), E237-E244. doi:10.1016/S2352-3026(17)30054-6

DOI: 10.1016/S2352-3026(17)30054-6

Effectiveness and safety of standard and lower dose apixaban compared to warfarin in non-valvular atrial fibrillation patients: a propensity score matched analysis (Conference Paper)

Li, X., Lip, G. Y. H., Keshishian, A., Hamilton, M., Horblyuk, R., Gupta, K., . . . Deitelzweig, S. (2017). Effectiveness and safety of standard and lower dose apixaban compared to warfarin in non-valvular atrial fibrillation patients: a propensity score matched analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 772). Retrieved from http://gateway.webofknowledge.com/

Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis (Conference Paper)

Awad, K., Serban, M. G., Penson, P., Mikhailidis, D. P., Toth, P. P., Jones, S. R., . . . Meta-Anal, L. B. P. (2017). Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 642-643). Retrieved from http://gateway.webofknowledge.com/

Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis (Journal article)

Awad, K., Serban, M. -C., Penson, P., Mikhailidis, D. P., Toth, P. P., Jones, S. R., . . . Col, L. B. P. M. -A. (2017). Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis. JOURNAL OF CLINICAL LIPIDOLOGY, 11(4), 972-985. doi:10.1016/j.jacl.2017.06.001

DOI: 10.1016/j.jacl.2017.06.001

Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials (Journal article)

Bala, M., Sahebkar, A., Ursoniu, S., Serban, M. -C., Undas, A., Mikhailidis, D. P., . . . Meta-Anal, L. B. P. (2017). Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials. PHARMACOLOGICAL RESEARCH, 124, 64-73. doi:10.1016/j.phrs.2017.07.024

DOI: 10.1016/j.phrs.2017.07.024

Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis (Journal article)

Awad, K., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Moriarty, P., Lip, G. Y. H., . . . Meta-anal, L. B. P. (2017). Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis. CARDIOVASCULAR DRUGS AND THERAPY, 31(4), 419-431. doi:10.1007/s10557-017-6743-0

DOI: 10.1007/s10557-017-6743-0

Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis (Conference Paper)

Awad, K., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Moriarty, P., Lip, G. Y. H., . . . Meta-Anal, L. B. P. (2017). Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 12). Retrieved from http://gateway.webofknowledge.com/

Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project (Journal article)

Li, W. -H., Huang, D., Chiang, C. -E., Lau, C. -P., Tse, H. -F., Chan, E. W., . . . Siu, C. -W. (2017). Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project. CLINICAL CARDIOLOGY, 40(4), 222-229. doi:10.1002/clc.22649

DOI: 10.1002/clc.22649

Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis (Journal article)

Zhu, W., Guo, L., Liu, F., Wan, R., Shen, Y., Lip, G. Y. H., & Hong, K. (2017). Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis. ONCOTARGET, 8(46), 81154-81166. doi:10.18632/oncotarget.20870

DOI: 10.18632/oncotarget.20870

Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation (Journal article)

Orenes-Pinero, E., Esteve-Pastor, M. A., Valdes, M., Lip, G. Y. H., & Marin, F. (2017). Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation. DRUG DISCOVERY TODAY, 22(10), 1565-1571. doi:10.1016/j.drudis.2017.05.010

DOI: 10.1016/j.drudis.2017.05.010

Epidemiological Trends in Atrial Fibrillation in Europe: The EURObservational Research Programme in Atrial Fibrillation Pilot and Long-Term Registries and Euro Heart Survey on Atrial Fibrillation (Conference Paper)

Proietti, M., Laroche, C., Nieuwlaat, R., Crijns, H. J., Maggioni, A., Lane, D. A., . . . Lip, G. Y. (2017). Epidemiological Trends in Atrial Fibrillation in Europe: The EURObservational Research Programme in Atrial Fibrillation Pilot and Long-Term Registries and Euro Heart Survey on Atrial Fibrillation. In CIRCULATION Vol. 136. Retrieved from http://gateway.webofknowledge.com/

Ethnic differences in the prevalence of peripheral arterial disease: a systematic review and meta-analysis. (Journal article)

Vitalis, A., Lip, G. Y. H., Kay, M., Vohra, R. K., & Shantsila, A. (2017). Ethnic differences in the prevalence of peripheral arterial disease: a systematic review and meta-analysis.. Expert review of cardiovascular therapy, 15(4), 327-338. doi:10.1080/14779072.2017.1305890

DOI: 10.1080/14779072.2017.1305890

European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (Journal article)

Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jais, P., Josephson, M. E., . . . Rickard, J. (2017). European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). EUROPACE, 19(3), 465-511. doi:10.1093/europace/euw301

DOI: 10.1093/europace/euw301

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (Journal article)

Gorenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J., Fogel, R. I., . . . Force, E. H. R. A. S. C. T. (2017). European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). EUROPACE, 19(2), 190-225. doi:10.1093/europace/euw242

DOI: 10.1093/europace/euw242

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (Journal article)

Gorenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J., Fogel, R. I., . . . Force, E. H. R. A. S. C. T. (2017). European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 24(1), 4-40. doi:10.1177/2047487316676037

DOI: 10.1177/2047487316676037

Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation (Journal article)

Potpara, T. S., Boriani, G., & Lip, G. Y. H. (2017). Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation. CURRENT MEDICAL RESEARCH AND OPINION, 33(6), 1175-1177. doi:10.1080/03007995.2017.1313210

DOI: 10.1080/03007995.2017.1313210

Evaluation of ABC-stroke and CHA2DS2-VASc ischemic scores in real-world atrial fibrillation patients receiving oral anticoagulation treatment (Conference Paper)

Rivera-Caravaca, J. M., Roldan, V., Esteve Pastor, M. A., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Evaluation of ABC-stroke and CHA2DS2-VASc ischemic scores in real-world atrial fibrillation patients receiving oral anticoagulation treatment. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1233). Retrieved from http://gateway.webofknowledge.com/

External Validation of the Simple NULL-PLEASE Clinical Score in Predicting Outcome of Out-of-Hospital Cardiac Arrest (Journal article)

Potpara, T. S., Mihajlovic, M., Stankovic, S., Jozic, T., Jozic, I., Asanin, M. R., . . . Lip, G. Y. H. (2017). External Validation of the Simple NULL-PLEASE Clinical Score in Predicting Outcome of Out-of-Hospital Cardiac Arrest. AMERICAN JOURNAL OF MEDICINE, 130(12). doi:10.1016/j.amjmed.2017.05.035

DOI: 10.1016/j.amjmed.2017.05.035

Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc (Conference Paper)

Nielsen, P. B., Skjoeth, F., Overvad, T. F., Larsen, T. B., & Lip, G. Y. H. (2017). Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1220). Retrieved from http://gateway.webofknowledge.com/

Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World" (Journal article)

Mazurek, M., & Lip, G. Y. H. (2017). Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World". GASTROENTEROLOGY, 152(5), 932-934. doi:10.1053/j.gastro.2017.02.027

DOI: 10.1053/j.gastro.2017.02.027

Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials (Journal article)

Proietti, M., & Lip, G. Y. H. (2017). Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 236, 244-248. doi:10.1016/j.ijcard.2017.02.127

DOI: 10.1016/j.ijcard.2017.02.127

Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (vol 6, 30271, 2016) (Journal article)

Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Petrescu, L., . . . Lip, G. Y. H. (2017). Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (vol 6, 30271, 2016). SCIENTIFIC REPORTS, 7. doi:10.1038/srep42379

DOI: 10.1038/srep42379

Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction (Journal article)

Sambola, A., Ruiz-Meana, M., Barba, I., Del Blanco, B. G., Barrabes, J. A., Lip, G. Y., . . . Garcia-Dorado, D. (2017). Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction. INTERNATIONAL JOURNAL OF CARDIOLOGY, 243, 9-14. doi:10.1016/j.ijcard.2017.04.089

DOI: 10.1016/j.ijcard.2017.04.089

Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry (Journal article)

Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., Proietti, M., & Lip, G. Y. H. (2017). Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry. MAYO CLINIC PROCEEDINGS, 92(8), 1203-1213. doi:10.1016/j.mayocp.2017.05.023

DOI: 10.1016/j.mayocp.2017.05.023

Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults >= 60 years of age (Journal article)

Shantsila, A., & Lip, G. Y. H. (2017). Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults >= 60 years of age. ANNALS OF INTERNAL MEDICINE, 166(8), JC38. doi:10.7326/ACPJC-2017-166-8-038

DOI: 10.7326/ACPJC-2017-166-8-038

Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS (Journal article)

Agewall, S., Camm, J., Barón Esquivias, G., Budts, W., Carerj, S., Casselman, F., . . . Vardas, P. (2017). Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS. Revista Española de Cardiología, 70(1), 50.e1-50.e84. doi:10.1016/j.recesp.2016.11.014

DOI: 10.1016/j.recesp.2016.11.014

Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST (Journal article)

Ibáñez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., . . . Zeymer, U. (2017). Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST. Revista Española de Cardiología, 70(12), 1082.e1-1082.e61. doi:10.1016/j.recesp.2017.10.048

DOI: 10.1016/j.recesp.2017.10.048

Guía ESC/EAS 2016 sobre el tratamiento de las dislipemias (Journal article)

Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., . . . Zimlichman, R. (2017). Guía ESC/EAS 2016 sobre el tratamiento de las dislipemias. Revista Española de Cardiología, 70(2), 115.e1-115.e64. doi:10.1016/j.recesp.2016.11.052

DOI: 10.1016/j.recesp.2016.11.052

HEALTH CARE COST IN PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY (Conference Paper)

Barrrios, R. J., Goette, A., Kwong, J., Ezekowitz, M. D., Banach, M. S., Hjortshen, S. P., . . . Lip, G. (2017). HEALTH CARE COST IN PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY. In VALUE IN HEALTH Vol. 20 (pp. A608). Retrieved from http://gateway.webofknowledge.com/

Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes (Journal article)

Dzeshka, M. S., Shahid, F., Shantsila, A., & Lip, G. Y. H. (2017). Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes. AMERICAN JOURNAL OF HYPERTENSION, 30(8), 733-755. doi:10.1093/ajh/hpx013

DOI: 10.1093/ajh/hpx013

Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks (Journal article)

Asuncion Esteve-Pastor, M., Rivera-Caravaca, J. M., & Lip, G. Y. H. (2017). Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks. AMERICAN JOURNAL OF HYPERTENSION, 30(11), 1063-1065. doi:10.1093/ajh/hpx135

DOI: 10.1093/ajh/hpx135

Hypertension and cardiac arrhythmias (Journal article)

Lip, G. Y. H., & Coca, A. (2017). Hypertension and cardiac arrhythmias. EUROPEAN HEART JOURNAL, 38(4), 223-225. doi:10.1093/eurheartj/ehw664

DOI: 10.1093/eurheartj/ehw664

Hypertension and cardiac arrhythmias: a consensus document fromthe European Heart RhythmAssociation (EHRA) and ESC Council on Hypertension, endorsed by the Heart RhythmSociety (HRS), Asia-Pacific Heart RhythmSociety (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)

Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., . . . Field, M. (2017). Hypertension and cardiac arrhythmias: a consensus document fromthe European Heart RhythmAssociation (EHRA) and ESC Council on Hypertension, endorsed by the Heart RhythmSociety (HRS), Asia-Pacific Heart RhythmSociety (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 19(6), 891-911. doi:10.1093/europace/eux091

DOI: 10.1093/europace/eux091

Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)

Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., . . . Field, M. (2017). Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 3(4), 235-250. doi:10.1093/ehjcvp/pvx019

DOI: 10.1093/ehjcvp/pvx019

INCIDENT ATRIAL FIBRILLATION ACCORDING TO GENDER IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY (Conference Paper)

Fauchier, L., Bisson, A., Angoulvant, D., Clementy, N., Babuty, D., & Lip, G. (2017). INCIDENT ATRIAL FIBRILLATION ACCORDING TO GENDER IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 367). Retrieved from http://gateway.webofknowledge.com/

INCREASED RATE OF PREVIOUS STROKE IN ASYMPTOMATIC/MINIMALLY SYMPTOMATIC VERSUS SYMPTOMATIC PATIENTS WITH NEWLY DETECTED ATRIAL FIBRILLATION WORLDWIDE: RESULTS FROM THE GLORIA-AF REGISTRY (Conference Paper)

Christow, S., Seidl, K., Diener, H. -C., Huisman, M., Lip, G., Rauch-Kroenert, U., . . . Senges, J. (2017). INCREASED RATE OF PREVIOUS STROKE IN ASYMPTOMATIC/MINIMALLY SYMPTOMATIC VERSUS SYMPTOMATIC PATIENTS WITH NEWLY DETECTED ATRIAL FIBRILLATION WORLDWIDE: RESULTS FROM THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 450). Retrieved from http://gateway.webofknowledge.com/

Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial (Conference Paper)

Goette, A., de Groot, J. R., Le Heuzey, J. -Y., Banach, M., Huber, K., Jin, J., . . . Lip, G. (2017). Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial. In CIRCULATION Vol. 136. Retrieved from http://gateway.webofknowledge.com/

Impact of aerobic fitness on cerebral blood flow and cerebral vascular responsiveness to CO2 in young and older men (Journal article)

Braz, I. D., Fluck, D., Lip, G. Y. H., Lundby, C., & Fisher, J. P. (2017). Impact of aerobic fitness on cerebral blood flow and cerebral vascular responsiveness to CO2 in young and older men. SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 27(6), 634-642. doi:10.1111/sms.12674

DOI: 10.1111/sms.12674

Impact of atrial fibrillation on quality of life and clinical outcomes: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry (Conference Paper)

Proietti, M., Lane, D. A., Laroche, C., Maggioni, A. P., Boriani, G., Lip, G. Y. H., & Investigators, E. O. R. P. -A. F. (2017). Impact of atrial fibrillation on quality of life and clinical outcomes: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1233). Retrieved from http://gateway.webofknowledge.com/

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation (Journal article)

Rivera-Caravaca, J. M., Roldan, V., Asuncion Esteve-Pastor, M., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation. SCIENTIFIC REPORTS, 7. doi:10.1038/s41598-017-11683-2

DOI: 10.1038/s41598-017-11683-2

Improvement and Aggravation of Spontaneous Unruptured Vertebral Artery Dissection. (Journal article)

Shibahara, T., Yasaka, M., Wakugawa, Y., Maeda, K., Uwatoko, T., Kuwashiro, T., . . . Okada, Y. (2017). Improvement and Aggravation of Spontaneous Unruptured Vertebral Artery Dissection.. Cerebrovascular diseases extra, 7(3), 153-164. doi:10.1159/000481442

DOI: 10.1159/000481442

Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction (Conference Paper)

Dzeshka, M. S., Appadoo, K., Shantsila, E., Snezhitskiy, V. A., & Lip, G. Y. H. (2017). Increased evidence of left ventricular myocardial fibrosis in patients with paroxysmal atrial fibrillation and sinus node dysfunction. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 379). Retrieved from http://gateway.webofknowledge.com/

Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark (Journal article)

Gadsboll, K., Staerk, L., Fosbol, E. L., Sindet-Pedersen, C., Gundlund, A., Lip, G. Y. H., . . . Olesen, J. B. (2017). Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark. EUROPEAN HEART JOURNAL, 38(12), 899-906. doi:10.1093/eurheartj/ehw658

DOI: 10.1093/eurheartj/ehw658

Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists (Journal article)

Lobos-Bejarano, J. M., Castellanos Rodriguez, A., Barrios, V., Escobar, C., Polo-Garcia, J., Carlos del Castillo-Rodriguez, J., . . . Team, P. A. U. L. A. S. (2017). Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 71(9). doi:10.1111/ijcp.12974

DOI: 10.1111/ijcp.12974

Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation (Journal article)

Hellman, T., Kiviniemi, T., Nuotio, I., Vasankari, T., Hartikainen, J., Lip, G. Y. H., & Airaksinen, K. E. J. (2017). Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation. THROMBOSIS RESEARCH, 156, 163-167. doi:10.1016/j.thromres.2017.06.026

DOI: 10.1016/j.thromres.2017.06.026

Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation (Journal article)

Begg, G. A., Karim, R., Oesterlein, T., Graham, L. N., Hogarth, A. J., Page, S. P., . . . Tayebjee, M. H. (2017). Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation. EUROPACE, 19(12), 1944-1950. doi:10.1093/europace/euw315

DOI: 10.1093/europace/euw315

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials (Journal article)

Proietti, M., Guiducci, E., Cheli, P., & Lip, G. Y. H. (2017). Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials. STROKE, 48(4), 857-866. doi:10.1161/STROKEAHA.116.015984

DOI: 10.1161/STROKEAHA.116.015984

Is atrial fibrillation another manifestation of organ damage in diabetes? (Journal article)

Miyazawa, K., & Lip, G. Y. H. (2017). Is atrial fibrillation another manifestation of organ damage in diabetes?. LANCET DIABETES & ENDOCRINOLOGY, 5(10), 761-762. doi:10.1016/S2213-8587(17)30282-6

DOI: 10.1016/S2213-8587(17)30282-6

Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study (Journal article)

Staerk, L., Fosbol, E. L., Lip, G. Y. H., Lamberts, M., Bonde, A. N., Torp-Pedersen, C., . . . Olesen, J. B. (2017). Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study. EUROPEAN HEART JOURNAL, 38(12), 907-915. doi:10.1093/eurheartj/ehw496

DOI: 10.1093/eurheartj/ehw496

Ischemic stroke risk in East Asian patients with CHA2DS2-VASc score of 1: systematic review and meta-analysis. (Journal article)

Bai, Y., Shantsila, A., & Lip, G. Y. H. (2017). Ischemic stroke risk in East Asian patients with CHA2DS2-VASc score of 1: systematic review and meta-analysis.. Expert review of cardiovascular therapy, 15(2), 145-150. doi:10.1080/14779072.2017.1281742

DOI: 10.1080/14779072.2017.1281742

LONG-TERM PREDICTION OF THE RISK OF ICTUS IN PATIENTS WITH ATRIAL FIBRILLATION: COMPARISON OF THE ABC-STROKE AND CHA2DS2-VASC SCALES (Conference Paper)

Rivera Caravaca, J. M., Esteve Pastor, M. A., Valdes, M., Vicente, V., Lip, G. Y. H., Marin, F., & Roldan, V. (2017). LONG-TERM PREDICTION OF THE RISK OF ICTUS IN PATIENTS WITH ATRIAL FIBRILLATION: COMPARISON OF THE ABC-STROKE AND CHA2DS2-VASC SCALES. In HAEMATOLOGICA Vol. 102 (pp. 2-3). Retrieved from http://gateway.webofknowledge.com/

Lifetime risks, projected numbers and adverse outcomes in asian patients with atrial fibrillation (Conference Paper)

Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2017). Lifetime risks, projected numbers and adverse outcomes in asian patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 980). Retrieved from http://gateway.webofknowledge.com/

Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention? (Journal article)

Kuo, L., Chao, T. -F., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2017). Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 6(6). doi:10.1161/JAHA.116.005307

DOI: 10.1161/JAHA.116.005307

Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA(2)DS(2)-VASc Scores (Journal article)

Rivera-Caravaca, J. M., Roldan, V., Esteve-Pastor, M. A., Valdes, M., Vicente, V., Lip, G. Y. H., & Marin, F. (2017). Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA(2)DS(2)-VASc Scores. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 6(7). doi:10.1161/JAHA.117.006490

DOI: 10.1161/JAHA.117.006490

Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation (Journal article)

Korompoki, E., Filippidis, F. T., Nielsen, P. B., Del Giudice, A., Lip, G. Y. H., Kuramatsu, J. B., . . . Veltkamp, R. (2017). Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation. NEUROLOGY, 89(7), 687-696. doi:10.1212/WNL.0000000000004235

DOI: 10.1212/WNL.0000000000004235

Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores The Murcia Atrial Fibrillation Project (Journal article)

Asuncion Esteve-Pastort, M., Rivera-Caravaca, J. M., Roldan, V., Vicente, V., Valdes, M., Marin, F., & Lip, G. Y. H. (2017). Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores The Murcia Atrial Fibrillation Project. THROMBOSIS AND HAEMOSTASIS, 117(10), 1848-1858. doi:10.1160/TH17-07-0478

DOI: 10.1160/TH17-07-0478

Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. (Journal article)

Asunción Esteve-Pastor, M., Miguel Rivera-Caravaca, J., Roldán, V., Vicente, V., Valdés, M., Marín, F., & Lip, G. Y. H. (2017). Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores.. Thrombosis and haemostasis, 117(10), 1848-1858. doi:10.1160/th17-07-0478

DOI: 10.1160/th17-07-0478

Lower Risk in Young Patients Aged < 50 With Atrial Fibrillation and Low CHA(2)DS(2)-VASc Risk Score (Conference Paper)

Fauchier, L., Bisson, A., Clementy, N., Angoulvant, D., Babuty, D., Lip, G. Y., & Freedman, B. (2017). Lower Risk in Young Patients Aged < 50 With Atrial Fibrillation and Low CHA(2)DS(2)-VASc Risk Score. In CIRCULATION Vol. 136. Retrieved from http://gateway.webofknowledge.com/

Malignant Hypertension Revisited-Does This Still Exist? (Journal article)

Shantsila, A., & Lip, G. Y. H. (2017). Malignant Hypertension Revisited-Does This Still Exist?. AMERICAN JOURNAL OF HYPERTENSION, 30(6), 543-549. doi:10.1093/ajh/hpx008

DOI: 10.1093/ajh/hpx008

Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis (Journal article)

Halvorsen, S., Storey, R. F., Rocca, B., Sibbing, D., ten Berg, J., Grove, E. L., . . . Thrombosis, E. S. C. W. G. (2017). Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. EUROPEAN HEART JOURNAL, 38(19), 1455-1462C. doi:10.1093/eurheartj/ehw454

DOI: 10.1093/eurheartj/ehw454

Medication burden and perception of anticoagulation treatments in atrial fibrillation patients: results from an international survey (Conference Paper)

Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2017). Medication burden and perception of anticoagulation treatments in atrial fibrillation patients: results from an international survey. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 777). Retrieved from http://gateway.webofknowledge.com/

Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban (Journal article)

Bai, Y., Shi, X. -B., Ma, C. -S., & Lip, G. Y. H. (2017). Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban. AMERICAN JOURNAL OF CARDIOLOGY, 120(9), 1689-1695. doi:10.1016/j.amjcard.2017.07.072

DOI: 10.1016/j.amjcard.2017.07.072

Microvesicles in vascular homeostasis and diseases Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology (Journal article)

Ridger, V. C., Boulanger, C. M., Angelillo-Scherrer, A., Badimon, L., Blanc-Brude, O., Bochaton-Piallat, M. -L., . . . Harrison, P. (2017). Microvesicles in vascular homeostasis and diseases Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology. THROMBOSIS AND HAEMOSTASIS, 117(7), 1296-1316. doi:10.1160/TH16-12-0943

DOI: 10.1160/TH16-12-0943

Microvesicles in vascular homeostasis and diseases. (Journal article)

Ridger, V. C., Boulanger, C. M., Angelillo-Scherrer, A., Badimon, L., Blanc-Brude, O., Bochaton-Piallat, M. -L., . . . Harrison, P. (2017). Microvesicles in vascular homeostasis and diseases.. Thrombosis and haemostasis, 117(7), 1296-1316. doi:10.1160/th16-12-0943

DOI: 10.1160/th16-12-0943

Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial (Journal article)

Guo, Y., Chen, Y., Lane, D. A., Liu, L., Wang, Y., & Lip, G. Y. H. (2017). Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial. AMERICAN JOURNAL OF MEDICINE, 130(12), 1388-+. doi:10.1016/j.amjmed.2017.07.003

DOI: 10.1016/j.amjmed.2017.07.003

Modelling projections for the risks related with atrial fibrillation in East Asia: a focus on ischaemic stroke and death (Journal article)

Bai, Y., Guo, S. -D., Shantsila, A., & Lip, G. Y. H. (2018). Modelling projections for the risks related with atrial fibrillation in East Asia: a focus on ischaemic stroke and death. EUROPACE, 20(10), 1584-1590. doi:10.1093/europace/eux328

DOI: 10.1093/europace/eux328

Monocyte counts predict major bleeding events in patients with atrial fibrillation (Conference Paper)

Shahid, F., Lip, G. Y. H., Montoro-Garcia, S., Rahmat, A., & Shantsila, E. (2017). Monocyte counts predict major bleeding events in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 779-780). Retrieved from http://gateway.webofknowledge.com/

New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose (Journal article)

Rubboli, A., Agewall, S., Huber, K., & Lip, G. Y. H. (2017). New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 40, E11-E12. doi:10.1016/j.ejim.2017.01.003

DOI: 10.1016/j.ejim.2017.01.003

Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction (Journal article)

Khan, A. A., & Lip, G. Y. H. (2017). Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction. ANNALS OF TRANSLATIONAL MEDICINE, 5(23). doi:10.21037/atm.2017.09.19

DOI: 10.21037/atm.2017.09.19

Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation (Journal article)

Rivera-Caravaca, J. M., Asuncion Esteve-Pastora, M., Roldan, V., Marin, F., & Lip, G. Y. H. (2017). Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation. EXPERT OPINION ON DRUG SAFETY, 16(9), 1051-1062. doi:10.1080/14740338.2017.1351542

DOI: 10.1080/14740338.2017.1351542

Novel Risk Markers and Risk Assessments for Cardiovascular Disease (Journal article)

Thomas, M. R., & Lip, G. Y. H. (2017). Novel Risk Markers and Risk Assessments for Cardiovascular Disease. CIRCULATION RESEARCH, 120(1), 133-149. doi:10.1161/CIRCRESAHA.116.309955

DOI: 10.1161/CIRCRESAHA.116.309955

Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS). (Journal article)

Sarkozy, A., De Potter, T., Heidbuchel, H., Ernst, S., Kosiuk, J., Vano, E., . . . ESC Scientific Document Group. (2017). Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS).. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 19(12), 1909-1922. doi:10.1093/europace/eux252

DOI: 10.1093/europace/eux252

Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world' (Journal article)

Voukalis, C., & Lip, G. Y. H. (2017). Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world'. HEART, 103(13), 977-978. doi:10.1136/heartjnl-2017-311162

DOI: 10.1136/heartjnl-2017-311162

Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry (Journal article)

Lahtela, H. M., Bah, A., Kiviniemi, T., Nammas, W., Schlitt, A., Rubboli, A., . . . Airaksinen, K. E. J. (2017). Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. CLINICAL CARDIOLOGY, 40(12), 1264-1270. doi:10.1002/clc.22821

DOI: 10.1002/clc.22821

Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation (Journal article)

Nielsen, P. B., Larsen, T. B., Skjoth, F., & Lip, G. Y. H. (2017). Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation. JAMA INTERNAL MEDICINE, 177(4), 563-570. doi:10.1001/jamainternmed.2016.9369

DOI: 10.1001/jamainternmed.2016.9369

Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios (Conference Paper)

Bonde, A. N., Staerk, L., Gislason, G., Torp-Pedersen, C., Lip, G. Y. H., & Olesen, J. B. (2017). Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 838-839). Retrieved from http://gateway.webofknowledge.com/

P-Wave Indices and Risk of Ischemic Stroke A Systematic Review and Meta-Analysis (Journal article)

He, J., Tse, G., Korantzopoulos, P., Letsas, K. P., Ali-Hasan-Al-Saegh, S., Kamel, H., . . . Liu, T. (2017). P-Wave Indices and Risk of Ischemic Stroke A Systematic Review and Meta-Analysis. STROKE, 48(8), 2066-+. doi:10.1161/STROKEAHA.117.017293

DOI: 10.1161/STROKEAHA.117.017293

PERSISTENCE WITH THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY (Conference Paper)

Paquette, M., Huisman, M., Lip, G., Diener, H. -C., Dubner, S., Halperin, J., . . . Nieuwlaat, R. (2017). PERSISTENCE WITH THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 374). Retrieved from http://gateway.webofknowledge.com/

PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY (Conference Paper)

McIntyre, W. F., Conen, D., Olshansky, B., Halperin, J., Hayek, E., Huisman, M., . . . Healey, J. (2017). PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 413). Retrieved from http://gateway.webofknowledge.com/

PREDICTORS OF INCIDENT ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY (Conference Paper)

Fauchier, L., Bisson, A., Angoulvant, D., Clementy, N., Babuty, D., & Lip, G. (2017). PREDICTORS OF INCIDENT ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 328). Retrieved from http://gateway.webofknowledge.com/

Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study (Journal article)

Clarkesmith, D. E., Lip, G. Y. H., & Lane, D. A. (2017). Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study. THROMBOSIS RESEARCH, 153, 19-27. doi:10.1016/j.thromres.2017.03.002

DOI: 10.1016/j.thromres.2017.03.002

Peripheral arterial disease amongst British ethnic minorities in a community based population: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) (Journal article)

Vitalis, A., Shantsila, A., Vohra, R. K., Kay, M., Bennett, P. C., Lip, G. Y. H., & Gill, P. S. (2017). Peripheral arterial disease amongst British ethnic minorities in a community based population: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 71(7). doi:10.1111/ijcp.12977

DOI: 10.1111/ijcp.12977

Peripheral arterial disease in a cohort of atrial fibrillation patients. The Atrial Fibrillation Follow Up Investigation Of Rhythm Management (AFFIRM) study (Conference Paper)

Vitalis, A., Lip, G. Y. H., Proietti, M., Olshansky, B., & Shantsila, A. (2017). Peripheral arterial disease in a cohort of atrial fibrillation patients. The Atrial Fibrillation Follow Up Investigation Of Rhythm Management (AFFIRM) study. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 452). Retrieved from http://gateway.webofknowledge.com/

Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation (Conference Paper)

Hellman, T. A., Kiviniemi, T., Nuotio, I., Vasankari, T., Hartikainen, J., Lip, G. Y. H., & Airaksinen, K. E. (2017). Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 839). Retrieved from http://gateway.webofknowledge.com/

Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation (Journal article)

Paquette, M., Franca, L. R., Teutsch, C., Diener, H. -C., Lu, S., Dubner, S. J., . . . Nieuwlaat, R. (2017). Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 70(13), 1573-1583. doi:10.1016/j.jacc.2017.07.793

DOI: 10.1016/j.jacc.2017.07.793

Persistency of left atrial linear lesions after radiofrequency catheter ablation for atrial fibrillation: Data from an invasive follow-up electrophysiology study (Journal article)

Mujovic, N., Marinkovic, M., Markovic, N., Stankovic, G., Lip, G. Y. H., Blomstrom-Lundqvist, C., . . . Potpara, T. S. (2017). Persistency of left atrial linear lesions after radiofrequency catheter ablation for atrial fibrillation: Data from an invasive follow-up electrophysiology study. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 28(12), 1403-1414. doi:10.1111/jce.13322

DOI: 10.1111/jce.13322

Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation (Journal article)

Potpara, T. S., & Lip, G. Y. H. (2017). Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 317(11), 1115-1116. doi:10.1001/jama.2017.1152

DOI: 10.1001/jama.2017.1152

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE (Journal article)

Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Borjesson, M., Brugada Terradellas, J., . . . Piepoli, M. (2017). Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 24(1), 41-69. doi:10.1177/2047487316676042

DOI: 10.1177/2047487316676042

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE (Journal article)

Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Borjesson, M., Brugada Terradellas, J., . . . Piepoli, M. (2017). Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. EUROPACE, 19(1), 139-163. doi:10.1093/europace/euw243

DOI: 10.1093/europace/euw243

Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score) (Journal article)

Jaakkola, S., Lip, G. Y. H., Biancari, F., Nuotio, I., Hartikainen, J. E. K., Ylitalo, A., & Airaksinen, K. E. J. (2017). Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score). AMERICAN JOURNAL OF CARDIOLOGY, 119(5), 749-752. doi:10.1016/j.amjcard.2016.11.026

DOI: 10.1016/j.amjcard.2016.11.026

Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score (Journal article)

Mujovic, N., Marinkovic, M., Markovic, N., Shantsila, A., Lip, G. Y. H., & Potpara, T. S. (2017). Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score. SCIENTIFIC REPORTS, 7. doi:10.1038/srep40828

DOI: 10.1038/srep40828

Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs) (Conference Paper)

Nielsen, P. B., Skjoeth, F., Larsen, T. B., Kjaeldgaard, J. N., & Lip, G. Y. H. (2017). Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs). In EUROPEAN HEART JOURNAL Vol. 38 (pp. 964). Retrieved from http://gateway.webofknowledge.com/

Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry (Journal article)

Shantsila, A., Shantsila, E., Beevers, D. G., & Lip, G. Y. H. (2017). Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry. JOURNAL OF HYPERTENSION, 35(11), 2310-2314. doi:10.1097/HJH.0000000000001446

DOI: 10.1097/HJH.0000000000001446

Predictors of warfarin discontinuation or switching among non-valvular atrial fibrillation patients (Conference Paper)

Lip, G. Y. H., Keshishian, A., Li, X., Lee, T. C., Mardekian, J., Posner, N., & Luo, X. (2017). Predictors of warfarin discontinuation or switching among non-valvular atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 774-775). Retrieved from http://gateway.webofknowledge.com/

Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry (Conference Paper)

Lip, G. Y. H., Teusch, C., Huisman, M. V., Diener, H. C., Dubner, S. J., Ma, C. S., . . . Halperin, J. L. (2017). Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 975). Retrieved from http://gateway.webofknowledge.com/

Previous thromboembolic disease and risk of death in atrial fibrillation: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry (Conference Paper)

Proietti, M., Laroche, C., Maggioni, A. P., Boriani, G., Lip, G. Y. H., & Investigators, E. O. R. P. -A. F. (2017). Previous thromboembolic disease and risk of death in atrial fibrillation: the EURObservational research programme in atrial fibrillation (EORP-AF) general pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 83). Retrieved from http://gateway.webofknowledge.com/

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial (Journal article)

Kirchhoff, P., Blank, B. F., Calvert, M., Camm, A. J., Chlouverakis, G., Diener, H. -C., . . . Vardas, P. (2017). Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. AMERICAN HEART JOURNAL, 190, 12-18. doi:10.1016/j.ahj.2017.04.015

DOI: 10.1016/j.ahj.2017.04.015

Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study (Journal article)

Fauchier, L., Clementy, N., Bisson, A., Stamboul, K., Ivanes, F., Angoulvant, D., . . . Lip, G. Y. H. (2017). Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study. CLINICAL RESEARCH IN CARDIOLOGY, 106(3), 202-210. doi:10.1007/s00392-016-1040-7

DOI: 10.1007/s00392-016-1040-7

Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review (Journal article)

Bikdeli, B., Abou Ziki, M. D., & Lip, G. Y. H. (2017). Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 43(8), 849-863. doi:10.1055/s-0036-1598005

DOI: 10.1055/s-0036-1598005

Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review (vol 43, pg 849, 2017) (Journal article)

Bikdeli, B., Abou Ziki, M. D., & Lip, G. Y. H. (2017). Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review (vol 43, pg 849, 2017). SEMINARS IN THROMBOSIS AND HEMOSTASIS, 43(8), E1. doi:10.1055/s-0037-1602761

DOI: 10.1055/s-0037-1602761

RATES OF STROKE AND BLEEDING WITH DABIGATRAN 150 AND 110 MG BID IN CLINICAL PRACTICE: THE GLORIA-AF REGISTRY (Conference Paper)

Lip, G., Huisman, M., Diener, H. -C., Dubner, S., Ma, C., Rothman, K., . . . Halperin, J. (2017). RATES OF STROKE AND BLEEDING WITH DABIGATRAN 150 AND 110 MG BID IN CLINICAL PRACTICE: THE GLORIA-AF REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 69 (pp. 541). Retrieved from http://gateway.webofknowledge.com/

REPLY: Apixaban Dosing in Chronic Kidney Disease Differences Between US and EU Labeling (Journal article)

Proietti, M., & Lip, G. Y. H. (2017). REPLY: Apixaban Dosing in Chronic Kidney Disease Differences Between US and EU Labeling. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(9), 1212. doi:10.1016/j.jacc.2016.11.075

DOI: 10.1016/j.jacc.2016.11.075

RIVAROXABAN VS. DABIGATRAN OR WARFARIN IN REAL-WORLD OBSERVATIONAL STUDIES OF STROKE PREVENTION IN ATRIAL FIBRILLATION: SYSTEMATIC REVIEW AND META-ANALYSIS (Conference Paper)

Bai, Y., Deng, H., Shantsila, A., & Lip, G. Y. H. (2017). RIVAROXABAN VS. DABIGATRAN OR WARFARIN IN REAL-WORLD OBSERVATIONAL STUDIES OF STROKE PREVENTION IN ATRIAL FIBRILLATION: SYSTEMATIC REVIEW AND META-ANALYSIS. In HEART Vol. 103 (pp. A36-A37). doi:10.1136/heartjnl-2017-311726.44

DOI: 10.1136/heartjnl-2017-311726.44

Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. (Journal article)

Ntaios, G., Papavasileiou, V., Makaritsis, K., Vemmos, K., Michel, P., & Lip, G. Y. H. (2017). Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.. Stroke, 48(9), 2494-2503. doi:10.1161/strokeaha.117.017549

DOI: 10.1161/strokeaha.117.017549

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy (Journal article)

Gibson, C. M., Pinto, D. S., Chi, G., Arbetter, D., Yee, M., Mehran, R., . . . Fox, K. A. A. (2017). Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy. CIRCULATION, 135(4), 323-+. doi:10.1161/CIRCULATIONAHA.116.025783

DOI: 10.1161/CIRCULATIONAHA.116.025783

Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry (Journal article)

Mazurek, M., Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., . . . Investigators, G. L. O. R. I. A. -A. F. (2017). Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry. THROMBOSIS AND HAEMOSTASIS, 117(12), 2376-2388. doi:10.1160/TH17-08-0555

DOI: 10.1160/TH17-08-0555

Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice (Journal article)

Mazurek, M., Huisman, M. V., & Lip, G. Y. H. (2017). Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice. AMERICAN JOURNAL OF MEDICINE, 130(2), 135-145. doi:10.1016/j.amjmed.2016.09.012

DOI: 10.1016/j.amjmed.2016.09.012

Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry) (Journal article)

Abe, M., Ogawa, H., Ishii, M., Masunaga, N., Esato, M., Chun, Y. -H., . . . Akao, M. (2017). Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry). AMERICAN JOURNAL OF CARDIOLOGY, 119(8), 1229-1237. doi:10.1016/j.amjcard.2017.01.005

DOI: 10.1016/j.amjcard.2017.01.005

Relation of congestive heart failure history to efficacy and safety of edoxaban for cardioversion of atrial fibrillation: subanalysis from the ENSURE-AF study (Conference Paper)

Dan, A., Dan, G. A., Merino, J. L., Merkely, B., Jin, J., Melino, M., . . . Goette, A. (2017). Relation of congestive heart failure history to efficacy and safety of edoxaban for cardioversion of atrial fibrillation: subanalysis from the ENSURE-AF study. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1368-1369). Retrieved from http://gateway.webofknowledge.com/

Relation of renal dysfunction to quality of anticoagulation control in patients with atrial fibrillation: The FANTASIIA registry (Conference Paper)

Esteve Pastor, M. A., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., Cequier, A., . . . Marin, F. (2017). Relation of renal dysfunction to quality of anticoagulation control in patients with atrial fibrillation: The FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1321). Retrieved from http://gateway.webofknowledge.com/

Relationship between renal function and circulating microparticles, soluble P-selectin and E- selectin levels in atrial fibrillation (Journal article)

Lau, Y. C., Xiong, Q., Blann, A. D., & Lip, G. Y. H. (2017). Relationship between renal function and circulating microparticles, soluble P-selectin and E- selectin levels in atrial fibrillation. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 43(1), 18-23. doi:10.1007/s11239-016-1427-3

DOI: 10.1007/s11239-016-1427-3

Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke (Journal article)

Bisson, A., Clementy, N., Bodin, A., Angoulvant, D., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2017). Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke. STROKE, 48(10), 2878-+. doi:10.1161/STROKEAHA.117.018251

DOI: 10.1161/STROKEAHA.117.018251

Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries (Journal article)

Bonde, A. N., Lip, G. Y. H., Kamper, A. -L., Staerk, L., Torp-Pedersen, C., Gislason, G., & Olesen, J. B. (2017). Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries. THROMBOSIS AND HAEMOSTASIS, 117(12), 2291-2299. doi:10.1160/TH17-03-0198

DOI: 10.1160/TH17-03-0198

Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study (Journal article)

Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2017). Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study. JOURNAL OF HUMAN HYPERTENSION, 31(3), 206-211. doi:10.1038/jhh.2016.68

DOI: 10.1038/jhh.2016.68

Renin-angiotensin blockade in atrial fibrillation: where are we now? (Journal article)

Shahid, F., Lip, G. Y. H., & Shantsila, E. (2017). Renin-angiotensin blockade in atrial fibrillation: where are we now?. JOURNAL OF HUMAN HYPERTENSION, 31(7), 425-426. doi:10.1038/jhh.2017.6

DOI: 10.1038/jhh.2017.6

Reply to Jolobe (Journal article)

Voukalis, C., Shantsila, E., & Lip, G. Y. (2017). Reply to Jolobe. The journal of the Royal College of Physicians of Edinburgh, 47(2), 205-206. doi:10.4997/jrcpe.2017.222

DOI: 10.4997/jrcpe.2017.222

Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis" (Journal article)

Bai, Y., Shantsila, A., & Lip, G. Y. H. (2017). Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis". STROKE, 48(6), E149. doi:10.1161/STROKEAHA.117.017460

DOI: 10.1161/STROKEAHA.117.017460

Response to: The Cause of the Arteriolar Injury in Malignant Hypertension (Journal article)

Shantsila, A., & Lip, G. Y. H. (2017). Response to: The Cause of the Arteriolar Injury in Malignant Hypertension. AMERICAN JOURNAL OF HYPERTENSION, 30(11), E15. doi:10.1093/ajh/hpx149

DOI: 10.1093/ajh/hpx149

Restarting Oral Anticoagulant Therapy After Major Bleeding Events in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Real-World Studies (Conference Paper)

Proietti, M., Romiti, G. F., Romanazzi, I., Farcomeni, A., Staerk, L., Nielsen, P. B., & Lip, G. Y. (2017). Restarting Oral Anticoagulant Therapy After Major Bleeding Events in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Real-World Studies. In CIRCULATION Vol. 136. Retrieved from http://gateway.webofknowledge.com/

Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure (Journal article)

Nakanishi, K., Di Tullio, M. R., Qian, M., Thompson, J. L. P., Labovitz, A. J., Mann, D. L., . . . Investigators, W. A. R. C. E. F. (2017). Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure. CEREBROVASCULAR DISEASES, 44(1-2), 43-50. doi:10.1159/000474958

DOI: 10.1159/000474958

Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease (Journal article)

Heitmar, R., Lip, G. Y. H., Ryder, R. E., & Blann, A. D. (2017). Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease. CARDIOVASCULAR DIABETOLOGY, 16. doi:10.1186/s12933-017-0534-6

DOI: 10.1186/s12933-017-0534-6

Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis (Journal article)

Niessner, A., Tamargo, J., Morais, J., Koller, L., Wassmann, S., Husted, S. E., . . . Agewall, S. (2017). Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis. EUROPEAN HEART JOURNAL, 38(22), 1710-1U99. doi:10.1093/eurheartj/ehv676

DOI: 10.1093/eurheartj/ehv676

Risk Stratification Models in Atrial Fibrillation (Journal article)

Shahid, F., & Lip, G. Y. H. (2017). Risk Stratification Models in Atrial Fibrillation. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 43(5), 505-513. doi:10.1055/s-0036-1597285

DOI: 10.1055/s-0036-1597285

Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation - A Nationwide Cohort Study (Journal article)

Chao, T. -F., Liu, C. -J., Tuan, T. -C., Chen, S. -J., Chen, T. -J., Lip, G. Y. H., & Chen, S. -A. (2017). Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation - A Nationwide Cohort Study. SCIENTIFIC REPORTS, 7. doi:10.1038/srep46445

DOI: 10.1038/srep46445

Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials (Journal article)

Abdul-Rahim, A. H., Perez, A. -C., MacIsaac, R. L., Jhund, P. S., Claggett, B. L., Carson, P. E., . . . Preserved, I. H. F. (2017). Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials. EUROPEAN HEART JOURNAL, 38(10), 742-750. doi:10.1093/eurheartj/ehw509

DOI: 10.1093/eurheartj/ehw509

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation Systematic Review and Meta-Analysis (Journal article)

Bai, Y., Deng, H., Shantsila, A., & Lip, G. Y. H. (2017). Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation Systematic Review and Meta-Analysis. STROKE, 48(4), 970-976. doi:10.1161/STROKEAHA.116.016275

DOI: 10.1161/STROKEAHA.116.016275

Rivaroxaban strategies improve the number of days patients remain out of the hospital and event free: A PIONEER substudy (Conference Paper)

Gibson, C. M., Arbetter, D. F., Jain, P., Mehran, R., Bode, C., Halperin, J., . . . Fox, K. A. A. (2017). Rivaroxaban strategies improve the number of days patients remain out of the hospital and event free: A PIONEER substudy. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 768). Retrieved from http://gateway.webofknowledge.com/

Rivaroxaban treatment strategies reduce costs associated with rehospitalizations due to bleeding and cardiovascular events: results from the PIONEER AF-PCI trial (Conference Paper)

Pinto, D. S., Tamez, H., Korjian, S., Daaboul, Y., Mehran, R., Bode, C., . . . Gibson, C. M. (2017). Rivaroxaban treatment strategies reduce costs associated with rehospitalizations due to bleeding and cardiovascular events: results from the PIONEER AF-PCI trial. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 965). Retrieved from http://gateway.webofknowledge.com/

Rivaroxaban treatment strategies reduce not only the first bleeding event, but all (including multiple) bleeding events: A PIONEER Substudy (Conference Paper)

Yee, M. K., Chi, G., Jain, P., Mehran, R., Bode, C., Halperin, J., . . . Gibson, C. M. (2017). Rivaroxaban treatment strategies reduce not only the first bleeding event, but all (including multiple) bleeding events: A PIONEER Substudy. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 963-964). Retrieved from http://gateway.webofknowledge.com/

Screening for Atrial Fibrillation A Report of the AF-SCREEN International Collaboration (Journal article)

Freedman, B., Camm, J., Calkins, H., Healey, J. S., Rosenqvist, M., Wang, J., . . . Collaboration, A. F. -S. C. R. E. E. N. I. (2017). Screening for Atrial Fibrillation A Report of the AF-SCREEN International Collaboration. CIRCULATION, 135(19), 1851-+. doi:10.1161/CIRCULATIONAHA.116.026693

DOI: 10.1161/CIRCULATIONAHA.116.026693

Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacin Cardiaca y Electrofisiologia (SOLAECE) (Journal article)

Mairesse, G. H., Moran, P., Van Gelder, I. C., Elsner, C., Rosenqvist, M., Mant, J., . . . Sapp, J. L. (2017). Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacin Cardiaca y Electrofisiologia (SOLAECE). EUROPACE, 19(10), 1589-1623. doi:10.1093/europace/eux177

DOI: 10.1093/europace/eux177

Secondary Versus Primary Stroke Prevention in Atrial Fibrillation Insights From the Darlington Atrial Fibrillation Registry (Journal article)

Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., Proietti, M., & Lip, G. Y. H. (2017). Secondary Versus Primary Stroke Prevention in Atrial Fibrillation Insights From the Darlington Atrial Fibrillation Registry. STROKE, 48(8), 2198-+. doi:10.1161/STROKEAHA.116.016146

DOI: 10.1161/STROKEAHA.116.016146

Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry (Journal article)

Proietti, M., Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., . . . Registry, E. O. R. P. -A. F. G. P. (2017). Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. EUROPACE, 19(4), 535-543. doi:10.1093/europace/euw150

DOI: 10.1093/europace/euw150

Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation. - The Fushimi AF Registry (Journal article)

Ogawa, H., Hamatani, Y., Doi, K., Tezuka, Y., An, Y., Ishii, M., . . . Investigators, F. A. F. R. (2017). Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation. - The Fushimi AF Registry. CIRCULATION JOURNAL, 81(10), 1403-1410. doi:10.1253/circj.CJ-17-0071

DOI: 10.1253/circj.CJ-17-0071

Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial (Journal article)

Essebag, V., Proietti, R., Birnie, D. H., Wang, J., Douketis, J., Coutu, B., . . . Healey, J. S. (2017). Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial. EUROPACE, 19(10), 1630-1636. doi:10.1093/europace/euw409

DOI: 10.1093/europace/euw409

Spontaneous Cardioversion in Nonvalvular Atrial Fibrillation in Patients Planned for Electrical Cardioversion: A Subanalysis of the ENSURE-AF Trial (Conference Paper)

Cohen, A. A., Heidbuchel, H., Le Heuzey, J. -Y., De Caterina, R., Merino, J. L., Jin, J., . . . Lip, G. Y. (2017). Spontaneous Cardioversion in Nonvalvular Atrial Fibrillation in Patients Planned for Electrical Cardioversion: A Subanalysis of the ENSURE-AF Trial. In CIRCULATION Vol. 136. Retrieved from http://gateway.webofknowledge.com/

Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation (Journal article)

Lip, G. Y. H., Lane, D. A., & Sarwar, S. (2017). Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation. EUROPEAN HEART JOURNAL, 38(40), 2980-2982. doi:10.1093/eurheartj/ehx554

DOI: 10.1093/eurheartj/ehx554

Stroke prevention in Atrial Fibrillation (Journal article)

Lip, G. Y. H. (2017). Stroke prevention in Atrial Fibrillation. EUROPEAN HEART JOURNAL, 38(1), 4-5. doi:10.1093/eurheartj/ehw584

DOI: 10.1093/eurheartj/ehw584

Stroke prevention in atrial fibrillation: Past, present and future Comparing the guidelines and practical decision-making (Journal article)

Lip, G. Y. H., Freedman, B., De Caterina, R., & Potpara, T. S. (2017). Stroke prevention in atrial fibrillation: Past, present and future Comparing the guidelines and practical decision-making. THROMBOSIS AND HAEMOSTASIS, 117(7), 1230-1239. doi:10.1160/TH16-11-0876

DOI: 10.1160/TH16-11-0876

Stroke prevention in atrial fibrillation: Past, present and future. (Journal article)

Lip, G. Y. H., Freedman, B., De Caterina, R., & Potpara, T. S. (2017). Stroke prevention in atrial fibrillation: Past, present and future.. Thrombosis and haemostasis, 117(7), 1230-1239. doi:10.1160/th16-11-0876

DOI: 10.1160/th16-11-0876

Stroke-Prophylaxis and 30-Day Clinical Outcomes After United States Emergency Department Diagnosis and Discharge for Atrial Fibrillation (Conference Paper)

Kea, B., Lin, A., Olshansky, B., Raitt, M., Lip, G. Y., Fu, R., & Sun, B. (2017). Stroke-Prophylaxis and 30-Day Clinical Outcomes After United States Emergency Department Diagnosis and Discharge for Atrial Fibrillation. In CIRCULATION Vol. 136. Retrieved from http://gateway.webofknowledge.com/

Subgroup Analysis From the RE-DUAL PCI Trial: Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (Conference Paper)

Oldgren, J., Steg, P. -G., Hohnloser, S. H., Lip, G. Y., Ellis, S. G., Kimura, T., . . . Kleine, E. (2017). Subgroup Analysis From the RE-DUAL PCI Trial: Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. In CIRCULATION Vol. 136 (pp. E457). Retrieved from http://gateway.webofknowledge.com/

Synergic effects of blood pressure control and quality of anticoagulation control on outcomes in patients with atrial fibrillation: the SPORTIF III and V trials (Conference Paper)

Proietti, M., & Lip, G. Y. H. (2017). Synergic effects of blood pressure control and quality of anticoagulation control on outcomes in patients with atrial fibrillation: the SPORTIF III and V trials. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 770). Retrieved from http://gateway.webofknowledge.com/

Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry (Journal article)

Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., . . . Grp, A. F. C. A. S. S. (2017). Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry. CLINICAL RESEARCH IN CARDIOLOGY, 106(6), 420-427. doi:10.1007/s00392-016-1071-0

DOI: 10.1007/s00392-016-1071-0

Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management) (Journal article)

Proietti, M., Romiti, G. F., Olshansky, B., & Lip, G. Y. H. (2017). Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). HYPERTENSION, 70(5), 949-958. doi:10.1161/HYPERTENSIONAHA.117.10106

DOI: 10.1161/HYPERTENSIONAHA.117.10106

Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care (Journal article)

Lane, D. A., Skjoth, F., Lip, G. Y. H., Larsen, T. B., & Kotecha, D. (2017). Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 6(5). doi:10.1161/JAHA.116.005155

DOI: 10.1161/JAHA.116.005155

Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study (Journal article)

Lee, S. -R., Choi, E. -K., Han, K. -D., Cha, M. -J., Oh, S., & Lip, G. Y. H. (2017). Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study. PLOS ONE, 12(12). doi:10.1371/journal.pone.0189495

DOI: 10.1371/journal.pone.0189495

The 2MACE score predicts cardiovascular events in real-world patients with atrial fibrillation: The FANTASIIA registry (Conference Paper)

Esteve Pastor, M. A., Perez-Copete, J., Rivera-Caravaca, J. M., Roldan, V., Roldan Rabadan, I., Muniz, J., . . . Marin, F. (2017). The 2MACE score predicts cardiovascular events in real-world patients with atrial fibrillation: The FANTASIIA registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1126-1127). Retrieved from http://gateway.webofknowledge.com/

The ABC pathway: an integrated approach to improve AF management (Journal article)

Lip, G. Y. H. (2017). The ABC pathway: an integrated approach to improve AF management. NATURE REVIEWS CARDIOLOGY, 14(11), 627-+. doi:10.1038/nrcardio.2017.153

DOI: 10.1038/nrcardio.2017.153

The CHADS(2) and CHA(2)DS(2)-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores (Journal article)

Tse, G., Lip, G. Y. H., & Liu, T. (2017). The CHADS(2) and CHA(2)DS(2)-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores. INTERNATIONAL JOURNAL OF CARDIOLOGY, 245, 181-182. doi:10.1016/j.ijcard.2017.07.109

DOI: 10.1016/j.ijcard.2017.07.109

The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2 (Journal article)

Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. -C., Dubner, S. J., . . . Investigators, G. L. O. R. I. A. -A. F. (2017). The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(7), 777-785. doi:10.1016/j.jacc.2016.11.061

DOI: 10.1016/j.jacc.2016.11.061

The Effect of Anticoagulation Rates on Time-Trends in Stroke Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data (Conference Paper)

Kim, T. -H., Yang, P. -S., Yu, H. T., Uhm, J. -S., Kim, J. -Y., Pak, H. -N., . . . Lip, G. Y. (2017). The Effect of Anticoagulation Rates on Time-Trends in Stroke Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data. In CIRCULATION Vol. 136. Retrieved from http://gateway.webofknowledge.com/

The Effect of Utilization of Non-vitamin K Antagonist Oral Anticoagulants on Time-Trends In Mortality and Hospitalization Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data (Conference Paper)

Yu, H. T., Yang, P. -S., Hwang, J., Ryu, S., Kim, T. -H., Uhm, J. -S., . . . Lip, G. Y. (2017). The Effect of Utilization of Non-vitamin K Antagonist Oral Anticoagulants on Time-Trends In Mortality and Hospitalization Rates for Atrial Fibrillation: A Nationwide Study Using the Korean National Health Insurance Data. In CIRCULATION Vol. 136. Retrieved from http://gateway.webofknowledge.com/

The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia (Journal article)

Bai, Y., Wang, Y. -L., Shantsila, A., & Lip, G. Y. H. (2017). The Global Burden of Atrial Fibrillation and Stroke A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia. CHEST, 152(4), 810-820. doi:10.1016/j.chest.2017.03.048

DOI: 10.1016/j.chest.2017.03.048

The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey (Journal article)

Potpara, T. S., Trendafilova, E., Dan, G. -A., Goda, A., Kusljugic, Z., Manola, S., . . . Investigators, B. A. L. K. A. N. -A. F. (2017). The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey. ADVANCES IN THERAPY, 34(8), 2043-2057. doi:10.1007/s12325-017-0589-5

DOI: 10.1007/s12325-017-0589-5

The comparison of the lipid profile in the population of Poland between 2004, 2006 and 2015 based on the results of the LIPIDOGRAM cohort studies (Conference Paper)

Banach, M., Wojtowicz, E., Tomaszewski, M., Catapano, A. L., Toth, P. P., Sattar, N., . . . Grp, L. -G. S. (2017). The comparison of the lipid profile in the population of Poland between 2004, 2006 and 2015 based on the results of the LIPIDOGRAM cohort studies. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1116). Retrieved from http://gateway.webofknowledge.com/

The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden (Journal article)

Boriani, G., Lip, G. Y. H., Ricci, R. P., Proclemer, A., Landolina, M., Lunati, M., . . . Gasparini, M. (2017). The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden. EUROPACE, 19(11), 1767-1775. doi:10.1093/europace/euw333

DOI: 10.1093/europace/euw333

The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review (Journal article)

De Caterina, R., & Lip, G. Y. H. (2017). The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review. CLINICAL RESEARCH IN CARDIOLOGY, 106(8), 565-572. doi:10.1007/s00392-017-1102-5

DOI: 10.1007/s00392-017-1102-5

The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors (Journal article)

Butler, J., Hamo, C. E., Filippatos, G., Pocock, S. J., Bernstein, R. A., Brueckmann, M., . . . Program, E. M. P. E. R. O. R. T. (2017). The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors. EUROPEAN JOURNAL OF HEART FAILURE, 19(11), 1390-1400. doi:10.1002/ejhf.933

DOI: 10.1002/ejhf.933

The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study (Journal article)

Lip, G. Y. H., Al-Saady, N., Ezekowitz, M. D., Banach, M., & Goette, A. (2017). The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. AMERICAN HEART JOURNAL, 193, 16-22. doi:10.1016/j.ahj.2017.07.010

DOI: 10.1016/j.ahj.2017.07.010

The relationship of renal function to outcome: a post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) study (Conference Paper)

Lip, G. Y. H., Al-Saady, N., Ezekowitz, M. D., Banach, M., & Goette, A. (2017). The relationship of renal function to outcome: a post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) study. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1369). Retrieved from http://gateway.webofknowledge.com/

The wearable cardioverter-defibrillator: current technology and evolving indications. (Journal article)

Reek, S., Burri, H., Roberts, P. R., Perings, C., Epstein, A. E., Klein, H. U., . . . Savelieva, I. (2017). The wearable cardioverter-defibrillator: current technology and evolving indications.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 19(3), 335-345. doi:10.1093/europace/euw180

DOI: 10.1093/europace/euw180

Thrombosis and Haemostasis: Past, present and future (Journal article)

Lip, G. Y. H., & Weber, C. (2017). Thrombosis and Haemostasis: Past, present and future. THROMBOSIS AND HAEMOSTASIS, 117(7), 1217-1218. doi:10.1160/TH17-05-0350

DOI: 10.1160/TH17-05-0350

Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry (Journal article)

Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., . . . Grp, A. F. C. A. S. S. (2017). Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry. AMERICAN HEART JOURNAL, 190, 86-93. doi:10.1016/j.ahj.2017.05.016

DOI: 10.1016/j.ahj.2017.05.016

To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation (Journal article)

Mazurek, M., & Lip, G. Y. H. (2017). To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation. HEART, 103(2), 93-95. doi:10.1136/heartjnl-2016-310255

DOI: 10.1136/heartjnl-2016-310255

Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA(2)DS(2)-VASc score (Journal article)

Overvad, T. F., Nielsen, P. B., & Lip, G. Y. H. (2017). Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA(2)DS(2)-VASc score. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 3(1), 37-41. doi:10.1093/ehjcvp/pvw022

DOI: 10.1093/ehjcvp/pvw022

Update in General Internal Medicine (vol 131, pg 199, 1999) (Journal article)

Lip, G. Y., Keshishian, A., Kamble, S., Pan, X., Mardekian, J., & Horblyuk, R. (2017). Update in General Internal Medicine (vol 131, pg 199, 1999). ANNALS OF INTERNAL MEDICINE, 166(11), 856. doi:10.7326/M17-0898

DOI: 10.7326/M17-0898

Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary. (Journal article)

Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H. -C., Hacke, W., . . . ESC Scientific Document Group. (2017). Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.. European heart journal, 38(27), 2137-2149. doi:10.1093/eurheartj/ehw058

DOI: 10.1093/eurheartj/ehw058

Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events (Conference Paper)

Roldan, V., Esteve Pastor, M. A., Rivera-Caravaca, J. M., Shantsila, A., Garcia Fernandez, A., Valdes, M., . . . Lip, G. Y. H. (2017). Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1232). Retrieved from http://gateway.webofknowledge.com/

Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase (Journal article)

Proietti, M., Laroche, C., Nyvad, O., Haberka, M., Vassilikos, V. P., Maggioni, A. P., . . . Investigators, E. O. R. P. -A. F. P. (2017). Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase. INTERNATIONAL JOURNAL OF CARDIOLOGY, 248, 166-172. doi:10.1016/j.ijcard.2017.08.055

DOI: 10.1016/j.ijcard.2017.08.055

Use of statins and adverse outcomes in patients with atrial fibrillation: the EURObservational research programme atrial fibrillation (EORP-AF) general pilot registry (Conference Paper)

Proietti, M., Laroche, C., Nyvad, O., Haberka, M., Vassilikos, V. P., Maggioni, A. P., . . . Registry, E. O. R. P. -A. F. G. P. (2017). Use of statins and adverse outcomes in patients with atrial fibrillation: the EURObservational research programme atrial fibrillation (EORP-AF) general pilot registry. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 12). Retrieved from http://gateway.webofknowledge.com/

Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation (Journal article)

Miguel Rivera-Caravaca, J., Marin, F., Asuncion Esteve-Pastor, M., Rana-Miguez, P., Anguita, M., Muniz, J., . . . Roldan, V. (2017). Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 120(12), 2176-2181. doi:10.1016/j.amjcard.2017.09.003

DOI: 10.1016/j.amjcard.2017.09.003

Validation of the Same-TT2R2 Score in a Multiethnic Cohort of Asian Patients with Atrial Fibrillation on Warfarin Therapy - A Multicenter Study (Conference Paper)

Khaw, C. S., Lim, M. S. H., Tiong, L. L., Tan, S. S. N., Ku, M. Y., Tan, C. S. Y., . . . Fong, A. Y. Y. (2017). Validation of the Same-TT2R2 Score in a Multiethnic Cohort of Asian Patients with Atrial Fibrillation on Warfarin Therapy - A Multicenter Study. In INTERNATIONAL JOURNAL OF CARDIOLOGY Vol. 249 (pp. S2). doi:10.1016/j.ijcard.2017.09.115

DOI: 10.1016/j.ijcard.2017.09.115

Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal (Journal article)

Potpara, T. S., Lip, G. Y. H., Blomstrom-Lundqvist, C., Chiang, C. -E., & Camm, A. J. (2017). Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal. AMERICAN JOURNAL OF MEDICINE, 130(7), 773-779. doi:10.1016/j.amjmed.2017.02.026

DOI: 10.1016/j.amjmed.2017.02.026

White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction (Journal article)

Andersen, S. D., Larsen, T. B., Gorst-Rasmussen, A., Yavarian, Y., Lip, G. Y. H., & Bach, F. W. (2017). White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction. CEREBROVASCULAR DISEASES, 43(1-2), 17-24. doi:10.1159/000450962

DOI: 10.1159/000450962

2016

"Unreal world" or "real world" data in oral anticoagulant treatment of atrial fibrillation (Journal article)

Freedman, B., & Lip, G. Y. H. (2016). "Unreal world" or "real world" data in oral anticoagulant treatment of atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 116(4), 587-589. doi:10.1160/TH16-08-0658

DOI: 10.1160/TH16-08-0658

'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry (Journal article)

Boriani, G., Laroche, C., Diemberger, I., Fantecchi, E., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. Y. H. (2016). 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry. EUROPACE, 18(5), 648-657. doi:10.1093/europace/euv390

DOI: 10.1093/europace/euv390

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (Journal article)

Roffi, M., Patrono, C., Collet, J. P., Mueller, C., Valgimigli, M., Andreotti, F., . . . Halle, M. (2016). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Russian Journal of Cardiology, 131(3), 9-63. doi:10.15829/1560-4071-2016-3-9-63

DOI: 10.15829/1560-4071-2016-3-9-63

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) (Journal article)

Roffi, M., Patrono, C., Collet, J. -P., Mueller, C., Valgimigli, M., Andreotti, F., . . . Zamorano, J. L. (2016). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). EUROPEAN HEART JOURNAL, 37(3), 267-+. doi:10.1093/eurheartj/ehv320

DOI: 10.1093/eurheartj/ehv320

2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). (Journal article)

Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J. -P., Del Zotti, F., . . . ESC Scientific Document Group . (2015). 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).. European heart journal, 36(44), 3075-3128. doi:10.1093/eurheartj/ehv319

DOI: 10.1093/eurheartj/ehv319

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). (Journal article)

Galiè, N., Humbert, M., Humbert, M., Vachiery, J. -L., Gibbs, S., Lang, I., . . . ESC Scientific Document Group . (2016). 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).. European heart journal, 37(1), 67-119. doi:10.1093/eurheartj/ehv317

DOI: 10.1093/eurheartj/ehv317

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. (Journal article)

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., . . . Document Reviewers. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.. European journal of heart failure, 18(8), 891-975. doi:10.1002/ejhf.592

DOI: 10.1002/ejhf.592

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (Journal article)

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . Zeppenfeld, K. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. EUROPACE, 18(11). doi:10.1093/europace/euw295

DOI: 10.1093/europace/euw295

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (Journal article)

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . Zeppenfeld, K. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 50(5), e1-e88. doi:10.1093/ejcts/ezw313

DOI: 10.1093/ejcts/ezw313

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (Journal article)

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., . . . ESC Scientific Document Group. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.. European heart journal, 37(38), 2893-2962. doi:10.1093/eurheartj/ehw210

DOI: 10.1093/eurheartj/ehw210

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (Journal article)

Luis Zamorano, J., Lancellotti, P., Rodriguez Munoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., . . . Suter, T. M. (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. KARDIOLOGIA POLSKA, 74(11), 1193-1233. doi:10.5603/KP.2016.0156

DOI: 10.5603/KP.2016.0156

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (Journal article)

Zamorano, J. L., Lancellotti, P., Munoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., . . . Windecker, S. (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. EUROPEAN HEART JOURNAL, 37(36), 2768-2801. doi:10.1093/eurheartj/ehw211

DOI: 10.1093/eurheartj/ehw211

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (Journal article)

Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., . . . ESC Scientific Document Group. (2016). 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.. European heart journal, 37(39), 2999-3058. doi:10.1093/eurheartj/ehw272

DOI: 10.1093/eurheartj/ehw272

2016 European Guidelines on cardiovascular disease prevention in clinical practice. (Journal article)

Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., . . . Monique Verschuren, W. M. (2016). 2016 European Guidelines on cardiovascular disease prevention in clinical practice.. Revista espanola de cardiologia (English ed.), 69(10), 939. doi:10.1016/j.rec.2016.09.009

DOI: 10.1016/j.rec.2016.09.009

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) (Journal article)

Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., . . . Members, T. F. (2016). 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 23(11), NP1-NP96. doi:10.1177/2047487316653709

DOI: 10.1177/2047487316653709

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). (Journal article)

Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., . . . ESC Scientific Document Group. (2016). 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).. European heart journal, 37(29), 2315-2381. doi:10.1093/eurheartj/ehw106

DOI: 10.1093/eurheartj/ehw106

A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients (Journal article)

Banach, M., Dinca, M., Ursoniu, S., Serban, M. -C., Howard, G., Mikhailidis, D. P., . . . Meta-Anal, L. B. P. (2016). A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients. PHARMACOLOGICAL RESEARCH, 111, 343-356. doi:10.1016/j.phrs.2016.06.005

DOI: 10.1016/j.phrs.2016.06.005

A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation (Journal article)

Marcucci, M., Skjoth, F., Lip, G. Y. H., Iorio, A., & Larsen, T. B. (2016). A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 785-790. doi:10.1016/j.ijcard.2015.11.035

DOI: 10.1016/j.ijcard.2015.11.035

A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme (Journal article)

Proietti, M., Mairesse, G. H., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Investig, B. H. R. (2016). A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme. EUROPACE, 18(12), 1779-1786. doi:10.1093/europace/euw069

DOI: 10.1093/europace/euw069

A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation (Journal article)

Lip, G. Y. H., Potpara, T., Boriani, G., & Blomstrom-Lundqvist, C. (2016). A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation. JOURNAL OF INTERNAL MEDICINE, 279(5), 467-476. doi:10.1111/joim.12468

DOI: 10.1111/joim.12468

Adherence to ESC antithrombotic guidelines improves mortality among Italian elderly AF patients: insights from the REPOSI study (Conference Paper)

Proietti, M., Nobili, A., Raparelli, V., Cangemi, R., Napoleone, L., Basili, S., . . . Investigators, R. E. P. O. S. I. (2016). Adherence to ESC antithrombotic guidelines improves mortality among Italian elderly AF patients: insights from the REPOSI study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 845). Retrieved from http://gateway.webofknowledge.com/

Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study (Journal article)

Proietti, M., Nobili, A., Raparelli, V., Napoleone, L., Mannucci, P. M., Lip, G. Y. H., & Investigators, R. E. P. O. S. I. (2016). Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study. CLINICAL RESEARCH IN CARDIOLOGY, 105(11), 912-920. doi:10.1007/s00392-016-0999-4

DOI: 10.1007/s00392-016-0999-4

Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the eurobservational research programme pilot survey on atrial fibrillation (Conference Paper)

Proietti, M., Raparelli, V., Laroche, C., Dan, G. A., Janion, M., Popescu, R., . . . Registry, E. O. R. P. -A. F. G. P. (2016). Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the eurobservational research programme pilot survey on atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 289). Retrieved from http://gateway.webofknowledge.com/

Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function (Journal article)

Lau, Y. C., Hardy, L. J., Philippou, H., Blann, A. D., & Lip, G. Y. H. (2016). Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function. THROMBOSIS AND HAEMOSTASIS, 116(3), 408-409. doi:10.1160/TH16-05-0361

DOI: 10.1160/TH16-05-0361

An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention PIONEER AF-PCI (Conference Paper)

Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., . . . Fox, K. (2016). An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention PIONEER AF-PCI. In CIRCULATION Vol. 134 (pp. E705). Retrieved from http://gateway.webofknowledge.com/

Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study (Journal article)

Violi, F., Davi, G., Proietti, M., Pastori, D., Hiatt, W. R., Corazza, G. R., . . . Fibrillation, A. R. A. P. A. C. I. S. A. (2016). Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study. THROMBOSIS AND HAEMOSTASIS, 115(4), 856-863. doi:10.1160/TH15-07-0612

DOI: 10.1160/TH15-07-0612

Anticoagulant therapy after venous thromboembolism and 10-year mortality (Journal article)

Larsen, T. B., Lip, G. Y. H., & Gorst-Rasmussen, A. (2016). Anticoagulant therapy after venous thromboembolism and 10-year mortality. INTERNATIONAL JOURNAL OF CARDIOLOGY, 208, 72-78. doi:10.1016/j.ijcard.2016.01.190

DOI: 10.1016/j.ijcard.2016.01.190

Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial (Conference Paper)

Lip, G. Y., Al-Saady, N., Jin, J., Sun, M., Melino, M., Winters, S. M., . . . Zamoryakhin, D. (2016). Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial. In CIRCULATION Vol. 134. Retrieved from http://gateway.webofknowledge.com/

Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial (Conference Paper)

Lip, G. Y., Al-Saady, N., Jin, J., Sun, M., Melino, M., Winters, S. M., . . . Zamoryakhin, D. (2016). Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial. In CIRCULATION Vol. 134. Retrieved from http://gateway.webofknowledge.com/

Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants (Journal article)

Enriquez, A., Lip, G. Y. H., & Baranchuk, A. (2016). Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants. EUROPACE, 18(7), 955-964. doi:10.1093/europace/euv030

DOI: 10.1093/europace/euv030

Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials (Conference Paper)

Brie, D., Sahebkar, A., Dinca, M., Ursoniu, S., Penson, P., Serban, M. C., . . . Meta-anal, L. B. P. (2016). Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 339). Retrieved from http://gateway.webofknowledge.com/

Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm (Withdrawn Paper. 2016, art. no. CD003333) (Journal article)

Lip, G. Y. H., Wrigley, B. J., & Pisters, R. (2016). Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm (Withdrawn Paper. 2016, art. no. CD003333). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD003333.pub2

DOI: 10.1002/14651858.CD003333.pub2

Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm (Journal article)

Shantsila, E., & Lip, G. Y. H. (2016). Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (9). doi:10.1002/14651858.CD003333.pub3

DOI: 10.1002/14651858.CD003333.pub3

Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation (Journal article)

Dzeshka, M. S., & Lip, G. Y. H. (2016). Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation. HEART FAILURE CLINICS, 12(2), 257-+. doi:10.1016/j.hfc.2015.08.021

DOI: 10.1016/j.hfc.2015.08.021

Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence? (Journal article)

Ancedy, Y., Lecoq, C., Saint Etienne, C., Ivanes, F., Angoulvant, D., Babuty, D., . . . Fauchier, L. (2016). Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 987-994. doi:10.1016/j.ijcard.2015.11.090

DOI: 10.1016/j.ijcard.2015.11.090

Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort (Journal article)

Huisman, M. V., Ma, C. S., Diener, H. -C., Dubner, S. J., Halperin, J. L., Rothman, K. J., . . . Investigators, G. L. O. R. I. A. -A. F. (2016). Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort. EUROPACE, 18(9), 1308-1318. doi:10.1093/europace/euw073

DOI: 10.1093/europace/euw073

Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project (Journal article)

Guo, Y. -T., Zhang, Y., Shi, X. -M., Shan, Z. -L., Wang, C. -J., Wang, Y. -T., . . . Lip, G. Y. H. (2016). Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project. SCIENTIFIC REPORTS, 6. doi:10.1038/srep31755

DOI: 10.1038/srep31755

Assessment of atrial fibrosis for the rhythm control of atrial fibrillation (Journal article)

Begg, G. A., Holden, A. V., Lip, G. Y. H., Plein, S., & Tayebjee, M. H. (2016). Assessment of atrial fibrosis for the rhythm control of atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 220, 155-161. doi:10.1016/j.ijcard.2016.06.144

DOI: 10.1016/j.ijcard.2016.06.144

Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation (Journal article)

Nedios, S., Seewoester, T., Lip, G. H. Y., Husser, D., Hindricks, G., Bollmann, A., & Kornej, J. (2016). Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 621-623. doi:10.1016/j.ijcard.2015.11.022

DOI: 10.1016/j.ijcard.2015.11.022

Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS) (Journal article)

Kwon, Y., Norby, F. L., Jensen, P. N., Agarwal, S. K., Soliman, E. Z., Lip, G. Y. H., . . . Chen, L. Y. (2016). Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS). PLOS ONE, 11(1). doi:10.1371/journal.pone.0147065

DOI: 10.1371/journal.pone.0147065

Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review (Journal article)

Woo, S. C. Y., Lip, G. Y. H., & Lip, P. L. (2016). Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review. EYE, 30(8), 1031-1038. doi:10.1038/eye.2016.111

DOI: 10.1038/eye.2016.111

Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients? (Journal article)

Shahid, F., & Lip, G. Y. H. (2016). Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients?. Arrhythmia & electrophysiology review, 5(3), 162-163. doi:10.15420/AER.2016.5.3.ED3

DOI: 10.15420/AER.2016.5.3.ED3

Atrial Fibrillation and Stroke Making Sense of Recent Observations on Anticoagulation (Journal article)

Proietti, M., & Lip, G. Y. H. (2016). Atrial Fibrillation and Stroke Making Sense of Recent Observations on Anticoagulation. CARDIOLOGY CLINICS, 34(2), 317-+. doi:10.1016/j.ccl.2015.12.006

DOI: 10.1016/j.ccl.2015.12.006

Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease (Journal article)

Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016). Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 68(13), 1452-1464. doi:10.1016/j.jacc.2016.06.057

DOI: 10.1016/j.jacc.2016.06.057

Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease (vol 68, pg 1452, 2016) (Journal article)

Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016). Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease (vol 68, pg 1452, 2016). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 68(25), 2921. doi:10.1016/j.jacc.2016.09.923

DOI: 10.1016/j.jacc.2016.09.923

Atrial Fibrillation in Patients With Hypertension Trajectories of Risk Factors in Yet Another Manifestation of Hypertensive Target Organ Damage (Journal article)

Lip, G. Y. H. (2016). Atrial Fibrillation in Patients With Hypertension Trajectories of Risk Factors in Yet Another Manifestation of Hypertensive Target Organ Damage. HYPERTENSION, 68(3), 544-545. doi:10.1161/HYPERTENSIONAHA.116.07901

DOI: 10.1161/HYPERTENSIONAHA.116.07901

Atrial fibrillation (Journal article)

Lip, G. Y. H., Fauchier, L., Freedman, S. B., Van Gelder, I., Natale, A., Gianni, C., . . . Lane, D. A. (2016). Atrial fibrillation. NATURE REVIEWS DISEASE PRIMERS, 2. doi:10.1038/nrdp.2016.16

DOI: 10.1038/nrdp.2016.16

Atrial fibrillation and diabetes mellitus: evidence of a risky, synergistic, interaction. The results of the EURObservational Research Programme - Atrial Fibrillation (EORP-AF) General Pilot Registry (Conference Paper)

Fumagalli, S., Said, S., Laroche, C., Gabbai, D., Boni, S., Marchionni, N., . . . Programme-Atr, E. R. (2016). Atrial fibrillation and diabetes mellitus: evidence of a risky, synergistic, interaction. The results of the EURObservational Research Programme - Atrial Fibrillation (EORP-AF) General Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 285-286). Retrieved from http://gateway.webofknowledge.com/

Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes (Journal article)

Kotecha, D., Chudasama, R., Lane, D. A., Kirchhof, P., & Lip, G. Y. H. (2016). Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes. INTERNATIONAL JOURNAL OF CARDIOLOGY, 203, 660-666. doi:10.1016/j.ijcard.2015.10.220

DOI: 10.1016/j.ijcard.2015.10.220

Atrial fibrillation and its complications: a focus on identifying risk factors and risk stratification (Journal article)

Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Atrial fibrillation and its complications: a focus on identifying risk factors and risk stratification. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2(2), 88-+. doi:10.1093/ehjcvp/pvv057

DOI: 10.1093/ehjcvp/pvv057

Atrial fibrillation and risk of stroke: a nationwide cohort study (Journal article)

Christiansen, C. B., Gerds, T. A., Olesen, J. B., Kristensen, S. L., Lamberts, M., Lip, G. Y. H., . . . Torp-Pedersen, C. (2016). Atrial fibrillation and risk of stroke: a nationwide cohort study. EUROPACE, 18(11), 1689-1697. doi:10.1093/europace/euv401

DOI: 10.1093/europace/euv401

Beta-blockers in heart failure patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (Conference Paper)

Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Sinagra, G., . . . Registry, E. O. R. P. -A. F. P. (2016). Beta-blockers in heart failure patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 205). Retrieved from http://gateway.webofknowledge.com/

Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores (Journal article)

Lip, G. Y. H., & Lane, D. A. (2016). Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 14(9), 1711-1714. doi:10.1111/jth.13386

DOI: 10.1111/jth.13386

Bleeding risk for non-valvular AF patients prescribed warfarin, or standard doses of apixaban 5mg BID, dabigatran 150mg BID or rivaroxaban 20mg QD in real-world practice: Findings from EHR (Conference Paper)

Lin, I., Masseria, C., Mardekian, J., Park, S., Horblyuk, R., Kamble, S., . . . Lip, G. Y. H. (2016). Bleeding risk for non-valvular AF patients prescribed warfarin, or standard doses of apixaban 5mg BID, dabigatran 150mg BID or rivaroxaban 20mg QD in real-world practice: Findings from EHR. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 402). Retrieved from http://gateway.webofknowledge.com/

Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation The AMADEUS Trial (Journal article)

Senoo, K., & Lip, G. Y. H. (2016). Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation The AMADEUS Trial. STROKE, 47(2), 523-526. doi:10.1161/STROKEAHA.115.011876

DOI: 10.1161/STROKEAHA.115.011876

CHA(2)DS(2)-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis (Journal article)

Philippart, R., Brunet-Bernard, A., Clementy, N., Bourguignon, T., Mirza, A., Angoulvant, D., . . . Fauchier, L. (2016). CHA(2)DS(2)-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 67(3), 343-344. doi:10.1016/j.jacc.2015.10.061

DOI: 10.1016/j.jacc.2015.10.061

CHA(2)DS(2)-VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm (Journal article)

Ye, S., Qian, M., Zhao, B., Buchsbaum, R., Sacco, R. L., Levin, B., . . . Investigators, W. A. R. C. E. F. (2016). CHA(2)DS(2)-VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm. EUROPEAN JOURNAL OF HEART FAILURE, 18(10), 1261-1266. doi:10.1002/ejhf.613

DOI: 10.1002/ejhf.613

CHA2DS2-VASC SCORE AND ADVERSE EVENTS IN PATIENTS WITH HEART FAILURE AND SINUS RHYTHM (Conference Paper)

Ye, S., Qian, M., Zhao, B., Lip, G., Buchsbaum, R., Sacco, R., . . . Investigators, W. A. R. C. E. F. (2016). CHA2DS2-VASC SCORE AND ADVERSE EVENTS IN PATIENTS WITH HEART FAILURE AND SINUS RHYTHM. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 1335). doi:10.1016/S0735-1097(16)31336-5

DOI: 10.1016/S0735-1097(16)31336-5

COMPARISON OF ORAL ANTI-COAGULANTS FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: TWO MULTI-CRITERIA DECISION ANALYSES (Conference Paper)

Tervonen, T., Ustyugova, A. V., Lip, G., Verdecchia, P., Bhashyam, S. S., Heinrich-Nols, J., . . . Marsh, K. (2016). COMPARISON OF ORAL ANTI-COAGULANTS FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: TWO MULTI-CRITERIA DECISION ANALYSES. In VALUE IN HEALTH Vol. 19 (pp. A349). doi:10.1016/j.jval.2016.09.014

DOI: 10.1016/j.jval.2016.09.014

Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy (Journal article)

Potpara, T. S., Jokic, V., Dagres, N., Marin, F., Prostran, M. S., Blomstrom-Lundqvist, C., & Lip, G. Y. H. (2016). Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy. CURRENT MEDICINAL CHEMISTRY, 23(19), 2070-2083. doi:10.2174/0929867323666160309114246

DOI: 10.2174/0929867323666160309114246

Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score (Journal article)

Pastori, D., Farcomeni, A., Poli, D., Antonucci, E., Angelico, F., Del Ben, M., . . . Violi, F. (2016). Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score. INTERNAL AND EMERGENCY MEDICINE, 11(2), 199-204. doi:10.1007/s11739-015-1326-1

DOI: 10.1007/s11739-015-1326-1

Carotid Atherosclerosis and Stroke in Atrial Fibrillation The Atherosclerosis Risk in Communities Study (Journal article)

Bekwelem, W., Jensen, P. N., Norby, F. L., Soliman, E. Z., Agarwal, S. K., Lip, G. Y. H., . . . Chen, L. Y. (2016). Carotid Atherosclerosis and Stroke in Atrial Fibrillation The Atherosclerosis Risk in Communities Study. STROKE, 47(6), 1643-U565. doi:10.1161/STROKEAHA.116.013133

DOI: 10.1161/STROKEAHA.116.013133

Causes of Death and Influencing Factors in Patients with Atrial Fibrillation (Journal article)

Fauchier, L., Villejoubert, O., Clementy, N., Bernard, A., Pierre, B., Angoulvant, D., . . . Lip, G. Y. H. (2016). Causes of Death and Influencing Factors in Patients with Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 129(12). doi:10.1016/j.amjmed.2016.06.045

DOI: 10.1016/j.amjmed.2016.06.045

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients (Conference Paper)

Rivera-Caravaca, J. M., Esteve-Pastor, M. A., Vicente, V., Valdes, M., Lip, G. Y., Marin, F., & Roldan-Schilling, V. (2016). Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1347-1348). Retrieved from http://gateway.webofknowledge.com/

Characteristics and outcomes in elderly Japanese and British patients with atrial fibrillation: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries (Conference Paper)

Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2016). Characteristics and outcomes in elderly Japanese and British patients with atrial fibrillation: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1345). Retrieved from http://gateway.webofknowledge.com/

Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials (Journal article)

Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials. EBIOMEDICINE, 8, 309-316. doi:10.1016/j.ebiom.2016.04.013

DOI: 10.1016/j.ebiom.2016.04.013

Chronic Osteomyelitis and Atrial Fibrillation: Revisiting the Link Between Inflammation Burden and Arrhythmia (Journal article)

Shahid, F., Lip, G. Y. H., & Shantsila, E. (2016). Chronic Osteomyelitis and Atrial Fibrillation: Revisiting the Link Between Inflammation Burden and Arrhythmia. CANADIAN JOURNAL OF CARDIOLOGY, 32(12), 1366-1368. doi:10.1016/j.cjca.2016.05.002

DOI: 10.1016/j.cjca.2016.05.002

Clinical Characteristics and Outcomes in Extreme Elderly (Age >= 85 Years) Japanese Patients With Atrial Fibrillation The Fushimi AF Registry (Journal article)

Yamashita, Y., Hamatani, Y., Esato, M., Chun, Y. -H., Tsuji, H., Wada, H., . . . Akao, M. (2016). Clinical Characteristics and Outcomes in Extreme Elderly (Age >= 85 Years) Japanese Patients With Atrial Fibrillation The Fushimi AF Registry. CHEST, 149(2), 401-412. doi:10.1378/chest.15-1095

DOI: 10.1378/chest.15-1095

Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial - (Journal article)

Kato, T. S., Di Tullio, M. R., Qian, M., Wu, M., Thompson, J. L. P., Mann, D. L., . . . Investigators, W. A. R. C. E. F. (2016). Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial -. CIRCULATION JOURNAL, 80(3), 619-+. doi:10.1253/circj.CJ-15-1054

DOI: 10.1253/circj.CJ-15-1054

Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program (Conference Paper)

Teutsch, C., Halperin, J., Diener, H. -C., Dubner, S., Ma, C., Rothman, K., . . . Lip, G. Y. H. (2016). Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1192-1193). Retrieved from http://gateway.webofknowledge.com/

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study (Journal article)

Larsen, T. B., Skjoth, F., Nielsen, P. B., Kjaeldgaard, J. N., & Lip, G. Y. H. (2016). Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ-BRITISH MEDICAL JOURNAL, 353. doi:10.1136/bmj.i3189

DOI: 10.1136/bmj.i3189

Comparison of oral anti-coagulants for stroke prevention in non-valvular atrial fibrillation: a multi-criteria decision analysis (Conference Paper)

Lip, G. Y. H., Verdecchia, P., Tervonen, T., Ustyugova, A., Heinrich-Nols, J., Gropper, S., . . . Marsh, K. (2016). Comparison of oral anti-coagulants for stroke prevention in non-valvular atrial fibrillation: a multi-criteria decision analysis. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 41). Retrieved from http://gateway.webofknowledge.com/

Contemporary results from EHR study of real-world bleeding risk among elderly and overall non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban and warfarin (Conference Paper)

Lin, I., Masseria, C., Mardekian, J., Park, S., Horblyuk, R., Kamble, S., . . . Lip, G. Y. H. (2016). Contemporary results from EHR study of real-world bleeding risk among elderly and overall non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban and warfarin. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 235-236). Retrieved from http://gateway.webofknowledge.com/

Coronary artery disease and use of dual or triple antithrombotic therapy in patients with atrial fibrillation: the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (Conference Paper)

Proietti, M., Raparelli, V., Tavazzi, L., Maggioni, A. P., Laroche, C., Boriani, G., . . . Registry, E. O. R. P. -A. F. G. P. (2016). Coronary artery disease and use of dual or triple antithrombotic therapy in patients with atrial fibrillation: the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1397). Retrieved from http://gateway.webofknowledge.com/

Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses (Journal article)

Li, X., Tse, V. C., Lau, W. C. Y., Cheung, B. M. Y., Lip, G. Y. H., Wong, I. C. K., & Chan, E. W. (2016). Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses. PLOS ONE, 11(6). doi:10.1371/journal.pone.0157129

DOI: 10.1371/journal.pone.0157129

Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke (Journal article)

Diamantopoulos, A., Sawyer, L. M., Lip, G. Y. H., Witte, K. K., Reynolds, M. R., Fauchier, L., . . . Diener, H. -C. (2016). Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. INTERNATIONAL JOURNAL OF STROKE, 11(3), 302-312. doi:10.1177/1747493015620803

DOI: 10.1177/1747493015620803

Country differences in patient perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment (Conference Paper)

Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2016). Country differences in patient perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 506). Retrieved from http://gateway.webofknowledge.com/

Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation The Chinese Atrial Fibrillation Registry Study (Journal article)

Chang, S. -S., Dong, J. -Z., Ma, C. -S., Du, X., Wu, J. -H., Tang, R. -B., . . . Lip, G. Y. H. (2016). Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation The Chinese Atrial Fibrillation Registry Study. STROKE, 47(7), 1803-1810. doi:10.1161/STROKEAHA.116.012988

DOI: 10.1161/STROKEAHA.116.012988

Dabigatran in clinical practice: Contemporary overview of the evidence (Journal article)

Ageno, W., Eikelboom, J., & Lip, G. Y. H. (2016). Dabigatran in clinical practice: Contemporary overview of the evidence. INTERNATIONAL JOURNAL OF CARDIOLOGY, 220, 417-428. doi:10.1016/j.ijcard.2016.06.078

DOI: 10.1016/j.ijcard.2016.06.078

Dabigatran in clinical practice: Contemporary overview of the evidence (vol 220, pg 417, 2016) (Journal article)

Ageno, W., Eikelboom, J., & Lip, G. Y. H. (2016). Dabigatran in clinical practice: Contemporary overview of the evidence (vol 220, pg 417, 2016). INTERNATIONAL JOURNAL OF CARDIOLOGY, 223, 1074-1076. doi:10.1016/j.ijcard.2016.08.332

DOI: 10.1016/j.ijcard.2016.08.332

Deep vs Lobar Intracerebral Hemorrhage on HAS-BLED Scoring System Response (Journal article)

Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Deep vs Lobar Intracerebral Hemorrhage on HAS-BLED Scoring System Response. CHEST, 149(6), 1590-1591. doi:10.1016/j.chest.2016.03.057

DOI: 10.1016/j.chest.2016.03.057

Deprivation and prediction of heart failure in minority ethnic patients: the Ethnic - Echocardiographic Heart of England Screening Study (E-ECHOES) (Conference Paper)

Shantsila, A., Shantsila, E., Gill, P. S., Lip, G. Y. H., & Investigators, E. -E. C. H. O. E. S. (2016). Deprivation and prediction of heart failure in minority ethnic patients: the Ethnic - Echocardiographic Heart of England Screening Study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1108). Retrieved from http://gateway.webofknowledge.com/

Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting (Journal article)

Cannon, C. P., Gropper, S., Bhatt, D. L., Ellis, S. G., Kimura, T., Lip, G. Y. H., . . . Comm, R. E. -D. U. A. L. P. C. I. S. (2016). Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting. CLINICAL CARDIOLOGY, 39(10), 555-564. doi:10.1002/clc.22572

DOI: 10.1002/clc.22572

Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population (Journal article)

Guo, Y., Wang, H., Tao, T., Tian, Y., Wang, Y., Chen, Y., & Lip, G. Y. H. (2016). Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population. PLOS ONE, 11(9). doi:10.1371/journal.pone.0163171

DOI: 10.1371/journal.pone.0163171

Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT) (Journal article)

Lip, G. Y. H., Waldo, A. L., Ip, J., Martin, D. T., Bersohn, M. M., Choucair, W. K., . . . Investigators, I. M. P. A. C. T. (2016). Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT). AMERICAN JOURNAL OF CARDIOLOGY, 118(11), 1680-1684. doi:10.1016/j.amjcard.2016.08.047

DOI: 10.1016/j.amjcard.2016.08.047

Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation (Journal article)

Melgaard, L., Gorst-Rasmussen, A., Sogaard, P., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2016). Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 209, 1-6. doi:10.1016/j.ijcard.2016.02.004

DOI: 10.1016/j.ijcard.2016.02.004

Difficult situations in anticoagulation after stroke: between Scylla and Charybdis (Journal article)

Ntaios, G., & Lip, G. Y. H. (2016). Difficult situations in anticoagulation after stroke: between Scylla and Charybdis. CURRENT OPINION IN NEUROLOGY, 29(1), 42-48. doi:10.1097/WCO.0000000000000283

DOI: 10.1097/WCO.0000000000000283

Does renal impairment affect the predictive value of the CHA2DS2VASc score for stroke risk assessment in patients with atrial fibrillation? (Conference Paper)

Fauchier, L., Halimi, J. M., Angoulvant, D., Vourc'h, P., Andres, C., Bisson, A., . . . Lip, G. Y. H. (2016). Does renal impairment affect the predictive value of the CHA2DS2VASc score for stroke risk assessment in patients with atrial fibrillation?. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 245). Retrieved from http://gateway.webofknowledge.com/

Drug-drug interactions of non-vitamin K oral anticoagulants (Journal article)

Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Drug-drug interactions of non-vitamin K oral anticoagulants. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 12(12), 1445-1461. doi:10.1080/17425255.2016.1225037

DOI: 10.1080/17425255.2016.1225037

EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation (Journal article)

Donal, E., Lip, G. Y. H., Galderisi, M., Goette, A., Shah, D., Marwan, M., . . . Habib, G. (2016). EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 17(4), 355-383. doi:10.1093/ehjci/jev354

DOI: 10.1093/ehjci/jev354

EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. (Journal article)

Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Cabrera, J. A., Chen, S. A., . . . Review coordinator: Alena Shantsila (UK). (2016). EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.. Journal of arrhythmia, 32(4), 247-278. doi:10.1016/j.joa.2016.05.002

DOI: 10.1016/j.joa.2016.05.002

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication (Journal article)

Goette, A., Kalman, J. M., Aguinaga, L., Akar, J., Angel Cabrera, J., Chen, S. A., . . . Nattel, S. (2016). EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. EUROPACE, 18(10), 1455-1490. doi:10.1093/europace/euw161

DOI: 10.1093/europace/euw161

Echocardiographic Structure and Function in Hypertensive Disorders of Pregnancy: A Systematic Review (Journal article)

Castleman, J. S., Ganapathy, R., Taki, F., Lip, G. Y. H., Steeds, R. P., & Kotecha, D. (2016). Echocardiographic Structure and Function in Hypertensive Disorders of Pregnancy: A Systematic Review. CIRCULATION-CARDIOVASCULAR IMAGING, 9(9). doi:10.1161/CIRCIMAGING.116.004888

DOI: 10.1161/CIRCIMAGING.116.004888

Editors' Choice 2015 papers in Thrombosis and Haemostasis (Journal article)

Weber, C., & Lip, G. Y. H. (2016). Editors' Choice 2015 papers in Thrombosis and Haemostasis. THROMBOSIS AND HAEMOSTASIS, 115(1), 230-232. doi:10.1160/TH15-11-0911

DOI: 10.1160/TH15-11-0911

Edoxaban in venous thromboembolism and stroke prevention: an appraisal. (Journal article)

Proietti, M., & Lip, G. Y. H. (2016). Edoxaban in venous thromboembolism and stroke prevention: an appraisal.. Vascular health and risk management, 12, 45-51. doi:10.2147/VHRM.S81569

DOI: 10.2147/VHRM.S81569

Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial (Journal article)

Goette, A., Merino, J. L., Ezekowitz, M. D., Zamoryakhin, D., Melino, M., Jin, J., . . . Investigators, E. N. S. U. R. E. -A. F. (2016). Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. LANCET, 388(10055), 1995-2003. doi:10.1016/S0140-6736(16)31474-X

DOI: 10.1016/S0140-6736(16)31474-X

Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation A Registry Study (Journal article)

Vestergaard, A. S., Skjoth, F., Lip, G. Y. H., & Larsen, T. B. (2016). Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation A Registry Study. STROKE, 47(4), 979-985. doi:10.1161/STROKEAHA.115.012338

DOI: 10.1161/STROKEAHA.115.012338

Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis (Journal article)

Kotecha, D., Manzano, L., Krum, H., Rosano, G., Holmes, J., Altman, D. G., . . . Collab, B. -B. H. F. (2016). Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. BMJ-BRITISH MEDICAL JOURNAL, 353. doi:10.1136/bmj.i1855

DOI: 10.1136/bmj.i1855

Effect of beta-blocker use on mortality in patients with atrial fibrillation. A cohort study (Conference Paper)

Fauchier, L., Clementy, N., Bisson, A., Angoulvant, D., Angoulvant, T. B., Bernard, A., . . . Lip, G. Y. H. (2016). Effect of beta-blocker use on mortality in patients with atrial fibrillation. A cohort study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 290). Retrieved from http://gateway.webofknowledge.com/

Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin (Journal article)

Lau, Y. C., Xiong, Q., Lip, G. Y. H., & Blann, A. D. (2016). Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin. ANNALS OF MEDICINE, 48(4), 275-281. doi:10.3109/07853890.2016.1166516

DOI: 10.3109/07853890.2016.1166516

Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study (Journal article)

Chan, E. W., Lau, W. C. Y., Siu, C. W., Lip, G. Y. H., Leung, W. K., Anand, S., . . . Wong, I. C. K. (2016). Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study. HEART RHYTHM, 13(8), 1581-1588. doi:10.1016/j.hrthm.2016.03.049

DOI: 10.1016/j.hrthm.2016.03.049

Effects of Aspirin on Endothelial Function and Hypertension (Journal article)

Dzeshka, M. S., Shantsila, A., & Lip, G. Y. H. (2016). Effects of Aspirin on Endothelial Function and Hypertension. CURRENT HYPERTENSION REPORTS, 18(11). doi:10.1007/s11906-016-0688-8

DOI: 10.1007/s11906-016-0688-8

Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Journal article)

Serban, M. -C., Sahebkar, A., Zanchetti, A., Mikhailidis, D. P., Howard, G., Antal, D., . . . Metaanal, L. B. P. (2016). Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5(7). doi:10.1161/JAHA.115.002713

DOI: 10.1161/JAHA.115.002713

Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation (Journal article)

Lau, Y. C., Xiong, Q., Shantsila, E., Lip, G. Y. H., & Blann, A. D. (2016). Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 42(4), 535-544. doi:10.1007/s11239-016-1399-3

DOI: 10.1007/s11239-016-1399-3

Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials (Journal article)

Brie, D., Sahebkar, A., Penson, P. E., Dinca, M., Ursoniu, S., Serban, M. -C., . . . Grp, L. B. P. M. C. (2016). Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials. JOURNAL OF HYPERTENSION, 34(12), 2318-2329. doi:10.1097/HJH.0000000000001086

DOI: 10.1097/HJH.0000000000001086

Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis (Journal article)

Rysz-Gorzynska, M., Gluba-Brzozka, A., Sahebkar, A., Serban, M. -C., Mikhailidis, D. P., Ursoniu, S., . . . Banach, M. (2016). Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. SCIENTIFIC REPORTS, 6. doi:10.1038/srep30060

DOI: 10.1038/srep30060

Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There? (Journal article)

Ntaios, G., Papavasileiou, V., Lip, G. Y. H., Milionis, H., Makaritsis, K., Vemmou, A., . . . Vemmos, K. (2016). Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There?. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 25(12), 2975-2980. doi:10.1016/j.jstrokecerebrovasdis.2016.08.015

DOI: 10.1016/j.jstrokecerebrovasdis.2016.08.015

Emerging Tools for Stroke Prevention in Atrial Fibrillation (Journal article)

Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Emerging Tools for Stroke Prevention in Atrial Fibrillation. EBIOMEDICINE, 4, 26-39. doi:10.1016/j.ebiom.2016.01.017

DOI: 10.1016/j.ebiom.2016.01.017

Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction? (Journal article)

Shantsila, E., & Lip, G. Y. H. (2016). Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?. EBIOMEDICINE, 4, 5-6. doi:10.1016/j.ebiom.2016.01.025

DOI: 10.1016/j.ebiom.2016.01.025

Endotoxemia as a trigger of thrombosis in cirrhosis (Journal article)

Violi, F., Lip, G. Y. H., & Cangemi, R. (2016). Endotoxemia as a trigger of thrombosis in cirrhosis. HAEMATOLOGICA, 101(4). doi:10.3324/haematol.2015.139972

DOI: 10.3324/haematol.2015.139972

Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles (Journal article)

Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2016). Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles. ANNALS OF MEDICINE, 48(6), 444-455. doi:10.1080/07853890.2016.1190861

DOI: 10.1080/07853890.2016.1190861

Ethnic disparities between Japanese and British atrial fibrillation patients with previous stroke: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries (Conference Paper)

Ogawa, H., Senoo, K., An, Y., Shantsila, A., Shantsila, E., Lane, D. A., . . . Lip, G. Y. H. (2016). Ethnic disparities between Japanese and British atrial fibrillation patients with previous stroke: Comparative analysis from the Fushimi and Darlington Atrial Fibrillation Registries. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1137-1138). Retrieved from http://gateway.webofknowledge.com/

Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting (Journal article)

Fauchier, L., Lecoq, C., Ancedy, Y., Stamboul, K., Saint Etienne, C., Ivanes, F., . . . Lip, G. Y. H. (2016). Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting. AMERICAN JOURNAL OF CARDIOLOGY, 118(5), 700-707. doi:10.1016/j.amjcard.2016.06.018

DOI: 10.1016/j.amjcard.2016.06.018

Evaluation of a 'color coding' system for the assessment of patients undergoing primary percutaneous coronary intervention (Journal article)

Ruiz-Nodar, J. M., Gomez-Sansano, J. M., Galcera, E., Mainar, V., Valencia, J., Pineda, J., . . . Lip, G. Y. H. (2016). Evaluation of a 'color coding' system for the assessment of patients undergoing primary percutaneous coronary intervention. INTERNATIONAL JOURNAL OF CARDIOLOGY, 212, 371-376. doi:10.1016/j.ijcard.2016.03.077

DOI: 10.1016/j.ijcard.2016.03.077

Evaluation of the Efficacy and Safety of Dual Antiplatelet Therapy with or Without Warfarin in Patients with a Clinical Indication for DAPT and Chronic Anticoagulation: A Meta-Analysis of Observational Studies (Journal article)

Bavishi, C., Koulova, A., Bangalore, S., Sawant, A., Chatterjee, S., Ather, S., . . . Tamis-Holland, J. E. (2016). Evaluation of the Efficacy and Safety of Dual Antiplatelet Therapy with or Without Warfarin in Patients with a Clinical Indication for DAPT and Chronic Anticoagulation: A Meta-Analysis of Observational Studies. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 88(1), E12-E22. doi:10.1002/ccd.26234

DOI: 10.1002/ccd.26234

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin (Journal article)

Senoo, K., Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin. AMERICAN JOURNAL OF MEDICINE, 129(6), 600-607. doi:10.1016/j.amjmed.2015.10.001

DOI: 10.1016/j.amjmed.2015.10.001

Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (Journal article)

Katritsis, D. G., Boriani, G., Cosio, F. G., Jais, P., Hindricks, G., Josephson, M. E., . . . Lundqvist, C. B. (2016). Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE).. Arrhythmia & electrophysiology review, 5(3), 210-224. doi:10.15420/aer.2016:5.3.GL1

DOI: 10.15420/aer.2016:5.3.GL1

Factors associated with quality of anticoagulation control in patients with atrial fibrillation and risk of stroke and bleeding (Conference Paper)

Bonde, A. N., Lip, G. Y. H., Kamper, A. L., Staerk, L., Gislason, G., Torp-Pedersen, C., & Olesen, J. B. (2016). Factors associated with quality of anticoagulation control in patients with atrial fibrillation and risk of stroke and bleeding. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 402). Retrieved from http://gateway.webofknowledge.com/

Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin (Journal article)

Senoo, K., & Lip, G. Y. H. (2016). Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin. STROKE, 47(6), 1665-U623. doi:10.1161/STROKEAHA.116.013173

DOI: 10.1161/STROKEAHA.116.013173

From clinical trials to real-world clinical practice: observations on the direct oral anticoagulants (Journal article)

Lip, G. Y. H. (2016). From clinical trials to real-world clinical practice: observations on the direct oral anticoagulants. LANCET HAEMATOLOGY, 3(1), E2-E3. doi:10.1016/S2352-3026(15)00282-3

DOI: 10.1016/S2352-3026(15)00282-3

From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency (Journal article)

Cremer, A., Amraoui, F., Lip, G. Y. H., Morales, E., Rubin, S., Segura, J., . . . Gosse, P. (2016). From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. JOURNAL OF HUMAN HYPERTENSION, 30(8), 463-466. doi:10.1038/jhh.2015.112

DOI: 10.1038/jhh.2015.112

Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes (Journal article)

Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Petrescu, L., . . . Lip, G. Y. H. (2016). Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. SCIENTIFIC REPORTS, 6. doi:10.1038/srep30271

DOI: 10.1038/srep30271

Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry (Conference Paper)

Mazurek, M., Shantsila, E., Lane, D., Wolff, A., Proietti, M., & Lip, G. Y. (2016). Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from http://gateway.webofknowledge.com/

Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa (Journal article)

Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J. -P., Zotti, F. D., . . . Walker, D. M. (2016). Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa. Revista Española de Cardiología, 69(1), 69.e1-69.e49. doi:10.1016/j.recesp.2015.11.015

DOI: 10.1016/j.recesp.2015.11.015

Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca (Journal article)

Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Zannad, F. (2016). Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca. Revista Española de Cardiología, 69(2), 176.e1-176.e77. doi:10.1016/j.recesp.2016.01.001

DOI: 10.1016/j.recesp.2016.01.001

Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (Journal article)

Ponikowski, A. D. G. D. T. P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., . . . Zamorano, J. L. (2016). Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Revista Española de Cardiología, 69(12), 1167.e1-1167.e85. doi:10.1016/j.recesp.2016.10.014

DOI: 10.1016/j.recesp.2016.10.014

Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar (Journal article)

Galiè, N., Humbert, M., Vachiery, J. -L., Gibbs, S., Lang, I., Torbicki, A., . . . Zamorano, J. L. (2016). Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar. Revista Española de Cardiología, 69(2), 177.e1-177.e62. doi:10.1016/j.recesp.2016.01.002

DOI: 10.1016/j.recesp.2016.01.002

HAS-BLED Versus ATRIA Risk Scores for Intracranial Hemorrhage in Patients Receiving Thrombolytics for Pulmonary Embolism (Journal article)

Chatterjee, S., Lip, G. Y. H., & Giri, J. (2016). HAS-BLED Versus ATRIA Risk Scores for Intracranial Hemorrhage in Patients Receiving Thrombolytics for Pulmonary Embolism. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 67(24), 2904-2905. doi:10.1016/j.jacc.2016.03.577

DOI: 10.1016/j.jacc.2016.03.577

Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis (Journal article)

Tang, L., Wu, Y. -Y., Lip, G. Y. H., Yin, P., & Hu, Y. (2016). Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis. LANCET HAEMATOLOGY, 3(1), E30-E44. doi:10.1016/S2352-3026(15)00228-8

DOI: 10.1016/S2352-3026(15)00228-8

How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring (Journal article)

Lip, G. Y. H. (2016). How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring. CIRCULATION, 133(13), 1290-1295. doi:10.1161/CIRCULATIONAHA.115.016797

DOI: 10.1161/CIRCULATIONAHA.115.016797

How to REVISIT the increasing "real world" evidence for stroke prevention in non-valvular atrial fibrillation? (Journal article)

Lip, G. Y. H. (2016). How to REVISIT the increasing "real world" evidence for stroke prevention in non-valvular atrial fibrillation?. CURRENT MEDICAL RESEARCH AND OPINION, 32(12), 2055-2057. doi:10.1080/03007995.2016.1254604

DOI: 10.1080/03007995.2016.1254604

Hypertension in patients with Atrial Fibrillation: the EURObservational research programme on atrial fibrillation (EORP-AF) pilot registry (Conference Paper)

Dan, G. A., Badila, E., Weiss, E., Laroche, C., Boriani, G., Dan, A., . . . Lip, G. Y. H. (2016). Hypertension in patients with Atrial Fibrillation: the EURObservational research programme on atrial fibrillation (EORP-AF) pilot registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 617). Retrieved from http://gateway.webofknowledge.com/

IMPACT OF AN ATRIAL FIBRILLATION DECISION SUPPORT TOOL (AFDST) ON THROMBOPROPHYLAXIS FOR ATRIAL FIBRILLATION (Conference Paper)

Eckman, M. H., Lip, G. Y., Wise, R. E., Speer, B., Sullivan, M. D., Walker, N., . . . Kues, J. (2016). IMPACT OF AN ATRIAL FIBRILLATION DECISION SUPPORT TOOL (AFDST) ON THROMBOPROPHYLAXIS FOR ATRIAL FIBRILLATION. In JOURNAL OF GENERAL INTERNAL MEDICINE Vol. 31 (pp. S258-S259). Retrieved from http://gateway.webofknowledge.com/

IMPACT OF L-CARNITINE ON PLASMA LIPOPROTEIN(A) CONCENTRATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (Conference Paper)

Serban, M. C., Mikhailidis, D. P., Toth, P., Jones, S., Muntner, P., Blaha, M., . . . Meta-Anal, L. B. P. (2016). IMPACT OF L-CARNITINE ON PLASMA LIPOPROTEIN(A) CONCENTRATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 2032). doi:10.1016/S0735-1097(16)32033-2

DOI: 10.1016/S0735-1097(16)32033-2

IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial (Journal article)

Shantsila, E., Haynes, R., Calvert, M., Fisher, J., Kirchhof, P., Gill, P. S., & Lip, G. Y. H. (2016). IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial. BMJ OPEN, 6(10). doi:10.1136/bmjopen-2016-012241

DOI: 10.1136/bmjopen-2016-012241

Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials (Journal article)

Serban, M. -C., Sahebkar, A., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Muntner, P., . . . Banach, M. (2016). Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials. SCIENTIFIC REPORTS, 6. doi:10.1038/srep19188

DOI: 10.1038/srep19188

Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure (Journal article)

Andreu-Cayuelas, J. M., Pastor-Perez, F. J., Puche, C. M., Mateo-Martinez, A., Garcia-Alberola, A., Flores-Blanco, P. J., . . . Manzano-Fernandez, S. (2016). Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure. REVISTA ESPANOLA DE CARDIOLOGIA, 69(2), 134-140. doi:10.1016/j.rec.2015.06.021

DOI: 10.1016/j.rec.2015.06.021

Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation (Journal article)

Eckman, M. H., Lip, G. Y. H., Wise, R. E., Speer, B., Sullivan, M., Walker, N., . . . Kues, J. (2016). Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation. AMERICAN HEART JOURNAL, 176, 17-27. doi:10.1016/j.ahj.2016.02.009

DOI: 10.1016/j.ahj.2016.02.009

Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry (Journal article)

Proietti, M., Laroche, C., Drozd, M., Vijgen, J., Cozma, D. C., Drozdz, J., . . . Investigators, E. O. R. P. -A. F. (2016). Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. AMERICAN HEART JOURNAL, 181, 83-91. doi:10.1016/j.ahj.2016.08.011

DOI: 10.1016/j.ahj.2016.08.011

Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms (Journal article)

Chrusciel, P., Sahebkar, A., Rembek-Wieliczko, M., Serban, M. -C., Ursoniu, S., Mikhailidis, D. P., . . . Meta-analysis, L. B. P. (2016). Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. ATHEROSCLEROSIS, 253, 194-208. doi:10.1016/j.atherosclerosis.2016.07.897

DOI: 10.1016/j.atherosclerosis.2016.07.897

Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms (Conference Paper)

Chrusciel, P., Sahebkar, A., Rembek, M., Serban, M. C., Ursoniu, S., Mikhailidis, D. P., . . . Meta-Analysis, L. B. P. (2016). Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 736). Retrieved from http://gateway.webofknowledge.com/

Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study (Journal article)

Chao, T. -F., Liu, C. -J., Tuan, T. -C., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study. MAYO CLINIC PROCEEDINGS, 91(5), 567-574. doi:10.1016/j.mayocp.2016.03.007

DOI: 10.1016/j.mayocp.2016.03.007

In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 years (Journal article)

Mazurek, M., & Lip, G. Y. H. (2016). In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 years. ANNALS OF INTERNAL MEDICINE, 165(8), JC38. doi:10.7326/ACPJC-2016-165-8-038

DOI: 10.7326/ACPJC-2016-165-8-038

Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study (Conference Paper)

Khalid, U., Egeberg, A., Ahlehoff, O., Lane, D., Gislason, G. H., Lip, G. Y. H., & Hansen, P. R. (2018). Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study. In JOURNAL OF THE AMERICAN HEART ASSOCIATION Vol. 7. doi:10.1161/JAHA.117.007227

DOI: 10.1161/JAHA.117.007227

Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis (Journal article)

Adlan, A. M., Paton, J. F. R., Lip, G. Y. H., Kitas, G. D., & Fisher, J. P. (2017). Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis. JOURNAL OF PHYSIOLOGY-LONDON, 595(3), 967-981. doi:10.1113/JP272944

DOI: 10.1113/JP272944

Inflammation and myocardial stiffness in hypertension: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) (Conference Paper)

Shantsila, A., Shantsila, E., Gill, P. S., & Lip, G. Y. H. (2016). Inflammation and myocardial stiffness in hypertension: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). In JOURNAL OF HUMAN HYPERTENSION Vol. 30 (pp. 648). Retrieved from http://gateway.webofknowledge.com/

Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True? A Systematic Review (Journal article)

Violi, F., Lip, G. Y. H., Pignatelli, P., & Pastori, D. (2016). Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True? A Systematic Review. MEDICINE, 95(10). doi:10.1097/MD.0000000000002895

DOI: 10.1097/MD.0000000000002895

International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives (Journal article)

Hsu, J. C., Akao, M., Abe, M., Anderson, K. L., Avezum, A., Glusenkamp, N., . . . Maddox, T. M. (2016). International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5(11). doi:10.1161/JAHA.116.004037

DOI: 10.1161/JAHA.116.004037

Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA(2)DS(2)-VASc Score of 1 (Men) or 2 (Women)? (Journal article)

Hung, Y., Chao, T. -F., Liu, C. -J., Tuan, T. -C., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA(2)DS(2)-VASc Score of 1 (Men) or 2 (Women)?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5(10). doi:10.1161/JAHA.116.003839

DOI: 10.1161/JAHA.116.003839

Is major bleeding risk for oral anticoagulants similar between non-valvular atrial fibrillation patients newly initiated on warfarin and propensity-score matched NOAC initiators? A real world study (Conference Paper)

Lip, G. Y. H., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Hamilton, M. (2016). Is major bleeding risk for oral anticoagulants similar between non-valvular atrial fibrillation patients newly initiated on warfarin and propensity-score matched NOAC initiators? A real world study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 493). Retrieved from http://gateway.webofknowledge.com/

Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low-moderate risk of stroke? (Journal article)

Fauchier, L., Ruiz-Nodar, J. M., Valdes, M., Angoulvant, D., Lip, G. Y. H., & Marin, F. (2016). Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low-moderate risk of stroke?. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 35, E9-E10. doi:10.1016/j.ejim.2016.08.022

DOI: 10.1016/j.ejim.2016.08.022

Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients? (Journal article)

Asuncion Esteve-Pastor, M., Garcia-Fernandez, A., Macias, M., Sogorb, F., Valdes, M., Roldan, V., . . . Investigators, F. A. N. T. A. S. I. I. A. (2016). Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?. CIRCULATION JOURNAL, 80(10), 2102-2108. doi:10.1253/circj.CJ-16-0471

DOI: 10.1253/circj.CJ-16-0471

Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis (Journal article)

Chan, P. -H., Huang, D., Yip, P. -S., Hai, J., Tse, H. -F., Chan, T. -M., . . . Siu, C. -W. (2016). Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis. EUROPACE, 18(5), 665-671. doi:10.1093/europace/euv289

DOI: 10.1093/europace/euv289

Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis (Journal article)

Lau, Y. C., Xiong, Q., Ranjit, P., Lip, G. Y. H., & Blann, A. D. (2016). Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 42(2), 233-244. doi:10.1007/s11239-016-1344-5

DOI: 10.1007/s11239-016-1344-5

Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial (Journal article)

Di Tullio, M. R., Qian, M., Thompson, J. L. P., Labovitz, A. J., Mann, D. L., Sacco, R. L., . . . Investigators, W. A. R. C. E. F. (2016). Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial. STROKE, 47(8), 2031-2037. doi:10.1161/STROKEAHA.116.013679

DOI: 10.1161/STROKEAHA.116.013679

Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation (Journal article)

Hamatani, Y., Ogawa, H., Takabayashi, K., Yamashita, Y., Takagi, D., Esato, M., . . . Akao, M. (2016). Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation. SCIENTIFIC REPORTS, 6. doi:10.1038/srep31042

DOI: 10.1038/srep31042

Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF) (Journal article)

Lip, G. Y. H., Hammerstingl, C., Marin, F., Cappato, R., Meng, I. L., Kirsch, B., . . . Investigators, C. L. O. T. -A. F. R. (2016). Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). AMERICAN HEART JOURNAL, 178, 126-134. doi:10.1016/j.ahj.2016.05.007

DOI: 10.1016/j.ahj.2016.05.007

Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF) (Conference Paper)

Lip, G. Y. H., Hammerstingl, C., Marin, F., Cappato, R., Meng, I. L., Kirsch, B., . . . Investigators, C. L. O. T. -A. F. R. (2016). Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). In EUROPEAN HEART JOURNAL Vol. 37 (pp. 501). Retrieved from http://gateway.webofknowledge.com/

Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) biomarker substudy (Conference Paper)

Marin, F., Hammerstingl, C., Cappato, R., Kramer, F., Meng, I. L., Cohen, A., . . . Lip, G. Y. H. (2016). Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) biomarker substudy. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 503). Retrieved from http://gateway.webofknowledge.com/

Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc Score of 1: Systematic Review and Meta-Analysis" (Journal article)

Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc Score of 1: Systematic Review and Meta-Analysis". STROKE, 47(7), e193. doi:10.1161/STROKEAHA.116.013672

DOI: 10.1161/STROKEAHA.116.013672

Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion (Journal article)

Garcia-Fernandez, A., Marin, F., Roldan, V., Gomez-Sansano, J. M., Hernandez-Romero, D., Valdes, M., . . . Lip, G. Y. H. (2016). Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion. CIRCULATION JOURNAL, 80(3), 605-612. doi:10.1253/circj.CJ-15-0992

DOI: 10.1253/circj.CJ-15-0992

Low volume-high intensity interval exercise elicits antioxidant and anti-inflammatory effects in humans (Journal article)

Wadley, A. J., Chen, Y. -W., Lip, G. Y. H., Fisher, J. P., & Aldred, S. (2016). Low volume-high intensity interval exercise elicits antioxidant and anti-inflammatory effects in humans. JOURNAL OF SPORTS SCIENCES, 34(1), 1-9. doi:10.1080/02640414.2015.1035666

DOI: 10.1080/02640414.2015.1035666

Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores (Journal article)

Proietti, M., Senoo, K., Lane, D. A., & Lip, G. Y. H. (2016). Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores. SCIENTIFIC REPORTS, 6. doi:10.1038/srep24376

DOI: 10.1038/srep24376

Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials (Journal article)

Proietti, M., & Lip, G. Y. H. (2016). Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials. AMERICAN JOURNAL OF MEDICINE, 129(10), 1110-1116. doi:10.1016/j.amjmed.2016.03.024

DOI: 10.1016/j.amjmed.2016.03.024

Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States (Journal article)

Lip, G. Y. H., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., . . . Phatak, H. (2016). Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 70(9), 752-763. doi:10.1111/ijcp.12863

DOI: 10.1111/ijcp.12863

Major bleeding risk in patients 75 years of age or older with non-valvular atrial fibrillation initiating oral anticoagulants: a real-world comparison of warfarin, apixaban, dabigatran, or rivaroxaban (Conference Paper)

Lip, G. Y. H., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Hamilton, M. (2016). Major bleeding risk in patients 75 years of age or older with non-valvular atrial fibrillation initiating oral anticoagulants: a real-world comparison of warfarin, apixaban, dabigatran, or rivaroxaban. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 500-501). Retrieved from http://gateway.webofknowledge.com/

Major cardiovascular outcomes in anticoagulated atrial fibrillation patients with one stroke risk factor (CHA2DS2-VASc 1 in males, 2 in females): impact of time in therapeutic range (Conference Paper)

Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Major cardiovascular outcomes in anticoagulated atrial fibrillation patients with one stroke risk factor (CHA2DS2-VASc 1 in males, 2 in females): impact of time in therapeutic range. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from http://gateway.webofknowledge.com/

Major cardiovascular risk factors in an unselected "real world" screening cohort: insights from the Belgian heart rhythm week programme (Conference Paper)

Proietti, M., Mairesse, G. H., Goethals, P., Scavee, C., Vijgen, J., Blankoff, I., . . . Week, B. H. R. (2016). Major cardiovascular risk factors in an unselected "real world" screening cohort: insights from the Belgian heart rhythm week programme. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 347-348). Retrieved from http://gateway.webofknowledge.com/

Management of atrial fibrillation in specific patient populations (Journal article)

Szymanski, F. M., Lip, G. Y. H., & Filipiak, K. J. (2016). Management of atrial fibrillation in specific patient populations. KARDIOLOGIA POLSKA, 74(1), 1-8. doi:10.5603/KP.a2015.0223

DOI: 10.5603/KP.a2015.0223

May your New Year be happy and prosperous with "Thrombosis and Haemostasis" (Journal article)

Lip, G. Y. H., & Weber, C. (2016). May your New Year be happy and prosperous with "Thrombosis and Haemostasis". THROMBOSIS AND HAEMOSTASIS, 115(1), 1-2. doi:10.1160/TH15-11-0912

DOI: 10.1160/TH15-11-0912

Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention (Journal article)

Kowalewski, M., Suwalski, P., Raffa, G. M., Slomka, A., Kowalkowska, M. E., Szwed, K. A., . . . Lip, G. Y. H. (2016). Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention. INTERNATIONAL JOURNAL OF CARDIOLOGY, 223, 186-194. doi:10.1016/j.ijcard.2016.08.089

DOI: 10.1016/j.ijcard.2016.08.089

Misconceptions on Interpretation of Risk Prediction Tools in Atrial Fibrillation (Journal article)

Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Misconceptions on Interpretation of Risk Prediction Tools in Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 129(5), E31. doi:10.1016/j.amjmed.2015.11.038

DOI: 10.1016/j.amjmed.2015.11.038

Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives (Journal article)

Blann, A. D., Boriani, G., & Lip, G. Y. H. (2016). Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives. EUROPACE, 18(10), 1507-1513. doi:10.1093/europace/euw211

DOI: 10.1093/europace/euw211

Monocyte-platelet aggregates associated with CD14++CD16+monocytes predict diffuse coronary artery disease: relationship to microvascular function (Conference Paper)

Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2016). Monocyte-platelet aggregates associated with CD14++CD16+monocytes predict diffuse coronary artery disease: relationship to microvascular function. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 812). Retrieved from http://gateway.webofknowledge.com/

Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke (Journal article)

Andersen, S. D., Skjoth, F., Yavarian, Y., Bach, F. W., Lip, G. Y. H., & Larsen, T. B. (2016). Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke. CEREBROVASCULAR DISEASES, 42(1-2), 73-80. doi:10.1159/000445196

DOI: 10.1159/000445196

Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation An analysis of 425,600 Chinese individuals without prior stroke (Journal article)

Guo, Y., Wang, H., Tian, Y., Wang, Y., & Lip, G. Y. H. (2016). Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation An analysis of 425,600 Chinese individuals without prior stroke. THROMBOSIS AND HAEMOSTASIS, 115(1), 184-192. doi:10.1160/TH15-07-0577

DOI: 10.1160/TH15-07-0577

Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA(2)DS(2)-VASc and Time in Therapeutic Range (Journal article)

Chan, P. -H., Huang, D., Lau, C. -P., Chan, E. W., Wong, I. C. K., Lip, G. Y. H., . . . Siu, C. -W. (2016). Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA(2)DS(2)-VASc and Time in Therapeutic Range. CANADIAN JOURNAL OF CARDIOLOGY, 32(10). doi:10.1016/j.cjca.2016.01.016

DOI: 10.1016/j.cjca.2016.01.016

Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population. (Journal article)

Blann, A. D., Pisters, R., & Lip, G. Y. H. (2016). Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population.. JACC. Clinical electrophysiology, 2(1), 47-54. doi:10.1016/j.jacep.2015.09.015

DOI: 10.1016/j.jacep.2015.09.015

Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry (Journal article)

Watanabe, E., Yamamoto, M., Kodama, I., Inoue, H., Atarashi, H., Okumura, K., . . . Investigators, J. -R. H. Y. T. H. M. R. (2016). Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 212, 311-317. doi:10.1016/j.ijcard.2016.03.008

DOI: 10.1016/j.ijcard.2016.03.008

Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation A Meta-Analysis of Randomized Controlled Trials (Journal article)

Kumar, S., Danik, S. B., Altman, R. K., Barrett, C. D., Lip, G. Y. H., Chatterjee, S., . . . Danik, J. S. (2016). Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation A Meta-Analysis of Randomized Controlled Trials. CARDIOLOGY IN REVIEW, 24(5), 218-223. doi:10.1097/CRD.0000000000000088

DOI: 10.1097/CRD.0000000000000088

Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease (Journal article)

Potpara, T. S., Jokic, V., Dagres, N., Larsen, T. B., Lane, D. A., Hindricks, G., & Lip, G. Y. H. (2016). Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease. CURRENT MEDICINAL CHEMISTRY, 23(19), 2055-2069. doi:10.2174/0929867323666160210130109

DOI: 10.2174/0929867323666160210130109

Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism (Journal article)

Blann, A. D., & Lip, G. Y. H. (2016). Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism. HEART, 102(12), 975-983. doi:10.1136/heartjnl-2014-307019

DOI: 10.1136/heartjnl-2014-307019

Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark (Journal article)

Staerk, L., Fosbol, E. L., Gadsboll, K., Sindet-Pedersen, C., Pallisgaard, J. L., Lamberts, M., . . . Olesen, J. B. (2016). Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark. SCIENTIFIC REPORTS, 6. doi:10.1038/srep31477

DOI: 10.1038/srep31477

Non-vitamin K antagonist oral anticoagulation usage in elderly patients with atrial fibrillation: Danish nationwide data with temporal trends from 2011 to 2015 (Conference Paper)

Staerk, L., Fosbol, E. L. F., Gadsboll, K. G., Sindet-Pedersen, C. S. P., Pallisgaard, J. L. P., Lamberts, M. L., . . . Olesen, J. B. O. (2016). Non-vitamin K antagonist oral anticoagulation usage in elderly patients with atrial fibrillation: Danish nationwide data with temporal trends from 2011 to 2015. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 501). Retrieved from http://gateway.webofknowledge.com/

Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease (Journal article)

Voukalis, C., Lip, G. Y. H., & Shantsila, E. (2016). Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease. EXPERT OPINION ON PHARMACOTHERAPY, 17(15), 2033-2047. doi:10.1080/14656566.2016.1232393

DOI: 10.1080/14656566.2016.1232393

Optimizing stroke prevention in elderly patients with atrial fibrillation (Journal article)

Lip, G. Y. H. (2016). Optimizing stroke prevention in elderly patients with atrial fibrillation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 14(11), 2121-2123. doi:10.1111/jth.13480

DOI: 10.1111/jth.13480

Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor The Loire Valley Atrial Fibrillation Project (Journal article)

Fauchier, L., Lecoq, C., Clementy, N., Bernard, A., Angoulvant, D., Ivanes, F., . . . Lip, G. Y. H. (2016). Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor The Loire Valley Atrial Fibrillation Project. CHEST, 149(4), 960-968. doi:10.1378/chest.15-1622

DOI: 10.1378/chest.15-1622

Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease (Journal article)

De Caterina, R., Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., . . . Weitz, J. I. (2016). Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease. THROMBOSIS AND HAEMOSTASIS, 115(4), 685-711. doi:10.1160/TH15-09-0703

DOI: 10.1160/TH15-09-0703

Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis The Loire Valley Atrial Fibrillation Project (Journal article)

Philippart, R., Brunet-Bernard, A., Clementy, N., Bourguignon, T., Mirza, A., Angoulvant, D., . . . Fauchier, L. (2016). Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis The Loire Valley Atrial Fibrillation Project. THROMBOSIS AND HAEMOSTASIS, 115(5), 1056-1063. doi:10.1160/TH16-01-0007

DOI: 10.1160/TH16-01-0007

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation (Journal article)

Bjorck, F., Renlund, H., Lip, G. Y. H., Wester, P., Svensson, P. J., & Sjalander, A. (2016). Outcomes in a Warfarin-Treated Population With Atrial Fibrillation. JAMA CARDIOLOGY, 1(2), 172-180. doi:10.1001/jamacardio.2016.0199

DOI: 10.1001/jamacardio.2016.0199

Overweight and obesity in female and male patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (Conference Paper)

Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Sinagra, G., . . . EORP, A. F. (2016). Overweight and obesity in female and male patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 929). Retrieved from http://gateway.webofknowledge.com/

PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY (Conference Paper)

Proietti, M., Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. (2016). PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 688). doi:10.1016/S0735-1097(16)30689-1

DOI: 10.1016/S0735-1097(16)30689-1

Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry (Conference Paper)

Teutsch, C., Huisman, M. V., Lip, G. Y. H., Diener, H. -C., Dubner, S. J., Changsheng, M., . . . Halperin, J. (2016). Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry. In BLOOD Vol. 128. Retrieved from http://gateway.webofknowledge.com/

Polish and European management strategies in patients with atrial fibrillation Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot) (Journal article)

Lenarczyk, R., Mitrega, K., Mazurek, M., Janion, M., Opolski, G., Drozdz, J., . . . Kalarus, Z. (2016). Polish and European management strategies in patients with atrial fibrillation Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot). POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 126(3), 138-148. doi:10.20452/pamw.3322

DOI: 10.20452/pamw.3322

Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial (Journal article)

Proietti, M., Raparelli, V., Olshansky, B., & Lip, G. Y. H. (2016). Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial. CLINICAL RESEARCH IN CARDIOLOGY, 105(5), 412-420. doi:10.1007/s00392-015-0936-y

DOI: 10.1007/s00392-015-0936-y

Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function (Conference Paper)

Bonde, A. N., Lip, G. Y. H., Kamper, A. L., Staerk, L., Torp-Pedersen, C., Gislason, G., & Olesen, J. B. (2016). Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 499-500). Retrieved from http://gateway.webofknowledge.com/

Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score (Conference Paper)

Jaakkola, S., Lip, G. Y., Nuotio, I., Biancari, F., Hartikainen, J. E., & Airaksinen, J. K. (2016). Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score. In CIRCULATION Vol. 134. Retrieved from http://gateway.webofknowledge.com/

Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score (Conference Paper)

Jaakkola, S., Lip, G. Y., Nuotio, I., Biancari, F., Hartikainen, J. E., & Airaksinen, J. K. (2016). Predicting the Risk of Failure and Recurrence After Electrical Cardioversion for Acute Atrial Fibrillation: Derivation and Validation of the AF-CVS Score. In CIRCULATION Vol. 134. Retrieved from http://gateway.webofknowledge.com/

Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial (Journal article)

Senoo, K., & Lip, G. Y. H. (2016). Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 221, 379-382. doi:10.1016/j.ijcard.2016.07.100

DOI: 10.1016/j.ijcard.2016.07.100

Preexisting cardiovascular comorbidities underlie newly diagnosed atrial fibrillation after acute ischemic stroke (Conference Paper)

Fauchier, L., Bisson, A., Clementy, N., Angoulvant, D., Babuty, D., & Lip, G. Y. H. (2016). Preexisting cardiovascular comorbidities underlie newly diagnosed atrial fibrillation after acute ischemic stroke. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 615). Retrieved from http://gateway.webofknowledge.com/

Premature Cardiac Aging in South Asian Compared to Afro-Caribbean Subjects in a Community-Based Screening Study (Journal article)

Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2016). Premature Cardiac Aging in South Asian Compared to Afro-Caribbean Subjects in a Community-Based Screening Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5(11). doi:10.1161/JAHA.116.004110

DOI: 10.1161/JAHA.116.004110

Premature cardiac ageing in South Asians: the ethnic-echocardiographic heart of England screening study (E-ECHOES) (Conference Paper)

Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2016). Premature cardiac ageing in South Asians: the ethnic-echocardiographic heart of England screening study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 37 (pp. 931). Retrieved from http://gateway.webofknowledge.com/

Preventing Thrombosis to Improve Outcomes in Heart Failure Patients (Journal article)

Shantsila, E., & Lip, G. Y. H. (2016). Preventing Thrombosis to Improve Outcomes in Heart Failure Patients. PROGRESS IN CARDIOVASCULAR DISEASES, 58(4), 386-392. doi:10.1016/j.pcad.2015.09.005

DOI: 10.1016/j.pcad.2015.09.005

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI (Journal article)

Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., . . . Fox, K. A. (2016). Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. NEW ENGLAND JOURNAL OF MEDICINE, 375(25), 2423-2434. doi:10.1056/NEJMoa1611594

DOI: 10.1056/NEJMoa1611594

Pulmonary Embolism As a Consequence of Ultrasonographic Examination of Extremities for Suspected Venous Thrombosis: A Systematic Review (Journal article)

Mehdipoor, G., Shabestari, A. A., Lip, G. Y. H., & Bikdeli, B. (2016). Pulmonary Embolism As a Consequence of Ultrasonographic Examination of Extremities for Suspected Venous Thrombosis: A Systematic Review. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 42(6), 636-641. doi:10.1055/s-0036-1571336

DOI: 10.1055/s-0036-1571336

REAL WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON APIXABAN, WARFARIN, DABIGATRAN OR RIVAROXABAN: A 1:1 PROPENSITY-SCORE MATCHED ANALYSIS (Conference Paper)

Lip, G., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Phatak, H. (2016). REAL WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON APIXABAN, WARFARIN, DABIGATRAN OR RIVAROXABAN: A 1:1 PROPENSITY-SCORE MATCHED ANALYSIS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 882). doi:10.1016/S0735-1097(16)30883-X

DOI: 10.1016/S0735-1097(16)30883-X

REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN (Conference Paper)

Tepper, P., Mardekian, J., Masseria, C., Horblyuk, R., Kamble, S., Hamilton, M., . . . Lip, G. Y. H. (2016). REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 662). doi:10.1016/S0735-1097(16)30663-5

DOI: 10.1016/S0735-1097(16)30663-5

RISKS OF ANTITHROMBOTIC TREATMENT AFTER GASTROINTESTINAL BLEEDING IN ATRIAL FIBRILLATION Reply (Journal article)

Staerk, L., & Lip, G. Y. H. (2016). RISKS OF ANTITHROMBOTIC TREATMENT AFTER GASTROINTESTINAL BLEEDING IN ATRIAL FIBRILLATION Reply. BMJ-BRITISH MEDICAL JOURNAL, 352. doi:10.1136/bmj.i266

DOI: 10.1136/bmj.i266

Rationale and design of the Chinese Atrial Fibrillation Registry Study (Journal article)

Du, X., Ma, C., Wu, J., Li, S., Ning, M., Tang, R., . . . Investigators, C. A. F. R. (2016). Rationale and design of the Chinese Atrial Fibrillation Registry Study. BMC CARDIOVASCULAR DISORDERS, 16. doi:10.1186/s12872-016-0308-1

DOI: 10.1186/s12872-016-0308-1

Real World Bleeding Risks in Non-valvular Atrial Fibrillation Patients With Heart Failure: Contemporary EHR Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin (Conference Paper)

Lin, I., Horblyuk, R., Mardekian, J., Park, S. H., Kamble, S., Hamilton, M., . . . Lip, G. Y. (2016). Real World Bleeding Risks in Non-valvular Atrial Fibrillation Patients With Heart Failure: Contemporary EHR Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin. In CIRCULATION Vol. 134. Retrieved from http://gateway.webofknowledge.com/

Real world comparison of major bleeding risk among nonvalvular atrial fibrillation patients newly initiated on apixaban, warfarin, dabigatran or rivaroxaban: a 1:1 propensity-score matched analysis (Conference Paper)

Lip, G., Keshishian, A., Kamble, S., Pan, X., Burns, L., Mardekian, J., . . . Phatak, H. (2016). Real world comparison of major bleeding risk among nonvalvular atrial fibrillation patients newly initiated on apixaban, warfarin, dabigatran or rivaroxaban: a 1:1 propensity-score matched analysis. In PHARMACOTHERAPY Vol. 36 (pp. E213). Retrieved from http://gateway.webofknowledge.com/

Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin A propensity score matched analysis (Journal article)

Lip, G. Y. H., Keshishian, A., Kamble, S., Pan, X., Mardekian, J., Horblyuk, R., & Hamilton, M. (2016). Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin A propensity score matched analysis. THROMBOSIS AND HAEMOSTASIS, 116(5), 975-986. doi:10.1160/TH16-05-0403

DOI: 10.1160/TH16-05-0403

Real-world comparisons of major bleeding risk and major bleeding-related hospitalization costs among elderly non-valvular atrial fibrillation patients newly initiated on apixaban or warfarin (Conference Paper)

Kamble, S., Keshishian, A., Pan, X., Mardekian, J., Horbkyuk, R., Hamilton, M., & Lip, G. Y. H. (2016). Real-world comparisons of major bleeding risk and major bleeding-related hospitalization costs among elderly non-valvular atrial fibrillation patients newly initiated on apixaban or warfarin. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 496). Retrieved from http://gateway.webofknowledge.com/

Recalibration of the HAS- BLED Score Should Hemorrhagic Stroke Account for One or Two Points? (Journal article)

Nielsen, P. B., Larsen, T. B., & Lip, G. Y. H. (2016). Recalibration of the HAS- BLED Score Should Hemorrhagic Stroke Account for One or Two Points?. CHEST, 149(2), 311-314. doi:10.1378/chest.15-1509

DOI: 10.1378/chest.15-1509

Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention. (Journal article)

Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention.. F1000Research, 5, 2887. doi:10.12688/f1000research.10176.1

DOI: 10.12688/f1000research.10176.1

Relation of Nonvalvular Atrial Fibrillati to Body Mass Index (from the SPORTIF Trials) (Conference Paper)

Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of Nonvalvular Atrial Fibrillati to Body Mass Index (from the SPORTIF Trials). In AMERICAN JOURNAL OF CARDIOLOGY Vol. 118 (pp. 72-78). doi:10.1016/j.amjcard.2016.04.013

DOI: 10.1016/j.amjcard.2016.04.013

Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM Trial (Journal article)

Proietti, M., Raparelli, V., Basili, S., Olshansky, B., & Lip, G. Y. H. (2016). Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM Trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 207, 258-263. doi:10.1016/j.ijcard.2016.01.169

DOI: 10.1016/j.ijcard.2016.01.169

Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials (Journal article)

Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 216, 168-172. doi:10.1016/j.ijcard.2016.04.131

DOI: 10.1016/j.ijcard.2016.04.131

Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: the SPORTIF trials (Conference Paper)

Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: the SPORTIF trials. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1348). Retrieved from http://gateway.webofknowledge.com/

Relationship between COPD and all-cause death in patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry (Conference Paper)

Proietti, M., Laroche, C., Tavazzi, L., Maggioni, A. P., Boriani, G., Lip, G. Y. H., & Registry, E. O. R. P. -A. F. G. P. (2016). Relationship between COPD and all-cause death in patients with atrial fibrillation: insights from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 292). Retrieved from http://gateway.webofknowledge.com/

Relationship of left ventricular hypertrophy to vascular events in patients with non-valvular atrial fibrillation: the ARAPACIS study (Conference Paper)

Proietti, M., Marra, A. M., Tassone, E. J., Corrao, S., Vestri, A. R., Perticone, F., . . . Grp, G. I. S. (2016). Relationship of left ventricular hypertrophy to vascular events in patients with non-valvular atrial fibrillation: the ARAPACIS study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 848-849). Retrieved from http://gateway.webofknowledge.com/

Relationship of rate and rhythm control strategies to adverse outcomes in patients with atrial fibrillation: the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry (Conference Paper)

Purmah, Y., Proietti, M., Laroche, C., Tavazzi, L., Maggioni, A. P., Boriani, G., . . . Investi, E. O. R. P. -A. F. G. P. R. (2016). Relationship of rate and rhythm control strategies to adverse outcomes in patients with atrial fibrillation: the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 601-602). Retrieved from http://gateway.webofknowledge.com/

Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups (Journal article)

Lip, G. Y. H., Mitchell, S. A., Liu, X., Liu, L. Z., Phatak, H., Kachroo, S., & Batson, S. (2016). Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups. INTERNATIONAL JOURNAL OF CARDIOLOGY, 204, 88-94. doi:10.1016/j.ijcard.2015.11.084

DOI: 10.1016/j.ijcard.2015.11.084

Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation An Observational Cohort Study (Journal article)

Bonde, A. N., Lip, G. Y. H., Kamper, A. -L., Fosbol, E. L., Staerk, L., Carlson, N., . . . Olesen, J. B. (2016). Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation An Observational Cohort Study. STROKE, 47(11), 2707-2713. doi:10.1161/STROKEAHA.116.014422

DOI: 10.1161/STROKEAHA.116.014422

Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke" (Journal article)

Pastori, D., Pignatelli, P., Saliola, M., Carnevale, R., Vicario, T., Cangemi, R., . . . Violi, F. (2016). Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke". INTERNATIONAL JOURNAL OF CARDIOLOGY, 202, 934-935. doi:10.1016/j.ijcard.2015.10.122

DOI: 10.1016/j.ijcard.2015.10.122

Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage" (Journal article)

Chao, T. -F., Liu, C. -J., Liao, J. -N., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage". CIRCULATION, 134(11), E230-E231. doi:10.1161/CIRCULATIONAHA.116.024174

DOI: 10.1161/CIRCULATIONAHA.116.024174

Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA(2)DS(2)-VASc Risk Factor Be Anticoagulated?" (Journal article)

Fauchier, L., Bisson, A., & Lip, G. Y. H. (2016). Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA(2)DS(2)-VASc Risk Factor Be Anticoagulated?". STROKE, 47(10), E239. doi:10.1161/STROKEAHA.116.014619

DOI: 10.1161/STROKEAHA.116.014619

Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring" (Journal article)

Lip, G. Y. H. (2016). Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring". CIRCULATION, 134(5), E33-E34. doi:10.1161/CIRCULATIONAHA.116.023663

DOI: 10.1161/CIRCULATIONAHA.116.023663

Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" (Journal article)

Nielsen, P. B., & Lip, G. Y. H. (2016). Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke". CIRCULATION, 134(18), E389-E390. doi:10.1161/CIRCULATIONAHA.116.024013

DOI: 10.1161/CIRCULATIONAHA.116.024013

Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source (Journal article)

Ntaios, G., Vemmos, K., Lip, G. Y. H., Koroboki, E., Manios, E., Vemmou, A., . . . Papavasileiou, V. (2016). Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source. STROKE, 47(9), 2278-2285. doi:10.1161/STROKEAHA.116.013713

DOI: 10.1161/STROKEAHA.116.013713

Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care (Journal article)

Gorst-Rasmussen, A., Lip, G. Y. H., & Larsen, T. B. (2016). Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25(11), 1236-1244. doi:10.1002/pds.4034

DOI: 10.1002/pds.4034

Role and analysis of monocyte subsets in cardiovascular disease Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis" (Journal article)

Weber, C., Shantsila, E., Hristov, M., Caligiuri, G., Guzik, T., Heine, G. H., . . . Lip, G. Y. H. (2016). Role and analysis of monocyte subsets in cardiovascular disease Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis". THROMBOSIS AND HAEMOSTASIS, 116(4), 626-637. doi:10.1160/TH16-02-0091

DOI: 10.1160/TH16-02-0091

SEX DIFFERENCES IN ANTITHROMBOTIC THERAPY: OBSERVATIONS FROM THE GLORIA-AF REGISTRY PROGRAM (Conference Paper)

Teutsch, C., Lip, G. Y. H., Diener, H. -C., Dubner, S., Halperin, J., Ma, C., . . . Huisman, M. (2016). SEX DIFFERENCES IN ANTITHROMBOTIC THERAPY: OBSERVATIONS FROM THE GLORIA-AF REGISTRY PROGRAM. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 794). doi:10.1016/S0735-1097(16)30795-1

DOI: 10.1016/S0735-1097(16)30795-1

STROKE AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION WITH RESUMPTION OF ORAL ANTICOAGULATION FOLLOWING TRAUMATIC INJURY: A DANISH NATIONWIDE COHORT STUDY (Conference Paper)

Staerk, L., Gislason, G., Lip, G., Fosbol, E., Sindet-Pedersen, C., Gadsboll, K., . . . Olesen, J. (2016). STROKE AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION WITH RESUMPTION OF ORAL ANTICOAGULATION FOLLOWING TRAUMATIC INJURY: A DANISH NATIONWIDE COHORT STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 892). doi:10.1016/S0735-1097(16)30893-2

DOI: 10.1016/S0735-1097(16)30893-2

Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry (Conference Paper)

Mazurek, M., Shantsila, E., Lane, D., Wolff, A., Proietti, M., & Lip, G. Y. (2016). Secondary versus primary stroke prevention in atrial fibrillation - Insights from the community-based darlington atrial fibrillation registry. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 845). Retrieved from http://gateway.webofknowledge.com/

Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists. (Journal article)

Tran, R. T., Rankin, A. J., Abdul-Rahim, A. H., Lip, G. Y., Rankin, A. C., & Lees, K. R. (2016). Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists.. The journal of the Royal College of Physicians of Edinburgh, 46(2), 87-92. doi:10.4997/jrcpe.2016.204

DOI: 10.4997/jrcpe.2016.204

Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA(2)DS(2)-VASc Risk Factor Be Anticoagulated? (Journal article)

Fauchier, L., Clementy, N., Bisson, A., Ivanes, F., Angoulvant, D., Babuty, D., & Lip, G. Y. H. (2016). Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA(2)DS(2)-VASc Risk Factor Be Anticoagulated?. STROKE, 47(7), 1831-1836. doi:10.1161/STROKEAHA.116.013253

DOI: 10.1161/STROKEAHA.116.013253

Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke (Journal article)

Lip, G. Y. H., & Nielsen, P. B. (2016). Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke. CIRCULATION, 133(15), 1498-1503. doi:10.1161/CIRCULATIONAHA.115.016713

DOI: 10.1161/CIRCULATIONAHA.115.016713

Stroke Prevention in Atrial Fibrillation: Focus on Latin America (Journal article)

Massaro, A. R., & Lip, G. Y. H. (2016). Stroke Prevention in Atrial Fibrillation: Focus on Latin America. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 107(6), 576-588. doi:10.5935/abc.20160116

DOI: 10.5935/abc.20160116

Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation (Conference Paper)

Bisson, A., Bernard, A., Bodin, A., Clementy, N., Babuty, D., Lip, G. Y. H., & Fauchier, L. (2019). Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation. In CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY Vol. 12. doi:10.1161/CIRCEP.118.006990

DOI: 10.1161/CIRCEP.118.006990

Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation (Conference Paper)

Fauchier, L., Philippart, R., Bernard, A., Clementy, N., Bourguignon, T., Angoulvant, D., . . . Lip, G. (2016). Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation. In CIRCULATION Vol. 134. Retrieved from http://gateway.webofknowledge.com/

Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study (Conference Paper)

Staerk, L., Fosbol, E. L. F., Bonde, A. N. B., Lip, G. Y. H. L., Torp-Pedersen, C. T. P., & Gislason, G. H. G. (2016). Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 393). Retrieved from http://gateway.webofknowledge.com/

Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom (Journal article)

Senoo, K., An, Y., Ogawa, H., Lane, D. A., Wolff, A., Shantsila, E., . . . Lip, G. Y. H. (2016). Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom. HEART, 102(23), 1878-1882. doi:10.1136/heartjnl-2016-309741

DOI: 10.1136/heartjnl-2016-309741

Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study (Journal article)

Nielsen, P. B., Larsen, T. B., Skjoth, F., Overvad, T. F., & Lip, G. Y. H. (2016). Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study. SCIENTIFIC REPORTS, 6. doi:10.1038/srep27410

DOI: 10.1038/srep27410

Stroke prevention in atrial fibrillation (Journal article)

Freedman, B., Potpara, T. S., & Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation. LANCET, 388(10046), 806-817. doi:10.1016/S0140-6736(16)31257-0

DOI: 10.1016/S0140-6736(16)31257-0

Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey (Journal article)

Potpara, T. S., Dan, G. -A., Trendafilova, E., Goda, A., Kusljugic, Z., Manola, S., . . . Investigators, B. A. L. K. A. N. -A. F. (2016). Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey. SCIENTIFIC REPORTS, 6. doi:10.1038/srep20432

DOI: 10.1038/srep20432

Stroke prevention in atrial fibrillation: can we do better? (Journal article)

Lane, D. A., & Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation: can we do better?. NATURE REVIEWS CARDIOLOGY, 13(9), 511-512. doi:10.1038/nrcardio.2016.117

DOI: 10.1038/nrcardio.2016.117

Stroke prevention in atrial fibrillation: changing concepts (vol 1, pg 76, 2015) (Journal article)

Lip, G. Y. H. (2016). Stroke prevention in atrial fibrillation: changing concepts (vol 1, pg 76, 2015). EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2(4), 217. Retrieved from http://gateway.webofknowledge.com/

Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey (Journal article)

Potpara, T. S., Lip, G. Y. H., Larsen, T. B., Madrid, A., Dobreanu, D., Jedrzejczyk-Patej, E., . . . Assoc, E. H. R. (2016). Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey. EUROPACE, 18(10), 1593-1598. doi:10.1093/europace/euw302

DOI: 10.1093/europace/euw302

Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project (Journal article)

Xiong, Q., Shantsila, A., Li, J., Hong, K., & Lip, G. Y. H. (2016). Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project. ARCHIVES OF MEDICAL SCIENCE, 12(1), 216-218. doi:10.5114/aoms.2016.57598

DOI: 10.5114/aoms.2016.57598

Symptom-to-door times in patients presenting with ST elevation myocardial infarction-do ethnic or gender differences exist? (Journal article)

Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2016). Symptom-to-door times in patients presenting with ST elevation myocardial infarction-do ethnic or gender differences exist?. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 109(3), 175-180. doi:10.1093/qjmed/hcv112

DOI: 10.1093/qjmed/hcv112

Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan (Journal article)

Nezu, T., Hosomi, N., Lip, G. Y. H., Aoki, S., Shimomura, R., Maruyama, H., . . . Registry, J. S. S. (2016). Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan. CIRCULATION JOURNAL, 80(9), 2033-2036. doi:10.1253/circj.CJ-16-0374

DOI: 10.1253/circj.CJ-16-0374

The 5-factor ORBIT bleeding score predicted major bleeding at 2 years in patients with atrial fibrillation (Journal article)

Lip, G. Y. H., & Lane, D. A. (2016). The 5-factor ORBIT bleeding score predicted major bleeding at 2 years in patients with atrial fibrillation. ANNALS OF INTERNAL MEDICINE, 164(2), JC11. doi:10.7326/ACPJC-2016-164-2-011

DOI: 10.7326/ACPJC-2016-164-2-011

The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion (Journal article)

Garcia-Fernandez, A., Marin, F., Roldan, V., Galcera-Jornet, E., Gabriel Martinez-Martinez, J., Valdes, M., . . . Lip, G. Y. H. (2016). The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion. INTERNATIONAL JOURNAL OF CARDIOLOGY, 217, 42-48. doi:10.1016/j.ijcard.2016.04.167

DOI: 10.1016/j.ijcard.2016.04.167

The Obesity Paradox in patients with non-valvular atrial fibrillation: observations from the SPORTIF trials (Conference Paper)

Proietti, M., Lane, D. A., & Lip, G. Y. H. (2016). The Obesity Paradox in patients with non-valvular atrial fibrillation: observations from the SPORTIF trials. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 828). Retrieved from http://gateway.webofknowledge.com/

The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VIE A real-life inception cohort study (Journal article)

Palareti, G., Antonucci, E., Lip, G. Y. H., Testa, S., Guazzaloca, G., Falanga, A., . . . Participants, S. -R. (2016). The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VIE A real-life inception cohort study. THROMBOSIS AND HAEMOSTASIS, 115(6), 1101-1108. doi:10.1160/TH15-10-0830

DOI: 10.1160/TH15-10-0830

The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation. (Journal article)

Esteve-Pastor, M. A., Roldán, V., Valdés, M., Lip, G. Y. H., & Marín, F. (2016). The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation.. Expert review of cardiovascular therapy, 14(2), 177-187. doi:10.1586/14779072.2016.1116941

DOI: 10.1586/14779072.2016.1116941

The Yin-Yang of Atrial Fibrillation and Pulmonary Embolism (Conference Paper)

Abou Ziki, M., Bikdeli, B., & Lip, G. (2016). The Yin-Yang of Atrial Fibrillation and Pulmonary Embolism. In CHEST Vol. 150 (pp. 1189A). doi:10.1016/j.chest.2016.08.1298

DOI: 10.1016/j.chest.2016.08.1298

The first prognostic model for stroke and death in patients with systolic heart failure (Journal article)

Freudenberger, R. S., Cheng, B., Mann, D. L., Thompson, J. L. P., Sacco, R. L., Buchsbaum, R., . . . Investigators, W. A. R. C. E. F. (2016). The first prognostic model for stroke and death in patients with systolic heart failure. JOURNAL OF CARDIOLOGY, 68(1-2), 100-103. doi:10.1016/j.jjcc.2015.09.014

DOI: 10.1016/j.jjcc.2015.09.014

The impact of atrial fibrillation on risk of recurrence and mortality among patients with venous thromboembolism (Conference Paper)

Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2016). The impact of atrial fibrillation on risk of recurrence and mortality among patients with venous thromboembolism. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 615). Retrieved from http://gateway.webofknowledge.com/

The impact of statin therapy on plasma levels of von Willebrand factor antigen Systematic review and meta-analysis of randomised placebo-controlled trials (Journal article)

Sahebkar, A., Serban, C., Ursoniu, S., Mikhailidis, D. P., Undas, A., Lip, G. Y. H., . . . Grp, L. B. P. M. C. (2016). The impact of statin therapy on plasma levels of von Willebrand factor antigen Systematic review and meta-analysis of randomised placebo-controlled trials. THROMBOSIS AND HAEMOSTASIS, 115(3), 520-532. doi:10.1160/TH15-08-0620

DOI: 10.1160/TH15-08-0620

Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry (Conference Paper)

Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., & Lip, G. Y. (2016). Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry. In CIRCULATION Vol. 134. Retrieved from http://gateway.webofknowledge.com/

Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry (Conference Paper)

Proietti, M., Airaksinen, K. E. J., Rubboli, A., Schlitt, A., Kiviniemi, T., Karjalainen, P. P., & Lip, G. Y. (2016). Time in Therapeutic Range and Major Adverse Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention on Triple Antithrombotic Therapy: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) Registry. In CIRCULATION Vol. 134. Retrieved from http://gateway.webofknowledge.com/

Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation (Journal article)

Chan, P. -H., Li, W. -H., Hai, J. -J., Chan, E. W., Wong, I. C. K., Tse, H. -F., . . . Siu, C. -W. (2016). Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation. CANADIAN JOURNAL OF CARDIOLOGY, 32(10). doi:10.1016/j.cjca.2015.10.029

DOI: 10.1016/j.cjca.2015.10.029

Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease Is Stroke Prevention Worth the Risk? (Journal article)

Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease Is Stroke Prevention Worth the Risk?. CHEST, 149(4), 891-892. doi:10.1016/j.chest.2015.09.026

DOI: 10.1016/j.chest.2015.09.026

Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study (Journal article)

Xia, S. -J., Du, X., Li, C., Wu, J. -H., Tang, R. -B., Chang, S. -S., . . . Ma, C. -S. (2016). Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 220, 284-289. doi:10.1016/j.ijcard.2016.06.113

DOI: 10.1016/j.ijcard.2016.06.113

Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage (Journal article)

Chao, T. -F., Liu, C. -J., Liao, J. -N., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2016). Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage. CIRCULATION, 133(16), 1540-+. doi:10.1161/CIRCULATIONAHA.115.019794

DOI: 10.1161/CIRCULATIONAHA.115.019794

Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice? (Journal article)

Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?. EUROPEAN JOURNAL OF HEART FAILURE, 18(9), 1172-1174. doi:10.1002/ejhf.552

DOI: 10.1002/ejhf.552

Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence (Journal article)

Chan, P. H., Hai, J. J., Chan, E. W., Li, W. H., Tse, H. F., Wong, I. C. K., . . . Siu, C. W. (2016). Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence. PLOS ONE, 11(3). doi:10.1371/journal.pone.0150674

DOI: 10.1371/journal.pone.0150674

Usefulness of the CHA(2)DS(2)-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation (Conference Paper)

Kuo, L., Chao, T. -F., Liu, C. -J., Chen, S. -J., Tuan, T. -C., Lin, Y. -J., . . . Chen, S. -A. (2018). Usefulness of the CHA(2)DS(2)-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation. In AMERICAN JOURNAL OF CARDIOLOGY Vol. 122 (pp. 2049-2054). doi:10.1016/j.amjcard.2018.08.056

DOI: 10.1016/j.amjcard.2018.08.056

Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea (Journal article)

Szymanski, F. M., Lip, G. Y. H., Filipiak, K. J., Platek, A. E., & Karpinski, G. (2016). Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea. INTERNATIONAL JOURNAL OF CARDIOLOGY, 204, 200-205. doi:10.1016/j.ijcard.2015.11.158

DOI: 10.1016/j.ijcard.2015.11.158

Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age (Journal article)

Eckman, M. H., Lip, G. Y. H., Wise, R. E., Speer, B., Sullivan, M., Walker, N., . . . Kues, J. (2016). Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 64(5), 1054-1060. doi:10.1111/jgs.14099

DOI: 10.1111/jgs.14099

Validation of a Modified CHA(2)DS(2)-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study (Journal article)

Chao, T. -F., Lip, G. Y. H., Liu, C. -J., Tuan, T. -C., Chen, S. -J., Wang, K. -L., . . . Chen, S. -A. (2016). Validation of a Modified CHA(2)DS(2)-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study. STROKE, 47(10), 2462-2469. doi:10.1161/STROKEAHA.116.013880

DOI: 10.1161/STROKEAHA.116.013880

Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation (Conference Paper)

Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2016). Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1006). Retrieved from http://gateway.webofknowledge.com/

Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study (Journal article)

Melgaard, L., Gorst-Rasmussen, A., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2016). Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study. PLOS ONE, 11(3). doi:10.1371/journal.pone.0152269

DOI: 10.1371/journal.pone.0152269

Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type (Journal article)

Wilson, D., Charidimou, A., Shakeshaft, C., Ambler, G., White, M., Cohen, H., . . . Collaborators, C. (2016). Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type. NEUROLOGY, 86(4), 360-366. doi:10.1212/WNL.0000000000002310

DOI: 10.1212/WNL.0000000000002310

Von Willebrand factor predicts adverse events in real world anticoagulated atrial fibrillation patients (Conference Paper)

Roldan-Schilling, V., Rivera-Caravaca, J. M., Hernandez-Romero, D., Esteve-Pastor, M. A., Vicente, V., Valdes, M., . . . Marin, F. (2016). Von Willebrand factor predicts adverse events in real world anticoagulated atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1200). Retrieved from http://gateway.webofknowledge.com/

WHAT DO REAL WORLD DATA SAY ABOUT SAFETY AND RESOURCE USE OF ORAL ANTAGONISTS? EARLY ANALYSIS OF NEWLY ANTICOAGULATED NON-VALVULAR ATRIAL FIBRILLATION PATIENTS USING EITHER APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN (Conference Paper)

Pan, X., Kamble, S., Burns, L., Kawabata, H., Mardekian, J., Masseria, C., . . . Lip, G. Y. H. (2016). WHAT DO REAL WORLD DATA SAY ABOUT SAFETY AND RESOURCE USE OF ORAL ANTAGONISTS? EARLY ANALYSIS OF NEWLY ANTICOAGULATED NON-VALVULAR ATRIAL FIBRILLATION PATIENTS USING EITHER APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 67 (pp. 894). doi:10.1016/S0735-1097(16)30895-6

DOI: 10.1016/S0735-1097(16)30895-6

What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation? (Journal article)

Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016). What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?. EUROPEAN HEART JOURNAL SUPPLEMENTS, 18(I), 18-24. doi:10.1093/eurheartj/suw049

DOI: 10.1093/eurheartj/suw049

When should we start thromboprophylaxis? The stroke risk threshold discrepancy between European and US guidelines for atrial fibrillation (Conference Paper)

Nielsen, P. B., Larsen, T. B., Skjoeth, F., Overvad, T. F., & Lip, G. Y. H. (2016). When should we start thromboprophylaxis? The stroke risk threshold discrepancy between European and US guidelines for atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 235). Retrieved from http://gateway.webofknowledge.com/

Which Oral Anti-Coagulant Do Patients Prefer for Stroke Prevention in Non-Valvular Atrial Fibrillation? (Conference Paper)

Lip, G. Y., Verdecchia, P., Tervonen, T., Ustyugova, A., Heinrich-Nols, J., Gropper, S., . . . Marsh, K. (2016). Which Oral Anti-Coagulant Do Patients Prefer for Stroke Prevention in Non-Valvular Atrial Fibrillation?. In CIRCULATION Vol. 134. Retrieved from http://gateway.webofknowledge.com/

[2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)]. (Journal article)

Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J. -P., Del Zotti, F., . . . Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC). (2016). [2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)].. Giornale italiano di cardiologia (2006), 17(4), 277-319. doi:10.1714/2214.23904

DOI: 10.1714/2214.23904

[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology]. (Journal article)

Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Task Force per il Trattamento dei Pazienti con Aritmie Ventricolari e la Prevenzione della Morte Cardiaca Improvvisa della Società Europea di Cardiologia. (2016). [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology].. Giornale italiano di cardiologia (2006), 17(2), 108-170. doi:10.1714/2174.23496

DOI: 10.1714/2174.23496

beta-Blockers in Atrial Fibrillation Patients With or Without Heart Failure Association With Mortality in a Nationwide Cohort Study (Journal article)

Nielsen, P. B., Larsen, T. B., Gorst-Rasmussen, A., Skjoth, F., & Lip, G. Y. H. (2016). beta-Blockers in Atrial Fibrillation Patients With or Without Heart Failure Association With Mortality in a Nationwide Cohort Study. CIRCULATION-HEART FAILURE, 9(2), 1-9. doi:10.1161/CIRCHEARTFAILURE.115.002597

DOI: 10.1161/CIRCHEARTFAILURE.115.002597

miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients (Journal article)

Orenes-Pinero, E., Marin, F., & Lip, G. Y. H. (2016). miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients. ANNALS OF TRANSLATIONAL MEDICINE, 4(10). doi:10.21037/atm.2016.05.27

DOI: 10.21037/atm.2016.05.27

2015

'Lone' atrial fibrillation: no longer lone or even alone. (Journal article)

Potpara, T. S., & Lip, G. Y. H. (2015). 'Lone' atrial fibrillation: no longer lone or even alone.. Current pharmaceutical design, 21(5), 531-532. doi:10.2174/1381612820666140826124522

DOI: 10.2174/1381612820666140826124522

2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). (Journal article)

Adler, Y., Charron, P., Imazio, M., Badano, L., Barón-Esquivias, G., Bogaert, J., . . . ESC Scientific Document Group . (2015). 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).. European heart journal, 36(42), 2921-2964. doi:10.1093/eurheartj/ehv318

DOI: 10.1093/eurheartj/ehv318

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) (Journal article)

Priori, S. G., Blomstrom-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Cardiology, E. S. (2015). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). EUROPEAN HEART JOURNAL, 36(41), 2793-+. doi:10.1093/eurheartj/ehv316

DOI: 10.1093/eurheartj/ehv316

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). (Journal article)

Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . ESC Scientific Document Group . (2015). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).. European heart journal, 36(41), 2793-2867. doi:10.1093/eurheartj/ehv316

DOI: 10.1093/eurheartj/ehv316

A Brief History of 'Lone' Atrial Fibrillation: From 'A Peculiar Pulse Irregularity' to a Modern Public Health Concern (Journal article)

Potpara, T. S., & Lip, G. Y. H. (2015). A Brief History of 'Lone' Atrial Fibrillation: From 'A Peculiar Pulse Irregularity' to a Modern Public Health Concern. CURRENT PHARMACEUTICAL DESIGN, 21(5), 679-696. doi:10.2174/1381612820666140929100209

DOI: 10.2174/1381612820666140929100209

A Happy New Year from Thrombosis and Haemostasis. A 5 year reflection from the Editorial team (Journal article)

Lip, G. Y. H., & Weber, C. (2015). A Happy New Year from Thrombosis and Haemostasis. A 5 year reflection from the Editorial team. THROMBOSIS AND HAEMOSTASIS, 113(1), 1-2. Retrieved from http://gateway.webofknowledge.com/

A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2) (Journal article)

Lip, G. Y. H., Halperin, J. L., Petersen, P., Rodgers, G. M., Pall, D., & Renfurm, R. W. (2015). A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2). JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(8), 1405-1413. doi:10.1111/jth.13025

DOI: 10.1111/jth.13025

A comprehensive insight of novel antioxidant therapies for atrial fibrillation management (Journal article)

Orenes-Pinero, E., Valdes, M., Lip, G. Y. H., & Marin, F. (2015). A comprehensive insight of novel antioxidant therapies for atrial fibrillation management. DRUG METABOLISM REVIEWS, 47(3), 388-400. doi:10.3109/03602532.2015.1077858

DOI: 10.3109/03602532.2015.1077858

A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study (Journal article)

Lip, G. Y. H., Merino, J., Ezekowitz, M., Ellenbogen, K., Zamoryakhin, D., Lanz, H., . . . Goette, A. (2015). A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. AMERICAN HEART JOURNAL, 169(5), 597-U28. doi:10.1016/j.ahj.2015.02.009

DOI: 10.1016/j.ahj.2015.02.009

A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference (Journal article)

Kirchhof, P., Breithardt, G., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boriani, G., . . . Camm, A. J. (2016). A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. EUROPACE, 18(1), 37-50. doi:10.1093/europace/euv304

DOI: 10.1093/europace/euv304

A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations (Conference Paper)

Serban, C., Sahebkar, A., Ursoniu, S., Mikhailidis, D. P., Rizzo, M., Lip, G. Y. H., . . . Banach, M. (2015). A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. In SCIENTIFIC REPORTS Vol. 5. doi:10.1038/srep09902

DOI: 10.1038/srep09902

ANTITHROMBOTIC TREATMENT IN RELATION TO AGE IN PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION IN NORTH AMERICA (GLORIA-AF PHASE II) (Conference Paper)

Halperin, J. L., Huisman, M., Diener, H. -C., Dubner, S., Ma, C., Rothman, K., . . . Lip, G. (2015). ANTITHROMBOTIC TREATMENT IN RELATION TO AGE IN PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION IN NORTH AMERICA (GLORIA-AF PHASE II). In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 65 (pp. A1518). doi:10.1016/S0735-1097(15)61518-2

DOI: 10.1016/S0735-1097(15)61518-2

Ability of bleeding risk scores for stratification of bleeding events in elderly patients with atrial fibrillation (Conference Paper)

Fauchier, L., Banerjee, A., Lagrenade, I., Clementy, N., Bernard, A., Angoulvant, D., . . . Lip, G. Y. H. (2015). Ability of bleeding risk scores for stratification of bleeding events in elderly patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1081-1082). Retrieved from http://gateway.webofknowledge.com/

Adverse cardiovascular outcomes in relation to suboptimal antithrombotic therapy use in patients undergoing peripheral artery disease angioplasty: lost opportunities? (Journal article)

Bodansky, D. M. S., Allon, I. R., Apostolakis, S., & Lip, G. Y. H. (2015). Adverse cardiovascular outcomes in relation to suboptimal antithrombotic therapy use in patients undergoing peripheral artery disease angioplasty: lost opportunities?. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(2), 162-168. doi:10.1111/ijcp.12470

DOI: 10.1111/ijcp.12470

Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation A Nationwide Cohort Study From Taiwan (Journal article)

Chao, T. -F., Wang, K. -L., Liu, C. -J., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2015). Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation A Nationwide Cohort Study From Taiwan. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(12), 1339-1347. doi:10.1016/j.jacc.2015.07.026

DOI: 10.1016/j.jacc.2015.07.026

Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation). (Journal article)

Fumagalli, S., Said, S. A. M., Laroche, C., Gabbai, D., Marchionni, N., Boriani, G., . . . EORP-AF Investigators. (2015). Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation).. JACC. Clinical electrophysiology, 1(4), 326-334. doi:10.1016/j.jacep.2015.02.019

DOI: 10.1016/j.jacep.2015.02.019

An update on atrial fibrillation: focus on stroke risk reduction strategies (Journal article)

Potpara, T. S., Jokic, V., Medic, B., Prostran, M., & Lip, G. Y. H. (2015). An update on atrial fibrillation: focus on stroke risk reduction strategies. MINERVA MEDICA, 106(5), 259-273. Retrieved from http://gateway.webofknowledge.com/

Analysis of vitamin D levels in patients with and without statin-associated myalgia - A systematic review and meta-analysis of 7 studies with 2420 patients (Journal article)

Michalska-Kasiczak, M., Sahebkar, A., Mikhailidis, D. P., Rysz, J., Muntner, P., Toth, P. P., . . . Meta-Anal, L. B. P. (2015). Analysis of vitamin D levels in patients with and without statin-associated myalgia - A systematic review and meta-analysis of 7 studies with 2420 patients. INTERNATIONAL JOURNAL OF CARDIOLOGY, 178, 111-116. doi:10.1016/j.ijcard.2014.10.118

DOI: 10.1016/j.ijcard.2014.10.118

Antidotes to non-vitamin K oral anticoagulants: necessary or not? (Journal article)

Proietti, M., & Lip, G. Y. H. (2015). Antidotes to non-vitamin K oral anticoagulants: necessary or not?. EXPERT OPINION ON PHARMACOTHERAPY, 16(11), 1573-1576. doi:10.1517/14656566.2015.1057119

DOI: 10.1517/14656566.2015.1057119

Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II (Conference Paper)

Huisman, M. V., Rothman, K. J., Paquette, M., Teutsch, C., Diener, H. C., Dubner, S. J., . . . Investigators, G. L. O. R. I. A. -A. F. (2015). Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II. In AMERICAN JOURNAL OF MEDICINE Vol. 128 (pp. 1306-+). doi:10.1016/j.amjmed.2015.07.013

DOI: 10.1016/j.amjmed.2015.07.013

Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESCWorking Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS) (Journal article)

Sticherling, C., Marin, F., Birnie, D., Boriani, G., Calkins, H., Dan, G. -A., . . . Lip, G. Y. H. (2015). Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESCWorking Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). EUROPACE, 17(8), 1197-1214. doi:10.1093/europace/euv190

DOI: 10.1093/europace/euv190

Antithrombotic management in patients with atrial fibrillation undergoing stent implantation: what is the impact of the ESC guidelines adherence? (Conference Paper)

Fauchier, L., Ancedy, Y., Lecoq, C., Saint Etienne, C., Ivanes, F., Babuty, D., . . . Lip, G. Y. H. (2015). Antithrombotic management in patients with atrial fibrillation undergoing stent implantation: what is the impact of the ESC guidelines adherence?. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1084). Retrieved from http://gateway.webofknowledge.com/

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis (Journal article)

Andreotti, F., Rocca, B., Husted, S., Ajjan, R. A., ten Berg, J., Cattaneo, M., . . . Grp, E. S. C. T. W. (2015). Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. EUROPEAN HEART JOURNAL, 36(46), 3238-+. doi:10.1093/eurheartj/ehv304

DOI: 10.1093/eurheartj/ehv304

Apixaban versus edoxaban for stroke prevention in nonvalvular atrial fibrillation (Journal article)

Xiong, Q., Lau, Y. C., & Lip, G. Y. H. (2015). Apixaban versus edoxaban for stroke prevention in nonvalvular atrial fibrillation. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 4(4), 367-376. doi:10.2217/CER.15.15

DOI: 10.2217/CER.15.15

Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease (Conference Paper)

Pastori, D., Pignatelli, P., Perticone, F., Sciacqua, A., Carnevale, R., Farcomeni, A., . . . Fibrillation, A. R. A. P. A. C. I. S. A. (2016). Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease. In INTERNATIONAL JOURNAL OF CARDIOLOGY Vol. 223 (pp. 619-624). doi:10.1016/j.ijcard.2016.08.224

DOI: 10.1016/j.ijcard.2016.08.224

Assessing Bleeding Risk With the HAS-BLED Score: Balancing Simplicity, Practicality, and Predictive Value in Bleeding-Risk Assessment (Journal article)

Lip, G. Y. H. (2015). Assessing Bleeding Risk With the HAS-BLED Score: Balancing Simplicity, Practicality, and Predictive Value in Bleeding-Risk Assessment. CLINICAL CARDIOLOGY, 38(9), 562-564. doi:10.1002/clc.22436

DOI: 10.1002/clc.22436

Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation Reply (Journal article)

Lip, G. Y. H., & Lane, D. A. (2015). Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation Reply. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(9), 949-950. Retrieved from http://gateway.webofknowledge.com/

Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors (Journal article)

Lip, G. Y. H., & Lane, D. A. (2015). Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors. EUROPEAN HEART JOURNAL, 36(46), 3265-3267. doi:10.1093/eurheartj/ehv415

DOI: 10.1093/eurheartj/ehv415

Assessment of a stroke risk stratification scheme in a heart failure population in sinus rhythm (Conference Paper)

Melgaard, L., Gorst-Rasmussen, A., Rasmussen, L. H., Lip, G. Y., & Larsen, T. B. (2015). Assessment of a stroke risk stratification scheme in a heart failure population in sinus rhythm. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 327). Retrieved from http://gateway.webofknowledge.com/

Assessment of the CHA(2)DS(2)-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation (Journal article)

Melgaard, L., Gorst-Rasmussen, A., Lane, D. A., Rasmussen, L. H., Larsen, T. B., & Lip, G. Y. H. (2015). Assessment of the CHA(2)DS(2)-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(10), 1030-1038. doi:10.1001/jama.2015.10725

DOI: 10.1001/jama.2015.10725

Association between statin use and plasma D-dimer levels (Journal article)

Sahebkar, A., Serban, C., Mikhailidis, D. P., Undas, A., Lip, G. Y. H., Muntner, P., . . . Grp, L. B. P. M. C. (2015). Association between statin use and plasma D-dimer levels. THROMBOSIS AND HAEMOSTASIS, 114(3), 546-557. doi:10.1160/TH14-11-0937

DOI: 10.1160/TH14-11-0937

Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry (Journal article)

Boriani, G., Laroche, C., Diemberger, I., Fantecchi, E., Popescu, M. I., Rasmussen, L. H., . . . Lip, G. Y. H. (2015). Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry. AMERICAN JOURNAL OF MEDICINE, 128(5), 509-U212. doi:10.1016/j.amjmed.2014.11.026

DOI: 10.1016/j.amjmed.2014.11.026

Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes (Journal article)

Xiong, Q., Proietti, M., Senoo, K., & Lip, G. Y. H. (2015). Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes. INTERNATIONAL JOURNAL OF CARDIOLOGY, 191, 172-177. doi:10.1016/j.ijcard.2015.05.011

DOI: 10.1016/j.ijcard.2015.05.011

Atrial Fibrillation Patients Categorized as "Not for Anticoagulation" According to the 2014 Canadian Cardiovascular Society Algorithm Are Not "Low Risk" (Journal article)

Lip, G. Y. H., Nielsen, P. B., Skjoth, F., Rasmussen, L. H., & Larsen, T. B. (2015). Atrial Fibrillation Patients Categorized as "Not for Anticoagulation" According to the 2014 Canadian Cardiovascular Society Algorithm Are Not "Low Risk". CANADIAN JOURNAL OF CARDIOLOGY, 31(1), 24-28. doi:10.1016/j.cjca.2014.10.018

DOI: 10.1016/j.cjca.2014.10.018

Atrial fibrillation (chronic). (Journal article)

Lane, D. A., Boos, C. J., & Lip, G. Y. H. (2015). Atrial fibrillation (chronic).. BMJ clinical evidence, 2015.

Atrial flutter and thromboembolic risk: a systematic review (Journal article)

Vadmann, H., Nielsen, P. B., Hjortshoj, S. P., Riahi, S., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2015). Atrial flutter and thromboembolic risk: a systematic review. HEART, 101(18), 1446-1455. doi:10.1136/heartjnl-2015-307550

DOI: 10.1136/heartjnl-2015-307550

Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study (Journal article)

Friberg, L., Benson, L., & Lip, G. Y. H. (2015). Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study. EUROPEAN HEART JOURNAL, 36(5), 297-306. doi:10.1093/eurheartj/ehu139

DOI: 10.1093/eurheartj/ehu139

Benefit of Anticoagulation Therapy in Hyperthyroidism-Related Atrial Fibrillation (Journal article)

Chan, P. -H., Hai, J., Yeung, C. -Y., Lip, G. Y. H., Lam, K. S. -L., Tse, H. -F., & Siu, C. -W. (2015). Benefit of Anticoagulation Therapy in Hyperthyroidism-Related Atrial Fibrillation. CLINICAL CARDIOLOGY, 38(8), 476-482. doi:10.1002/clc.22427

DOI: 10.1002/clc.22427

Best Practice for Atrial Fibrillation Patient Education (Journal article)

Lane, D. A., Barker, R. V., & Lip, G. Y. H. (2015). Best Practice for Atrial Fibrillation Patient Education. CURRENT PHARMACEUTICAL DESIGN, 21(5), 533-543. Retrieved from http://gateway.webofknowledge.com/

Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin (Journal article)

Ye, S., Cheng, B., Lip, G. Y. H., Buchsbaum, R., Sacco, R. L., Levin, B., . . . Investigators, W. A. R. C. E. F. (2015). Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin. AMERICAN JOURNAL OF CARDIOLOGY, 116(6), 904-912. doi:10.1016/j.amjcard.2015.06.016

DOI: 10.1016/j.amjcard.2015.06.016

Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study (Journal article)

Lip, G. Y. H., Skjoth, F., Overvad, K., Rasmussen, L. H., & Larsen, T. B. (2015). Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. CLINICAL RESEARCH IN CARDIOLOGY, 104(12), 1088-1096. doi:10.1007/s00392-015-0878-4

DOI: 10.1007/s00392-015-0878-4

Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: The AFCAS study (Journal article)

Kiviniemi, T., Airaksinen, K. E. J., Rubboli, A., Biancari, F., Valencia, J., Lip, G. Y. H., . . . AFCAS, M. P. A. F. (2015). Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: The AFCAS study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 183, 105-110. doi:10.1016/j.ijcard.2015.01.056

DOI: 10.1016/j.ijcard.2015.01.056

CD14(+)+CD16(+)CCR2+MONOCYTES ARE INCREASED IN DIFFUSE CORONARY ARTERY DISEASE (Conference Paper)

Brown, R., Lip, G., Varma, C., & Shantsila, E. (2015). CD14(+)+CD16(+)CCR2+MONOCYTES ARE INCREASED IN DIFFUSE CORONARY ARTERY DISEASE. In HEART Vol. 101 (pp. A90). Retrieved from http://gateway.webofknowledge.com/

CD36 expression and lipid metabolism following an oral glucose challenge in South Asians. (Journal article)

Patel, J. V., Banerjee, A., Montoro-Garcia, S., Shantsila, E., Alam, M., Flinders, P., . . . Gill, P. S. (2015). CD36 expression and lipid metabolism following an oral glucose challenge in South Asians.. World journal of diabetes, 6(7), 983-989. doi:10.4239/wjd.v6.i7.983

DOI: 10.4239/wjd.v6.i7.983

CD4(+) T cell surface alpha enolase is lower in older adults (Journal article)

Bennett, S. J., Augustyniak, E. M., Dunston, C. R., Brown, R. A., Shantsila, E., Lip, G. Y. H., . . . Griffiths, H. R. (2015). CD4(+) T cell surface alpha enolase is lower in older adults. MECHANISMS OF AGEING AND DEVELOPMENT, 152, 56-62. doi:10.1016/j.mad.2015.09.005

DOI: 10.1016/j.mad.2015.09.005

Can venous thromboembolism navigate the prevention of cardiovascular complications? (Journal article)

Shantsila, A., & Lip, G. Y. H. (2015). Can venous thromboembolism navigate the prevention of cardiovascular complications?. Annals of translational medicine, 3(9), 116. doi:10.3978/j.issn.2305-5839.2015.04.10

DOI: 10.3978/j.issn.2305-5839.2015.04.10

Cardiac Fibrosis in Patients With Atrial Fibrillation Mechanisms and Clinical Implications (Journal article)

Dzeshka, M. S., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2015). Cardiac Fibrosis in Patients With Atrial Fibrillation Mechanisms and Clinical Implications. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(8), 943-959. doi:10.1016/j.jacc.2015.06.1313

DOI: 10.1016/j.jacc.2015.06.1313

Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE) (Journal article)

Lane, D. A., Aguinaga, L., Blomstrom-Lundqvist, C., Boriani, G., Dan, G. -A., Hills, M. T., . . . Potpara, T. S. (2015). Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). EUROPACE, 17(12), 1747-1769. doi:10.1093/europace/euv233

DOI: 10.1093/europace/euv233

Cardiovascular risk prediction: balancing complexity against simple practicality (Journal article)

Dzeshka, M. S., Gill, P. S., & Lip, G. Y. H. (2015). Cardiovascular risk prediction: balancing complexity against simple practicality. BRITISH JOURNAL OF GENERAL PRACTICE, 65(630), 4-5. doi:10.3399/bjgp15X683005

DOI: 10.3399/bjgp15X683005

Catheter Ablation of Atrial Fibrillation and Thromboembolic Risk (Journal article)

Kornej, J., Hindricks, G., Lip, G. Y. H., & Bollmann, A. (2015). Catheter Ablation of Atrial Fibrillation and Thromboembolic Risk. CIRCULATION JOURNAL, 79(2), 444. doi:10.1253/circj.CJ-14-1006

DOI: 10.1253/circj.CJ-14-1006

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF. (Journal article)

Pokorney, S. D., Piccini, J. P., Stevens, S. R., Patel, M. R., Pieper, K. S., Halperin, J. L., . . . ROCKET AF Steering Committee Investigators. (2016). Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.. Journal of the American Heart Association, 5(3), e002197. doi:10.1161/JAHA.115.002197

DOI: 10.1161/JAHA.115.002197

Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS(2) and CHA(2)DS(2)-VASc scores and arrhythmia recurrences (Journal article)

Kornej, J., Hindricks, G., Banerjee, A., Arya, A., Sommer, P., Rolf, S., . . . Bollmann, A. (2015). Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS(2) and CHA(2)DS(2)-VASc scores and arrhythmia recurrences. HEART, 101(2), 126-131. doi:10.1136/heartjnl-2014-306013

DOI: 10.1136/heartjnl-2014-306013

Characteristics of patients initiating oral anticoagulant therapy for management of non-valvular atrial fibrillation (NVAF) (Conference Paper)

Masseria, C., Lin, I., Mardekian, J., Frean, M., Phatak, H., Kamble, S., . . . Lip, G. Y. H. (2015). Characteristics of patients initiating oral anticoagulant therapy for management of non-valvular atrial fibrillation (NVAF). In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1084). Retrieved from http://gateway.webofknowledge.com/

Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation (Journal article)

Shields, A. M., & Lip, G. Y. H. (2015). Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation. JOURNAL OF INTERNAL MEDICINE, 278(1), 1-18. doi:10.1111/joim.12360

DOI: 10.1111/joim.12360

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society (Journal article)

Boriani, G., Savelieva, I., Dan, G. -A., Deharo, J. C., Ferro, C., Israel, C. W., . . . Lip, G. Y. H. (2015). Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. EUROPACE, 17(8), 1169-1196. doi:10.1093/europace/euv202

DOI: 10.1093/europace/euv202

Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients (Journal article)

Lip, G. Y. H., Lanitis, T., Mardekian, J., Kongnakorn, T., Phatak, H., & Dorian, P. (2015). Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients. STROKE, 46(10), 2830-2837. doi:10.1161/STROKEAHA.115.009995

DOI: 10.1161/STROKEAHA.115.009995

Clinical and demographic characteristics according to dosage among non-valvular atrial fibrillation patients newly initiated on novel oral anticoagulants (Conference Paper)

Masseria, C., Lin, I., Mardekian, J., Frean, M., Phatak, H., Kamble, S., . . . Lip, G. Y. H. (2015). Clinical and demographic characteristics according to dosage among non-valvular atrial fibrillation patients newly initiated on novel oral anticoagulants. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1079). Retrieved from http://gateway.webofknowledge.com/

Comparative Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation (Journal article)

Senoo, K., & Lip, G. Y. H. (2015). Comparative Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 41(2), 146-153. doi:10.1055/s-0035-1544156

DOI: 10.1055/s-0035-1544156

Comparative cost-effectiveness of oral anticoagulants for stroke prevention in non-valvular atrial fibrillation patients in the UK (Conference Paper)

Lip, G. Y. H., Lanitis, T., Kongnakorn, T., Phatak, H., Liu, L., Lawrence, J., & Dorian, P. (2015). Comparative cost-effectiveness of oral anticoagulants for stroke prevention in non-valvular atrial fibrillation patients in the UK. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 864). Retrieved from http://gateway.webofknowledge.com/

Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes Comprehensive network meta-analysis of 42 randomised trials involving 117,353 patients (Journal article)

Navarese, E. P., Andreotti, F., Kolodziejczak, M., Schulze, V., Wolff, G., Dias, S., . . . Kelm, M. (2015). Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes Comprehensive network meta-analysis of 42 randomised trials involving 117,353 patients. THROMBOSIS AND HAEMOSTASIS, 114(5), 933-944. doi:10.1160/TH14-12-1066

DOI: 10.1160/TH14-12-1066

Comparison of Estimated Glomerular Filtration Rate Equations for Dosing New Oral Anticoagulants in Patients With Atrial Fibrillation (Journal article)

Manzano-Fernandez, S., Andreu-Cayuelas, J. M., Marin, F., Orenes-Pinero, E., Gallego, P., Valdes, M., . . . Roldan, V. (2015). Comparison of Estimated Glomerular Filtration Rate Equations for Dosing New Oral Anticoagulants in Patients With Atrial Fibrillation. REVISTA ESPANOLA DE CARDIOLOGIA, 68(6), 497-504. doi:10.1016/j.rec.2014.06.026

DOI: 10.1016/j.rec.2014.06.026

Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation. (Journal article)

Madzak, A., Larsen, T. B., Lane, D. A., Lip, G. Y. H., & Nielsen, P. B. (2015). Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation.. Expert review of cardiovascular therapy, 13(10), 1155-1163. doi:10.1586/14779072.2015.1086643

DOI: 10.1586/14779072.2015.1086643

Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany (Journal article)

Krejczy, M., Harenberg, J., Wehling, M., Obermann, K., & Lip, G. Y. H. (2015). Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany. BIOMED RESEARCH INTERNATIONAL. doi:10.1155/2015/876923

DOI: 10.1155/2015/876923

Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation (Journal article)

Lip, G. Y. H., Lanitis, T., Kongnakorn, T., Phatak, H., Chalkiadaki, C., Liu, X., . . . Dorian, P. (2015). Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation. CLINICAL THERAPEUTICS, 37(11), 2476-2488. doi:10.1016/j.clinthera.2015.09.005

DOI: 10.1016/j.clinthera.2015.09.005

Cryptogenic Strokes and Second Ischemic Stroke Rates in Relation to the CHADS(2) and CHA(2)DS(2)-VASc Risk Scores (Conference Paper)

Hunter, T. D., Lip, G. Y., Quiroz, M. E., MolIenkopf, S. A., & Turakhia, M. P. (2015). Cryptogenic Strokes and Second Ischemic Stroke Rates in Relation to the CHADS(2) and CHA(2)DS(2)-VASc Risk Scores. In STROKE Vol. 46. Retrieved from http://gateway.webofknowledge.com/

D-Dimer elevation and adverse outcomes (Journal article)

Halaby, R., Popma, C. J., Cohen, A., Chi, G., Zacarkim, M. R., Romero, G., . . . Gibson, C. M. (2015). D-Dimer elevation and adverse outcomes. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 39(1), 55-59. doi:10.1007/s11239-014-1101-6

DOI: 10.1007/s11239-014-1101-6

DIGOXIN - FRIEND OR FOE? A COMPREHENSIVE REVIEW OF DIGOXIN USE AND MORTALITY (Conference Paper)

Ziff, O., Kotecha, D., Samra, M., Kirchhof, P., Steeds, R., Griffith, M., . . . Lip, G. Y. H. (2015). DIGOXIN - FRIEND OR FOE? A COMPREHENSIVE REVIEW OF DIGOXIN USE AND MORTALITY. In HEART Vol. 101 (pp. A14-A15). doi:10.1136/heartjnl-2015-308066.26

DOI: 10.1136/heartjnl-2015-308066.26

DOES HOME-BASED, SLOW DEEP BREATHING TRAINING REDUCE CENTRAL SYMPATHETIC OUTFLOW AND ENHANCE BAROREFLEX SENSIVITIY IN PRIMARY HYPERTENSION? (Conference Paper)

Shantsila, A., Adlan, A. M., Lip, G. Y. H., Pickering, A. E., Paton, J. F. R., & Fisher, J. P. (2015). DOES HOME-BASED, SLOW DEEP BREATHING TRAINING REDUCE CENTRAL SYMPATHETIC OUTFLOW AND ENHANCE BAROREFLEX SENSIVITIY IN PRIMARY HYPERTENSION?. In HEART Vol. 101 (pp. A83). Retrieved from http://gateway.webofknowledge.com/

Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study (Journal article)

Gorst-Rasmussen, A., Skjoth, F., Larsen, T. B., Rasmussen, L. H., Lip, G. Y. H., & Lane, D. A. (2015). Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(4), 495-504. doi:10.1111/jth.12845

DOI: 10.1111/jth.12845

Dabigatran and Myocardial Infarction (Journal article)

Hohnloser, S. H., & Lip, G. Y. H. (2015). Dabigatran and Myocardial Infarction. CHEST, 147(2), E70-E71. doi:10.1378/chest.14-2534

DOI: 10.1378/chest.14-2534

Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making (Journal article)

Eckman, M. H., Wise, R. E., Naylor, K., Arduser, L., Lip, G. Y. H., Kissela, B., . . . Costea, A. (2015). Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making. CURRENT MEDICAL RESEARCH AND OPINION, 31(4), 603-614. doi:10.1185/03007995.2015.1019608

DOI: 10.1185/03007995.2015.1019608

Development and validation of a new assay for assessing clot integrity (Journal article)

Ranjit, P., Lau, Y., Lip, G. Y. H., & Blann, A. D. (2015). Development and validation of a new assay for assessing clot integrity. VASCULAR PHARMACOLOGY, 71, 102-107. doi:10.1016/j.vph.2015.02.013

DOI: 10.1016/j.vph.2015.02.013

Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference (Journal article)

Zolfaghari, S., Harenberg, J., Froelich, L., Weiss, C., Wehling, M., Wild, P., . . . Lip, G. Y. H. (2015). Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 41(2), 166-177. doi:10.1055/s-0035-1546467

DOI: 10.1055/s-0035-1546467

Diabetes as a risk factor of stroke and death in heart failure patients in sinus rhythm - a nationwide cohort study (Conference Paper)

Melgaard, L. L., Gorst-Rasmussen, A., Lip, G., & Larsen, T. B. (2015). Diabetes as a risk factor of stroke and death in heart failure patients in sinus rhythm - a nationwide cohort study. In EUROPEAN JOURNAL OF HEART FAILURE Vol. 17 (pp. 70). Retrieved from http://gateway.webofknowledge.com/

Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice (Journal article)

Boriani, G., Lane, D. A., Windecker, S., Huber, K., Kirchhof, P., & Lip, G. Y. H. (2015). Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice. EUROPACE, 17(9), 1319-1322. doi:10.1093/europace/euu303

DOI: 10.1093/europace/euu303

Do all AF patients with a CHA2DS2-VASc score of 2 (males) or 3 (females) have the same risk of ischemic stroke? A nationwide population-based cohort study (Conference Paper)

Liao, J. -N., Chao, T. F., Lip, G. Y., & Chen, S. A. (2015). Do all AF patients with a CHA2DS2-VASc score of 2 (males) or 3 (females) have the same risk of ischemic stroke? A nationwide population-based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 901). Retrieved from http://gateway.webofknowledge.com/

Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (Journal article)

Lip, G. Y. H., Rushton-Smith, S. K., Goldhaber, S. Z., Fitzmaurice, D. A., Mantovani, L. G., Goto, S., . . . Investigators, G. A. R. F. I. E. L. D. -A. F. (2015). Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation? The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 8(2), S12-S20. doi:10.1161/CIRCOUTCOMES.114.001556

DOI: 10.1161/CIRCOUTCOMES.114.001556

Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation Nationwide Cohort Study (Journal article)

Overvad, T. F., Skjoth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015). Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation Nationwide Cohort Study. STROKE, 46(8), 2168-2174. doi:10.1161/STROKEAHA.115.009371

DOI: 10.1161/STROKEAHA.115.009371

Duration of diabetes mellitus and thromboembolic events in atrial fibrillation: a nationwide cohort study (Conference Paper)

Overvad, T. F., Skjoeth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015). Duration of diabetes mellitus and thromboembolic events in atrial fibrillation: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 910). Retrieved from http://gateway.webofknowledge.com/

ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS ASPIRIN IN THE LOW RISK NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN THE US: HOW MAY RESULTS FROM AVERROES HELP IMPROVE PATIENT CARE? (Conference Paper)

Lip, G. Y. H., Lanitis, T., Mardekian, J., Kongnakorn, T., Phatak, H., & Dorian, P. (2015). ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS ASPIRIN IN THE LOW RISK NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN THE US: HOW MAY RESULTS FROM AVERROES HELP IMPROVE PATIENT CARE?. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 65 (pp. A347). doi:10.1016/S0735-1097(15)60347-3

DOI: 10.1016/S0735-1097(15)60347-3

ESTIMATING THE LIFETIME CLINICAL RISK/BENEFITS OF APIXABAN VERSUS EDOXABAN IN NON-VALVULAR ATRIAL FIBRILLATION (Conference Paper)

Phatak, H., Dorian, P., Kongnakorn, T., Lanitis, T., Liu, X., Mardekian, J., . . . Lip, G. (2015). ESTIMATING THE LIFETIME CLINICAL RISK/BENEFITS OF APIXABAN VERSUS EDOXABAN IN NON-VALVULAR ATRIAL FIBRILLATION. In VALUE IN HEALTH Vol. 18 (pp. A131). doi:10.1016/j.jval.2015.03.762

DOI: 10.1016/j.jval.2015.03.762

Editors' Choice papers in Thrombosis and Haemostasis (Journal article)

Weber, C., & Lip, G. Y. H. (2015). Editors' Choice papers in Thrombosis and Haemostasis. THROMBOSIS AND HAEMOSTASIS, 113(1), 217-220. Retrieved from http://gateway.webofknowledge.com/

Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (Journal article)

Dzeshka, M. S., & Lip, G. Y. H. (2015). Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. EXPERT OPINION ON PHARMACOTHERAPY, 16(17), 2661-2678. doi:10.1517/14656566.2015.1104301

DOI: 10.1517/14656566.2015.1104301

Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation An indirect comparison analysis (Journal article)

Blann, A. D., Skjoth, F., Rasmussen, L. H., Larsen, T. B., & Lip, G. Y. H. (2015). Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation An indirect comparison analysis. THROMBOSIS AND HAEMOSTASIS, 114(2), 403-409. doi:10.1160/TH15-05-0383

DOI: 10.1160/TH15-05-0383

Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)

Angoulvant, D., Villejoubert, O., Bejan-Angoulvant, T., Ivanes, F., Saint Etienne, C., Lip, G. Y. H., & Fauchier, L. (2015). Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CHEST, 148(2), 491-498. doi:10.1378/chest.14-3006

DOI: 10.1378/chest.14-3006

Effect of alcohol intake on diastolic function: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) (Conference Paper)

Shantsila, E., Shantsila, A., Gill, P. S., & Lip, G. Y. H. (2015). Effect of alcohol intake on diastolic function: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 36 (pp. 314-315). Retrieved from http://gateway.webofknowledge.com/

Effect of digoxin on all-cause mortality in patients with atrial fibrillation: a population-based cohort study (Conference Paper)

Fauchier, L., Laborie, G., Clementy, N., Bernard, A., Angoulvant, D., Lip, G. Y. H., & Babuty, D. (2015). Effect of digoxin on all-cause mortality in patients with atrial fibrillation: a population-based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 899). Retrieved from http://gateway.webofknowledge.com/

Effect of rivaroxaban and warfarin on fibrin clot structure (Conference Paper)

Lau, Y. C., Xiong, Q., Blann, A., & Lip, G. Y. H. (2015). Effect of rivaroxaban and warfarin on fibrin clot structure. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 744). Retrieved from http://gateway.webofknowledge.com/

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State (Journal article)

Orenes-Pinero, E., Pineda, J., Roldan, V., Hernandez-Romero, D., Marco, P., Tello-Montoliu, A., . . . Marin, F. (2015). Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 22(6), 610-617. doi:10.5551/jat.26161

DOI: 10.5551/jat.26161

Effects of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-analysis of Randomized Controlled Trials (Journal article)

Banach, M., Serban, C., Sahebkar, A., Ursoniu, S., Rysz, J., Muntner, P., . . . Lipid, B. P. M. A. C. (2015). Effects of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-analysis of Randomized Controlled Trials. MAYO CLINIC PROCEEDINGS, 90(1), 24-34. doi:10.1016/j.mayocp.2014.08.021

DOI: 10.1016/j.mayocp.2014.08.021

Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. (Journal article)

Banach, M., Serban, C., Sahebkar, A., Ursoniu, S., Rysz, J., Muntner, P., . . . Lipid and Blood Pressure Meta-analysis Collaboration Group. (2015). Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials.. Mayo Clinic proceedings, 90(1), 24-34. doi:10.1016/j.mayocp.2014.08.021

DOI: 10.1016/j.mayocp.2014.08.021

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation - Meta-Analysis - (Journal article)

Senoo, K., Lau, Y. C., Dzeshka, M., Lane, D., Okumura, K., & Lip, G. Y. H. (2015). Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation - Meta-Analysis -. CIRCULATION JOURNAL, 79(2), 339-345. doi:10.1253/circj.CJ-14-1042

DOI: 10.1253/circj.CJ-14-1042

Endothelial (Dys) Function in Lone Atrial Fibrillation (Journal article)

Polovina, M. M., Lip, G. Y. H., & Potpara, T. S. (2015). Endothelial (Dys) Function in Lone Atrial Fibrillation. CURRENT PHARMACEUTICAL DESIGN, 21(5), 622-645. Retrieved from http://gateway.webofknowledge.com/

Erectile dysfunction in atrial fibrillation: A risk factor for stroke or a reflection of stroke risk factors? (Journal article)

Brown, R. A., & Lip, G. Y. H. (2015). Erectile dysfunction in atrial fibrillation: A risk factor for stroke or a reflection of stroke risk factors?. CARDIOLOGY JOURNAL, 22(4), 359-361. doi:10.5603/CJ.2015.0049

DOI: 10.5603/CJ.2015.0049

Erratum: Stroke prevention in atrial fibrillation: A systematic review (JAMA - Journal of the American Medical Association (2015) 313:19 (1950-1962)) (Journal article)

Lip, G. Y. H., & Lane, D. A. (2015). Erratum: Stroke prevention in atrial fibrillation: A systematic review (JAMA - Journal of the American Medical Association (2015) 313:19 (1950-1962)). JAMA - Journal of the American Medical Association, 314(8), 837.

Ethnic differences in the diurnal variation of symptom onset time for acute ST elevation myocardial infarction - An observational cohort study (Journal article)

Brown, R. A., Lip, G. Y. H., Varma, C., & Shantsila, E. (2015). Ethnic differences in the diurnal variation of symptom onset time for acute ST elevation myocardial infarction - An observational cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 187, 414-416. doi:10.1016/j.ijcard.2015.03.371

DOI: 10.1016/j.ijcard.2015.03.371

Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study. (Journal article)

Echocardiographic Normal Ranges Meta-Analysis of the Left Heart Collaboration. (2015). Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study.. JACC. Cardiovascular imaging, 8(6), 656-665. doi:10.1016/j.jcmg.2015.02.014

DOI: 10.1016/j.jcmg.2015.02.014

European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society (Journal article)

Lip, G. Y. H., Heinzel, F. R., Gaita, F., Gonzalez Juanatey, J. R., Le Heuzey, J. Y., Potpara, T., . . . Pieske, B. (2016). European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. EUROPACE, 18(1), 12-36. doi:10.1093/europace/euv191

DOI: 10.1093/europace/euv191

European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society (Journal article)

Lip, G. Y. H., Heinzel, F. R., Gaita, F., Gonzalez Juanatey, J. R., Le Heuzey, J. Y., Potpara, T., . . . Pieske, B. (2015). European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. EUROPEAN JOURNAL OF HEART FAILURE, 17(9), 848-874. doi:10.1002/ejhf.338

DOI: 10.1002/ejhf.338

Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation (Journal article)

Lip, G. Y. H., Rasmussen, L. H., Olsson, S. B., Jensen, E., Hamren, B., Eriksson, U. G., & Wahlander, K. (2015). Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 80(6), 1362-1373. doi:10.1111/bcp.12719

DOI: 10.1111/bcp.12719

FROM MALIGNANT HYPERTENSION TO HYPERTENSION-MOD: MA MODERN DEFINITION FOR AN OLD BUT STILL DANGEROUS EMERGENCY (Conference Paper)

Gosse, P., Cremer, A., Amraoui, F., Lip, G., Morales, E., Rubin, S., . . . Van den Born, B. (2015). FROM MALIGNANT HYPERTENSION TO HYPERTENSION-MOD: MA MODERN DEFINITION FOR AN OLD BUT STILL DANGEROUS EMERGENCY. In JOURNAL OF HYPERTENSION Vol. 33 (pp. E397). doi:10.1097/01.hjh.0000468619.68444.40

DOI: 10.1097/01.hjh.0000468619.68444.40

Female gender and atrial fibrillation: An association with worse prognosis and outcomes (Journal article)

Kornej, J., Bollmann, A., Hindricks, G., & Lip, G. Y. H. (2015). Female gender and atrial fibrillation: An association with worse prognosis and outcomes. INTERNATIONAL JOURNAL OF CARDIOLOGY, 184, 321-322. doi:10.1016/j.ijcard.2015.02.062

DOI: 10.1016/j.ijcard.2015.02.062

Female sex is associated with a lower risk of stroke in patients with heart failure (Journal article)

Melgaard, L., Gorst-Rasmussen, A., Lip, G. Y. H., Rasmussen, L. H., & Larsen, T. B. (2015). Female sex is associated with a lower risk of stroke in patients with heart failure. AMERICAN HEART JOURNAL, 169(3), 396-403. doi:10.1016/j.ahj.2014.12.004

DOI: 10.1016/j.ahj.2014.12.004

Fondaparinux in atrial fibrillation - old dog, new tricks? (Journal article)

Lau, Y. C., Brown, R. A., & Lip, G. Y. H. (2015). Fondaparinux in atrial fibrillation - old dog, new tricks?. ARCHIVES OF CARDIOVASCULAR DISEASES, 108(2), 85-87. doi:10.1016/j.acvd.2014.12.001

DOI: 10.1016/j.acvd.2014.12.001

Free Light Chains in patients with acute coronary syndromes: Relationships to inflammation and renal function (Journal article)

Shantsila, E., Tapp, L. D., & Lip, G. Y. H. (2015). Free Light Chains in patients with acute coronary syndromes: Relationships to inflammation and renal function. INTERNATIONAL JOURNAL OF CARDIOLOGY, 185, 322-327. doi:10.1016/j.ijcard.2015.03.105

DOI: 10.1016/j.ijcard.2015.03.105

Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation (Journal article)

Proietti, M., Marra, A. M., Tassone, E. J., De Vuono, S., Corrao, S., Gobbi, P., . . . Grp, G. I. S. (2015). Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation. AMERICAN JOURNAL OF CARDIOLOGY, 116(6), 877-882. doi:10.1016/j.amjcard.2015.05.060

DOI: 10.1016/j.amjcard.2015.05.060

Futility of supplementation with Coenzyme Q10 for statin-induced myopathy: an updated (2015) meta-analysis of randomized controlled trials (Conference Paper)

Banach, M., Serban, C., Sahebkar, A., Rysz, J., Muntner, P., Toth, P. P., . . . Meta-anal, L. B. P. (2015). Futility of supplementation with Coenzyme Q10 for statin-induced myopathy: an updated (2015) meta-analysis of randomized controlled trials. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1047). Retrieved from http://gateway.webofknowledge.com/

Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control. (Journal article)

Chan, P. -H., Li, W. -H., Hai, J. -J., Chan, K. -H., Tse, H. -F., Cheung, B. M. -Y., . . . Siu, C. -W. (2015). Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control.. European heart journal. Cardiovascular pharmacotherapy, 1(4), 265-272. doi:10.1093/ehjcvp/pvv032

DOI: 10.1093/ehjcvp/pvv032

Gender differences in clinical characteristics and inpatient outcomes amongst 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Registry (Conference Paper)

Xiong, Q., Shantsila, A., Zhou, Q., Liu, Y., Shen, Y., Lane, D., . . . Lip, G. Y. H. (2015). Gender differences in clinical characteristics and inpatient outcomes amongst 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Registry. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C184). doi:10.1016/j.jacc.2015.06.703

DOI: 10.1016/j.jacc.2015.06.703

Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool (Journal article)

Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2015). Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(8), 840-845. doi:10.1111/ijcp.12625

DOI: 10.1111/ijcp.12625

Guideline adherence for stroke prevention and risk of mortality in patients with atrial fibrillation (Conference Paper)

Chao, T. F., Lip, G. Y. H., & Chen, S. A. (2015). Guideline adherence for stroke prevention and risk of mortality in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 907-908). Retrieved from http://gateway.webofknowledge.com/

Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST (Journal article)

Roffi, M., Patrono, C., Collet, J. -P., Mueller, C., Valgimigli, M., Andreotti, F., . . . Zamorano, J. L. (2015). Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST. Revista Española de Cardiología, 68(12), 1125.e1-1125.e64. doi:10.1016/j.recesp.2015.10.012

DOI: 10.1016/j.recesp.2015.10.012

Haemostasis and Thrombosis: Observations on Atrial Fibrillation and Platelets (Chapter)

Lip, G. Y. H., & Velu, S. (2015). Haemostasis and Thrombosis: Observations on Atrial Fibrillation and Platelets. In PanVascular Medicine, Second Edition (pp. 975-992). doi:10.1007/978-3-642-37078-6_29

DOI: 10.1007/978-3-642-37078-6_29

Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation (Journal article)

Lip, G. Y. H., Laroche, C., Popescu, M. I., Rasmussen, L. H., Vitali-Serdoz, L., Dan, G. -A., . . . Boriani, G. (2015). Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation. EUROPEAN JOURNAL OF HEART FAILURE, 17(6), 570-582. doi:10.1002/ejhf.254

DOI: 10.1002/ejhf.254

Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice (Journal article)

Wolff, A., Shantsila, E., Lip, G. Y. H., & Lane, D. A. (2015). Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice. AGE AND AGEING, 44(5), 874-878. doi:10.1093/ageing/afv071

DOI: 10.1093/ageing/afv071

Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry (Journal article)

Lip, G. Y. H., Laroche, C., Popescu, M. I., Rasmussen, L. H., Vitali-Serdoz, L., Dan, G. -A., . . . Boriani, G. (2015). Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. EUROPACE, 17(12), 1777-1786. doi:10.1093/europace/euv269

DOI: 10.1093/europace/euv269

Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation (Journal article)

Pastori, D., Pignatelli, P., Saliola, M., Carnevale, R., Vicario, T., Del Ben, M., . . . Violi, F. (2015). Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation. INTERNATIONAL JOURNAL OF CARDIOLOGY, 201, 513-516. doi:10.1016/j.ijcard.2015.08.054

DOI: 10.1016/j.ijcard.2015.08.054

Incidence of Myocardial Infarction and Vascular Death in Elderly Patients With Atrial Fibrillation Taking Anticoagulants Relation to Atherosclerotic Risk Factors (Journal article)

Pastori, D., Pignatelli, P., Angelico, F., Farcomeni, A., Del Ben, M., Vicario, T., . . . Violi, F. (2015). Incidence of Myocardial Infarction and Vascular Death in Elderly Patients With Atrial Fibrillation Taking Anticoagulants Relation to Atherosclerotic Risk Factors. CHEST, 147(6), 1644-1650. doi:10.1378/chest.14-2414

DOI: 10.1378/chest.14-2414

Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation The Fushimi Atrial Fibrillation Registry (Journal article)

Takabayashi, K., Hamatani, Y., Yamashita, Y., Takagi, D., Unoki, T., Ishii, M., . . . Akao, M. (2015). Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation The Fushimi Atrial Fibrillation Registry. STROKE, 46(12), 3354-3361. doi:10.1161/STROKEAHA.115.010947

DOI: 10.1161/STROKEAHA.115.010947

Increased Stroke Risk in Atrial Fibrillation Patients With Heart Failure Does Ejection Fraction Matter? (Journal article)

Kotecha, D., Banerjee, A., & Lip, G. Y. H. (2015). Increased Stroke Risk in Atrial Fibrillation Patients With Heart Failure Does Ejection Fraction Matter?. STROKE, 46(3), 608-609. doi:10.1161/STROKEAHA.114.008421

DOI: 10.1161/STROKEAHA.114.008421

Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome (Journal article)

Ramcharan, K. S., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2015). Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 30(3), 315-321. doi:10.1007/s00384-014-2116-3

DOI: 10.1007/s00384-014-2116-3

Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism (Journal article)

Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2015). Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism. CURRENT VASCULAR PHARMACOLOGY, 13(2), 192-201. doi:10.2174/15701611113116660165

DOI: 10.2174/15701611113116660165

Influence of age on respiratory modulation of muscle sympathetic nerve activity, blood pressure and baroreflex function in humans (Journal article)

Shantsila, A., McIntyre, D. B., Lip, G. Y. H., Fadel, P. J., Paton, J. F. R., Pickering, A. E., & Fisher, J. P. (2015). Influence of age on respiratory modulation of muscle sympathetic nerve activity, blood pressure and baroreflex function in humans. EXPERIMENTAL PHYSIOLOGY, 100(9), 1039-1051. doi:10.1113/EP085071

DOI: 10.1113/EP085071

Intracerebral haemorrhage, atrial fibrillation, and anticoagulation (Journal article)

Wilson, D., Salman, R. A. -S., Klijn, C. J. M., Lip, G. Y. H., & Werring, D. J. (2015). Intracerebral haemorrhage, atrial fibrillation, and anticoagulation. LANCET, 386(10005), 1736-1737. doi:10.1016/S0140-6736(15)00695-9

DOI: 10.1016/S0140-6736(15)00695-9

Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation A Nationwide Cohort Study (Journal article)

Nielsen, P. B., Larsen, T. B., Gorst-Rasmussen, A., Skjoth, F., Rasmussen, L. H., & Lip, G. Y. H. (2015). Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation A Nationwide Cohort Study. CHEST, 147(6), 1651-1658. doi:10.1378/chest.14-2099

DOI: 10.1378/chest.14-2099

Is Major Bleeding Risk for Oral Anticoagulants Similar Among Newly Initiated Non Valvular Atrial Fibrillation Patients? (Conference Paper)

Lip, G. Y., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., . . . Hemant, P. (2015). Is Major Bleeding Risk for Oral Anticoagulants Similar Among Newly Initiated Non Valvular Atrial Fibrillation Patients?. In CIRCULATION Vol. 132. Retrieved from http://gateway.webofknowledge.com/

Ischemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin Impact of Quality of Anticoagulation Control (Journal article)

Ho, C. -W., Ho, M. -H., Chan, P. -H., Hai, J. -J., Cheung, E., Yeung, C. -Y., . . . Siu, C. -W. (2015). Ischemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin Impact of Quality of Anticoagulation Control. STROKE, 46(1), 23-30. doi:10.1161/STROKEAHA.114.006476

DOI: 10.1161/STROKEAHA.114.006476

LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention (Journal article)

Dias, H. K. I., Brown, C. L. R., Polidori, M. C., Lip, G. Y. H., & Griffiths, H. R. (2015). LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention. CLINICAL SCIENCE, 129(12), 1195-1206. doi:10.1042/CS20150351

DOI: 10.1042/CS20150351

Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors - Results from a systematic review and meta-analysis of randomized controlled trials (Journal article)

Sahebkar, A., Serban, C., Ursoniu, S., Wong, N. D., Muntner, P., Graham, I. M., . . . Coll, L. B. P. M. (2015). Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors - Results from a systematic review and meta-analysis of randomized controlled trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 189, 47-55. doi:10.1016/j.ijcard.2015.04.008

DOI: 10.1016/j.ijcard.2015.04.008

Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation (Conference Paper)

Ntaios, G., Lip, G. Y. H., Lambrou, D., Papavasileiou, V., Manios, E., Milionis, H., . . . Vemmos, K. (2015). Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 49-50). Retrieved from http://gateway.webofknowledge.com/

Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation (Journal article)

Ntaios, G., Lip, G. Y. H., Lambrou, D., Papavasileiou, V., Manios, E., Milionis, H., . . . Vemmos, K. (2015). Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation. NEUROLOGY, 84(12), 1213-1219. doi:10.1212/WNL.0000000000001402

DOI: 10.1212/WNL.0000000000001402

Matching the NOAC to the Patient Remember the Modifiable Bleeding Risk Factors (Journal article)

Lip, G. Y. H., & Lane, D. A. (2015). Matching the NOAC to the Patient Remember the Modifiable Bleeding Risk Factors. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(21), 2282-2284. doi:10.1016/j.jacc.2015.07.086

DOI: 10.1016/j.jacc.2015.07.086

Meet the Editorial Board (Journal article)

Lip, G. (2015). Meet the Editorial Board. Current Pharmaceutical Design, 21(17), 2167. doi:10.2174/138161282117150430124606

DOI: 10.2174/138161282117150430124606

Mental health prognosis of young venous thromboembolism patients. A nationwide cohort study on psychotropic drug purchases (Conference Paper)

Hojen, A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., & Larsen, T. B. (2015). Mental health prognosis of young venous thromboembolism patients. A nationwide cohort study on psychotropic drug purchases. In EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING Vol. 14 (pp. S7). Retrieved from http://gateway.webofknowledge.com/

Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic (Journal article)

Hajhosseiny, R., Matthews, G. K., & Lip, G. Y. H. (2015). Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic. HEART RHYTHM, 12(11), 2332-2343. doi:10.1016/j.hrthm.2015.06.038

DOI: 10.1016/j.hrthm.2015.06.038

Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation (Journal article)

Ben Freedman, S., Gersh, B. J., & Lip, G. Y. H. (2015). Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation. EUROPEAN HEART JOURNAL, 36(11), 653-656. doi:10.1093/eurheartj/ehu494

DOI: 10.1093/eurheartj/ehu494

Missed opportunities to prevent ischaemic stroke? Frequency of non-anticoagulation in a prospective multicentre cohort study of AF-associated ischaemic stroke and TIA (Conference Paper)

Wilson, D., Shakeshaft, C., Charidimou, A., Ambler, G., White, M., Cohen, H., . . . Collaborators, C. (2015). Missed opportunities to prevent ischaemic stroke? Frequency of non-anticoagulation in a prospective multicentre cohort study of AF-associated ischaemic stroke and TIA. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 6). Retrieved from http://gateway.webofknowledge.com/

Monitoring changes in thioredoxin and over-oxidised peroxiredoxin in response to exercise in humans (Journal article)

Wadley, A. J., Chen, Y. W., Bennett, S. J., Lip, G. Y. H., Turner, J. E., Fisher, J. P., & Aldred, S. (2015). Monitoring changes in thioredoxin and over-oxidised peroxiredoxin in response to exercise in humans. FREE RADICAL RESEARCH, 49(3), 290-298. doi:10.3109/10715762.2014.1000890

DOI: 10.3109/10715762.2014.1000890

Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants. (Journal article)

Rahmat, N. A., & Lip, G. Y. H. (2015). Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants.. Arrhythmia & electrophysiology review, 4(2), 90-95. doi:10.15420/aer.2015.04.02.90

DOI: 10.15420/aer.2015.04.02.90

Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA(2)DS(2)-VASc Score (Beyond Sex) (Journal article)

Lip, G. Y. H., Skjoth, F., Rasmussen, L. H., Nielsen, P. B., & Larsen, T. B. (2015). Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA(2)DS(2)-VASc Score (Beyond Sex). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(4), 488-490. doi:10.1016/j.jacc.2015.05.044

DOI: 10.1016/j.jacc.2015.05.044

Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study (Journal article)

Blann, A. D., Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2015). Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 201, 693-698. doi:10.1016/j.ijcard.2015.08.074

DOI: 10.1016/j.ijcard.2015.08.074

New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint (Journal article)

Rubboli, A., Agewall, S., Huber, K., & Lip, G. Y. H. (2015). New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. INTERNATIONAL JOURNAL OF CARDIOLOGY, 196, 133-138. doi:10.1016/j.ijcard.2015.06.006

DOI: 10.1016/j.ijcard.2015.06.006

Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation Meta-Analysis (Journal article)

Wang, K. -L., Lip, G. Y. H., Lin, S. -J., & Chiang, C. -E. (2015). Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation Meta-Analysis. STROKE, 46(9), 2555-2561. doi:10.1161/STROKEAHA.115.009947

DOI: 10.1161/STROKEAHA.115.009947

Non-steroidal anti-inflammatory drugs and incident atrial fibrillation. (Journal article)

Proietti, M., & Lip, G. Y. H. (2015). Non-steroidal anti-inflammatory drugs and incident atrial fibrillation.. European heart journal. Cardiovascular pharmacotherapy, 1(2), 115-116. doi:10.1093/ehjcvp/pvv007

DOI: 10.1093/ehjcvp/pvv007

Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA(2)DS(2)-VASc score (Journal article)

Lip, G. Y. H., Skjoth, F., Nielsen, P. B., & Larsen, T. B. (2015). Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA(2)DS(2)-VASc score. THROMBOSIS AND HAEMOSTASIS, 114(4), 826-834. doi:10.1160/TH15-07-0565

DOI: 10.1160/TH15-07-0565

Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients with Atrial Fibrillation and Heart Failure: A Systemic Review and Meta-analysis of randomized trials (Conference Paper)

Xiong, Q., Lau, Y., Senoo, K., Hong, K., & Lip, G. Y. H. (2015). Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients with Atrial Fibrillation and Heart Failure: A Systemic Review and Meta-analysis of randomized trials. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C269-C270). doi:10.1016/j.jacc.2015.06.1049

DOI: 10.1016/j.jacc.2015.06.1049

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal (Journal article)

Lip, G. Y. H., Wang, K. -L., & Chiang, C. -E. (2015). Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal. INTERNATIONAL JOURNAL OF CARDIOLOGY, 180, 246-254. doi:10.1016/j.ijcard.2014.11.182

DOI: 10.1016/j.ijcard.2014.11.182

Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials (Journal article)

Xiong, Q., Lau, Y. C., Senoo, K., Lane, D. A., Hong, K., & Lip, G. Y. H. (2015). Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials. EUROPEAN JOURNAL OF HEART FAILURE, 17(11), 1192-1200. doi:10.1002/ejhf.343

DOI: 10.1002/ejhf.343

Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis (Journal article)

Caldeira, D., Costa, J., Ferreira, J. J., Lip, G. Y. H., & Pinto, F. J. (2015). Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis. CLINICAL RESEARCH IN CARDIOLOGY, 104(7), 582-590. doi:10.1007/s00392-015-0821-8

DOI: 10.1007/s00392-015-0821-8

Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now? (Journal article)

Dzeshka, M. S., & Lip, G. Y. H. (2015). Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?. TRENDS IN CARDIOVASCULAR MEDICINE, 25(4), 315-336. doi:10.1016/j.tcm.2014.10.017

DOI: 10.1016/j.tcm.2014.10.017

Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation. (Journal article)

Lip, G. Y. (2015). Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation.. Expert review of cardiovascular therapy, 13(9), 963-965. doi:10.1586/14779072.2015.1071665

DOI: 10.1586/14779072.2015.1071665

Not all thromboembolism comes from the left atrial appendage in atrial fibrillation (Journal article)

Senoo, K., & Lip, G. Y. H. (2015). Not all thromboembolism comes from the left atrial appendage in atrial fibrillation. HEART, 101(11), 830-831. doi:10.1136/heartjnl-2015-307451

DOI: 10.1136/heartjnl-2015-307451

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials (Journal article)

Navarese, E. P., Andreotti, F., Schulze, V., Kolodziejczak, M., Buffon, A., Brouwer, M., . . . Valgimigli, M. (2015). Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials. BMJ-BRITISH MEDICAL JOURNAL, 350. doi:10.1136/bmj.h1618

DOI: 10.1136/bmj.h1618

Optimising stroke prevention in patients with atrial fibrillation (Journal article)

Lane, D. A., Wolff, A., Shantsila, E., & Lip, G. Y. H. (2015). Optimising stroke prevention in patients with atrial fibrillation. BRITISH JOURNAL OF GENERAL PRACTICE, 65(632), 117. doi:10.3399/bjgp15X683905

DOI: 10.3399/bjgp15X683905

Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort (Journal article)

Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2015). Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort. BRITISH JOURNAL OF GENERAL PRACTICE, 65(630), E16-E23. doi:10.3399/bjgp15X683113

DOI: 10.3399/bjgp15X683113

Optimizing Atrial Fibrillation Management From ICU and Beyond (Journal article)

Walkey, A. J., Hogarth, K., & Lip, G. Y. H. (2015). Optimizing Atrial Fibrillation Management From ICU and Beyond. CHEST, 148(4), 859-864. doi:10.1378/chest.15-0358

DOI: 10.1378/chest.15-0358

Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes (Journal article)

Potpara, T. S., Lane, D. A., & Lip, G. Y. H. (2015). Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes. EUROPACE, 17(4), 507-508. doi:10.1093/europace/euv041

DOI: 10.1093/europace/euv041

Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk (Journal article)

Potpara, T. S., & Lip, G. Y. H. (2015). Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk. PROGRESS IN CARDIOVASCULAR DISEASES, 58(2), 177-194. doi:10.1016/j.pcad.2015.07.003

DOI: 10.1016/j.pcad.2015.07.003

Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA(2)DS(2)-VASc Score (Journal article)

Lip, G. Y. H., Skjoth, F., Rasmussen, L. H., & Larsen, T. B. (2015). Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA(2)DS(2)-VASc Score. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 65(14), 1385-1394. doi:10.1016/j.jacc.2015.01.044

DOI: 10.1016/j.jacc.2015.01.044

PATTERNS OF NEWLY DETECTED ATRIAL FIBRILLATION AND ANTITHROMBOTIC TREATMENT IN NORTH AMERICA (GLORIA-AF PHASE II) (Conference Paper)

Halperin, J. L., Huisman, M., Diener, H. -C., Dubner, S. J., Ma, C., Rothman, K., . . . Lip, G. (2015). PATTERNS OF NEWLY DETECTED ATRIAL FIBRILLATION AND ANTITHROMBOTIC TREATMENT IN NORTH AMERICA (GLORIA-AF PHASE II). In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 65 (pp. A1520). doi:10.1016/S0735-1097(15)61520-0

DOI: 10.1016/S0735-1097(15)61520-0

Paroxysmal versus non-paroxysmal atrial fibrillation in Europe: the EORP-AF General Pilot Registry (Conference Paper)

Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Dan, G. A., . . . Registry, E. O. R. P. -A. F. G. P. (2015). Paroxysmal versus non-paroxysmal atrial fibrillation in Europe: the EORP-AF General Pilot Registry. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 803). Retrieved from http://gateway.webofknowledge.com/

Patients With Ischemic Stroke and Incident Atrial Fibrillation A Nationwide Cohort Study (Journal article)

Fauchier, L., Clementy, N., Pelade, C., Collignon, C., Nicolle, E., & Lip, G. Y. H. (2015). Patients With Ischemic Stroke and Incident Atrial Fibrillation A Nationwide Cohort Study. STROKE, 46(9), 2432-2437. doi:10.1161/STROKEAHA.115.010270

DOI: 10.1161/STROKEAHA.115.010270

Patients with atrial fibrillation undergoing percutaneous coronary intervention (Journal article)

Dzeshka, M. S., Brown, R. A., & Lip, G. Y. H. (2015). Patients with atrial fibrillation undergoing percutaneous coronary intervention. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 125(1-2), 73-+. doi:10.20452/pamw.2650

DOI: 10.20452/pamw.2650

Patients with atrial fibrillation undergoing percutaneous coronary intervention Current concepts and concerns: part II (Journal article)

Dzeshka, M. S., Brown, R. A., & Lip, G. Y. H. (2015). Patients with atrial fibrillation undergoing percutaneous coronary intervention Current concepts and concerns: part II. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 125(3), 172-180. Retrieved from http://gateway.webofknowledge.com/

Patterns in atrial fibrillation management and 'real-world' adherence to guidelines in the Balkan Region: an overview of the Balkan-atrial fibrillation survey (Journal article)

Potpara, T. S., Lip, G. Y. H., & Investigators, B. A. F. (2015). Patterns in atrial fibrillation management and 'real-world' adherence to guidelines in the Balkan Region: an overview of the Balkan-atrial fibrillation survey. EUROPEAN HEART JOURNAL, 36(30), 1943-1944. Retrieved from http://gateway.webofknowledge.com/

Patterns of Newly Detected Atrial Fibrillation and Antithrombotic Treatment in GLORIA-AF Phase II (Conference Paper)

Halperin, J. L., Huisman, M. V., Diener, H. -C., Dubner, S. J., Ma, C., Rothman, K. J., . . . Lip, G. H. (2015). Patterns of Newly Detected Atrial Fibrillation and Antithrombotic Treatment in GLORIA-AF Phase II. In CIRCULATION Vol. 132. Retrieved from http://gateway.webofknowledge.com/

Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation (Journal article)

Xiong, Q., Lau, Y. C., & Lip, G. Y. H. (2015). Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 11(6), 937-948. doi:10.1517/17425255.2015.1027683

DOI: 10.1517/17425255.2015.1027683

Plasma cell-free DNA levels are elevated in patients with acute ischemic heart failure partially due to neutrophil extracellular trap formation (Conference Paper)

Brill, A., Shantsila, E., Ponomaryov, T., Dinsdale, R., Harrison, P., & Lip, G. (2015). Plasma cell-free DNA levels are elevated in patients with acute ischemic heart failure partially due to neutrophil extracellular trap formation. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 13 (pp. 379-380). Retrieved from http://gateway.webofknowledge.com/

Predicting intracranial bleeding risk in patients with atrial fibrillation using several bleeding risk scores (Conference Paper)

Fauchier, L., Banerjee, A., Lagrenade, I., Clementy, N., Angoulvant, D., Bernard, A., . . . Lip, G. Y. H. (2015). Predicting intracranial bleeding risk in patients with atrial fibrillation using several bleeding risk scores. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 338). Retrieved from http://gateway.webofknowledge.com/

Predictive Value of the SAMe-TTR2R2 to predict quality of oral anticoagulation in atrial fibrillation: a prospective validation in the multicentre Spanish observational registry fantasiia (Conference Paper)

Marin, F., Roldan-Schilling, V., Bertomeu-Gonzalez, V., Cequier, A., Muniz, J., Roldan, I., . . . Anguita, M. (2015). Predictive Value of the SAMe-TTR2R2 to predict quality of oral anticoagulation in atrial fibrillation: a prospective validation in the multicentre Spanish observational registry fantasiia. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1064-1065). Retrieved from http://gateway.webofknowledge.com/

Predictive accuracy of CHA(2)DS(2)-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy (Journal article)

Capodanno, D., Rossini, R., Musumeci, G., Lettieri, C., Senni, M., Valsecchi, O., . . . Lip, G. Y. H. (2015). Predictive accuracy of CHA(2)DS(2)-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy. INTERNATIONAL JOURNAL OF CARDIOLOGY, 199, 319-325. doi:10.1016/j.ijcard.2015.07.064

DOI: 10.1016/j.ijcard.2015.07.064

Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry (Conference Paper)

Hamatani, Y., Yamashita, Y., Esato, M., Chun, Y. -H., Tsuji, H., Wada, H., . . . Akao, M. (2015). Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry. In PLOS ONE Vol. 10. doi:10.1371/journal.pone.0142394

DOI: 10.1371/journal.pone.0142394

Prevalence and associations of small vessel disease markers in an ischaemic stroke and TIA cohort with atrial fibrillation: Baseline characteristics of patients in the CROMIS-2 study (Conference Paper)

Wilson, D., Shakeshaft, C., Charidimou, A., Ambler, G., White, M., Cohen, H., . . . Microbleeds, C. R. (2015). Prevalence and associations of small vessel disease markers in an ischaemic stroke and TIA cohort with atrial fibrillation: Baseline characteristics of patients in the CROMIS-2 study. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 11-12). Retrieved from http://gateway.webofknowledge.com/

Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China New Insights Into the Global Burden of Atrial Fibrillation (Journal article)

Guo, Y., Tian, Y., Wang, H., Si, Q., Wang, Y., & Lip, G. Y. H. (2015). Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China New Insights Into the Global Burden of Atrial Fibrillation. CHEST, 147(1), 109-119. doi:10.1378/chest.14-0321

DOI: 10.1378/chest.14-0321

Prognosis in patients with atrial fibrillation and CHA2DS2-VASc score=1 in a community based cohort study (Conference Paper)

Fauchier, L., Lecoq, C., Clementy, N., Angoulvant, D., Babuty, D., & Lip, G. Y. H. (2015). Prognosis in patients with atrial fibrillation and CHA2DS2-VASc score=1 in a community based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 863). Retrieved from http://gateway.webofknowledge.com/

Prognosis in patients with atrial fibrillation with a presumed temporary cause in a community based cohort study (Conference Paper)

Fauchier, L., Clementy, N., Angoulvant, D., Babuty, D., Bernard, A., & Lip, G. Y. H. (2015). Prognosis in patients with atrial fibrillation with a presumed temporary cause in a community based cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 164). Retrieved from http://gateway.webofknowledge.com/

Prognostic value of CHA(2)DS(2)-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project (Journal article)

Philippart, R., Brunet-Bernard, A., Clementy, N., Bourguignon, T., Mirza, A., Babuty, D., . . . Fauchier, L. (2015). Prognostic value of CHA(2)DS(2)-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project. EUROPEAN HEART JOURNAL, 36(28), 1822-1830. doi:10.1093/eurheartj/ehv163

DOI: 10.1093/eurheartj/ehv163

Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on theTreatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013 (Conference Paper)

Van Wagoner, D. R., Piccini, J. P., Albert, C. M., Anderson, M. E., Benjamin, E. J., Brundel, B., . . . Wehrens, X. H. T. (2015). Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on theTreatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013. In HEART RHYTHM Vol. 12 (pp. E5-U37). doi:10.1016/j.hrthm.2014.11.011

DOI: 10.1016/j.hrthm.2014.11.011

Psychosocial consequences of venous thromboembolism in youth. Results from a mixed methods study (Conference Paper)

Hojen, A. A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., . . . Larsen, T. B. (2015). Psychosocial consequences of venous thromboembolism in youth. Results from a mixed methods study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 283). Retrieved from http://gateway.webofknowledge.com/

Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction Trial Substudy (Journal article)

Homma, S., Thompson, J. L. P., Qian, M., Ye, S., Di Tullio, M. R., Lip, G. Y. H., . . . Anker, S. D. (2015). Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction Trial Substudy. CIRCULATION-HEART FAILURE, 8(3), 504-509. doi:10.1161/CIRCHEARTFAILURE.114.001725

DOI: 10.1161/CIRCHEARTFAILURE.114.001725

Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices (Journal article)

Martin, D. T., Bersohn, M. M., Waldo, A. L., Wathen, M. S., Choucair, W. K., Lip, G. Y. H., . . . Investigators, I. M. P. A. C. T. (2015). Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. EUROPEAN HEART JOURNAL, 36(26), 1660-1668. doi:10.1093/eurheartj/ehv115

DOI: 10.1093/eurheartj/ehv115

Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF) (Journal article)

Lip, G. Y. H., Hammerstingl, C., Marin, F., Cappato, R., Meng, I. L., Kirsch, B., . . . Cohen, A. (2015). Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF). AMERICAN HEART JOURNAL, 169(4), 464-+. doi:10.1016/j.ahj.2014.12.020

DOI: 10.1016/j.ahj.2014.12.020

Real world comparison of major bleeding risk among non-valvular atrial fibrillation patients newly initiated on apixaban, dabigatran, rivaroxaban or warfarin (Conference Paper)

Lip, G. Y. H., Pan, X., Kamble, S., Kawabata, H., Mardekian, J., Masseria, C., . . . Phatak, H. (2015). Real world comparison of major bleeding risk among non-valvular atrial fibrillation patients newly initiated on apixaban, dabigatran, rivaroxaban or warfarin. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1085). Retrieved from http://gateway.webofknowledge.com/

Real-world bleeding risk among non-valvular atrial fibrillation (NVAF) patients prescribed apixaban, dabigatran, rivaroxaban and warfarin: analysis of electronic health records (Conference Paper)

Lin, I., Masseria, C., Mardekian, J., Frean, M., Phatak, H., Kamble, S., . . . Lip, G. Y. H. (2015). Real-world bleeding risk among non-valvular atrial fibrillation (NVAF) patients prescribed apixaban, dabigatran, rivaroxaban and warfarin: analysis of electronic health records. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1084). Retrieved from http://gateway.webofknowledge.com/

Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients on apixaban, dabigatran, rivaroxaban: cohorts comprising new initiators and/or switchers from warfarin (Conference Paper)

Tepper, P., Mardekian, J., Masseria, C., Phatak, H., Kamble, S., Abdulsattar, Y., . . . Lip, G. Y. H. (2015). Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients on apixaban, dabigatran, rivaroxaban: cohorts comprising new initiators and/or switchers from warfarin. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 339). Retrieved from http://gateway.webofknowledge.com/

Recent scientific documents from the European Heart Rhythm Association (EHRA) (Journal article)

Gorenek, B., & Lip, G. Y. H. (2015). Recent scientific documents from the European Heart Rhythm Association (EHRA). EUROPACE, 17(8), 1161-1163. doi:10.1093/europace/euv193

DOI: 10.1093/europace/euv193

Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment (Journal article)

Husted, S., Lip, G. Y. H., & De Caterina, R. (2015). Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(11), 2130-2132. doi:10.1111/jth.13124

DOI: 10.1111/jth.13124

Recurrent Stroke The Value of the CHA(2)DS(2) VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort (Journal article)

Andersen, S. D., Gorst-Rasmussen, A., Lip, G. Y. H., Bach, F. W., & Larsen, T. B. (2015). Recurrent Stroke The Value of the CHA(2)DS(2) VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort. STROKE, 46(9), 2491-2497. doi:10.1161/STROKEAHA.115.009912

DOI: 10.1161/STROKEAHA.115.009912

Relation of prior cerebral microbleeds to clinical characteristics of patients presenting with acute intracerebral hemorrhage (Conference Paper)

Nakamura, A., Yasaka, M., Lip, G. Y., Wakugawa, Y., Kuwashiro, T., Tsurusaki, Y., . . . Okada, Y. (2015). Relation of prior cerebral microbleeds to clinical characteristics of patients presenting with acute intracerebral hemorrhage. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 293). Retrieved from http://gateway.webofknowledge.com/

Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists (Journal article)

Pignatelli, P., Pastori, D., Vicario, T., Bucci, T., Del Ben, M., Russo, R., . . . Violi, F. (2015). Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists. EUROPACE, 17(8), 1223-1228. doi:10.1093/europace/euv127

DOI: 10.1093/europace/euv127

Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentr cohort study (Journal article)

Violi, F., Pastori, D., Perticone, F., Hiatt, W. R., Sciacqua, A., Basili, S., . . . Regis, A. R. A. P. A. C. I. S. A. F. (2015). Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentr cohort study. BMJ OPEN, 5(5). doi:10.1136/bmjopen-2015-008026

DOI: 10.1136/bmjopen-2015-008026

Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation AMADEUS Trial (Journal article)

Senoo, K., & Lip, G. Y. H. (2015). Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation AMADEUS Trial. STROKE, 46(11), 3202-3207. doi:10.1161/STROKEAHA.115.010614

DOI: 10.1161/STROKEAHA.115.010614

Relationship of renal impairment and diastolic dysfunction to hypertension in minority ethnic groups: ethnic-echocardiographic heart of England screening study (E-ECHOES) (Conference Paper)

Shantsila, A., Gill, P. S., Shantsila, E., & Lip, G. Y. H. (2015). Relationship of renal impairment and diastolic dysfunction to hypertension in minority ethnic groups: ethnic-echocardiographic heart of England screening study (E-ECHOES). In EUROPEAN HEART JOURNAL Vol. 36 (pp. 25). Retrieved from http://gateway.webofknowledge.com/

Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial (Journal article)

Lahtela, H. M., Kiviniemi, T. O., Puurunen, M. K., Schlitt, A., Rubboli, A., Ylitalo, A., . . . Airaksinen, K. E. J. (2015). Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial. PLOS ONE, 10(6). doi:10.1371/journal.pone.0128492

DOI: 10.1371/journal.pone.0128492

Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis (Journal article)

Nielsen, P. B., Lane, D. A., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2015). Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis. CLINICAL RESEARCH IN CARDIOLOGY, 104(5), 418-429. doi:10.1007/s00392-014-0797-9

DOI: 10.1007/s00392-014-0797-9

Renal, endothelial function, warfarin management, and the CHADS(2), CHA(2)DS(2)VASc and HAS-BLED scores in predicting MACE in AF (Journal article)

Blann, A. D., & Lip, G. Y. H. (2015). Renal, endothelial function, warfarin management, and the CHADS(2), CHA(2)DS(2)VASc and HAS-BLED scores in predicting MACE in AF. THROMBOSIS AND HAEMOSTASIS, 113(5), 1155-1157. doi:10.1160/TH14-11-0932

DOI: 10.1160/TH14-11-0932

Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation AMADEUS Trial (Journal article)

Senoo, K., Lip, G. Y. H., Lane, D. A., Bueller, H. R., & Kotecha, D. (2015). Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation AMADEUS Trial. STROKE, 46(9), 2523-2528. doi:10.1161/STROKEAHA.115.009487

DOI: 10.1161/STROKEAHA.115.009487

Response to Letter Regarding Article, " Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation : Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure ( CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca- Heart Failure ( GISSI- HF) Trials." (Journal article)

Abdul-Rahim, A. H., Perez, A. -C., Fulton, R. L., Jhund, P. S., Latini, R., Tognoni, G., . . . McMurray, J. J. V. (2015). Response to Letter Regarding Article, " Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation : Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure ( CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca- Heart Failure ( GISSI- HF) Trials.". CIRCULATION, 132(22), E358. doi:10.1161/CIRCULATIONAHA.115.018395

DOI: 10.1161/CIRCULATIONAHA.115.018395

Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding A Nationwide Cohort Study (Journal article)

Nielsen, P. B., Larsen, T. B., Skjoth, F., Gorst-Rasmussen, A., Rasmussen, L. H., & Lip, G. Y. H. (2015). Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding A Nationwide Cohort Study. CIRCULATION, 132(6), 517-525. doi:10.1161/CIRCULATIONAHA.115.015735

DOI: 10.1161/CIRCULATIONAHA.115.015735

Risk and prediction of dementia in patients with atrial fibrillation - A nationwide population-based cohort study (Journal article)

Liao, J. -N., Chao, T. -F., Liu, C. -J., Wang, K. -L., Chen, S. -J., Tuan, T. -C., . . . Chen, S. -A. (2015). Risk and prediction of dementia in patients with atrial fibrillation - A nationwide population-based cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 199, 25-30. doi:10.1016/j.ijcard.2015.06.170

DOI: 10.1016/j.ijcard.2015.06.170

Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study (Journal article)

Chen, P. -C., Lip, G. Y. H., Yeh, G., Lin, H. -J., & Chien, K. -L. (2015). Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study. PLOS ONE, 10(4). doi:10.1371/journal.pone.0125257

DOI: 10.1371/journal.pone.0125257

Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation (Journal article)

Lerario, M. P., Gialdini, G., Lapidus, D. M., Shaw, M. M., Navi, B. B., Merkler, A. E., . . . Kamel, H. (2015). Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation. PLOS ONE, 10(12). doi:10.1371/journal.pone.0145579

DOI: 10.1371/journal.pone.0145579

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials (Journal article)

Abdul-Rahim, A. H., Perez, A. -C., Fulton, R. L., Jhund, P. S., Latini, R., Tognoni, G., . . . Comm, G. -H. F. G. I. S. S. I. -H. F. (2015). Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials. CIRCULATION, 131(17), 1486-1494. doi:10.1161/CIRCULATIONAHA.114.013760

DOI: 10.1161/CIRCULATIONAHA.114.013760

Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study (Journal article)

Staerk, L., Gislason, G. H., Lip, G. Y. H., Fosbol, E. L., Hansen, M. L., Lamberts, M., . . . Olesen, J. B. (2015). Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study. EUROPACE, 17(8), 1215-1222. doi:10.1093/europace/euv119

DOI: 10.1093/europace/euv119

Risk of major bleeding in different indications for new oral anticoagulants: Insights from a meta-analysis of approved dosages from 50 randomized trials (Journal article)

Sardar, P., Chatterjee, S., Lavie, C. J., Giri, J. S., Ghosh, J., Mukherjee, D., & Lip, G. Y. H. (2015). Risk of major bleeding in different indications for new oral anticoagulants: Insights from a meta-analysis of approved dosages from 50 randomized trials. INTERNATIONAL JOURNAL OF CARDIOLOGY, 179, 279-287. doi:10.1016/j.ijcard.2014.11.101

DOI: 10.1016/j.ijcard.2014.11.101

SOUTH ASIAN ETHNICITY IS INDEPENDENTLY RELATED TO DIASTOLIC FUNCTION IN HYPERTENSION (Conference Paper)

Shantsila, A., Gill, P. S., Shantsila, E., & Lip, G. Y. H. (2015). SOUTH ASIAN ETHNICITY IS INDEPENDENTLY RELATED TO DIASTOLIC FUNCTION IN HYPERTENSION. In HEART Vol. 101 (pp. A71). doi:10.1136/heartjnl-2015-308066.124

DOI: 10.1136/heartjnl-2015-308066.124

Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention (Journal article)

Brown, R. A., Shantsila, E., Varma, C., & Lip, G. Y. H. (2015). Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(11), 1334-1340. doi:10.1111/ijcp.12702

DOI: 10.1111/ijcp.12702

Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data (Journal article)

Ziff, O. J., Lane, D. A., Samra, M., Griffith, M., Kirchhof, P., Lip, G. Y. H., . . . Kotecha, D. (2015). Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ-BRITISH MEDICAL JOURNAL, 351. doi:10.1136/bmj.h4451

DOI: 10.1136/bmj.h4451

Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach (Journal article)

Verdecchia, P., Angeli, F., Bartolini, C., De Filippo, V., Aita, A., Di Giacomo, L., . . . Reboldi, G. (2015). Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach. EXPERT OPINION ON DRUG SAFETY, 14(1), 7-20. doi:10.1517/14740338.2014.971009

DOI: 10.1517/14740338.2014.971009

Safety and efficacy of well managed warfarin A report from the Swedish quality register Auricula (Journal article)

Sjogren, V., Grzymala-Lubanski, B., Renlund, H., Friberg, L., Lip, G. Y. H., Svensson, P. J., & Sjalander, A. (2015). Safety and efficacy of well managed warfarin A report from the Swedish quality register Auricula. THROMBOSIS AND HAEMOSTASIS, 113(6), 1370-1377. doi:10.1160/TH14-10-0859

DOI: 10.1160/TH14-10-0859

Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation (Journal article)

Xiong, Q., & Lip, G. Y. H. (2015). Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 17(2). doi:10.1007/s11940-014-0331-4

DOI: 10.1007/s11940-014-0331-4

Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation (Journal article)

Pignatelli, P., Pastori, D., Carnevale, R., Farcomeni, A., Cangemi, R., Nocella, C., . . . Violi, F. (2015). Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 113(3), 617-624. doi:10.1160/TH14-07-0571

DOI: 10.1160/TH14-07-0571

Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project (Journal article)

Xiong, Q., Shantsila, A., Lane, D. A., Zhou, Q., Liu, Y., Shen, Y., . . . Lip, G. Y. H. (2015). Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 201, 195-199. doi:10.1016/j.ijcard.2015.08.076

DOI: 10.1016/j.ijcard.2015.08.076

Sex-related differences in epidemiologic and clinical presentation of atrial fibrillation in the Balkan countries - insights from the BALKAN AF Snap Shot Survey (Conference Paper)

Polovina, M., Goshev, E., Kusljugic, Z., Music, L. J., Gjergo, H., Dan, G. A., . . . Survey, B. A. L. K. A. N. A. F. S. S. (2015). Sex-related differences in epidemiologic and clinical presentation of atrial fibrillation in the Balkan countries - insights from the BALKAN AF Snap Shot Survey. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 900-901). Retrieved from http://gateway.webofknowledge.com/

Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry (Journal article)

Kornej, J., Kosiuk, J., Hindricks, G., Arya, A., Sommer, P., Rolf, S., . . . Bollmann, A. (2015). Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry. CLINICAL RESEARCH IN CARDIOLOGY, 104(7), 603-610. doi:10.1007/s00392-015-0823-6

DOI: 10.1007/s00392-015-0823-6

Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA(2)DS(2)-VASc Score (Beyond Sex) Receive Oral Anticoagulation? (Journal article)

Chao, T. -F., Liu, C. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., Lo, L. -W., . . . Chen, S. -A. (2015). Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA(2)DS(2)-VASc Score (Beyond Sex) Receive Oral Anticoagulation?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 65(7), 635-642. doi:10.1016/j.jacc.2014.11.046

DOI: 10.1016/j.jacc.2014.11.046

Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT2R2 score. (Journal article)

Proietti, M., & Lip, G. Y. H. (2015). Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT2R2 score.. European heart journal. Cardiovascular pharmacotherapy, 1(3), 150-152. doi:10.1093/ehjcvp/pvv012

DOI: 10.1093/ehjcvp/pvv012

Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduces out-of-hours door-to-balloon time but not mortality (Journal article)

Brown, R. A., Varma, C., Connolly, D. L., Ahmad, R., Shantsila, E., & Lip, G. Y. H. (2015). Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduces out-of-hours door-to-balloon time but not mortality. INTERNATIONAL JOURNAL OF CARDIOLOGY, 186, 226-230. doi:10.1016/j.ijcard.2015.03.172

DOI: 10.1016/j.ijcard.2015.03.172

Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure (Journal article)

Montoro-Garcia, S., Shantsila, E., Wrigley, B. J., Tapp, L. D., Abellan Aleman, J., & Lip, G. Y. H. (2015). Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure. REVISTA ESPANOLA DE CARDIOLOGIA, 68(11), 951-958. doi:10.1016/j.rec.2014.11.016

DOI: 10.1016/j.rec.2014.11.016

Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics (Journal article)

Albertsen, I. E., Overvad, T. F., Lip, G. Y. H., & Larsen, T. B. (2015). Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics. CURRENT OPINION IN CARDIOLOGY, 30(5), 512-517. doi:10.1097/HCO.0000000000000205

DOI: 10.1097/HCO.0000000000000205

Statin therapy and plasma coenzyme Q10 concentrations-A systematic review and meta-analysis of placebo-controlled trials (Journal article)

Banach, M., Serban, C., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., . . . Pressure, L. B. (2015). Statin therapy and plasma coenzyme Q10 concentrations-A systematic review and meta-analysis of placebo-controlled trials. PHARMACOLOGICAL RESEARCH, 99, 329-336. doi:10.1016/j.phrs.2015.07.008

DOI: 10.1016/j.phrs.2015.07.008

Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials (Journal article)

Sahebkar, A., Kotani, K., Serban, C., Ursoniu, S., Mikhailidis, D. P., Jones, S. R., . . . Meta-Anal, L. B. P. (2015). Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials. ATHEROSCLEROSIS, 241(2), 433-442. doi:10.1016/j.atherosclerosis.2015.05.022

DOI: 10.1016/j.atherosclerosis.2015.05.022

Statin therapy reduces von Willebrand factor antigen levels: A systematic review and meta-analysis of randomized placebo-controlled trials (Conference Paper)

Sahebkar, A., Serban, C., Ursoniu, S., Mihaescu, R., Mikhailidis, D. P., Muntner, P., . . . Grp, L. B. P. M. C. (2015). Statin therapy reduces von Willebrand factor antigen levels: A systematic review and meta-analysis of randomized placebo-controlled trials. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 224). Retrieved from http://gateway.webofknowledge.com/

Statin treatment is associated with improved prognosis in patients with af-related stroke (Conference Paper)

Ntaios, G., Papavasileiou, V., Makaritsis, K., Milionis, H., Manios, E., Michel, P., . . . Vemmos, K. (2015). Statin treatment is associated with improved prognosis in patients with af-related stroke. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 275-276). Retrieved from http://gateway.webofknowledge.com/

Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study (Journal article)

Chao, T. -F., Liu, C. -J., Chen, S. -J., Wang, K. -L., Lin, Y. -J., Chang, S. -L., . . . Chen, S. -A. (2015). Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 196, 91-97. doi:10.1016/j.ijcard.2015.05.159

DOI: 10.1016/j.ijcard.2015.05.159

Stroke Prevention in Atrial Fibrillation A Systematic Review (Journal article)

Lip, G. Y. H., & Lane, D. A. (2015). Stroke Prevention in Atrial Fibrillation A Systematic Review. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 313(19), 1950-1962. doi:10.1001/jama.2015.4369

DOI: 10.1001/jama.2015.4369

Stroke Prevention in Atrial Fibrillation: A Systematic Review (vol 313, pg 1950, 2015) (Journal article)

Lip, G. Y. H., & Lane, D. A. (2015). Stroke Prevention in Atrial Fibrillation: A Systematic Review (vol 313, pg 1950, 2015). JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(8), 837. Retrieved from http://gateway.webofknowledge.com/

Stroke Risk,Factors Beyond the CHA(2)DS(2)-VASc Score: Can We Improve Our Identification of "High. Stroke Risk" Patients With Atrial Fibrillation? (Journal article)

Szymanski, F. M., Lip, G. Y. H., Filipiak, K. J., Platek, A. E., Hrynkiewicz-Szymanska, A., & Opolski, G. (2015). Stroke Risk,Factors Beyond the CHA(2)DS(2)-VASc Score: Can We Improve Our Identification of "High. Stroke Risk" Patients With Atrial Fibrillation?. AMERICAN JOURNAL OF CARDIOLOGY, 116(11), 1781-1788. doi:10.1016/j.amjcard.2015.08.049

DOI: 10.1016/j.amjcard.2015.08.049

Stroke and Major Bleeding Risk in Elderly Patients Aged >= 75 Years With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)

Lip, G. Y. H., Clementy, N., Pericart, L., Banerjee, A., & Fauchier, L. (2015). Stroke and Major Bleeding Risk in Elderly Patients Aged >= 75 Years With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. STROKE, 46(1), 143-150. doi:10.1161/STROKEAHA.114.007199

DOI: 10.1161/STROKEAHA.114.007199

Stroke and bleeding risk-associated use of antithrombotic therapies for stroke prevention in atrial fibrillation in routine clinical practice: the BALKAN-AF Survey (Conference Paper)

Potpara, T. S., Dan, G. A., Trendafilova, E., Paparisto, V., Kusljugic, Z., Polovina, M. M., . . . Grp, B. A. L. K. A. N. -A. F. S. (2015). Stroke and bleeding risk-associated use of antithrombotic therapies for stroke prevention in atrial fibrillation in routine clinical practice: the BALKAN-AF Survey. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1082-1083). Retrieved from http://gateway.webofknowledge.com/

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study (Conference Paper)

Staerk, L., Lip, G. Y. H., Olesen, J. B., Fosbol, E. L., Pallisgaard, J. L., Bonde, A. N., . . . Gislason, G. H. (2015). Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. In BMJ-BRITISH MEDICAL JOURNAL Vol. 351. doi:10.1136/bmj.h5876

DOI: 10.1136/bmj.h5876

Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis (Journal article)

Shantsila, E., & Lip, G. Y. H. (2015). Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13(11), 1968-1970. doi:10.1111/jth.13121

DOI: 10.1111/jth.13121

Stroke prevention in atrial fibrillation: Where are we now? (Journal article)

Lip, G. Y. H. (2015). Stroke prevention in atrial fibrillation: Where are we now?. Indian Heart Journal, 67 Suppl 2, S1-S3. doi:10.1016/j.ihj.2015.11.002

DOI: 10.1016/j.ihj.2015.11.002

Stroke prevention in atrial fibrillation: changing concepts. (Journal article)

Lip, G. Y. H. (2015). Stroke prevention in atrial fibrillation: changing concepts.. European heart journal. Cardiovascular pharmacotherapy, 1(2), 76-79. doi:10.1093/ehjcvp/pvu003

DOI: 10.1093/ehjcvp/pvu003

Stroke risk reduction with oral anticoagulation using CHA(2)DS(2)-VASc in a Japanese AF population: A modeling analysis (Journal article)

Senoo, K., Lane, D. A., & Lip, G. Y. H. (2015). Stroke risk reduction with oral anticoagulation using CHA(2)DS(2)-VASc in a Japanese AF population: A modeling analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 181, 247-254. doi:10.1016/j.ijcard.2014.11.196

DOI: 10.1016/j.ijcard.2014.11.196

Suboptimal oral anticoagulation use among Chinese nonvalvular Atrial Fibrillation Patients: the Nanchang Atrial Fibrillation project (Conference Paper)

Xiong, Q., Shantsila, A., Cheng, X., Hong, K., & Lip, G. Y. H. (2015). Suboptimal oral anticoagulation use among Chinese nonvalvular Atrial Fibrillation Patients: the Nanchang Atrial Fibrillation project. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C271-C272). Retrieved from http://gateway.webofknowledge.com/

Switching from a vitamin K antagonist to a NOAC (Journal article)

Senoo, K., & Lip, G. Y. H. (2015). Switching from a vitamin K antagonist to a NOAC. LANCET HAEMATOLOGY, 2(4), E132-E133. doi:10.1016/S2352-3026(15)00041-1

DOI: 10.1016/S2352-3026(15)00041-1

Sympathetic nerve activity and arterial baroreflex function in rheumatoid arthritis (Conference Paper)

Adlan, A. M., Paton, J. F. R., Lip, G. Y. H., Kitas, G. D., & Fisher, J. P. (2015). Sympathetic nerve activity and arterial baroreflex function in rheumatoid arthritis. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 728). Retrieved from http://gateway.webofknowledge.com/

THE IMPACT OF DIFFERENT GLYCAEMIC INDEX CARBOHYDRATE STAPLE FOODS ON SOUTH ASIAN DIABETIC AND CARDIOVASCULAR INDICES OF HEALTH: A RCT (Conference Paper)

Patel, J., Flinders, P., Gill, P., Lip, G., & Hughes, E. (2015). THE IMPACT OF DIFFERENT GLYCAEMIC INDEX CARBOHYDRATE STAPLE FOODS ON SOUTH ASIAN DIABETIC AND CARDIOVASCULAR INDICES OF HEALTH: A RCT. In ATHEROSCLEROSIS Vol. 241 (pp. E191-E192). doi:10.1016/j.atherosclerosis.2015.04.936

DOI: 10.1016/j.atherosclerosis.2015.04.936

The CHA(2)DS(2)-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history (Journal article)

Lip, G. Y. H. (2015). The CHA(2)DS(2)-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history. EUROPEAN HEART JOURNAL, 36(42), 2880-2885. Retrieved from http://gateway.webofknowledge.com/

The CHADS(2) and CHA(2)DS(2)-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis (Journal article)

Xiong, Q., Chen, S., Senoo, K., Proietti, M., Hong, K., & Lip, G. Y. H. (2015). The CHADS(2) and CHA(2)DS(2)-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis. INTERNATIONAL JOURNAL OF CARDIOLOGY, 195, 237-242. doi:10.1016/j.ijcard.2015.05.115

DOI: 10.1016/j.ijcard.2015.05.115

The CHADS(2) and CHA(2)DS(2)-VASc scores for predicting ischemic stroke amongst Asian patients with atrial fibrillation: A systemic review and meta-analysis (Conference Paper)

Xiong, Q., Chen, S., Senoo, K., Proietti, M., Hong, K., & Lip, G. Y. H. (2015). The CHADS(2) and CHA(2)DS(2)-VASc scores for predicting ischemic stroke amongst Asian patients with atrial fibrillation: A systemic review and meta-analysis. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 66 (pp. C271). Retrieved from http://gateway.webofknowledge.com/

The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods (Journal article)

Charidimou, A., Wilson, D., Shakeshaft, C., Ambler, G., White, M., Cohen, H., . . . Werring, D. J. (2015). The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods. INTERNATIONAL JOURNAL OF STROKE, 10, 155-161. doi:10.1111/ijs.12569

DOI: 10.1111/ijs.12569

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment (Journal article)

Kooiman, J., van Hagen, N., del Sol, A. I., Planken, E. V., Lip, G. Y. H., van der Meer, F. J. M., . . . Huisman, M. V. (2015). The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment. PLOS ONE, 10(4). doi:10.1371/journal.pone.0122520

DOI: 10.1371/journal.pone.0122520

The Impact of Associated Diabetic Retinopathy on Stroke and Severe Bleeding Risk in Diabetic Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)

Lip, G. Y. H., Clementy, N., Pierre, B., Boyer, M., & Fauchier, L. (2015). The Impact of Associated Diabetic Retinopathy on Stroke and Severe Bleeding Risk in Diabetic Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project. CHEST, 147(4), 1103-1110. doi:10.1378/chest.14-2096

DOI: 10.1378/chest.14-2096

The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study (Journal article)

Roldan, V., Cancio, S., Galvez, J., Valdes, M., Vicente, V., Marin, F., & Lip, G. Y. H. (2015). The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study. AMERICAN JOURNAL OF MEDICINE, 128(11), 1237-1243. doi:10.1016/j.amjmed.2015.05.036

DOI: 10.1016/j.amjmed.2015.05.036

The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists (Journal article)

Fauchier, L., Angoulvant, D., & Lip, G. Y. H. (2015). The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists. EUROPACE, 17(5), 671-673. doi:10.1093/europace/euv088

DOI: 10.1093/europace/euv088

Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study (Journal article)

Wolsk, E., Lamberts, M., Hansen, M. L., Blanche, P., Kober, L., Torp-Pedersen, C., . . . Gislason, G. (2015). Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study. EUROPEAN JOURNAL OF HEART FAILURE, 17(8), 828-836. doi:10.1002/ejhf.309

DOI: 10.1002/ejhf.309

Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation (Journal article)

Guo, Y., Wang, H., Tian, Y., Wang, Y., & Lip, G. Y. H. (2015). Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation. CHEST, 148(1), 62-72. doi:10.1378/chest.14-2018

DOI: 10.1378/chest.14-2018

Triple Therapy for Atrial Fibrillation and ACS With or Without PCI (Journal article)

Capodanno, D., & Lip, G. Y. H. (2015). Triple Therapy for Atrial Fibrillation and ACS With or Without PCI. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 65(5), 515-516. doi:10.1016/j.jacc.2014.10.063

DOI: 10.1016/j.jacc.2014.10.063

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement (Journal article)

Capodanno, D., Lip, G. Y. H., Windecker, S., Huber, K., Kirchhof, P., Boriani, G., . . . Byrne, R. A. (2015). Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement. EUROINTERVENTION, 10(9), 1015-1021. doi:10.4244/EIJV10I9A174

DOI: 10.4244/EIJV10I9A174

Urinary 11-dehydro-thromboxane B-2 is associated with cardiovascular events and mortality in patients with atrial fibrillation (Journal article)

Pastori, D., Pignatelli, P., Farcomeni, A., Cangemi, R., Hiatt, W. R., Bartimoccia, S., . . . Violi, F. (2015). Urinary 11-dehydro-thromboxane B-2 is associated with cardiovascular events and mortality in patients with atrial fibrillation. AMERICAN HEART JOURNAL, 170(3), 490-+. doi:10.1016/j.ahj.2015.05.011

DOI: 10.1016/j.ahj.2015.05.011

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients (Conference Paper)

Pastori, D., Pignatelli, P. P., Cangemi, R. C., Hiatt, W. R. H., Farcomeni, A. F., Vicario, T. V., . . . Violi, F. V. (2015). Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 903). Retrieved from http://gateway.webofknowledge.com/

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients (Conference Paper)

Pignatelli, P., Pastori, D., Hiatt, W. R., Lip, G., & Violi, F. (2015). Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in atrial fibrillation patients. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 13 (pp. 519). Retrieved from http://gateway.webofknowledge.com/

Use of an Insertable Cardiac Monitor to Detect Atrial Fibrillation is Cost Effective in Patients with Cryptogenic Stroke (Conference Paper)

Diamantopoulos, A., Sawyer, L., Sungher, D., Lip, G., Witte, K., Reynolds, M. R., . . . Diener, H. -C. (2015). Use of an Insertable Cardiac Monitor to Detect Atrial Fibrillation is Cost Effective in Patients with Cryptogenic Stroke. In STROKE Vol. 46. Retrieved from http://gateway.webofknowledge.com/

Use of antithrombotic therapy in patients with atrial fibrillation and prior stroke: insights from the global GLORIA-AF registry (Conference Paper)

Lip, G. Y. H., Halperin, J. L., Diener, H. C., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Huisman, M. V. (2015). Use of antithrombotic therapy in patients with atrial fibrillation and prior stroke: insights from the global GLORIA-AF registry. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 243). Retrieved from http://gateway.webofknowledge.com/

Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic (Journal article)

Lee, S. I., Sayers, M., Lip, G. Y. H., & Lane, D. A. (2015). Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 69(11), 1341-1348. doi:10.1111/ijcp.12712

DOI: 10.1111/ijcp.12712

Use of oral anticoagulants in combination with antiplatelet therapy: insights from the GLORIA-AF registry (Conference Paper)

Lip, G. Y. H., Halperin, J., Diener, H. C., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Huisman, M. V. (2015). Use of oral anticoagulants in combination with antiplatelet therapy: insights from the GLORIA-AF registry. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 235). Retrieved from http://gateway.webofknowledge.com/

Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study (Journal article)

Hojen, A. A., Gorst-Rasmussen, A., Lip, G. Y. H., Lane, D. A., Rasmussen, L. H., Sorensen, E. E., & Larsen, T. B. (2015). Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study. THROMBOSIS RESEARCH, 135(4), 643-647. doi:10.1016/j.thromres.2015.01.024

DOI: 10.1016/j.thromres.2015.01.024

Using the CHA(2)DS(2)-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application (Journal article)

Nielsen, P. B., Skjoth, F., Rasmussen, L. H., Larsen, T. B., & Lip, G. Y. H. (2015). Using the CHA(2)DS(2)-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application. CANADIAN JOURNAL OF CARDIOLOGY, 31(6). doi:10.1016/j.cjca.2015.01.034

DOI: 10.1016/j.cjca.2015.01.034

Validation of SAME-TT2R2 score for predicting poor anticoagulation in a prospective real world cohort of atrial fibrillation patients initiating Vitamin K antagonists (Conference Paper)

Roldan-Schilling, V., Marin, F., Cancio, S., Galvez, J., Valdes, M., Vicente, V., & Lip, G. Y. H. (2015). Validation of SAME-TT2R2 score for predicting poor anticoagulation in a prospective real world cohort of atrial fibrillation patients initiating Vitamin K antagonists. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 803-804). Retrieved from http://gateway.webofknowledge.com/

Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study (Conference Paper)

Melgaard, L., Gorst-Rasmussen, A., Larsen, T. B., & Lip, G. (2015). Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study. In EUROPEAN JOURNAL OF HEART FAILURE Vol. 17 (pp. 249). Retrieved from http://gateway.webofknowledge.com/

Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study (Conference Paper)

Melgaard, L., Gorst-Rasmussen, A., Lip, G., & Larsen, T. B. (2015). Vascular disease as a risk factor of stroke or death in heart failure patients in sinus rhythm: a nationwide cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 28-29). Retrieved from http://gateway.webofknowledge.com/

Volume and functional outcome of intracerebral haemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Prospective, multicentre cross sectional study (Conference Paper)

Wilson, D., Charidimou, A., Shakeshaft, C., Ambler, G., White, M., Cohen, H., . . . Collaborators, C. (2015). Volume and functional outcome of intracerebral haemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Prospective, multicentre cross sectional study. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 62). Retrieved from http://gateway.webofknowledge.com/

Volume and functional outcome of intracerebral hemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Multicenter cross sectional observational study (Conference Paper)

Wilson, D., Charidimou, A., Shakeshaft, C., Ambler, G., White, M. J., Cohen, H., . . . Werring, D. J. (2015). Volume and functional outcome of intracerebral hemorrhage associated with non-vitamin K oral anticoagulants compared to warfarin: Multicenter cross sectional observational study. In INTERNATIONAL JOURNAL OF STROKE Vol. 10 (pp. 59-60). Retrieved from http://gateway.webofknowledge.com/

Warfarin and major adverse cardiovascular events in the "Real World" of patients with atrial fibrillation (Conference Paper)

Pignatelli, P., Pastori, D., Lip, G., & Violi, F. (2015). Warfarin and major adverse cardiovascular events in the "Real World" of patients with atrial fibrillation. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 13 (pp. 392). Retrieved from http://gateway.webofknowledge.com/

Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation (Journal article)

Dzeshka, M. S., & Lip, G. Y. H. (2015). Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation. EXPERT OPINION ON DRUG SAFETY, 14(1), 45-62. doi:10.1517/14740338.2015.973847

DOI: 10.1517/14740338.2015.973847

What we have learned from the ESC position paper on arrhythmias in acute coronary syndromes (Journal article)

Gorenek, B., Kudaiberdieva, G., & Lip, G. (2015). What we have learned from the ESC position paper on arrhythmias in acute coronary syndromes. ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 15(2), 94-96. doi:10.5152/akd.2015.6206

DOI: 10.5152/akd.2015.6206

Withdrawn as Duplicate: The CHA₂DS₂-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history. (Journal article)

Lip, G. Y. H. (2015). Withdrawn as Duplicate: The CHA₂DS₂-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history.. European heart journal, 36(42), 2880-2885. doi:10.1093/eurheartj/ehv431

DOI: 10.1093/eurheartj/ehv431

Wytyczne ESC dotyczące postępowania u pacjentów z komorowymi zaburzeniami rytmu oraz zapobiegania nagłym zgonom sercowym w 2015 roku (Journal article)

Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., . . . Van Veldhuisen, D. J. (2015). Wytyczne ESC dotyczące postępowania u pacjentów z komorowymi zaburzeniami rytmu oraz zapobiegania nagłym zgonom sercowym w 2015 roku. Kardiologia Polska, 73(10), 795-900. doi:10.5603/KP.2015.0190

DOI: 10.5603/KP.2015.0190

open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI) (Journal article)

Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F., Wildgoose, P., . . . Fox, K. (2015). open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). AMERICAN HEART JOURNAL, 169(4), 472-+. doi:10.1016/j.ahj.2014.12.006

DOI: 10.1016/j.ahj.2014.12.006

sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation (Journal article)

Vilchez, J. A., Perez-Cuellar, M., Marin, F., Gallego, P., Manzano-Fernandez, S., Valdes, M., . . . Roldan, V. (2015). sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 45(9), 899-905. doi:10.1111/eci.12482

DOI: 10.1111/eci.12482

2014

"Finding atrial fibrillation in acute stroke patients: just keep looking, just keep looking (with prolonged ECG monitoring)" (Conference Paper)

Weerathunga, J., Kausar, S., Blann, A., & Lip, G. (2014). "Finding atrial fibrillation in acute stroke patients: just keep looking, just keep looking (with prolonged ECG monitoring)". In CEREBROVASCULAR DISEASES Vol. 37 (pp. 224). Retrieved from http://gateway.webofknowledge.com/

'Real-World' Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey (Journal article)

Lip, G. Y. H., Laroche, C., Dan, G. -A., Santini, M., Kalarus, Z., Rasmussen, L. H., . . . Maggioni, A. P. (2014). 'Real-World' Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey. AMERICAN JOURNAL OF MEDICINE, 127(6), 519-U169. doi:10.1016/j.amjmed.2013.12.022

DOI: 10.1016/j.amjmed.2013.12.022

A Persisting Dilemma for Triple Antithrombotic Therapy Are We Close to Finding the Correct Answer? Reply (Journal article)

Lamberts, M., Gislason, G. H., Olesen, J. B., Kristensen, S. L., Olsen, A. -M. S., Mikkelsen, A., . . . Hansen, M. L. (2014). A Persisting Dilemma for Triple Antithrombotic Therapy Are We Close to Finding the Correct Answer? Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 64(2), 231-232. doi:10.1016/j.jacc.2013.11.049

DOI: 10.1016/j.jacc.2013.11.049

A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation (Journal article)

Banerjee, A., Fauchier, L., Vourc'h, P., Andres, C. R., Taillandier, S., Halimi, J. M., & Lip, G. Y. H. (2014). A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation. CHEST, 145(6), 1370-1382. doi:10.1378/chest.13-2103

DOI: 10.1378/chest.13-2103

A multi-biomarker strategy for predicting stroke in stable anticoagulated patients with atrial fibrillation (Conference Paper)

Roldan-Schilling, V., Gallego, P., Vilchez, J. A., Jover, E., Puche, C., Manzano-Fernandez, S., . . . Marin, F. (2014). A multi-biomarker strategy for predicting stroke in stable anticoagulated patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 179). Retrieved from http://gateway.webofknowledge.com/

A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry (Journal article)

Lip, G. Y. H., Laroche, C., Dan, G. -A., Santini, M., Kalarus, Z., Rasmussen, L. H., . . . Maggioni, A. P. (2014). A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. EUROPACE, 16(3), 308-319. doi:10.1093/europace/eut373

DOI: 10.1093/europace/eut373

A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin (Journal article)

Poli, D., Antonucci, E., Testa, S., & Lip, G. Y. H. (2014). A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin. INTERNAL AND EMERGENCY MEDICINE, 9(4), 443-447. doi:10.1007/s11739-014-1065-8

DOI: 10.1007/s11739-014-1065-8

A very happy new year 2014 from Thrombosis and Haemostasis! (Journal article)

Lip, G. Y. H., & Weber, C. (2014). A very happy new year 2014 from Thrombosis and Haemostasis!. THROMBOSIS AND HAEMOSTASIS, 111(1), 1-2. Retrieved from http://gateway.webofknowledge.com/

ACP Journal Club. In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2 and CHA2DS2-VASc. (Journal article)

Marcucci, M. (2014). ACP Journal Club. In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2 and CHA2DS2-VASc.. Annals of internal medicine, 160(10), JC13. doi:10.7326/0003-4819-160-10-201405200-02013

DOI: 10.7326/0003-4819-160-10-201405200-02013

Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AF (Journal article)

Lau, Y. C., & Lip, G. Y. H. (2014). Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AF. ANNALS OF INTERNAL MEDICINE, 160(10). doi:10.7326/0003-4819-160-10-201405200-02005

DOI: 10.7326/0003-4819-160-10-201405200-02005

Abnormal fibrin clot structure in chronic heart failure (Conference Paper)

Ranjit, P., Lau, Y. C., Blann, A., & Lip, G. Y. H. (2014). Abnormal fibrin clot structure in chronic heart failure. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 507). Retrieved from http://gateway.webofknowledge.com/

Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end? (Journal article)

Lau, Y. C., & Lip, G. Y. H. (2014). Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?. EUROPACE, 16(5), 619-620. doi:10.1093/europace/eut356

DOI: 10.1093/europace/eut356

Acute myocardial infarction in patients with atrial fibrillation with a CHA(2)DS(2)-VASc score of 0 or 1: A nationwide cohort study (Journal article)

Chao, T. -F., Huang, Y. -C., Liu, C. -J., Chen, S. -J., Wang, K. -L., Lin, Y. -J., . . . Chen, S. -A. (2014). Acute myocardial infarction in patients with atrial fibrillation with a CHA(2)DS(2)-VASc score of 0 or 1: A nationwide cohort study. HEART RHYTHM, 11(11), 1941-1947. doi:10.1016/j.hrthm.2014.08.003

DOI: 10.1016/j.hrthm.2014.08.003

Addition of Smoking Status Improves Risk Prediction of Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study (Conference Paper)

Kwon, Y., Lopez, F. L., Agarwal, S. K., Soliman, E. Z., Lip, G. Y., Alonso, A., & Chen, L. Y. (2014). Addition of Smoking Status Improves Risk Prediction of Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study. In CIRCULATION Vol. 130. Retrieved from http://gateway.webofknowledge.com/

Age Dependence of Risk Factors for Stroke and Death in Young Patients With Atrial Fibrillation A Nationwide Study (Journal article)

Melgaard, L., Rasmussen, L. H., Skjoth, F., Lip, G. Y. H., & Larsen, T. B. (2014). Age Dependence of Risk Factors for Stroke and Death in Young Patients With Atrial Fibrillation A Nationwide Study. STROKE, 45(5), 1331-1337. doi:10.1161/STROKEAHA.114.004903

DOI: 10.1161/STROKEAHA.114.004903

An "unlikely" Wells rule score (<= 1) plus a negative D-dimer result excluded DVT in noncancer patients (Journal article)

Brown, R. A., & Lip, G. Y. H. (2014). An "unlikely" Wells rule score (<= 1) plus a negative D-dimer result excluded DVT in noncancer patients. ANNALS OF INTERNAL MEDICINE, 161(2). doi:10.7326/0003-4819-161-2-201407150-02009

DOI: 10.7326/0003-4819-161-2-201407150-02009

Analysis of Vitamin D Levels in Patients With and Without Statin-induced Myalgia - A Systematic Review and Meta-analysis of 7 Studies with 2416 Patients (Conference Paper)

Michalska-Kasiczak, M., Sahebkar, A., Mikhailidis, D. P., Rysz, J., Muntner, P., Toth, P. P., . . . Banach, M. (2014). Analysis of Vitamin D Levels in Patients With and Without Statin-induced Myalgia - A Systematic Review and Meta-analysis of 7 Studies with 2416 Patients. In CIRCULATION Vol. 130. Retrieved from http://gateway.webofknowledge.com/

Ankle-Brachial Index in Patients With Nonvalvular Atrial Fibrillation Reply (Journal article)

Violi, F., Davi, G., Hiatt, W., Lip, G. Y. H., Corazza, G. R., Perticone, F., . . . Investigators, A. R. A. P. A. C. I. S. S. (2014). Ankle-Brachial Index in Patients With Nonvalvular Atrial Fibrillation Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 63(14), 1457-1458. doi:10.1016/j.jacc.2013.11.011

DOI: 10.1016/j.jacc.2013.11.011

Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions? (Journal article)

Clemens, A., Strack, A., Noack, H., Konstantinides, S., Brueckmann, M., & Lip, G. Y. H. (2014). Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions?. ANNALS OF MEDICINE, 46(8), 672-678. doi:10.3109/07853890.2014.952327

DOI: 10.3109/07853890.2014.952327

Anticoagulation versus placebo for heart failure in sinus rhythm (Journal article)

Lip, G. Y. H., & Shantsila, E. (2014). Anticoagulation versus placebo for heart failure in sinus rhythm. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD003336.pub3

DOI: 10.1002/14651858.CD003336.pub3

Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant A Nationwide Cohort Study (Journal article)

Lamberts, M., Gislason, G. H., Lip, G. Y. H., Lassen, J. F., Olesen, J. B., Mikkelsen, A. P., . . . Hansen, M. L. (2014). Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant A Nationwide Cohort Study. CIRCULATION, 129(15), 1577-1585. doi:10.1161/CIRCULATIONAHA.113.004834

DOI: 10.1161/CIRCULATIONAHA.113.004834

Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease A Nationwide Cohort Study (Journal article)

Lamberts, M., Lip, G. Y. H., Ruwald, M. H., Hansen, M. L., Ozcan, C., Kristensen, S. L., . . . Gislason, G. H. (2014). Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease A Nationwide Cohort Study. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 63(24), 2689-2698. doi:10.1016/j.jacc.2014.03.039

DOI: 10.1016/j.jacc.2014.03.039

Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation (Journal article)

Dzeshka, M. S., & Lip, G. Y. H. (2014). Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation. CARDIOLOGY CLINICS, 32(4), 585-+. doi:10.1016/j.ccl.2014.07.009

DOI: 10.1016/j.ccl.2014.07.009

Antithrombotic treatment of atrial fibrillation in general practice: application of the GRASP-AF audit tool (Conference Paper)

Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2014). Antithrombotic treatment of atrial fibrillation in general practice: application of the GRASP-AF audit tool. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1104). Retrieved from http://gateway.webofknowledge.com/

Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America - The GLORIA-AF registry program (Conference Paper)

Huisman, M. V., Lip, G. Y. H., Diener, H. C., Dubner, S. J., Ma, C. S., Rothman, K. J., . . . Halperin, J. L. (2014). Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America - The GLORIA-AF registry program. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 777). Retrieved from http://gateway.webofknowledge.com/

Aspirin still overprescribed for stroke prevention in atrial fibrillation. (Journal article)

Taylor, J. (2014). Aspirin still overprescribed for stroke prevention in atrial fibrillation.. European Heart Journal, 35(22), 1422.

Assess bleeding risk with HAS-BLED and assess stroke risk with CHA(2)DS(2)-VASc in patients with atrial fibrillation (Journal article)

Lau, Y. C., Lip, G. Y. H., & Gallego, P. (2014). Assess bleeding risk with HAS-BLED and assess stroke risk with CHA(2)DS(2)-VASc in patients with atrial fibrillation. HYPERTENSION RESEARCH, 37(7), 699-700. doi:10.1038/hr.2014.63

DOI: 10.1038/hr.2014.63

Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial (Journal article)

Shaffer, J. A., Thompson, J. L. P., Cheng, B., Ye, S., Lip, G. Y. H., Mann, D. L., . . . Investigators, W. A. R. C. E. F. (2014). Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 177(2), 715-717. doi:10.1016/j.ijcard.2014.10.012

DOI: 10.1016/j.ijcard.2014.10.012

Atrial Fibrillation During Sepsis A Determinant of Long-term Outcomes? (Journal article)

Lau, Y. C., & Lip, G. Y. H. (2014). Atrial Fibrillation During Sepsis A Determinant of Long-term Outcomes?. CHEST, 146(5), 1138-1140. doi:10.1378/chest.14-0986

DOI: 10.1378/chest.14-0986

Atrial Fibrillation and Heart Failure: A Bad Combination (Journal article)

Lau, Y. C., Lane, D. A., & Lip, G. Y. H. (2014). Atrial Fibrillation and Heart Failure: A Bad Combination. AMERICAN JOURNAL OF CARDIOLOGY, 113(7), 1196-1197. doi:10.1016/j.amjcard.2014.01.002

DOI: 10.1016/j.amjcard.2014.01.002

Atrial Fibrillation in Cryptogenic Stroke Look Harder, Look Longer, But Just Keep Looking (Journal article)

Lau, Y. C., Lane, D. A., & Lip, G. Y. H. (2014). Atrial Fibrillation in Cryptogenic Stroke Look Harder, Look Longer, But Just Keep Looking. STROKE, 45(11), 3184-3185. doi:10.1161/STROKEAHA.114.006862

DOI: 10.1161/STROKEAHA.114.006862

Atrial fibrillation (Journal article)

Lau, Y. C., & Lip, G. Y. H. (2014). Atrial fibrillation. Medicine, 42(10), 598-603. doi:10.1016/j.mpmed.2014.07.013

DOI: 10.1016/j.mpmed.2014.07.013

Atrial fibrillation (acute onset). (Journal article)

Lip, G. Y. H., & Apostolakis, S. (2014). Atrial fibrillation (acute onset).. BMJ clinical evidence, 2014.

Atrial fibrillation ... more than simply being irregularly irregular (Journal article)

Lip, G. Y. H. (2014). Atrial fibrillation ... more than simply being irregularly irregular. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 68(4), 408-409. doi:10.1111/ijcp.12416

DOI: 10.1111/ijcp.12416

Atrial fibrillation and heart failure: meta-analysis of clinical outcomes in reduced versus preserved ejection fraction (Conference Paper)

Kotecha, D., Chudasama, R., Lane, D. A., Kirchhof, P., & Lip, G. Y. H. (2014). Atrial fibrillation and heart failure: meta-analysis of clinical outcomes in reduced versus preserved ejection fraction. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1029). Retrieved from http://gateway.webofknowledge.com/

Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye (Journal article)

Plunkett, O., Lip, P. L., & Lip, G. Y. H. (2014). Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye. BRITISH JOURNAL OF OPHTHALMOLOGY, 98(9), 1141-1143. doi:10.1136/bjophthalmol-2013-304646

DOI: 10.1136/bjophthalmol-2013-304646

Atrial fibrillation and stroke prevention: brief observations on the last decade. (Journal article)

Lip, G. Y. (2014). Atrial fibrillation and stroke prevention: brief observations on the last decade.. Expert review of cardiovascular therapy, 12(4), 403-406. doi:10.1586/14779072.2014.896196

DOI: 10.1586/14779072.2014.896196

Au-In-based Hermetic Sealing for MEMS Packaging for Down-Hole Application (Journal article)

Chidambaram, V., Bangtao, C., Lip, G. C., & Woo, D. R. M. (2014). Au-In-based Hermetic Sealing for MEMS Packaging for Down-Hole Application. JOURNAL OF ELECTRONIC MATERIALS, 43(7), 2498-2509. doi:10.1007/s11664-014-3131-4

DOI: 10.1007/s11664-014-3131-4

Autonomic function and rheumatoid arthritis-A systematic review (Journal article)

Adlan, A. M., Lip, G. Y. H., Paton, J. F. R., Kitas, G. D., & Fisher, J. P. (2014). Autonomic function and rheumatoid arthritis-A systematic review. SEMINARS IN ARTHRITIS AND RHEUMATISM, 44(3), 283-304. doi:10.1016/j.semarthrit.2014.06.003

DOI: 10.1016/j.semarthrit.2014.06.003

Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - Insights From the AFCAS Registry (Journal article)

Kiviniemi, T., Puurunen, M., Schlitt, A., Rubboli, A., Karjalainen, P., Nammas, W., . . . Airaksinen, K. E. J. (2014). Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - Insights From the AFCAS Registry. CIRCULATION JOURNAL, 78(11), 2674-2681. doi:10.1253/circj.CJ-14-0792

DOI: 10.1253/circj.CJ-14-0792

Benefits valuation of potable water quality improvement in Malaysia: the case of Kajang Municipality (Journal article)

Othman, J., Lip, G. H., & Jafari, Y. (2014). Benefits valuation of potable water quality improvement in Malaysia: the case of Kajang Municipality. International Journal of Water Resources Development, 30(4), 621-634. doi:10.1080/07900627.2013.876851

DOI: 10.1080/07900627.2013.876851

Biomarkers in atrial fibrillation: an overview (Journal article)

Vilchez, J. A., Roldan, V., Hernandez-Romero, D., Valdes, M., Lip, G. Y. H., & Marin, F. (2014). Biomarkers in atrial fibrillation: an overview. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 68(4), 434-443. doi:10.1111/ijcp.12304

DOI: 10.1111/ijcp.12304

Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy (Journal article)

Kiviniemi, T., Karjalainen, P., Niemela, M., Rubboli, A., Lip, G. Y. H., Schlitt, A., . . . Airaksinen, K. E. J. (2014). Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy. THROMBOSIS RESEARCH, 133(4), 695-696. doi:10.1016/j.thromres.2014.01.038

DOI: 10.1016/j.thromres.2014.01.038

Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation (Journal article)

Larsen, T. B., Gorst-Rasmussen, A., Rasmussen, L. H., Skjoth, F., Rosenzweig, M., & Lip, G. Y. H. (2014). Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation. AMERICAN JOURNAL OF MEDICINE, 127(7), 650-+. doi:10.1016/j.amjmed.2014.01.031

DOI: 10.1016/j.amjmed.2014.01.031

CHADS(2), CHA(2)DS(2)-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention (Journal article)

Puurunen, M. K., Kiviniemi, T., Schlitt, A., Rubboli, A., Dietrich, B., Karjalainen, P., . . . Airaksinen, K. E. J. (2014). CHADS(2), CHA(2)DS(2)-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. THROMBOSIS RESEARCH, 133(4), 560-566. doi:10.1016/j.thromres.2014.01.007

DOI: 10.1016/j.thromres.2014.01.007

CLINICAL OUTCOME OF PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BARE-METAL VERSUS DRUG-ELUTING STENTS: INSIGHTS FROM THE AFCAS REGISTRY (Conference Paper)

Puurunen, M. K., Kiviniemi, T., Schlitt, A., Rubboli, A., Karjalainen, P., Biancari, F., . . . Airaksinen, J. (2014). CLINICAL OUTCOME OF PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BARE-METAL VERSUS DRUG-ELUTING STENTS: INSIGHTS FROM THE AFCAS REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A1681). doi:10.1016/S0735-1097(14)61684-3

DOI: 10.1016/S0735-1097(14)61684-3

COGNITIVE FUNCTION IN AMBULATORY PATIENTS WITH SYSTOLIC HEART FAILURE: INSIGHTS FROM THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Conference Paper)

Ye, S., Graham, S., Qian, M., Sanford, L. R., Di Tullio, M., Sacco, R., . . . Investigators, W. R. C. E. F. (2014). COGNITIVE FUNCTION IN AMBULATORY PATIENTS WITH SYSTOLIC HEART FAILURE: INSIGHTS FROM THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A946). doi:10.1016/S0735-1097(14)60946-3

DOI: 10.1016/S0735-1097(14)60946-3

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. (Journal article)

Gorenek, B., Blomström Lundqvist, C., Brugada Terradellas, J., Camm, A. J., Hindricks, G., Huber, K., . . . Savelieva, I. (2014). Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.. Europace, 16(11), 1655-1673. doi:10.1093/europace/euu208

DOI: 10.1093/europace/euu208

Cardiopulmonary resuscitation with a different slant: the importance of perimortem caesarean delivery (Conference Paper)

Castleman, J. S., Miti, C., Ajibona, O. O., Lip, G. Y. H., & Ganapathy, R. (2014). Cardiopulmonary resuscitation with a different slant: the importance of perimortem caesarean delivery. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1208-1209). Retrieved from http://gateway.webofknowledge.com/

Cardiovascular risk in patients with sleep apnea with or without continuous positive airway pressure therapy among 4.5 million Danes (Conference Paper)

Lamberts, M., Nielsen, O. W., Lip, G. Y. H., Ruwald, M. H., Christiansen, C. B., Kristensen, S. L., . . . Gislason, G. H. (2014). Cardiovascular risk in patients with sleep apnea with or without continuous positive airway pressure therapy among 4.5 million Danes. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 345-346). Retrieved from http://gateway.webofknowledge.com/

Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults (Journal article)

Lamberts, M., Nielsen, O. W., Lip, G. Y. H., Ruwald, M. H., Christiansen, C. B., Kristensen, S. L., . . . Gislason, G. H. (2014). Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults. JOURNAL OF INTERNAL MEDICINE, 276(6), 659-666. doi:10.1111/joim.12302

DOI: 10.1111/joim.12302

Circulating microparticles: challenges and perspectives of flow cytometric assessment (Journal article)

Shantsila, E., Montoro-Garcia, S., Gallego, P., & Lip, G. Y. H. (2014). Circulating microparticles: challenges and perspectives of flow cytometric assessment. THROMBOSIS AND HAEMOSTASIS, 111(6), 1009-1014. doi:10.1160/TH13-11-0937

DOI: 10.1160/TH13-11-0937

Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation: The Catanzaro atrial fibrillation project (Journal article)

Perticone, F., Sciacqua, A., Perticone, M., Tassone, E. J., Sesti, G., Violi, F., & Lip, G. Y. H. (2014). Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation: The Catanzaro atrial fibrillation project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 177(2), 666-668. doi:10.1016/j.ijcard.2014.09.169

DOI: 10.1016/j.ijcard.2014.09.169

Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial (Journal article)

Graham, S., Ye, S., Qian, M., Sanford, A. R., Di Tullio, M. R., Sacco, R. L., . . . Investigators, W. A. R. C. E. F. (2014). Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. PLOS ONE, 9(11). doi:10.1371/journal.pone.0113447

DOI: 10.1371/journal.pone.0113447

Common Questions in Anticoagulation Management in Atrial Fibrillation. (Journal article)

Gallego, P., Roldán, V., & Lip, G. Y. H. (2014). Common Questions in Anticoagulation Management in Atrial Fibrillation.. Cardiac electrophysiology clinics, 6(1), 79-86. doi:10.1016/j.ccep.2013.10.005

DOI: 10.1016/j.ccep.2013.10.005

Comparing the 'New' R(2)CHADS(2) With the 'Old' CHA(2)DS(2)-VASc Scores for Predicting Thromboembolism in Patients Undergoing Atrial Fibrillation Ablation: New Does Not Mean Better (Journal article)

Kornej, J., & Lip, G. Y. H. (2014). Comparing the 'New' R(2)CHADS(2) With the 'Old' CHA(2)DS(2)-VASc Scores for Predicting Thromboembolism in Patients Undergoing Atrial Fibrillation Ablation: New Does Not Mean Better. CANADIAN JOURNAL OF CARDIOLOGY, 30(4), 385-387. doi:10.1016/j.cjca.2013.12.015

DOI: 10.1016/j.cjca.2013.12.015

Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation (Journal article)

Aakre, C. A., McLeod, C. J., Cha, S. S., Tsang, T. S. M., Lip, G. Y. H., & Gersh, B. J. (2014). Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation. STROKE, 45(2), 426-431. doi:10.1161/STROKEAHA.113.002585

DOI: 10.1161/STROKEAHA.113.002585

Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation (Conference Paper)

Andreu Cayuelas, J. M., Manzano-Fernandez, S., Sanchez-Martinez, M., Marin, F., Orenes-Pinero, E., Gallego, P., . . . Roldan, V. (2014). Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 383). Retrieved from http://gateway.webofknowledge.com/

Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation The Loire Valley Atrial Fibrillation Project (Journal article)

Banerjee, A., Fauchier, L., Bernard-Brunet, A., Clementy, N., & Lip, G. Y. H. (2014). Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation The Loire Valley Atrial Fibrillation Project. THROMBOSIS AND HAEMOSTASIS, 111(3), 549-556. doi:10.1160/TH13-12-1033

DOI: 10.1160/TH13-12-1033

Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches? (Journal article)

Lip, G. Y. H., Al-Khatib, S. M., Cosio, F. G., Banerjee, A., Savelieva, I., Ruskin, J., . . . Camm, A. J. (2014). Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches?. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 3(4). doi:10.1161/JAHA.114.001179

DOI: 10.1161/JAHA.114.001179

Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study (Journal article)

Crijns, H. J. G. M., Weijs, B., Fairley, A. -M., Lewalter, T., Maggioni, A. P., Martin, A., . . . Le Heuzey, J. -Y. (2014). Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 172(3), 588-594. doi:10.1016/j.ijcard.2014.01.099

DOI: 10.1016/j.ijcard.2014.01.099

Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation (Journal article)

Senoo, K., Suzuki, S., Sagara, K., Otsuka, T., Matsuno, S., Uejima, T., . . . Yamashita, T. (2014). Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation. JOURNAL OF CARDIOLOGY, 63(1-2), 123-127. doi:10.1016/j.jjcc.2013.08.007

DOI: 10.1016/j.jjcc.2013.08.007

Correction: Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria (Journal article)

Correction: Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria (2014). PLoS ONE, 9(9), e109437. doi:10.1371/journal.pone.0109437

DOI: 10.1371/journal.pone.0109437

Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation (Journal article)

Lip, G. Y. H., Kongnakorn, T., Phatak, H., Kuznik, A., Lanitiss, T., Liu, L. Z., . . . Dorian, P. (2014). Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation. CLINICAL THERAPEUTICS, 36(2), 192-210. doi:10.1016/j.clinthera.2013.12.011

DOI: 10.1016/j.clinthera.2013.12.011

Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients (Conference Paper)

Lip, G. Y., Lanitis, T., Kongnakorn, T., Phatak, H., Liu, L. Z., Lawrence, J., & Dorian, P. (2014). Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients. In CIRCULATION Vol. 130. Retrieved from http://gateway.webofknowledge.com/

Cost-effectiveness of apixaban compared to edoxaban for stroke prevention in non-valvular atrial fibrillation (Conference Paper)

Lip, G. Y. H., Kongnakorn, T., Lanitis, T., Phatak, H., Liu, J. X. C., Kuznik, A., . . . Dorian, P. (2014). Cost-effectiveness of apixaban compared to edoxaban for stroke prevention in non-valvular atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1108-1109). Retrieved from http://gateway.webofknowledge.com/

Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation (Journal article)

Dorian, P., Kongnakorn, T., Phatak, H., Rublee, D. A., Kuznik, A., Lanitis, T., . . . Lip, G. Y. H. (2014). Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation. EUROPEAN HEART JOURNAL, 35(28), 1897-1906. doi:10.1093/eurheartj/ehu006

DOI: 10.1093/eurheartj/ehu006

Cost-effectiveness of non-Vitamin-K oral anticoagulants compared to warfarin in patients with non-valvular atrial fibrillation (Conference Paper)

Harenberg, J., Krejczy, M., Wehling, M., Obermann, K., & Lip, G. Y. H. (2014). Cost-effectiveness of non-Vitamin-K oral anticoagulants compared to warfarin in patients with non-valvular atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 1107). Retrieved from http://gateway.webofknowledge.com/

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study (Journal article)

Larsen, T. B., Rasmussen, L. H., Gorst-Rasmussen, A., Skjoth, F., Lane, D. A., & Lip, G. Y. H. (2014). Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study. AMERICAN JOURNAL OF MEDICINE, 127(12), 1172-+. doi:10.1016/j.amjmed.2014.07.023

DOI: 10.1016/j.amjmed.2014.07.023

Dabigatran etexilate for venous thromboembolism: a safety evaluation (Journal article)

Brown, R., Lip, G. Y. H., & Gallego, P. (2014). Dabigatran etexilate for venous thromboembolism: a safety evaluation. EXPERT OPINION ON DRUG SAFETY, 13(5), 639-647. doi:10.1517/14740338.2014.895321

DOI: 10.1517/14740338.2014.895321

Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation (Journal article)

Huisman, M. V., Lip, G. Y. H., Diener, H. C., Dubner, S. J., Halperin, J. L., Ma, C. S., . . . Bartels, D. B. (2014). Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation. AMERICAN HEART JOURNAL, 167(3), 329-334. doi:10.1016/j.ahj.2013.12.006

DOI: 10.1016/j.ahj.2013.12.006

Development of ruggedized timer and temperature sensor packaging for 300°C/30kpsi downhole environment (Conference Paper)

Yuan, H. H., Kuruveettil, H., Ching, E. W. L., Rong, E. P. J., Lip, G. C., & Woo, D. R. M. (2014). Development of ruggedized timer and temperature sensor packaging for 300°C/30kpsi downhole environment. In Proceedings of the 16th Electronics Packaging Technology Conference, EPTC 2014 (pp. 606-610). doi:10.1109/EPTC.2014.7028366

DOI: 10.1109/EPTC.2014.7028366

Device-guided slow deep breathing in essential hypertension: is cardiac or sympathetic baroreflex sensitivity altered? (Conference Paper)

Shantsila, A., Adlan, A., Lip, G., Pickering, A., Paton, J., & Fisher, J. (2014). Device-guided slow deep breathing in essential hypertension: is cardiac or sympathetic baroreflex sensitivity altered?. In FASEB JOURNAL Vol. 28. Retrieved from http://gateway.webofknowledge.com/

EHRA/HRS/APHRS expert consensus on ventricular arrhythmias (Journal article)

Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., . . . Savelieva, I. (2014). EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Journal of Arrhythmia, 30(5), 327-349. doi:10.1016/j.joa.2014.08.001

DOI: 10.1016/j.joa.2014.08.001

EHRA/HRS/APHRS expert consensus on ventricular arrhythmias (Journal article)

Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., . . . Savelieva, I. (2014). EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. EUROPACE, 16(9), 1257-1283. doi:10.1093/europace/euu194

DOI: 10.1093/europace/euu194

EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. (Journal article)

Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., . . . EP-Europace,UK. (2014). EHRA/HRS/APHRS expert consensus on ventricular arrhythmias.. Heart rhythm, 11(10), e166-e196. doi:10.1016/j.hrthm.2014.07.024

DOI: 10.1016/j.hrthm.2014.07.024

ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS CURRENT STANDARD OF CARE REGIMEN IN A UNITED STATES NON-VALVULAR ATRIAL FIBRILLATION POPULATION SIMILAR TO THAT ENROLLED IN ARISTOTLE AND AVERROES (Conference Paper)

Phatak, H., Dorian, P., Kongnakorn, T., Lanitis, T., Kuznik, A., Mardekian, J., . . . Lip, G. (2014). ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS CURRENT STANDARD OF CARE REGIMEN IN A UNITED STATES NON-VALVULAR ATRIAL FIBRILLATION POPULATION SIMILAR TO THAT ENROLLED IN ARISTOTLE AND AVERROES. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A422). doi:10.1016/S0735-1097(14)60422-8

DOI: 10.1016/S0735-1097(14)60422-8

ETHNIC AND GENDER DIFFERENCES IN SYMPTOM-TO-DOOR TIMES IN PATIENTS PRESENTING WITH ST ELEVATION MYOCARDIAL INFARCTION (Conference Paper)

Brown, R., Shantsila, E., Varma, C., & Lip, G. (2014). ETHNIC AND GENDER DIFFERENCES IN SYMPTOM-TO-DOOR TIMES IN PATIENTS PRESENTING WITH ST ELEVATION MYOCARDIAL INFARCTION. In HEART Vol. 100 (pp. A18-A19). doi:10.1136/heartjnl-2014-306118.34

DOI: 10.1136/heartjnl-2014-306118.34

Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: Incidence, characteristics, and risk factors (Journal article)

Kosiuk, J., Kornej, J., Bollmann, A., Piorkowski, C., Myrda, K., Arya, A., . . . Hindricks, G. (2014). Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: Incidence, characteristics, and risk factors. HEART RHYTHM, 11(11), 1934-1940. doi:10.1016/j.hrthm.2014.07.039

DOI: 10.1016/j.hrthm.2014.07.039

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study. (Journal article)

Montalescot, G., Pitt, B., Lopez de Sa, E., Hamm, C. W., Flather, M., Verheugt, F., . . . REMINDER Investigators. (2014). Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study.. European heart journal, 35(34), 2295-2302. doi:10.1093/eurheartj/ehu164

DOI: 10.1093/eurheartj/ehu164

Early management of atrial fibrillation to prevent cardiovascular complications (Journal article)

Nattel, S., Guasch, E., Savelieva, I., Cosio, F. G., Valverde, I., Halperin, J. L., . . . Camm, A. J. (2014). Early management of atrial fibrillation to prevent cardiovascular complications. EUROPEAN HEART JOURNAL, 35(22), 1448-1U32. doi:10.1093/eurheartj/ehu028

DOI: 10.1093/eurheartj/ehu028

Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons (Journal article)

Verdecchia, P., Angeli, F., Lip, G. Y. H., & Reboldi, G. (2014). Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons. PLOS ONE, 9(6). doi:10.1371/journal.pone.0100478

DOI: 10.1371/journal.pone.0100478

Edoxaban: a focused review of its clinical pharmacology (Journal article)

Lip, G. Y. H., & Agnelli, G. (2014). Edoxaban: a focused review of its clinical pharmacology. EUROPEAN HEART JOURNAL, 35(28), 1844-1855. doi:10.1093/eurheartj/ehu181

DOI: 10.1093/eurheartj/ehu181

Effect of device guided slow deep breathing on central sympathetic outflow and arterial baroreflex sensitivity in young healthy individuals (Conference Paper)

Shantsila, A., Adlan, A. M., Lip, G., Pickering, A., Paton, J., & Fisher, J. (2014). Effect of device guided slow deep breathing on central sympathetic outflow and arterial baroreflex sensitivity in young healthy individuals. In FASEB JOURNAL Vol. 28. Retrieved from http://gateway.webofknowledge.com/

Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer (Journal article)

Ramcharan, K. S., Lip, G. Y. H., Stonelake, P. S., & Blann, A. D. (2014). Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer. BRITISH JOURNAL OF CANCER, 111(9), 1742-1749. doi:10.1038/bjc.2014.491

DOI: 10.1038/bjc.2014.491

Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation (Journal article)

Kornej, J., Dinov, B., Blann, A. D., Rolf, S., Arya, A., Schmidl, J., . . . Lip, G. Y. H. (2014). Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation. PLOS ONE, 9(11). doi:10.1371/journal.pone.0111760

DOI: 10.1371/journal.pone.0111760

Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease (Journal article)

Kooiman, J., van Rein, N., Spaans, B., van Beers, K. A. J., Bank, J. R., de Peppel, W. R. V., . . . Huisman, M. V. (2014). Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease. PLOS ONE, 9(5). doi:10.1371/journal.pone.0094420

DOI: 10.1371/journal.pone.0094420

Efficacy and safety of apixaban vs edoxaban for stroke prevention in non-valvular atrial fibrillation: an indirect treatment analysis (Conference Paper)

Lip, G. Y. H., Mitchell, S. A., Liu, X. C., Phatak, H., & Batson, S. (2014). Efficacy and safety of apixaban vs edoxaban for stroke prevention in non-valvular atrial fibrillation: an indirect treatment analysis. In EUROPEAN HEART JOURNAL Vol. 35 (pp. 895-896). Retrieved from http://gateway.webofknowledge.com/

Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation (Journal article)

Skjoth, F., Larsen, T. B., Rasmussen, L. H., & Lip, G. Y. H. (2014). Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 111(5), 981-988. doi:10.1160/TH14-02-0118

DOI: 10.1160/TH14-02-0118

Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis (Journal article)

Kotecha, D., Holmes, J., Krum, H., Altman, D. G., Manzano, L., Cleland, J. G. F., . . . Collab, B. -B. H. F. (2014). Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. LANCET, 384(9961), 2235-2243. doi:10.1016/S0140-6736(14)61373-8

DOI: 10.1016/S0140-6736(14)61373-8

Exercise-induced changes in inflammatory processes: Implications for thrombogenesis in cardiovascular disease (Journal article)

Chen, Y. -W., Apostolakis, S., & Lip, G. Y. H. (2014). Exercise-induced changes in inflammatory processes: Implications for thrombogenesis in cardiovascular disease. ANNALS OF MEDICINE, 46(7), 439-455. doi:10.3109/07853890.2014.927713

DOI: 10.3109/07853890.2014.927713

Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis (Journal article)

Jaipersad, A. S., Shantsila, A., Lip, G. Y. H., & Shantsila, E. (2014). Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis. ANNALS OF MEDICINE, 46(7), 530-538. doi:10.3109/07853890.2014.931101

DOI: 10.3109/07853890.2014.931101

Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation (Journal article)

Overvad, T. F., Rasmussen, L. H., Skjoth, F., Overvad, K., Albertsen, I. E., Lane, D. A., . . . Larsen, T. B. (2014). Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. THROMBOSIS AND HAEMOSTASIS, 112(4), 789-795. doi:10.1160/TH14-06-0545

DOI: 10.1160/TH14-06-0545

Free Light Chains in Patients With Acute Heart Failure Secondary to Atherosclerotic Coronary Artery Disease (Journal article)

Shantsila, E., Wrigley, B., & Lip, G. Y. H. (2014). Free Light Chains in Patients With Acute Heart Failure Secondary to Atherosclerotic Coronary Artery Disease. AMERICAN JOURNAL OF CARDIOLOGY, 114(8), 1243-1248. doi:10.1016/j.amjcard.2014.07.049

DOI: 10.1016/j.amjcard.2014.07.049

High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery (Journal article)

Hernandez-Romero, D., Antonio Vilchez, J., Lahoz, A., Romero-Aniorte, A. I., Orenes-Pinero, E., Caballero, L., . . . Marin, F. (2014). High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 45(4), 733-738. doi:10.1093/ejcts/ezt488

DOI: 10.1093/ejcts/ezt488

Hormone Replacement Therapy and Adverse Outcomes in Women With Atrial Fibrillation An Analysis From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management Trial (Journal article)

Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2014). Hormone Replacement Therapy and Adverse Outcomes in Women With Atrial Fibrillation An Analysis From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management Trial. STROKE, 45(10), 3076-+. doi:10.1161/STROKEAHA.114.006668

DOI: 10.1161/STROKEAHA.114.006668

IMPACT OF ANEMIA ON CLINICAL OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AFCAS REGISTRY (Conference Paper)

Puurunen, M. K., Kiviniemi, T., Nammas, W., Schlitt, A., Rubboli, A., Nyman, K., . . . Airaksinen, J. (2014). IMPACT OF ANEMIA ON CLINICAL OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AFCAS REGISTRY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 63 (pp. A1857). doi:10.1016/S0735-1097(14)61860-X

DOI: 10.1016/S0735-1097(14)61860-X

Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation (Journal article)

Yasaka, M., & Lip, G. Y. H. (2014). Impact of Non-Vitamin K Antagonist Oral Anticoagulants on